primaryid$caseid$caseversion$i_f_code$event_dt$mfr_dt$init_fda_dt$fda_dt$rept_cod$auth_num$mfr_num$mfr_sndr$lit_ref$age$age_cod$age_grp$sex$e_sub$wt$wt_cod$rept_dt$to_mfr$occp_cod$reporter_country$occr_country
100115733$10011573$3$F$20130801$20221118$20140314$20221123$EXP$$CA-MERCK-1403CAN005674$MERCK$$75$YR$$M$Y$58.05$KG$20221123$$HP$CA$CA
1002130537$10021305$37$F$20210415$20220928$20140319$20221005$EXP$$PHHY2014CA019281$NOVARTIS$$43$YR$$M$Y$$$20221005$$HP$CA$CA
100234223$10023422$3$F$20120301$20221003$20140320$20221007$EXP$$US-ROCHE-1362929$ROCHE$$67$YR$$F$Y$$$20221007$$LW$US$
100260594$10026059$4$F$20120101$20221124$20140320$20221130$EXP$DE-BFARM-13321363$DE-MYLANLABS-2014S1005326$MYLAN$$63$YR$$M$Y$88$KG$20221130$$HP$DE$DE
100518358$10051835$8$F$20130715$20221125$20140402$20221201$EXP$$CA-ROCHE-1247938$ROCHE$$50$YR$$F$Y$59$KG$20221201$$HP$CA$
100614443$10061444$3$F$$20221123$20140407$20221130$EXP$$EG-ROCHE-1372609$ROCHE$El-Dosouky I, ElHawari S, Emara M. and Hamed E. Types and predictors of interferon/ribavirin induced cardiac complications in the egyptian patients with chronic hepatitis c virus-Abs. no.P1107. Journal of Hepatology 2014 Apr;60 (SUPP 1):S446-7.$$$$$Y$$$20221130$$MD$EG$
1006401873$10064018$73$F$20121201$20221222$20140408$20221226$EXP$$CA-ROCHE-1173339$ROCHE$$71$YR$$F$Y$76$KG$20221226$$HP$CA$
100746869$10074686$9$F$20090714$20221222$20140414$20221230$EXP$$CA-ROCHE-1383185$ROCHE$$52$YR$$M$Y$$$20221230$$HP$CA$CA
100832487$10083248$7$F$20120201$20221108$20140417$20221116$EXP$$CA-ROCHE-1385175$ROCHE$$46$YR$$M$Y$$$20221116$$CN$CA$CA
100900002$10090000$2$F$20140101$20221021$20140421$20221027$EXP$$CA-JNJFOC-20140411796$JOHNSON AND JOHNSON$$54$YR$A$F$Y$57$KG$20221027$$HP$CA$CA
1009456310$10094563$10$F$20130101$20221004$20140422$20221011$PER$$US-PFIZER INC-2014108421$PFIZER$$46$YR$$F$Y$69$KG$20221011$$MD$US$US
101397357$10139735$7$F$20140101$20221008$20140429$20221012$EXP$$BR-SHIRE-BR201401513$TAKEDA$$16$YR$$M$Y$$$20221012$$HP$BR$BR
1014222242$10142222$42$F$20131201$20221216$20140430$20221221$EXP$$CA-ROCHE-1319269$ROCHE$$52$YR$$M$Y$88.2$KG$20221221$$MD$CA$
1015212328$10152123$28$F$20131205$20221115$20140505$20221123$EXP$$CA-ROCHE-1393055$ROCHE$$38$YR$$F$Y$110$KG$20221123$$CN$CA$CA
101530275$10153027$5$F$20131001$20220926$20140505$20221007$EXP$$US-ASTELLAS-2014US004619$ASTELLAS$$65$YR$$F$Y$$$20221007$$CN$US$US
1015648243$10156482$43$F$20121101$20221216$20140507$20221220$EXP$$CA-ROCHE-1162866$ROCHE$$65$YR$$F$Y$63.5$KG$20221220$$HP$CA$
1016133054$10161330$54$F$20120806$20221117$20140509$20221121$EXP$$CA-ROCHE-1113310$ROCHE$$66$YR$$F$Y$69$KG$20221121$$CN$CA$
1017572229$10175722$29$F$20121201$20221011$20140516$20221013$EXP$$CA-ROCHE-1176621$ROCHE$$65$YR$$F$Y$57$KG$20221013$$HP$CA$
101834686$10183468$6$F$20131216$20221003$20140520$20221004$EXP$$FR-SHIRE-ALL1-2014-01294$TAKEDA$$41$YR$$F$Y$61$KG$20221004$$CN$FR$FR
1020049437$10200494$37$F$20120801$20221227$20140528$20221229$EXP$$CA-ROCHE-1112151$ROCHE$$27$YR$$M$Y$80$KG$20221229$$HP$CA$
102151802$10215180$2$F$$20221031$20140603$20221102$EXP$$PHHY2014NL063730$NOVARTIS$Janssen S, Bergmans DCJJ, van Mook WNKA. Oxaliplatin induced multi organ failure: a condition intensivists should be aware of. NETH-J-CRIT-CARE. 2013;17(5):36$70$YR$$F$Y$$$20221102$$HP$NL$NL
102158494$10215849$4$F$20100101$20221130$20140604$20221207$PER$$US-AMGEN-USASP2014040911$AMGEN$$66$YR$E$F$Y$$$20221207$$CN$US$US
102184243$10218424$3$F$20121003$20221213$20140605$20221222$EXP$$FR-JNJFOC-20140600868$JOHNSON AND JOHNSON$$87$YR$E$M$Y$73$KG$20221222$$HP$FR$FR
1023164235$10231642$35$F$20120505$20221128$20140611$20221206$EXP$$PHHY2012CA036601$NOVARTIS$$55$YR$$F$Y$$$20221206$$HP$CA$CA
1023181918$10231819$18$F$20150818$20221109$20140612$20221117$EXP$$CA-ROCHE-1416720$ROCHE$$53$YR$$F$Y$$$20221117$$MD$CA$CA
1023233515$10232335$15$F$20130801$20221003$20140612$20221007$EXP$$PHHY2013CA066835$NOVARTIS$$72$YR$$M$Y$$$20221007$$HP$CA$CA
1023686418$10236864$18$F$20140101$20221007$20140613$20221011$EXP$$US-PFIZER INC-2014161083$PFIZER$$53$YR$$F$Y$$$20221011$$HP$US$US
102404993$10240499$3$F$20120723$20221003$20140617$20221006$EXP$$US-ROCHE-1418124$ROCHE$$61$YR$$F$Y$$$20221006$$LW$US$
1026087144$10260871$44$F$20120818$20221129$20140626$20221201$EXP$$CA-ROCHE-1131745$ROCHE$$57$YR$$F$Y$68$KG$20221201$$CN$CA$
102686218$10268621$8$F$20190319$20221109$20140630$20221111$EXP$$US-PFIZER INC-2014177544$PFIZER$$73$YR$$F$Y$$$20221111$$CN$US$US
1027487980$10274879$80$F$20151125$20221220$20140702$20221222$EXP$$CA-ROCHE-1404692$ROCHE$$46$YR$$M$Y$103$KG$20221222$$HP$CA$
1028518540$10285185$40$F$20140703$20221111$20140708$20221115$EXP$$CA-ROCHE-1267909$ROCHE$$49$YR$$F$Y$79$KG$20221115$$HP$CA$
102951214$10295121$4$F$$20211013$20140710$20221008$PER$$US-PURDUE-USA-2014-0113143$PURDUE$$$$$F$Y$$$20221008$$CN$US$US
1030948610$10309486$10$F$$20221014$20140717$20221121$EXP$$CA-ROCHE-1435384$ROCHE$$72$YR$$M$Y$$$20221121$$MD$CA$CA
103311375$10331137$5$F$20140714$20221103$20140722$20221202$EXP$$JP-AstraZeneca-2014SE52033$ASTRAZENECA$$21539$DY$$F$Y$71$KG$20221202$$MD$JP$
103343176$10334317$6$F$20140710$20221112$20140723$20221117$EXP$$PHHY2014IN087849$NOVARTIS$$35$YR$$F$Y$58$KG$20221117$$CN$IN$IN
103422754$10342275$4$F$$20221120$20140725$20221202$EXP$$FR-JNJFOC-20140709992$JOHNSON AND JOHNSON$$$$$$Y$$$20221202$$MD$FR$FR
103488627$10348862$7$F$20140710$20221205$20140729$20221216$EXP$$US-PFIZER INC-2014204200$PFIZER$$70$YR$$M$Y$90.7$KG$20221216$$MD$US$US
103613677$10361367$7$F$20130701$20221007$20140805$20221013$EXP$$US-ROCHE-1444666$ROCHE$$57$YR$$M$Y$85.352$KG$20221013$$MD$US$
103763213$10376321$3$F$20140523$20221111$20140811$20221121$EXP$SE-MPA-2014-004383$SE-PFIZER INC-2014219900$PFIZER$$91$YR$$F$Y$$$20221121$$MD$SE$SE
103830048$10383004$8$F$20140602$20221221$20140813$20221227$EXP$$US-SA-2014SA082625$SANOFI AVENTIS$$26$YR$A$F$Y$83.9$KG$20221227$$MD$US$US
1039251711$10392517$11$F$20170913$20221213$20140819$20221219$EXP$$PHHY2013AU123443$NOVARTIS$$63$YR$$M$Y$59.4$KG$20221219$$MD$AU$AU
103935282$10393528$2$F$$20221114$20140819$20221123$EXP$$ALCN2014AT004606$ALCON$Diesner SC, Bannert C, Gruber S, Dehlink E, Eiwegger T, Szepfalusi Z. The mydriaticum cyclopentolate induces severe allergy in a 5-year-old child. Klln Padiatr. 2014;226 (4):252-253$$$$$Y$$$20221123$$HP$AT$AT
1040513312$10405133$12$F$20110815$20221219$20140825$20221227$EXP$$CA-ROCHE-1454049$ROCHE$$56$YR$$F$Y$$$20221227$$CN$CA$CA
1041491122$10414911$22$F$20140217$20221117$20140828$20221130$EXP$$PHHY2012CA025137$NOVARTIS$$$$$F$Y$$$20221130$$HP$CA$CA
104249075$10424907$5$F$$20221012$20140902$20221018$PER$$US-JNJFOC-20140827232$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20221018$$HP$US$US
104266825$10426682$5$F$20070101$20221107$20140903$20221117$PER$$US-JNJFOC-20140827260$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221117$$LW$US$US
1042881839$10428818$39$F$20140130$20221207$20140904$20221215$EXP$$CA-ROCHE-1457280$ROCHE$$54$YR$$F$Y$85$KG$20221215$$CN$CA$CA
104660044$10466004$4$F$20040423$20221222$20140922$20221227$EXP$$US-ROCHE-1464701$ROCHE$$51$YR$$F$Y$$$20221227$$LW$US$
1046886629$10468866$29$F$20120719$20221017$20140923$20221019$EXP$$CA-ROCHE-1101096$ROCHE$$33$YR$$F$Y$61$KG$20221019$$HP$CA$
104803045$10480304$5$F$20140908$20221004$20140929$20221010$EXP$$US-SHIRE-US201406146$TAKEDA$$52$YR$$F$Y$55.78$KG$20221010$$CN$US$US
1048329111$10483291$11$F$20150402$20221206$20140930$20221209$EXP$$CA-ROCHE-1467535$ROCHE$$52$YR$$F$Y$65$KG$20221209$$MD$CA$CA
1049624415$10496244$15$F$$20221111$20141003$20221117$EXP$$CA-009507513-1410CAN000297$MERCK$unknown. unknown. unknown$78$YR$$F$Y$$$20221117$$HP$CA$CA
105075462$10507546$2$F$$20221208$20141009$20221213$PER$$US-PFIZER INC-2014275038$PFIZER$$$$$F$Y$$$20221213$$CN$US$US
105099892$10509989$2$F$20130703$20221227$20141010$20221230$EXP$$RU-SHIRE-RU201406658$TAKEDA$$5$YR$$M$Y$$$20221230$$MD$RU$RU
105144242$10514424$2$F$20141002$20221115$20141013$20221121$EXP$$CA-JNJFOC-20141001651$JOHNSON AND JOHNSON$$37$YR$A$F$Y$62$KG$20221121$$HP$CA$CA
105154134$10515413$4$F$20120101$20221103$20141014$20221116$EXP$$FR-AUROBINDO-AUR-APL-2014-10735$AUROBINDO$Rabenkogo A, Vigue MG, Jeziorski E. Drug reaction with eosinophilia and systemic symptoms. Arch Pediatr. 2014$9$YR$$F$Y$$$20221116$$HP$FR$FR
1051596715$10515967$15$F$20131024$20221104$20141014$20221110$EXP$$PHHY2013CA024321$NOVARTIS$$70$YR$$M$Y$110.2$KG$20221110$$HP$CA$CA
105160162$10516016$2$F$$20221121$20141014$20221125$EXP$$PHHY2014SI129440$NOVARTIS$Kogoj A. Selective serotonin reuptake inhibitors-induced delirium: A case review. PSYCHIATRIA DANUBINA. 2014;26(3):277-80$86$YR$$M$Y$$$20221125$$HP$SI$SI
1052690053$10526900$53$F$20140701$20221103$20141020$20221107$EXP$$CA-ROCHE-1341517$ROCHE$$75$YR$$M$Y$78$KG$20221107$$CN$CA$
105323424$10532342$4$F$20140101$20221208$20141021$20221212$EXP$$US-PURDUE-USA-2014-0115432$PURDUE$$$$$F$Y$99.773$KG$20221212$$CN$US$US
1053322617$10533226$17$F$20180101$20221208$20141022$20221220$EXP$GB-MHRA-ADR 22718008$GB-Accord-026599$ACCORD$$66$YR$E$M$Y$98.97$KG$20221220$$PH$GB$GB
1054348110$10543481$10$F$20090101$20221014$20141027$20221020$EXP$$US-PFIZER INC-2014290373$PFIZER$$77$YR$$F$Y$59$KG$20221020$$CN$US$US
105559472$10555947$2$F$$20221003$20141030$20221010$EXP$$PHHY2014PL138837$NOVARTIS$Kusztal M, Piotrowski P, Mazanowska O, Misiak B, Kantorska-Janiec M, Boratynska M et al.. Catatonic episode after kidney transplantation. GENERAL HOSPITAL PSYCHIATRY. 2014;36(3):360e3-360e5$21$YR$$F$Y$$$20221010$$HP$PL$PL
105576044$10557604$4$F$$20221130$20141031$20221207$EXP$$CA-MALLINCKRODT-T201403798$SPECGX$$37$YR$$M$Y$122$KG$20221207$$HP$CA$CA
105636858$10563685$8$F$20140916$20161227$20141104$20221021$EXP$$JP-BAYER-2014-158276$BAYER$$55$YR$A$F$Y$64.5$KG$20221021$$MD$JP$JP
105701195$10570119$5$F$20130901$20221101$20141107$20221107$EXP$$CA-ROCHE-1159378$ROCHE$$67$YR$$F$Y$81$KG$20221107$$CN$CA$
105733332$10573333$2$F$$20221212$20141110$20221214$PER$$US-BAYER-2014-164943$BAYER$$$$$F$Y$$$20221214$$CN$US$US
105881184$10588118$4$F$20141106$20221109$20141117$20221114$EXP$$US-SHIRE-US201407776$TAKEDA$$53$YR$$F$Y$$$20221114$$CN$US$US
1058928655$10589286$55$F$20141101$20221018$20141118$20221025$EXP$$CA-ROCHE-1491350$ROCHE$$61$YR$$F$Y$$$20221026$$MD$CA$CA
105912134$10591213$4$F$20141001$20221212$20141118$20221216$EXP$$US-SHIRE-US201407553$TAKEDA$$9$YR$$M$Y$323$KG$20221216$$CN$US$US
105977282$10597728$2$F$20140801$20141113$20141121$20221123$PER$$US-AMGEN-USASP2014088321$AMGEN$$82$YR$E$F$Y$$$20221122$$CN$US$US
1060044427$10600444$27$F$$20221212$20141124$20221222$PER$$CA-AMGEN-CANSP2014090423$AMGEN$$51$YR$A$F$Y$110$KG$20221222$$HP$CA$CA
106022753$10602275$3$F$20131108$20221003$20141124$20221010$EXP$$JP-PFIZER INC-2014318472$PFIZER$Kikuchi, R.. A case of invasive thymoma complicated by tumour lysis syndrome by steroid pulse therapy. The 55th Meeting of the Japan Lung Cancer Society. 2014;54(5):606$72$YR$$F$Y$37$KG$20221010$$MD$JP$JP
106209603$10620960$3$F$$20221216$20141202$20221230$EXP$$DE-RANBAXY-2014RR-89307$RANBAXY$Koschny R, Lutz M, Seckinger J, Schwenger V, Stremmel W, Eisenbach C. Extracorporeal life support and plasmapheresis in a case of severe polyintoxication. J Emerg Med. 2014;47 (5):527-531$21$YR$$F$Y$$$20221230$$MD$DE$DE
1062481015$10624810$15$F$20120220$20221118$20141204$20221125$EXP$$CA-ROCHE-1325548$ROCHE$$15$YR$$M$Y$$$20221125$$CN$CA$CA
106335934$10633593$4$F$19970101$20221116$20141205$20221119$PER$$US-JNJFOC-20141119143$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221119$$LW$US$US
1063710644$10637106$44$F$20140101$20221220$20141208$20221227$EXP$$CA-ROCHE-1504349$ROCHE$$68$YR$$F$Y$95.238$KG$20221227$$HP$CA$CA
106386833$10638683$3$F$20140807$20160413$20141208$20221109$EXP$$JP-BAYER-2014-177858$BAYER$$54$YR$A$M$Y$$$20221109$$MD$JP$JP
1064526734$10645267$34$F$20131231$20221122$20141211$20221124$EXP$$CA-ROCHE-1303094$ROCHE$$47$YR$$F$Y$76.5$KG$20221124$$CN$CA$
1065715210$10657152$10$F$20140701$20220929$20141217$20221001$EXP$$FR-MERCK-1412FRA007081$MERCK$Renard S. Severe Pulmonary Arterial Hypertension in Patients treated for Hepatitis C with Sofosbuvir. CHEST. 2016;149 (3):e69-e73$48$YR$$M$Y$$$20221001$$HP$FR$FR
1067454612$10674546$12$F$20110407$20221008$20141224$20221013$EXP$$FR-SHIRE-FR201409190$TAKEDA$$8$YR$$M$Y$$$20221013$$HP$FR$FR
1068446226$10684462$26$F$20140101$20221108$20141231$20221114$EXP$$PHHY2013CA109032$NOVARTIS$$$$$F$Y$$$20221114$$HP$CA$CA
106876194$10687619$4$F$20080101$20221117$20150102$20221122$EXP$$US-PFIZER INC-2014360643$PFIZER$$21$YR$$M$Y$57$KG$20221122$$CN$US$US
106893282$10689328$2$F$20130415$20220922$20150105$20221004$EXP$$SE-AUROBINDO-AUR-APL-2014-13513$AUROBINDO$$1$MON$$F$Y$$$20221004$$MD$SE$SE
1069613621$10696136$21$F$20140806$20221109$20150107$20221111$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-005629$BRISTOL MYERS SQUIBB$Watanabe R, et al. A case of fulminant type 1 diabetes mellitus developed in a patient after use of anti-PD-1 antibody. Folia Endocrinologica Japonica 2015;91(3):865.$74$YR$E$F$Y$42$KG$20221111$$MD$JP$JP
1069770312$10697703$12$F$20140701$20220929$20150108$20221004$EXP$$US-PFIZER INC-2015003827$PFIZER$$64$YR$$M$Y$99.79$KG$20221004$$CN$US$US
107025935$10702593$5$F$20080301$20221006$20150109$20221010$EXP$$CZ-009507513-1501CZE002662$MERCK$Demlova R, Melicharkova K, Rehal Z, Kren L, Oslejskova H, Sterba J et al. Successful use of metronomic vinblastine and fluorothymidine pet imaging for the management of intramedullary spinal cord anaplastic oligoastrocytoma in a child. Current Oncology. 2014;21(6):E790-3$11$YR$$F$Y$$$20221010$$MD$CZ$CZ
1071271830$10712718$30$F$20130916$20220923$20150115$20221001$EXP$$CA-ROCHE-1520634$ROCHE$$44$YR$$F$Y$$$20221001$$MD$CA$CA
107137505$10713750$5$F$20150612$20221206$20150115$20221209$EXP$$US-PFIZER INC-2015011167$PFIZER$$62$YR$$M$Y$113$KG$20221209$$CN$US$US
107330945$10733094$5$F$$20221007$20150123$20221017$EXP$$CA-PFIZER INC-2015026574$PFIZER$$$$$M$Y$$$20221017$$HP$CA$CA
1074197910$10741979$10$F$$20221212$20150127$20221216$EXP$$US-PFIZER INC-2015030234$PFIZER$$62$YR$$F$Y$83.91$KG$20221216$$HP$US$US
107480794$10748079$4$F$$20221201$20150129$20221205$PER$$US-PFIZER INC-2015033492$PFIZER$$62$YR$$F$Y$$$20221205$$MD$US$US
1076503413$10765034$13$F$20080101$20221212$20150205$20221216$EXP$$US-PFIZER INC-2015048780$PFIZER$$62$YR$$F$Y$43.09$KG$20221216$$CN$US$US
107718025$10771802$5$F$20141201$20221021$20150206$20221025$EXP$$PHHY2014CA163869$NOVARTIS$$52$YR$$F$Y$$$20221025$$CN$CA$CA
107770836$10777083$6$F$$20221228$20150209$20221230$PER$$US-PFIZER INC-2015050888$PFIZER$$66$YR$$F$Y$61.23$KG$20221230$$HP$US$US
107971742$10797174$2$F$20111215$20220929$20150216$20221006$EXP$$US-TEVA-483390USA$TEVA$$$$$F$Y$$$20221006$$LW$US$US
108306052$10830605$2$F$$20221202$20150219$20221213$PER$$US-009507513-1502USA004838$MERCK$$$$$F$Y$$$20221213$$MD$US$US
1086958425$10869584$25$F$20131105$20221107$20150226$20221116$EXP$$CA-ROCHE-1544517$ROCHE$$38$YR$$M$Y$65$KG$20221116$$CN$CA$CA
1087204326$10872043$26$F$20150201$20220321$20150226$20221202$EXP$$US-JAZZ-2015-US-002582$JAZZ$$44$YR$$F$Y$$$20221202$$CN$US$US
108720446$10872044$6$F$20140711$20221205$20150226$20221212$PER$$US-JAZZ-2014-US-009109$JAZZ$$61$YR$$M$Y$117.91$KG$20221212$$MD$US$US
108788105$10878810$5$F$20141205$20221220$20150302$20221222$EXP$$US-ABBVIE-15P-163-1352741-00$ABBVIE$$24$YR$$M$Y$$$20221222$$MD$US$US
1088003252$10880032$52$F$20080117$20221024$20150302$20221027$EXP$$PHMT2008CA00492$GLAXOSMITHKLINE$$$$$$Y$$$20221027$$MD$CA$CA
108809815$10880981$5$F$20150127$20221209$20150303$20221216$EXP$$US-PFIZER INC-2015073270$PFIZER$$63$YR$$F$Y$$$20221216$$CN$US$US
108820173$10882017$3$F$20150227$20221019$20150303$20221024$EXP$$CA-PFIZER INC-2015070868$PFIZER$$54$YR$$M$Y$$$20221024$$CN$CA$CA
109165036$10916503$6$F$19820101$20221109$20150311$20221123$EXP$$2015-0731-SPO$ASCEND$$53$YR$$F$Y$75$KG$20221123$$CN$FR$FR
109199792$10919979$2$F$20070101$20221222$20150317$20221227$EXP$$US-ROCHE-1551243$ROCHE$$$$$F$Y$$$20221227$$LW$US$
109325263$10932526$3$F$20130101$20221010$20150320$20221018$PER$$US-JNJFOC-20140814052$JOHNSON AND JOHNSON$$$$$M$Y$$$20221018$$LW$US$US
109337154$10933715$4$F$20030101$20221010$20150320$20221014$PER$$US-JNJFOC-20140814047$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221014$$HP$US$US
109399493$10939949$3$F$20020101$20221012$20150322$20221018$PER$$US-JNJFOC-20140814026$JOHNSON AND JOHNSON$$$$$M$Y$107.6$KG$20221018$$HP$US$US
109436708$10943670$8$F$20041020$20221207$20150322$20221212$EXP$$US-JNJFOC-20141115580$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20221212$$HP$US$US
109439923$10943992$3$F$20120205$20221222$20150323$20221228$EXP$$US-ROCHE-1554779$ROCHE$$71$YR$$F$Y$$$20221228$$LW$US$
109460695$10946069$5$F$$20221012$20150322$20221018$PER$$US-JNJFOC-20140814018$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221018$$HP$US$US
109680228$10968022$8$F$20140307$20221213$20150330$20221219$EXP$$US-JAZZ-2014-US-002347$JAZZ$$56$YR$$M$Y$87.07$KG$20221219$$MD$US$US
109762043$10976204$3$F$20040601$20221019$20150401$20221027$EXP$$US-JNJFOC-20140414401$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20221027$$LW$US$US
1098206351$10982063$51$F$20130101$20221221$20150403$20221225$EXP$$CA-ROCHE-1350337$ROCHE$$$$$F$Y$50$KG$20221226$$CN$CA$
109893398$10989339$8$F$20190114$20221129$20150406$20221202$EXP$$US-PFIZER INC-2015113764$PFIZER$$57$YR$$F$Y$113.4$KG$20221202$$CN$US$US
1099047554$10990475$54$F$20150312$20220928$20150406$20221004$EXP$$CA-ROCHE-1551832$ROCHE$$57$YR$$M$Y$84.6$KG$20221004$$HP$CA$
109912044$10991204$4$F$20010101$20221114$20150406$20221125$PER$$US-JNJFOC-20150403986$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221125$$LW$US$US
1100310630$11003106$30$F$20141226$20221228$20150409$20221230$EXP$$PHHY2014CA170176$NOVARTIS$$61$YR$$M$Y$$$20221230$$HP$CA$CA
1101084316$11010843$16$F$20160708$20221123$20150410$20221130$EXP$$PHHY2014CA055951$NOVARTIS$$45$YR$$M$Y$$$20221130$$MD$CA$CA
110205884$11020588$4$F$$20221013$20150413$20221014$EXP$$CA-ROCHE-1562340$ROCHE$$90$YR$$F$Y$$$20221014$$HP$CA$
1102411311$11024113$11$F$20140101$20221018$20150413$20221025$EXP$$PHHY2014CA064714$NOVARTIS$$68$YR$$M$Y$$$20221025$$HP$CA$CA
110524756$11052475$6$F$$20220929$20150421$20221012$PER$$US-JNJFOC-20150322333$JOHNSON AND JOHNSON$$$$$M$Y$$$20221010$$LW$US$US
110534575$11053457$5$F$20130101$20221107$20150421$20221111$EXP$$US-JNJFOC-20141108721$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20221111$$LW$US$US
110579242$11057924$2$F$$20221110$20150423$20221114$EXP$$CA-ROCHE-1567485$ROCHE$$24$YR$$M$Y$$$20221114$$HP$CA$
1106106422$11061064$22$F$$20221021$20150424$20221027$EXP$$CA-ROCHE-1566475$ROCHE$$69$YR$$F$Y$$$20221027$$CN$CA$
1106154321$11061543$21$F$20140101$20221006$20150424$20221018$EXP$$US-PFIZER INC-2015135782$PFIZER$$60$YR$$F$Y$$$20221018$$MD$US$US
1106955816$11069558$16$F$20211001$20220926$20150427$20221003$EXP$$BR-GLAXOSMITHKLINE INC.-BR2015GSK056220$GLAXOSMITHKLINE$$$$$$Y$$$20221003$$CN$BR$BR
1107001411$11070014$11$F$20131127$20221102$20150427$20221108$EXP$$PHHY2013CA139827$NOVARTIS$$64$YR$$F$Y$$$20221108$$HP$CA$CA
1107395118$11073951$18$F$20100703$20201231$20150429$20221004$EXP$$CA-ROCHE-1512211$ROCHE$$52$YR$$M$Y$$$20221004$$CN$CA$CA
1107519838$11075198$38$F$20150211$20221024$20150429$20221102$EXP$$CA-ROCHE-1570320$ROCHE$$43$YR$$F$Y$$$20221102$$CN$CA$CA
110758042$11075804$2$F$$20221114$20150429$20221123$EXP$$JP-ROCHE-1570432$ROCHE$Hoshida Y, Watanabe K, Eguchi G, et al A case of monoclonal-associated PML in patient suffering from duodenal DLBCL treated with rituximab.. Proceedings of The Japanese Society of Pathology 2015 Mar;104 (1):441-.$$$$M$Y$$$20221123$$MD$JP$
1107681228$11076812$28$F$20130122$20221114$20150429$20221118$EXP$$PHHY2013CA007723$NOVARTIS$$66$YR$$M$Y$$$20221118$$HP$CA$CA
1107775736$11077757$36$F$20150416$20221213$20150430$20221220$EXP$$CA-ROCHE-1570993$ROCHE$$67$YR$$F$Y$88.2$KG$20221220$$MD$CA$CA
1108647915$11086479$15$F$20150416$20221027$20150504$20221102$EXP$$CA-ROCHE-1571124$ROCHE$$66$YR$$M$Y$$$20221101$$HP$CA$CA
111092653$11109265$3$F$20060101$20221116$20150513$20221127$PER$$US-JNJFOC-20150506074$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221127$$LW$US$US
111172966$11117296$6$F$20130402$20221013$20150515$20221016$EXP$$PHHY2015AU058774$NOVARTIS$$50$YR$$M$Y$90$KG$20221017$$MD$AU$AU
111398754$11139875$4$F$20140101$20221214$20150527$20221220$PER$$US-PFIZER INC-2015165209$PFIZER$$55$YR$$F$Y$73$KG$20221220$$CN$US$US
111402683$11140268$3$F$$20221107$20150525$20221113$EXP$$US-JNJFOC-20150107078$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20221114$$HP$US$US
111405024$11140502$4$F$20090326$20221213$20150525$20221221$PER$$US-JNJFOC-20141117511$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221222$$HP$US$US
111405234$11140523$4$F$20030101$20221108$20150525$20221110$PER$$US-JNJFOC-20140813995$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221110$$HP$US$US
111411202$11141120$2$F$20030101$20221101$20150525$20221103$PER$$US-JNJFOC-20140814041$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221103$$HP$US$US
111411382$11141138$2$F$$20221107$20150525$20221109$PER$$US-JNJFOC-20141001973$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221109$$LW$US$US
1115384211$11153842$11$F$20150901$20221212$20150602$20221220$PER$$CA-AMGEN-CANSP2015052272$AMGEN$$56$YR$A$F$Y$$$20221220$$HP$CA$CA
1115594135$11155941$35$F$20150505$20221006$20150602$20221018$EXP$$NL-SA-2015SA071357$SANOFI AVENTIS$$38$YR$A$F$Y$62$KG$20221018$$HP$NL$NL
1115851226$11158512$26$F$20150101$20221004$20150603$20221014$EXP$$CA-PFIZER INC-2015183008$PFIZER$$60$YR$$F$Y$97$KG$20221014$$CN$CA$CA
111665232$11166523$2$F$20060101$20221101$20150605$20221104$PER$$US-JNJFOC-20150511251$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221104$$LW$US$US
111665242$11166524$2$F$20030101$20221108$20150605$20221111$PER$$US-JNJFOC-20150511292$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221111$$HP$US$US
111666043$11166604$3$F$20100101$20221108$20150605$20221111$PER$$US-JNJFOC-20150511288$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221111$$HP$US$US
111666182$11166618$2$F$20110101$20221012$20150605$20221021$PER$$US-JNJFOC-20150511336$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221021$$HP$US$US
111679973$11167997$3$F$20130620$20221222$20150605$20221227$EXP$$US-ROCHE-1589122$ROCHE$$66$YR$$F$Y$$$20221227$$LW$US$
1117339623$11173396$23$F$20130313$20221019$20150608$20221025$EXP$$PHHY2013CA025650$NOVARTIS$$40$YR$$M$Y$70$KG$20221025$$CN$CA$CA
111765028$11176502$8$F$20141203$20221011$20150610$20221014$EXP$$CA-ROCHE-1591119$ROCHE$$58$YR$$M$Y$128$KG$20221014$$MD$CA$CA
111770694$11177069$4$F$20071215$20220923$20150610$20221005$EXP$$US-ROCHE-1591609$ROCHE$$65$YR$$F$Y$$$20221005$$LW$US$
1117933919$11179339$19$F$$20221202$20150610$20221205$EXP$$CA-ROCHE-1590696$ROCHE$$72$YR$$F$Y$$$20221205$$MD$CA$
1118130018$11181300$18$F$20150122$20221101$20150611$20221107$EXP$$PHHY2015CA012543$NOVARTIS$$63$YR$$M$Y$$$20221107$$CN$CA$CA
1118855212$11188552$12$F$20121227$20221219$20150615$20221228$EXP$$CA-ROCHE-1593339$ROCHE$$62$YR$$F$Y$80$KG$20221228$$MD$CA$CA
1119006911$11190069$11$F$20211027$20221220$20150615$20221223$PER$$US-PFIZER INC-2015196944$PFIZER$$66$YR$$M$Y$$$20221223$$CN$US$US
111941595$11194159$5$F$20150101$20221103$20150616$20221108$EXP$$US-INCYTE CORPORATION-2015IN002663$INCYTE$$$$$$Y$$$20221108$$CN$US$US
111966503$11196650$3$F$$20221003$20150617$20221005$EXP$$US-PFIZER INC-2015198727$PFIZER$$60$YR$$M$Y$$$20221005$$CN$US$US
1119717612$11197176$12$F$20220628$20221025$20150617$20221103$PER$$US-SA-2014SA087746$SANOFI AVENTIS$$29$YR$A$F$Y$52.6$KG$20221103$$MD$US$US
1120064015$11200640$15$F$20150612$20221212$20150618$20221221$EXP$$CA-PFIZER INC-2015202903$PFIZER$$73$YR$$F$Y$$$20221221$$MD$CA$CA
1121096112$11210961$12$F$20150615$20221114$20150623$20221130$PER$$US-BIOMARINAP-US-2015-106664$BIOMARIN$$$$$$Y$$$20221130$$CN$US$US
1121119650$11211196$50$F$20150401$20221024$20150623$20221102$EXP$$CA-ROCHE-1597909$ROCHE$$62$YR$$F$Y$$$20221102$$CN$CA$CA
112113093$11211309$3$F$20150417$20221107$20150623$20221115$EXP$$CA-ROCHE-1597855$ROCHE$$55$YR$$M$Y$$$20221115$$MD$CA$CA
1121349812$11213498$12$F$20150612$20221212$20150623$20221220$PER$$CA-AMGEN-CANSP2015060003$AMGEN$$73$YR$E$F$Y$$$20221220$$HP$CA$CA
1121749410$11217494$10$F$20140717$20221129$20150625$20221206$EXP$$CA-ROCHE-1599129$ROCHE$$59$YR$$F$Y$126.4$KG$20221206$$MD$CA$CA
1123238628$11232386$28$F$20150602$20221121$20150701$20221122$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-041921$BRISTOL MYERS SQUIBB$Suzuki S, Ishikawa N, Konoeda F, Seki N, Fukushima S, Takahashi K, et al. Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan. Neurology 2017; 89: 1-8.$81$YR$E$M$Y$85$KG$20221122$$MD$JP$JP
1125764511$11257645$11$F$20140919$20221216$20150710$20221223$EXP$$CA-ROCHE-1605988$ROCHE$$38$YR$$F$Y$$$20221223$$CN$CA$CA
112598992$11259899$2$F$20141024$20201007$20150710$20221008$PER$$US-PURDUE-USA-2014-0118622$PURDUE$$0$YR$$F$Y$$$20221008$$CN$US$US
1126087925$11260879$25$F$20210101$20221221$20150710$20221226$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK098504$GLAXOSMITHKLINE$$$$$$Y$$$20221226$$CN$BR$BR
112626725$11262672$5$F$20150612$20211130$20150710$20221008$PER$$US-PURDUE-USA-2015-0124254$PURDUE$$72$YR$$F$Y$$$20221008$$CN$US$US
112654706$11265470$6$F$20150201$20220930$20150713$20221006$EXP$$PT-ABBVIE-15K-130-1422289-00$ABBVIE$$38$YR$$F$Y$$$20221006$$CN$PT$PT
1127535214$11275352$14$F$20140101$20221031$20150716$20221104$EXP$$CA-ROCHE-1455724$ROCHE$$70$YR$$F$Y$$$20221104$$CN$CA$CA
1128678323$11286783$23$F$20150101$20221018$20150721$20221025$EXP$$PHHY2015CA083694$NOVARTIS$$$$$M$Y$$$20221025$$MD$CA$CA
1130269516$11302695$16$F$20150710$20221220$20150723$20221227$EXP$$CA-ROCHE-1612329$ROCHE$$71$YR$$M$Y$$$20221227$$MD$COUNTRY NOT SPECIFIED$CA
1131096039$11310960$39$F$20150914$20221228$20150726$20221230$EXP$$CA-ROCHE-1610105$ROCHE$$47$YR$$F$Y$54$KG$20221230$$HP$CA$
113145096$11314509$6$F$$20221227$20150727$20221229$PER$$US-PFIZER INC-2015237832$PFIZER$$53$YR$$F$Y$91$KG$20221229$$CN$US$US
113153994$11315399$4$F$$20221125$20150728$20221128$EXP$$CA-ROCHE-1611796$ROCHE$$46$YR$$F$Y$73$KG$20221129$$HP$CA$
1132353620$11323536$20$F$20111216$20221107$20150730$20221109$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2015JPN102901$VIIV$$$$$$Y$$$20221109$$MD$JP$JP
1132363620$11323636$20$F$20111216$20221107$20150730$20221109$EXP$$JP-GLAXOSMITHKLINE INC.-JP2015JPN102901$GLAXOSMITHKLINE$$$$$$Y$$$20221109$$MD$JP$JP
113262893$11326289$3$F$$20221123$20150731$20221129$EXP$$AU-Orion Corporation ORION PHARMA-TREX2015-0493$ORION$Watts M, Chan R. Survival versus a fatal outcome in two cases of Anncaliia algerae microsporidial myositis. Neuromuscular Disorders. 2012;22(9-10):855.$66$YR$E$M$Y$$$20221129$$MD$AU$
113276416$11327641$6$F$20140901$20221219$20150731$20221223$EXP$$CA-JNJFOC-20150719488$JOHNSON AND JOHNSON$$50$YR$A$F$Y$74$KG$20221223$$HP$CA$CA
1132997413$11329974$13$F$20121101$20221107$20150803$20221109$EXP$$JP-VIIV HEALTHCARE ULC-JP2015JPN107326$VIIV$$$$$$Y$$$20221109$$MD$JP$JP
1133067913$11330679$13$F$20121101$20221107$20150803$20221109$EXP$$JP-GLAXOSMITHKLINE-JP2015JPN107326$GLAXOSMITHKLINE$$$$$$Y$$$20221109$$MD$JP$JP
113365899$11336589$9$F$20150622$20221205$20150804$20221213$EXP$$IT-PFIZER INC-2015247986$PFIZER$$53$YR$$M$Y$65$KG$20221213$$MD$IT$IT
113624752$11362475$2$F$$20221024$20150810$20221031$EXP$$CA-GLAXOSMITHKLINE-CA2015GSK113983$GLAXOSMITHKLINE$$$$$$Y$$$20221031$$MD$CA$CA
113689332$11368933$2$F$20150101$20221202$20150812$20221207$PER$$US-AMGEN-USASL2015080477$AMGEN$$46$YR$A$F$Y$$$20221207$$CN$US$US
1137703937$11377039$37$F$20150727$20221115$20150813$20221123$EXP$$CO-INCYTE CORPORATION-2015IN003787$INCYTE$$$$$$Y$$$20221123$$CN$CO$CO
113827153$11382715$3$F$20150101$20221117$20150814$20221128$EXP$$US-JAZZ-2015-US-011803$JAZZ$$$$$M$Y$$$20221128$$MD$US$US
113868657$11386865$7$F$20140201$20221111$20150817$20221116$PER$$US-PFIZER INC-2015267334$PFIZER$$60$YR$$F$Y$67$KG$20221116$$CN$US$US
1138896010$11388960$10$F$20220912$20221129$20150817$20221201$EXP$$US-PFIZER INC-2015273572$PFIZER$$69$YR$$F$Y$73$KG$20221201$$CN$US$US
113986072$11398607$2$F$20150804$20221103$20150820$20221118$EXP$$IT-AUROBINDO-AUR-APL-2015-07365$AUROBINDO$$56$YR$$F$Y$$$20221118$$MD$IT$IT
1143790613$11437906$13$F$20150612$20221206$20150831$20221208$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-056744$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20221208$$MD$CA$CA
1144906030$11449060$30$F$20150502$20220524$20150902$20221123$EXP$$GB-ROCHE-1588876$ROCHE$$43$YR$$F$Y$80.6$KG$20221123$$MD$GB$GB
1146495518$11464955$18$F$20150305$20221219$20150907$20221222$EXP$$CA-ROCHE-1520973$ROCHE$$32$YR$$F$Y$71$KG$20221222$$HP$CA$
1146542812$11465428$12$F$$20221012$20150907$20221013$EXP$$CA-ROCHE-1630210$ROCHE$$54$YR$$M$Y$$$20221013$$HP$CA$
114722818$11472281$8$F$$20221219$20150908$20221222$PER$$US-PFIZER INC-2015283708$PFIZER$$60$YR$$F$Y$90.703$KG$20221222$$CN$US$US
114761366$11476136$6$F$20150515$20221223$20150909$20221226$EXP$$JP-SHIRE-JP201511107AA$TAKEDA$$74$YR$$F$Y$43$KG$20221226$$CN$JP$JP
114854362$11485436$2$F$$20221212$20150909$20221220$EXP$$US-JAZZ-2015-US-000175$JAZZ$$$$$F$Y$$$20221220$$CN$US$US
114880832$11488083$2$F$20150201$20221209$20150909$20221213$EXP$$US-JAZZ-2015-US-003504$JAZZ$$31$YR$$F$Y$$$20221213$$MD$US$US
1149767216$11497672$16$F$$20221201$20150911$20221206$EXP$$CA-INCYTE CORPORATION-2013IN000165$INCYTE$$$$$$Y$$$20221206$$CN$CA$CA
1151945664$11519456$64$F$20150901$20221212$20150918$20221216$PER$$CA-AMGEN-CANSP2015095516$AMGEN$$43$YR$$F$Y$68$KG$20221216$$HP$CA$CA
1152525487$11525254$87$F$$20221220$20150918$20221229$EXP$$CA-PFIZER INC-2015308388$PFIZER$$43$YR$$F$Y$68$KG$20221229$$HP$CA$CA
1152988110$11529881$10$F$20110101$20221212$20150921$20221220$EXP$$CA-PFIZER INC-2015293041$PFIZER$$65$YR$$F$Y$$$20221220$$CN$CA$CA
1153197313$11531973$13$F$20150101$20221128$20150921$20221206$EXP$$CA-PFIZER INC-2015300302$PFIZER$$69$YR$$M$Y$$$20221206$$CN$CA$CA
115334828$11533482$8$F$20140101$20221201$20150921$20221207$EXP$$US-JAZZ-2015-US-013813$JAZZ$$$$$M$Y$$$20221207$$MD$US$US
115334852$11533485$2$F$$20221206$20150921$20221212$EXP$$US-JAZZ-2015-US-013887$JAZZ$$$$$F$Y$$$20221212$$CN$US$US
115411145$11541114$5$F$$20221006$20150923$20221010$PER$$US-PFIZER INC-2015065708$PFIZER$$71$YR$$F$Y$48$KG$20221010$$CN$US$US
115492603$11549260$3$F$20150623$20221216$20150924$20221223$EXP$$US-INCYTE CORPORATION-2015IN002988$INCYTE$$$$$$Y$$$20221223$$CN$US$US
115576017$11557601$7$F$20140121$20221207$20150926$20221212$EXP$$PHHY2013CA121592$NOVARTIS$$63$YR$$F$Y$$$20221212$$HP$CA$CA
1156506845$11565068$45$F$$20221128$20150928$20221201$EXP$$CA-009507513-1509CAN012569$MERCK$$$$$F$Y$97$KG$20221201$$HP$CA$CA
1157420921$11574209$21$F$20140325$20221019$20150930$20221027$EXP$$CA-ROCHE-1639907$ROCHE$$63$YR$$M$Y$89$KG$20221027$$CN$CA$CA
1157787011$11577870$11$F$20150918$20221220$20150930$20221227$EXP$$US-PFIZER INC-2015319862$PFIZER$$17$YR$$M$Y$78$KG$20221227$$CN$US$US
1158070937$11580709$37$F$$20221010$20150930$20221029$EXP$$CA-ABBVIE-15K-028-1471671-00$ABBVIE$$$$$F$Y$$$20221029$$HP$CA$CA
115952949$11595294$9$F$20130101$20221102$20151006$20221108$EXP$$CA-ROCHE-1641632$ROCHE$$49$YR$$M$Y$$$20221108$$CN$CA$CA
1159703019$11597030$19$F$20150801$20221201$20151006$20221208$EXP$$GB-ROCHE-1641219$ROCHE$$73$YR$$F$Y$$$20221208$$HP$GB$GB
115990327$11599032$7$F$$20221018$20151006$20221021$PER$$US-PFIZER INC-2015330789$PFIZER$$70$YR$$F$Y$54$KG$20221021$$CN$US$US
116141494$11614149$4$F$$20221129$20151008$20221205$EXP$$US-JAZZ-2014-US-010846$JAZZ$$$$$F$Y$$$20221205$$CN$US$US
1161812065$11618120$65$F$20150416$20221205$20151010$20221209$EXP$$PHHY2012CA016363$NOVARTIS$$63$YR$$F$Y$$$20221209$$HP$CA$CA
116313906$11631390$6$F$20180829$20221215$20151014$20221223$EXP$$CA-ROCHE-1645569$ROCHE$$50$YR$$F$Y$$$20221223$$MD$CA$CA
116356689$11635668$9$F$20151002$20221005$20151016$20221006$EXP$$US-PFIZER INC-2015341707$PFIZER$$63$YR$$F$Y$97.506$KG$20221006$$HP$US$US
1163606321$11636063$21$F$20151002$20221214$20151016$20221221$EXP$$CA-ROCHE-1646696$ROCHE$$20$YR$$M$Y$$$20221221$$MD$CA$CA
116372803$11637280$3$F$$20221109$20151016$20221112$EXP$$US-SHIRE-US201512542$TAKEDA$$$$$F$Y$$$20221112$$MD$US$US
116506392$11650639$2$F$$20150528$20151021$20221020$PER$$US-NOVOPROD-448531$NOVO NORDISK$$$$$M$Y$$$20221020$$CN$US$US
116592596$11659259$6$F$20150728$20221103$20151026$20221110$EXP$$CA-ROCHE-1648222$ROCHE$$66$YR$$F$Y$$$20221110$$MD$CA$
116612706$11661270$6$F$20150801$20221115$20151026$20221121$EXP$$CA-TAKEDA-2015TUS011190$TAKEDA$$56$YR$$F$Y$$$20221121$$MD$CA$CA
1166243427$11662434$27$F$20150728$20221209$20151027$20221221$EXP$$CA-ROCHE-1650800$ROCHE$$71$YR$$F$Y$$$20221221$$MD$CA$CA
1166352368$11663523$68$F$20151001$20221209$20151027$20221213$EXP$$CA-ROCHE-1649929$ROCHE$$41$YR$$F$Y$85$KG$20221213$$HP$CA$
1166544319$11665443$19$F$20151001$20221012$20151027$20221018$EXP$$US-PFIZER INC-2015356674$PFIZER$$42$YR$$F$Y$64.5$KG$20221018$$HP$US$US
1167242234$11672422$34$F$20151001$20221221$20151028$20221222$EXP$$PHHY2015CA117737$NOVARTIS$$74$YR$$F$Y$$$20221222$$HP$CA$CA
1168069212$11680692$12$F$20150722$20221202$20151029$20221212$EXP$$CA-ROCHE-1650806$ROCHE$$77$YR$$F$Y$$$20221212$$MD$CA$CA
116847947$11684794$7$F$20150101$20221205$20151029$20221207$EXP$$PHHY2015CA138225$NOVARTIS$$36$YR$$M$Y$$$20221207$$CN$CA$CA
116866658$11686665$8$F$20150101$20221122$20151030$20221124$EXP$$US-PFIZER INC-2015365254$PFIZER$$65$YR$$M$Y$$$20221124$$CN$US$US
116876935$11687693$5$F$20150501$20221021$20151030$20221103$EXP$FR-JNJFOC-20151015480$FR-JNJFOC-20151015480$JOHNSON AND JOHNSON$$25$YR$A$M$Y$58$KG$20221103$$MD$FR$FR
1168789254$11687892$54$F$20150101$20221031$20151030$20221107$EXP$$PHHY2015CA139740$NOVARTIS$$$$$F$Y$$$20221107$$CN$CA$CA
1168870915$11688709$15$F$20130101$20221114$20151102$20221123$EXP$$CA-ROCHE-1652828$ROCHE$$54$YR$$M$Y$106$KG$20221123$$MD$CA$CA
1169056711$11690567$11$F$$20221018$20151102$20221020$EXP$$US-PFIZER INC-2015371949$PFIZER$$70$YR$$F$Y$62$KG$20221020$$CN$US$US
1169227552$11692275$52$F$20151011$20221103$20151103$20221107$EXP$$CA-ROCHE-1653795$ROCHE$$45$YR$$F$Y$90$KG$20221107$$HP$CA$
1169545367$11695453$67$F$20150804$20221027$20151104$20221104$EXP$$PHHY2015CA100891$NOVARTIS$$68$YR$$M$Y$$$20221104$$MD$CA$CA
1169665432$11696654$32$F$20160928$20221220$20151104$20221223$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK033029$GLAXOSMITHKLINE$$$$$$Y$$$20221223$$MD$BR$BR
117017308$11701730$8$F$20151020$20221117$20151105$20221121$EXP$$US-PFIZER INC-2015376270$PFIZER$$58$YR$$F$Y$$$20221121$$CN$US$US
117026999$11702699$9$F$20110101$20221209$20151105$20221216$EXP$$US-PFIZER INC-2015371915$PFIZER$$60$YR$$F$Y$54$KG$20221216$$CN$US$US
1171983620$11719836$20$F$20150801$20221124$20151110$20221202$EXP$$CA-ROCHE-1656679$ROCHE$$28$YR$$F$Y$$$20221202$$MD$CA$CA
1172654912$11726549$12$F$20130326$20221004$20151112$20221013$EXP$$CA-ROCHE-1659147$ROCHE$$73$YR$$M$Y$$$20221011$$MD$CA$CA
1172683929$11726839$29$F$20130913$20221201$20151112$20221209$EXP$$CA-ROCHE-1659165$ROCHE$$61$YR$$M$Y$$$20221209$$MD$CA$CA
117353303$11735330$3$F$20150829$20221006$20151113$20221010$EXP$$PHHO2015IE016349$NOVARTIS$$76$YR$$M$Y$85.3$KG$20221010$$MD$IE$IE
117401154$11740115$4$F$20100101$20221128$20151113$20221205$EXP$$US-JAZZ-2015-US-018836$JAZZ$$$$$F$Y$$$20221205$$MD$US$US
117430168$11743016$8$F$20150904$20221003$20151116$20221014$EXP$$CN-PFIZER INC-2015388713$PFIZER$$60$YR$$F$Y$80$KG$20221014$$MD$CN$CN
117431617$11743161$7$F$20140101$20221011$20151116$20221021$EXP$$US-ELI_LILLY_AND_COMPANY-US201511001495$ELI LILLY AND CO$$$$$M$Y$$$20221021$$CN$US$US
117474082$11747408$2$F$20150101$20220929$20151117$20221007$PER$$US-BAYER-2015-465878$BAYER$$60$YR$A$F$Y$$$20221007$$CN$US$US
1174958422$11749584$22$F$20130606$20221003$20151118$20221013$EXP$$CA-ROCHE-1660484$ROCHE$$63$YR$$F$Y$75$KG$20221011$$CN$CA$CA
117496992$11749699$2$F$20081120$20221102$20151118$20221108$EXP$$US-ROCHE-1661922$ROCHE$$48$YR$$F$Y$$$20221108$$MD$US$
117526432$11752643$2$F$$20221111$20151119$20221125$EXP$$US-MACLEODS PHARMACEUTICALS US LTD-MAC2015002161$MACLEODS$Hattab YA, Speredelozzi D, Bajwa O.. Rivaroxaban causing spontanuos splenic rupture.. American Journal of Respiratory and Critical Care Medicine.. 2015;191:A4632$$$$$Y$$$20221125$$MD$US$US
1175728427$11757284$27$F$20130805$20221019$20151120$20221025$EXP$$PHHY2013CA085930$NOVARTIS$$79$YR$$M$Y$$$20221025$$HP$CA$CA
117667363$11766736$3$F$20091004$20221102$20151123$20221108$EXP$$US-ROCHE-1661946$ROCHE$$58$YR$$F$Y$$$20221108$$MD$US$
1177184910$11771849$10$F$20151101$20221208$20151124$20221216$EXP$$US-PFIZER INC-2015398522$PFIZER$$72$YR$$F$Y$$$20221216$$CN$US$US
117749013$11774901$3$F$20130101$20211124$20151124$20221017$EXP$$US-JAZZ-2015-US-019706$JAZZ$$$$$M$Y$$$20221017$$MD$US$US
1178262525$11782625$25$F$20140201$20221122$20151127$20221129$EXP$$CA-ROCHE-1668392$ROCHE$$55$YR$$M$Y$78$KG$20221129$$MD$CA$CA
1178500220$11785002$20$F$20130429$20221109$20151130$20221114$EXP$$CA-ROCHE-1141931$ROCHE$$50$YR$$F$Y$106$KG$20221114$$CN$CA$
117862994$11786299$4$F$$20221006$20151130$20221019$EXP$$US-PFIZER INC-2015401364$PFIZER$Blair, P.. DRESS syndrome presenting after initiation of mycobacterium avium complex osteomyelitis treatment. BMJ Case Reports. 2015;10.1136/bcr-2015-210907$79$YR$$M$Y$$$20221019$$HP$US$US
117876837$11787683$7$F$20150101$20221205$20151130$20221212$EXP$$US-JAZZ-2015-US-020315$JAZZ$$$$$F$Y$$$20221212$$HP$US$US
1178812812$11788128$12$F$20141201$20221212$20151201$20221219$EXP$$CA-ROCHE-1513163$ROCHE$$61$YR$$M$Y$83.9$KG$20221219$$CN$CA$
1178896360$11788963$60$F$20151112$20221206$20151201$20221208$EXP$$PHHY2015CA151030$NOVARTIS$$61$YR$$F$Y$$$20221208$$HP$CA$CA
117915402$11791540$2$F$20151120$20221012$20151201$20221020$EXP$$JP-BAUSCH-BL-2015-028453$BAUSCH AND LOMB$$59$YR$$M$Y$$$20221020$$MD$JP$JP
117917868$11791786$8$F$$20221004$20151201$20221004$EXP$$US-PFIZER INC-2015398901$PFIZER$$56$YR$$F$Y$$$20221004$$CN$US$US
117931714$11793171$4$F$$20220926$20151202$20221003$EXP$$CA-GLAXOSMITHKLINE-CA2014GSK054940$GLAXOSMITHKLINE$$$$$$Y$$$20221003$$CN$CA$CA
118100073$11810007$3$F$20180803$20221027$20151208$20221104$EXP$$CA-ROCHE-1674514$ROCHE$$53$YR$$F$Y$$$20221104$$CN$CA$CA
118129063$11812906$3$F$$20220930$20151209$20221004$EXP$$BR-PFIZER INC-2015411022$PFIZER$$75$YR$$M$Y$67$KG$20221004$$CN$BR$BR
118172843$11817284$3$F$20080101$20221116$20151210$20221121$PER$$US-JNJFOC-20151111235$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221122$$HP$US$US
118175423$11817542$3$F$20080101$20221205$20151210$20221208$PER$$US-JNJFOC-20151110244$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221208$$LW$US$US
118179684$11817968$4$F$20130101$20221020$20151210$20221102$PER$$US-JNJFOC-20151108020$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221102$$HP$US$US
118181404$11818140$4$F$20040101$20221017$20151210$20221021$PER$$US-JNJFOC-20151106146$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221021$$LW$US$US
118183087$11818308$7$F$20120101$20220922$20151210$20221003$PER$$US-JNJFOC-20151100778$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221003$$HP$US$US
118187334$11818733$4$F$20100101$20221031$20151210$20221108$PER$$US-JNJFOC-20151113973$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20221108$$HP$US$US
118192197$11819219$7$F$20080101$20221003$20151210$20221012$EXP$$US-JNJFOC-20151114373$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221010$$HP$US$US
118193373$11819337$3$F$20040101$20221221$20151210$20221227$PER$$US-JNJFOC-20150923152$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221227$$LW$US$US
1182542956$11825429$56$F$20150101$20221109$20151211$20221112$EXP$$CA-ROCHE-1417303$ROCHE$$$$$F$Y$107$KG$20221112$$HP$CA$
1183072018$11830720$18$F$20151202$20221110$20151214$20221118$EXP$$CA-ROCHE-1676032$ROCHE$$61$YR$$F$Y$$$20221118$$MD$CA$CA
118317432$11831743$2$F$$20220927$20151214$20221011$EXP$$US-PFIZER INC-2015435456$PFIZER$Rafferty, E.. Allergy to multiple unrelated drugs containing FD+C no 2: The importance of excipients.. Annals of Allergy, Asthma and Immunology. 2015;115:5(1):A91$11$YR$$M$Y$$$20221011$$HP$US$US
118376622$11837662$2$F$20151123$20220927$20151215$20221003$EXP$$DE-009507513-1512DEU001161$MERCK$$63$YR$$F$Y$$$20221003$$MD$DE$DE
118462142$11846214$2$F$20150801$20221208$20151217$20221212$EXP$DE-BOEHRINGER INGELHEIM GMBH, GERMANY-2015-BI-66253DE$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2015-BI-66253DE$BOEHRINGER INGELHEIM$$97$YR$E$F$Y$49$KG$20221212$$PH$DE$DE
118480743$11848074$3$F$20160801$20221228$20151217$20221230$EXP$$US-JAZZ-2015-US-021584$JAZZ$$25$YR$$M$Y$$$20221230$$MD$US$US
1185237311$11852373$11$F$20150812$20221006$20151218$20221012$EXP$$FR-GILEAD-2015-0186154$GILEAD$$51$YR$A$M$Y$57$KG$20221012$$MD$FR$FR
118587596$11858759$6$F$$20220919$20151222$20221001$EXP$$CA-AUROBINDO-AUR-APL-2015-11455$AUROBINDO$Ashley M. Yu, BHSc and Joel G. DeKoven, MD, MHSc, FRCPC. Occupational Airborne Contact Dermatitis From Proton Pump Inhibitors. Dermatitis. 2015;26 (6):287-90$58$YR$$M$Y$$$20221001$$MD$CA$CA
1186359518$11863595$18$F$20140101$20221021$20151223$20221028$EXP$$PHHY2014CA154360$NOVARTIS$$$$$F$Y$$$20221028$$HP$CA$CA
118696776$11869677$6$F$20150423$20170515$20151228$20221108$EXP$$JP-ROCHE-1660326$ROCHE$Yamazaki O, Tachikawa S, Yamazaki O, Kono J. Skin Disorder Which Developed after Treatment for Advanced Malignant Melanoma Was Switched from Nivolumab to Vemurafenib (Abstract 72-O ). Journal of Environmental Dermatology and Cutaneous Allergology /; Abstracts of the 45th Annual Meeting of the Japanese Society for Dermatoallergology and Contact Dermatitis 2015 Nov;9 (5):452-.$62$YR$$F$Y$46$KG$20221108$$MD$JP$JP
1187110917$11871109$17$F$20141224$20221020$20151228$20221025$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2015JPN180189$VIIV$$$$$$Y$$$20221025$$MD$JP$JP
118782398$11878239$8$F$20151119$20221028$20151230$20221101$EXP$$PHHY2015CA154224$NOVARTIS$$48$YR$$F$Y$$$20221101$$MD$CA$CA
118804154$11880415$4$F$20150909$20221222$20151230$20221223$EXP$$CA-TAKEDA-2015TUS018178$TAKEDA$$59$YR$$F$Y$$$20221223$$CN$CA$CA
118876006$11887600$6$F$20211026$20221211$20160105$20221224$EXP$$GB-AUROBINDO-AUR-APL-2015-11984$AUROBINDO$Jessica Head. A 12-year-old Bella Donna. Archives of Disease in Childhood,. Education and Practice Edition. 2014;99 (5):173-80$12$YR$$F$Y$$$20221224$$MD$GB$GB
118951176$11895117$6$F$20170101$20221201$20160107$20221208$EXP$$US-PFIZER INC-2015442538$PFIZER$$41$YR$$M$Y$113$KG$20221208$$CN$US$US
119053443$11905344$3$F$20120301$20221012$20160109$20221020$PER$$US-JNJFOC-20151222368$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20221020$$LW$US$US
119054788$11905478$8$F$$20221221$20160109$20221226$PER$$US-JNJFOC-20151222369$JOHNSON AND JOHNSON$$$$$M$Y$$$20221226$$LW$US$US
1191259921$11912599$21$F$20150101$20210331$20160113$20221214$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-093211$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20221214$$HP$CA$CA
1191791312$11917913$12$F$20140101$20221208$20160114$20221215$PER$$US-PFIZER INC-2016015258$PFIZER$$46$YR$$F$Y$73$KG$20221215$$CN$US$US
1193375733$11933757$33$F$20140806$20221215$20160121$20221219$EXP$$CA-ROCHE-1434589$ROCHE$$73$YR$$F$Y$87$KG$20221219$$HP$CA$
119338252$11933825$2$F$$20221012$20160121$20221014$EXP$$US-SHIRE-US201600378$TAKEDA$$$$$M$Y$$$20221014$$CN$US$US
1193535521$11935355$21$F$20150401$20221219$20160121$20221223$EXP$$US-PFIZER INC-2016017803$PFIZER$$74$YR$$M$Y$124$KG$20221223$$CN$US$US
1193793114$11937931$14$F$20160217$20221129$20160122$20221206$EXP$$CA-ROCHE-1698822$ROCHE$$42$YR$$M$Y$$$20221206$$HP$CA$CA
119538505$11953850$5$F$20161225$20221114$20160126$20221116$PER$$US-PFIZER INC-2015476213$PFIZER$$41$YR$$F$Y$$$20221116$$HP$US$US
119539343$11953934$3$F$$20221107$20160125$20221107$PER$$US-BIOGEN-2016BI00173051$BIOGEN$$$$$F$Y$$$20221107$$CN$US$US
1196876532$11968765$32$F$20141208$20221212$20160128$20221214$EXP$$CA-ROCHE-1219752$ROCHE$$40$YR$$M$Y$67$KG$20221214$$MD$CA$
119760027$11976002$7$F$20120319$20221026$20160129$20221104$EXP$$CA-ROCHE-1132487$ROCHE$$39$YR$$F$Y$77$KG$20221104$$HP$CA$
119768444$11976844$4$F$$20221018$20160129$20221021$PER$$US-BIOGEN-2016BI00177407$BIOGEN$$$$$M$Y$$$20221021$$CN$US$US
1199484817$11994848$17$F$20151201$20220930$20160203$20221007$EXP$$GB-ROCHE-1677596$ROCHE$$69$YR$$F$Y$$$20221007$$MD$GB$GB
1203751634$12037516$34$F$20150601$20221031$20160208$20221103$EXP$$PHHY2015CA076388$NOVARTIS$$65$YR$$F$Y$$$20221103$$HP$CA$CA
120375559$12037555$9$F$20151224$20221019$20160208$20221031$EXP$$PHHY2016CO015670$NOVARTIS$$38$YR$$F$Y$55$KG$20221031$$CN$CO$CO
1204027945$12040279$45$F$20201127$20221104$20160208$20221108$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK160212$GLAXOSMITHKLINE$$$$$$Y$$$20221108$$MD$BR$BR
120510172$12051017$2$F$20140305$20220913$20160208$20221001$PER$$US-ABBVIE-15P-163-1392790-00$ABBVIE$$45$YR$$F$Y$$$20221001$$HP$US$US
120685052$12068505$2$F$$20221208$20160211$20221213$PER$$US-BIOGEN-2016BI00179440$BIOGEN$$$$$F$Y$$$20221213$$CN$US$US
120723023$12072302$3$F$20090101$20221222$20160212$20221229$EXP$$PHHY2016CR018492$NOVARTIS$$$$$M$Y$$$20221229$$CN$CR$CR
1207531612$12075316$12$F$$20221026$20160212$20221110$EXP$$CA-AUROBINDO-AUR-APL-2016-01463$AUROBINDO$Abidi S, Ursuliak Z, Morrison J, Teehan MD, Tibbo PG, Gardner DM.. Incidence of oculogyric crisis and long-term outcomes with second-generation antipsychotics in a first-episode psychosis program. Journal of Clinical Psychopharmacology. 2015;35(6):715-718$22$YR$$F$Y$$$20221110$$MD$CA$CA
1207853042$12078530$42$F$20150101$20221123$20160216$20221129$EXP$$CA-ROCHE-1711280$ROCHE$$46$YR$$F$Y$$$20221129$$MD$CA$CA
1207965615$12079656$15$F$$20221207$20160216$20221212$EXP$$US-PFIZER INC-2016088306$PFIZER$$62$YR$$F$Y$$$20221212$$HP$US$US
120822789$12082278$9$F$20121205$20221124$20160217$20221128$EXP$$CA-ROCHE-1177020$ROCHE$$54$YR$$F$Y$53$KG$20221128$$CN$CA$
1208261920$12082619$20$F$$20221222$20160217$20221230$EXP$$GB-drreddys-GER/UKI/12/0025687$DR REDDYS$$15$YR$T$F$Y$$$20221230$$MD$GB$GB
120847822$12084782$2$F$$20221006$20160217$20221018$EXP$$DE-PFIZER INC-2016091452$PFIZER$Barthel, D.. Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics. Journal of Rheumatology. 2015;42 (11):2160-2165$17$YR$$F$Y$$$20221018$$MD$DE$DE
120858434$12085843$4$F$20150801$20221024$20160217$20221030$EXP$$BR-BIOGEN-2016BI00190635$BIOGEN$$30$YR$$F$Y$62$KG$20221030$$HP$BR$BR
120914922$12091492$2$F$$20221006$20160218$20221018$EXP$$DE-PFIZER INC-2016091453$PFIZER$Barthel, D.. Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics. Journal of Rheumatology. 2015;42 (11):2160-2165$17$YR$$M$Y$$$20221018$$MD$DE$DE
120968074$12096807$4$F$20140101$20221012$20160220$20221020$EXP$$US-ACORDA-ACO_108922_2015$ACORDA$$$$$F$Y$$$20221020$$MD$US$US
121037492$12103749$2$F$20221212$20221212$20160223$20221215$PER$$US-BIOGEN-2016BI00190216$BIOGEN$$53$YR$$F$Y$$$20221215$$CN$US$US
1211751215$12117512$15$F$20151002$20221130$20160225$20221208$EXP$$CA-ROCHE-1716708$ROCHE$$35$YR$$F$Y$$$20221208$$MD$CA$CA
121182282$12118228$2$F$$20221213$20160226$20221222$PER$$US-AMGEN-USASL2016021584$AMGEN$$55$YR$A$F$Y$$$20221222$$CN$US$US
121210476$12121047$6$F$$20221208$20160226$20221215$PER$$US-PFIZER INC-2016060858$PFIZER$$39$YR$$F$Y$$$20221215$$CN$US$US
1212230538$12122305$38$F$20151219$20221011$20160226$20221014$EXP$$PHHY2015CA172640$NOVARTIS$$61$YR$$F$Y$$$20221014$$CN$CA$CA
121249903$12124990$3$F$20150101$20220930$20160229$20221010$PER$$US-AMGEN-USASL2016023986$AMGEN$$45$YR$A$F$Y$$$20221009$$CN$US$US
121262314$12126231$4$F$20150814$20221025$20160229$20221103$EXP$$CA-009507513-1602CAN010951$MERCK$$47$YR$$F$Y$$$20221103$$PH$CA$CA
121275712$12127571$2$F$$20221221$20160229$20221229$EXP$GB-MHRA-ADR 23357992$GB-PERRIGO-16GB001878$PERRIGO$$$$$$Y$$$20221229$$HP$GB$GB
121283862$12128386$2$F$$20221221$20160229$20221227$EXP$$US-JAZZ-2016-US-003401$JAZZ$$$$$F$Y$$$20221227$$CN$US$US
1213337524$12133375$24$F$$20221212$20160301$20221220$PER$$CA-AMGEN-CANSP2016018438$AMGEN$$65$YR$E$F$Y$$$20221220$$HP$CA$CA
121336525$12133652$5$F$$20221222$20160301$20221229$EXP$GB-MHRA-ADR 23357992$PHHY2016GB024615$NOVARTIS$$4$MON$$$Y$$$20221229$$MD$GB$GB
1213390062$12133900$62$F$20141010$20220924$20160301$20221003$EXP$$CA-ROCHE-1474767$ROCHE$$49$YR$$M$Y$70$KG$20221003$$HP$CA$
121379633$12137963$3$F$$20221215$20160302$20221220$EXP$$GB-AstraZeneca-2016SE19198$ASTRAZENECA$$20$WK$$$Y$$$20221219$$MD$GB$
121389339$12138933$9$F$$20221128$20160302$20221130$EXP$$US-PFIZER INC-2016132391$PFIZER$$68$YR$$F$Y$48$KG$20221130$$CN$US$US
1213946921$12139469$21$F$20121119$20221021$20160303$20221027$EXP$$CA-ROCHE-1162790$ROCHE$$43$YR$$F$Y$63$KG$20221027$$HP$CA$
121453152$12145315$2$F$20151116$20220916$20160304$20221109$EXP$$PHHY2016CA028172$NOVARTIS$$40$YR$$F$Y$$$20221109$$MD$CA$CA
1214630877$12146308$77$F$$20221212$20160304$20221227$EXP$$CA-PFIZER INC-2016130747$PFIZER$$63$YR$$F$Y$$$20221227$$MD$CA$CA
121474823$12147482$3$F$$20221025$20160304$20221031$EXP$$CA-GLAXOSMITHKLINE-CA2016GSK029540$GLAXOSMITHKLINE$$$$$$Y$$$20221031$$PH$CA$CA
121480403$12148040$3$F$20160101$20221005$20160304$20221007$EXP$$CA-TAKEDA-2016TUS003625$TAKEDA$$42$YR$$F$Y$$$20221007$$CN$CA$CA
121532082$12153208$2$F$$20221028$20160305$20221101$PER$$US-BIOGEN-2016BI00194396$BIOGEN$$$$$F$Y$$$20221101$$CN$US$US
121591643$12159164$3$F$$20221130$20160308$20221209$EXP$GB-MHRA-ADR 23357992$GB-APOTEX-2016AP006943$APOTEX$$$$N$$Y$$$20221209$$MD$GB$GB
121611666$12161166$6$F$$20220929$20160308$20221101$EXP$$CA-ABBVIE-10P-163-0641882-00$ABBVIE$$52$YR$$M$Y$$$20221101$$HP$CA$CA
121699232$12169923$2$F$$20221118$20160310$20221123$PER$$PHEH2016US005763$NOVARTIS$Kim S, Chen L, Hebert A, Slopis J, Koenig MK, Patel A. Erythema nodosum in the setting of everolimus use. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2016;AB98$35$YR$$F$Y$$$20221123$$HP$US$US
121701502$12170150$2$F$$20221118$20160311$20221123$PER$$PHEH2016US005686$NOVARTIS$Kim S, Chen L, Hebert A, Slopis J, Koenig MK, Patel A. Erythema nodosum in the setting of everolimus use. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2016;AB98$25$YR$$M$Y$$$20221123$$HP$US$US
1217131112$12171311$12$F$20160101$20221111$20160311$20221114$PER$$US-PFIZER INC-2016108785$PFIZER$$79$YR$$F$Y$73$KG$20221114$$HP$US$US
121758873$12175887$3$F$20150805$20221013$20160314$20221020$EXP$$US-BIOGEN-2015BI154964$BIOGEN$$42$YR$$F$Y$$$20221020$$MD$US$US
121804805$12180480$5$F$$20221003$20160315$20221007$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-016441$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20221007$$CN$GB$GB
121826693$12182669$3$F$20131012$20221003$20160316$20221006$EXP$$AT-SHIRE-AT201603091$TAKEDA$$68$YR$$M$Y$$$20221006$$MD$AT$AT
121860583$12186058$3$F$$20221130$20160317$20221208$EXP$$JP-ROCHE-1726721$ROCHE$PRIVACY P, Sato K, Sumi M, Kaiume H, Ueki T, Hiroshima Y, Kobayashi H et al Perforated upper gastrointestinal ulcers potentially attributable to mycophenolate mofetil after allogeneic hematopoietic stem cell transplantation. The Japanese Journal of Clinical Hematology 2022;63(10):1402-1408.$46$YR$$M$Y$$$20221208$$MD$JP$JP
1218664123$12186641$23$F$20151201$20221221$20160317$20221228$EXP$$CA-ROCHE-1727203$ROCHE$$11$YR$$F$Y$$$20221228$$MD$CA$CA
121984753$12198475$3$F$20120101$20220926$20160322$20221006$PER$$US-JNJFOC-20160308491$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221006$$LW$US$US
122091106$12209110$6$F$20151201$20221121$20160324$20221125$EXP$$DE-ABBVIE-16K-062-1589815-00$ABBVIE$$60$YR$$M$Y$$$20221125$$MD$DE$DE
1222015118$12220151$18$F$20151020$20221207$20160330$20221214$EXP$$CA-ROCHE-1546279$ROCHE$$60$YR$$M$Y$105$KG$20221214$$HP$CA$
122306663$12230666$3$F$$20221222$20160401$20221229$EXP$$CA-BAXTER-2016BAX016268$BAXTER$$27$YR$$F$Y$$$20221229$$HP$CA$CA
1223243925$12232439$25$F$20160101$20221012$20160401$20221017$EXP$$CA-TAKEDA-2016TUS005281$TAKEDA$$60$YR$$F$Y$$$20221017$$HP$CA$CA
1223244413$12232444$13$F$$20221214$20160401$20221222$PER$$US-PFIZER INC-2016186718$PFIZER$$21$YR$$M$Y$77.11$KG$20221222$$MD$US$US
1223270414$12232704$14$F$20150827$20221118$20160401$20221124$EXP$$CA-TAKEDA-2016TUS004214$TAKEDA$$54$YR$$F$Y$$$20221124$$CN$CA$CA
122367384$12236738$4$F$$20221213$20160405$20221226$EXP$$GB-AUROBINDO-AUR-APL-2016-02203$AUROBINDO$$20$WK$$$Y$$$20221226$$MD$GB$GB
122422523$12242252$3$F$20150825$20190902$20160406$20221017$EXP$$JP-JNJFOC-20150904854$JOHNSON AND JOHNSON$$68$YR$E$F$Y$52$KG$20221017$$MD$JP$JP
122426543$12242654$3$F$20160323$20221107$20160406$20221115$EXP$$US-BIOGEN-2016BI00213721$BIOGEN$$64$YR$$F$Y$$$20221115$$CN$US$US
1224266314$12242663$14$F$20081101$20221118$20160406$20221123$EXP$$US-PFIZER INC-2016015358$PFIZER$$58$YR$$F$Y$81$KG$20221123$$HP$US$US
1224450765$12244507$65$F$20120901$20221220$20160407$20221222$EXP$$CA-ROCHE-1132730$ROCHE$$66$YR$$F$Y$61$KG$20221222$$HP$CA$
122454192$12245419$2$F$20160318$20221014$20160407$20221017$PER$$US-BIOGEN-2016BI00212652$BIOGEN$$67$YR$$F$Y$$$20221017$$CN$US$US
122653124$12265312$4$F$20160301$20221107$20160413$20221110$EXP$$US-SHIRE-US201604300$TAKEDA$$8$YR$$M$Y$22.676$KG$20221110$$CN$US$US
122657786$12265778$6$F$$20221214$20160413$20221221$EXP$$CA-BAXALTA-2016BLT002214$TAKEDA$$27$YR$$F$Y$$$20221221$$HP$CA$CA
122801899$12280189$9$F$20141111$20221113$20160419$20221121$EXP$$CA-ROCHE-1742724$ROCHE$$48$YR$$F$Y$$$20221121$$MD$CA$CA
122808493$12280849$3$F$20160122$20220920$20160419$20221004$EXP$$SE-AUROBINDO-AUR-APL-2016-04852$AUROBINDO$$33$YR$$F$Y$$$20221004$$MD$SE$SE
1228955324$12289553$24$F$20140101$20221213$20160421$20221219$EXP$$PHHY2014CA116710$NOVARTIS$$67$YR$$F$Y$77.098$KG$20221219$$CN$CA$CA
1229013121$12290131$21$F$20210101$20220930$20160421$20221004$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK011740$GLAXOSMITHKLINE$$$$$$Y$$$20221004$$CN$BR$BR
1229416317$12294163$17$F$20121120$20221213$20160422$20221220$EXP$$CA-ROCHE-1745200$ROCHE$$41$YR$$M$Y$122.7$KG$20221220$$CN$CA$CA
123033222$12303322$2$F$$20220926$20160426$20221003$PER$$US-JNJFOC-20160406141$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
123033787$12303378$7$F$20090203$20220929$20160426$20221012$PER$$US-JNJFOC-20160402019$JOHNSON AND JOHNSON$$7$YR$C$M$Y$25.424$KG$20221012$$HP$US$US
123040763$12304076$3$F$20030316$20221116$20160426$20221125$PER$$US-JNJFOC-20160412153$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221125$$HP$US$US
1230456623$12304566$23$F$20150701$20221118$20160426$20221123$EXP$$PHHY2016CA055639$NOVARTIS$$55$YR$$F$Y$$$20221123$$MD$CA$CA
1230619210$12306192$10$F$20160701$20221123$20160426$20221128$EXP$$US-PFIZER INC-2016226395$PFIZER$$57$YR$$M$Y$113$KG$20221128$$CN$US$US
123069373$12306937$3$F$20080301$20221214$20160426$20221221$EXP$$US-JAZZ-JPI-P-003173$JAZZ$$48$YR$$F$Y$$$20221221$$CN$US$US
123088954$12308895$4$F$20140101$20221221$20160427$20221226$EXP$$US-JAZZ-2015-US-011496$JAZZ$$$$$M$Y$$$20221226$$MD$US$US
1231139711$12311397$11$F$20150717$20221026$20160427$20221107$EXP$$DE-INCYTE CORPORATION-2016IN000383$INCYTE$$$$$$Y$$$20221107$$MD$DE$DE
1231249417$12312494$17$F$20090209$20221220$20160428$20221227$PER$$CA-AMGEN-CANSP2016039095$AMGEN$$57$YR$A$M$Y$$$20221227$$HP$CA$CA
123158604$12315860$4$F$20150101$20221209$20160428$20221215$EXP$$US-JAZZ-2016-US-007509$JAZZ$$$$$M$Y$126.98$KG$20221215$$HP$US$US
1232125915$12321259$15$F$20160119$20220906$20160502$20221202$EXP$$GB-ROCHE-1748037$ROCHE$$80$YR$$F$Y$$$20221202$$MD$GB$GB
123214566$12321456$6$F$$20181010$20160502$20221231$PER$$PHEH2016US010509$NOVARTIS$$$$$F$Y$86$KG$20221231$$HP$US$US
1232155510$12321555$10$F$$20221212$20160502$20221220$PER$$CA-AMGEN-CANSP2016054806$AMGEN$$58$YR$A$F$Y$$$20221220$$HP$CA$CA
1232522011$12325220$11$F$20150901$20221201$20160502$20221206$EXP$$CA-DSJP-DSU-2015-130567$DAIICHI$$74$YR$$F$Y$$$20221206$$HP$CA$CA
123255648$12325564$8$F$$20180310$20160503$20221229$EXP$$PHEH2016US010512$NOVARTIS$$$$$$Y$$$20221229$$MD$US$US
123262568$12326256$8$F$$20221121$20160503$20221123$EXP$$CA-ROCHE-1750136$ROCHE$$50$YR$$M$Y$$$20221123$$HP$CA$
1232625826$12326258$26$F$20150801$20221024$20160503$20221102$EXP$$CA-ROCHE-1750044$ROCHE$$34$YR$$M$Y$$$20221101$$CN$CA$CA
1233195424$12331954$24$F$19900101$20221216$20160504$20221227$EXP$$US-PFIZER INC-2016204050$PFIZER$$33$YR$$F$Y$52.154$KG$20221227$$MD$US$US
1233264520$12332645$20$F$20160410$20221216$20160504$20221222$EXP$$US-PFIZER INC-2016230773$PFIZER$$77$YR$$F$Y$58$KG$20221222$$CN$US$US
123356804$12335680$4$F$20160428$20221206$20160505$20221207$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-033720$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20221207$$HP$US$US
123389598$12338959$8$F$20160502$20221208$20160505$20221214$PER$$US-PFIZER INC-2016243931$PFIZER$$59$YR$$F$Y$71.67$KG$20221214$$HP$US$US
123394074$12339407$4$F$20150101$20221012$20160505$20221018$EXP$$US-JAZZ-2015-US-012623$JAZZ$$$$$F$Y$$$20221018$$HP$US$US
123415128$12341512$8$F$$20221013$20160506$20221020$EXP$$PHHY2016CA059634$NOVARTIS$$$$$M$Y$$$20221020$$CN$CA$CA
1234662210$12346622$10$F$20190801$20221220$20160509$20221223$EXP$$US-PFIZER INC-2016150950$PFIZER$$26$YR$$M$Y$$$20221223$$HP$US$US
123483287$12348328$7$F$20150901$20221102$20160509$20221118$EXP$$FR-JNJFOC-20151101884$JOHNSON AND JOHNSON$$31$YR$A$M$Y$52$KG$20221118$$MD$FR$FR
123559386$12355938$6$F$$20221213$20160511$20221215$EXP$$US-JAZZ-2016-US-008484$JAZZ$$$$$F$Y$$$20221215$$CN$US$US
123562423$12356242$3$F$$20221014$20160511$20221021$PER$$US-BIOGEN-2016BI00235995$BIOGEN$$$$$M$Y$$$20221021$$CN$US$US
123565437$12356543$7$F$20160101$20221005$20160511$20221010$EXP$$PHHY2016CA053475$NOVARTIS$$28$YR$$M$Y$$$20221010$$MD$CA$CA
1235836628$12358366$28$F$20131029$20221111$20160512$20221121$EXP$$CA-ROCHE-1756306$ROCHE$$51$YR$$F$Y$$$20221121$$CN$CA$CA
1236543817$12365438$17$F$20140101$20221021$20160512$20221028$EXP$$BR-BIOGEN-2016BI00235292$BIOGEN$$$$$F$Y$69$KG$20221028$$CN$BR$BR
123656032$12365603$2$F$$20221206$20160513$20221213$EXP$$CN-ROCHE-1755331$ROCHE$Fang J, Zhang R, Wang H, Hong M, Wu Q, Nie D, You Y, Zhong Z, Li W, Hu Y and Xia L Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study. Doi: 10.1016/j.leu. Leukemia Research 2016 Jul 01;46:61-8.$$$$$Y$$$20221213$$HP$CN$
123671773$12367177$3$F$$20221107$20160513$20221116$PER$$US-JNJFOC-20160500360$JOHNSON AND JOHNSON$$$$$M$Y$$$20221116$$LW$US$US
1237099728$12370997$28$F$20160101$20221212$20160516$20221222$PER$$CA-AMGEN-CANSP2016061225$AMGEN$$63$YR$A$F$Y$$$20221221$$HP$CA$CA
123711785$12371178$5$F$$20221214$20160516$20221222$PER$$US-PFIZER INC-2016224142$PFIZER$$63$YR$$F$Y$63$KG$20221222$$CN$US$US
123714736$12371473$6$F$20150730$20220706$20160516$20221219$EXP$$US-ROCHE-1756698$ROCHE$$62$YR$$M$Y$72.6$KG$20221219$$MD$US$
123743135$12374313$5$F$20131201$20221215$20160517$20221221$EXP$$US-JAZZ-2015-US-013892$JAZZ$$36$YR$$F$Y$$$20221221$$CN$US$US
1237554632$12375546$32$F$20150101$20221212$20160517$20221222$EXP$$CA-PFIZER INC-2015440794$PFIZER$$42$YR$$F$Y$97$KG$20221222$$MD$CA$CA
1238083419$12380834$19$F$20160401$20221215$20160518$20221222$EXP$$CA-ROCHE-1758483$ROCHE$$23$YR$$F$Y$$$20221222$$MD$CA$CA
1238547412$12385474$12$F$20160101$20221006$20160519$20221012$EXP$$PHHY2016AR068913$NOVARTIS$$69$YR$$F$Y$$$20221012$$CN$AR$AR
123865166$12386516$6$F$$20221031$20160519$20221108$EXP$$US-JAZZ-2015-US-021618$JAZZ$$$$$M$Y$$$20221108$$MD$US$US
1238769511$12387695$11$F$20141201$20221117$20160520$20221121$EXP$$CA-ROCHE-1761274$ROCHE$$45$YR$$F$Y$$$20221121$$CN$COUNTRY NOT SPECIFIED$CA
1239002315$12390023$15$F$20151201$20221103$20160520$20221111$EXP$$US-JAZZ-2016-US-000603$JAZZ$$47$YR$$F$Y$$$20221111$$MD$US$US
1239210611$12392106$11$F$20130617$20221114$20160523$20221121$EXP$$CA-ROCHE-1760131$ROCHE$$40$YR$$F$Y$57$KG$20221121$$HP$CA$CA
1239630314$12396303$14$F$20160514$20221203$20160524$20221209$EXP$$CO-SHIRE-CO201606313$TAKEDA$$3$YR$$M$Y$46$KG$20221209$$HP$CO$CO
123980633$12398063$3$F$20160517$20221213$20160524$20221216$EXP$$US-ROCHE-1762004$ROCHE$$$$$M$Y$$$20221216$$MD$US$
124067318$12406731$8$F$20100101$20221222$20160526$20221226$EXP$$US-JAZZ-2015-US-015583$JAZZ$$$$$M$Y$$$20221226$$CN$US$US
124096415$12409641$5$F$$20221212$20160526$20221222$EXP$$CO-INCYTE CORPORATION-2016IN003124$INCYTE$$$$$$Y$$$20221222$$CN$CO$CO
124111243$12411124$3$F$20210415$20221026$20160527$20221102$EXP$$CA-ROCHE-1764540$ROCHE$$45$YR$$F$Y$$$20221102$$MD$CA$CA
124128583$12412858$3$F$20080101$20221221$20160527$20221227$PER$$US-JAZZ-2016-US-009492$JAZZ$$33$YR$$F$Y$$$20221227$$MD$US$US
1241398810$12413988$10$F$20160101$20221206$20160527$20221213$EXP$$US-JAZZ-2016-US-009575$JAZZ$$$$$F$Y$$$20221213$$MD$US$US
124140502$12414050$2$F$20220714$20220812$20160527$20221026$PER$$US-JAZZ-2015-US-016307$JAZZ$$35$YR$$M$Y$$$20221026$$HP$US$US
124168389$12416838$9$F$$20221201$20160530$20221201$EXP$$US-PFIZER INC-2016280298$PFIZER$$76$YR$$F$Y$$$20221201$$CN$US$US
1241761815$12417618$15$F$20131130$20221024$20160530$20221027$EXP$$PHHY2016CO071682$NOVARTIS$$58$YR$$F$Y$71$KG$20221027$$CN$CO$CO
124207668$12420766$8$F$20130627$20221216$20160531$20221220$EXP$$ES-009507513-1504ESP009226$MERCK$$66$YR$$F$Y$$$20221220$$HP$ES$ES
124253344$12425334$4$F$20160125$20221109$20160601$20221111$EXP$FR-AFSSAPS-PA20160131$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2016-BI-34467FF$BOEHRINGER INGELHEIM$$49$YR$A$M$Y$$$20221111$$HP$FR$FR
1242661011$12426610$11$F$20140528$20221108$20160601$20221115$EXP$$PHHY2013CA144082$NOVARTIS$$83$YR$$F$Y$$$20221115$$HP$CA$CA
124316183$12431618$3$F$20160510$20221027$20160603$20221104$EXP$$US-SHIRE-US201606609$TAKEDA$$24$YR$$M$Y$55$KG$20221104$$HP$US$US
124457012$12445701$2$F$20060101$20220926$20160608$20221006$PER$$US-JNJFOC-20160523024$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221006$$HP$US$US
124457535$12445753$5$F$$20221019$20160608$20221027$PER$$US-JNJFOC-20160411835$JOHNSON AND JOHNSON$$$$$M$Y$$$20221027$$LW$US$US
124462127$12446212$7$F$$20221126$20160608$20221207$PER$$US-BIOGEN-2016BI00240291$BIOGEN$$$$$F$Y$63.5$KG$20221207$$CN$US$US
124500342$12450034$2$F$$20221024$20160609$20221027$PER$$US-BIOGEN-2016BI00241319$BIOGEN$$$$$F$Y$$$20221027$$CN$US$US
124505682$12450568$2$F$20121001$20221101$20160609$20221114$EXP$IT-MLMSERVICE-20160526-0293587-1$IT-LUPIN PHARMACEUTICALS INC.-2016-02427$LUPIN$Del Casale A, Rapinesi C, Brugnoli R, Girardi P, Sacco M, Giardini M, et al.. Effectiveness of switching from oral ziprasidone to risperidone in a patient with comorbid autistic disorder, profound intellectual disability, gilbert syndrome, and exacerbation of psychosis. Psychiatria Danubina. 2016;28(1):91-94$28$YR$$M$Y$$$20221114$$MD$IT$IT
124604347$12460434$7$F$$20221202$20160613$20221208$EXP$$US-PFIZER INC-2016266871$PFIZER$$72$YR$$F$Y$$$20221208$$CN$US$US
1246649225$12466492$25$F$20120801$20221109$20160615$20221118$EXP$$CA-ROCHE-1775252$ROCHE$$79$YR$$F$Y$$$20221118$$CN$CA$CA
124681188$12468118$8$F$20150901$20221207$20160615$20221212$EXP$$US-PFIZER INC-2016287804$MYLAN$$67$YR$$M$Y$77$KG$20221212$$CN$US$US
124681349$12468134$9$F$20060101$20221221$20160615$20221227$EXP$$US-PFIZER INC-2016297763$PFIZER$$70$YR$$F$Y$56.961$KG$20221227$$MD$US$US
1247755431$12477554$31$F$20151221$20221019$20160617$20221025$EXP$$PHHY2015CA169582$NOVARTIS$$59$YR$$F$Y$$$20221025$$CN$CA$CA
124813377$12481337$7$F$20080101$20221026$20160620$20221031$EXP$$US-BIOGEN-2010BI033734$BIOGEN$$$$$F$Y$93.524$KG$20221031$$CN$US$US
124825915$12482591$5$F$$20221017$20160620$20221021$EXP$$US-ARIAD PHARMACEUTICALS, INC-2016US006617$TAKEDA$$$$$M$Y$79$KG$20221021$$MD$US$US
124828986$12482898$6$F$20150715$20221221$20160620$20221223$EXP$$PHHY2016CO012426$NOVARTIS$$67$YR$$F$Y$67$KG$20221223$$CN$CO$CO
124845626$12484562$6$F$20140901$20221128$20160621$20221205$EXP$$US-JAZZ-2016-US-011104$JAZZ$$41$YR$$F$Y$$$20221205$$MD$US$US
124904574$12490457$4$F$20160101$20221011$20160622$20221018$EXP$$US-JAZZ-2016-US-011165$JAZZ$$$$$F$Y$$$20221018$$CN$US$US
124930793$12493079$3$F$$20220929$20160623$20221012$EXP$$US-PFIZER INC-2016295837$PFIZER$Thind, G.. A case of Takotsubo cardiomyopathy in a patient with anaphylaxis treated with epinephrine. Journal of General Internal Medicine. 2016;31:2(1):S497$58$YR$$F$Y$$$20221012$$MD$US$US
125008673$12500867$3$F$20160530$20221118$20160627$20221123$EXP$$CA-BIOGEN-2016BI00253886$BIOGEN$$42$YR$$M$Y$$$20221123$$MD$CA$CA
1250841710$12508417$10$F$20160702$20221117$20160629$20221123$EXP$$CA-PFIZER INC-2016305222$PFIZER$$71$YR$$M$Y$$$20221123$$CN$CA$CA
1251723525$12517235$25$F$20160101$20221116$20160630$20221124$EXP$$CA-ROCHE-1785228$ROCHE$$68$YR$$F$Y$$$20221124$$CN$CA$CA
125172424$12517242$4$F$$20221115$20160630$20221121$EXP$$AU-PFIZER INC-2970434$PFIZER$Kennedy, B.. Interaction between voriconazole and flucloxacillin during treatment of disseminated Scedosporium apiospermum infection. Journal of Antimicrobial Chemotherapy. 2015;70(7):2171-2173$8$DEC$$M$Y$$$20221121$$HP$AU$AU
125173072$12517307$2$F$$20221114$20160630$20221122$EXP$$CA-AstraZeneca-2016SE68616$ASTRAZENECA$$56$YR$$F$Y$91$KG$20221122$$MD$CA$
1251759423$12517594$23$F$20160205$20221209$20160630$20221216$EXP$$PHHY2016CL088658$NOVARTIS$$$$$F$Y$69.5$KG$20221216$$MD$CL$CL
1252085719$12520857$19$F$20190318$20221219$20160701$20221227$EXP$$US-PFIZER INC-2016320631$PFIZER$$66$YR$$F$Y$120$KG$20221227$$CN$US$US
125216122$12521612$2$F$$20221014$20160701$20221018$EXP$$PHHY2016CA090326$NOVARTIS$$$$$F$Y$$$20221018$$CN$CA$CA
1252758724$12527587$24$F$20121001$20221005$20160705$20221013$EXP$$CA-ROCHE-1786206$ROCHE$$70$YR$$M$Y$$$20221011$$CN$CA$CA
125295212$12529521$2$F$20121201$20221003$20160706$20221028$EXP$SE-ABBVIE-16K-150-1665610-00$SE-ABBVIE-16K-150-1665610-00$ABBVIE$$62$YR$$M$Y$$$20221028$$MD$SE$SE
125321247$12532124$7$F$20160304$20220929$20160706$20221004$EXP$$CA-TAKEDA-2016TUS002594$TAKEDA$$61$YR$$F$Y$$$20221004$$HP$CA$CA
125332002$12533200$2$F$$20200526$20160706$20221008$PER$$US-PURDUE-USA-2015-0127244$PURDUE$$$$$F$Y$$$20221008$$LW$US$US
125377179$12537717$9$F$$20221031$20160707$20221107$EXP$$US-ARIAD PHARMACEUTICALS, INC-2016US006397$TAKEDA$$$$$F$Y$70$KG$20221107$$CN$US$US
125383772$12538377$2$F$20160301$20211028$20160707$20221017$EXP$$US-JAZZ-2016-US-012221$JAZZ$$55$YR$$F$Y$$$20221017$$CN$US$US
125387485$12538748$5$F$20160702$20221108$20160708$20221111$EXP$$FR-ROCHE-1789528$ROCHE$$67$YR$$M$Y$81$KG$20221111$$MD$FR$
125418069$12541806$9$F$20160629$20221121$20160708$20221126$EXP$$JP-BAXALTA-2016BXJ004710$TAKEDA$$67$YR$$M$Y$63$KG$20221126$$CN$JP$JP
125462377$12546237$7$F$20160621$20221007$20160711$20221012$EXP$$CA-TAKEDA-2016TUS011508$TAKEDA$$64$YR$$M$Y$$$20221012$$CN$CA$CA
1254955512$12549555$12$F$20130101$20221205$20160712$20221209$EXP$$US-PFIZER INC-2016335757$PFIZER$$72$YR$$F$Y$59$KG$20221209$$CN$US$US
125497395$12549739$5$F$20160530$20221026$20160712$20221102$EXP$$US-PFIZER INC-2016304153$PFIZER$$71$YR$$F$Y$94.8$KG$20221102$$CN$US$US
125549212$12554921$2$F$$20221121$20160713$20221124$PER$$US-BIOGEN-2016BI00263439$BIOGEN$$$$$F$Y$$$20221124$$CN$US$US
125579983$12557998$3$F$20140101$20220929$20160714$20221026$PER$$US-JAZZ-2016-US-000698$JAZZ$$$$$F$Y$58.957$KG$20221026$$MD$US$US
125595733$12559573$3$F$20150720$20221215$20160715$20221221$EXP$$PHHY2015CA076195$NOVARTIS$$50$YR$$F$Y$$$20221222$$MD$CA$CA
125635877$12563587$7$F$20160707$20221123$20160715$20221129$EXP$$US-JAZZ-2016-US-012720$JAZZ$$50$YR$$M$Y$$$20221129$$MD$US$US
1256496029$12564960$29$F$20150721$20221106$20160718$20221108$EXP$$GB-ROCHE-1657697$ROCHE$$75$YR$$F$Y$$$20221108$$MD$GB$GB
1256922210$12569222$10$F$20161205$20221102$20160719$20221107$EXP$$PHHY2016CO096699$NOVARTIS$$73$YR$$M$Y$80$KG$20221107$$CN$CO$CO
1257115229$12571152$29$F$$20221221$20160719$20221230$EXP$$CA-PFIZER INC-2016324063$PFIZER$$85$YR$$M$Y$$$20221230$$MD$CA$CA
125801184$12580118$4$F$$20180312$20160721$20221228$EXP$$PHHY2016PT099049$NOVARTIS$$$$$$Y$$$20221228$$CN$PT$PT
1258496617$12584966$17$F$20160101$20221116$20160722$20221123$EXP$$BR-TAKEDA-2016TUS012630$TAKEDA$$$$$M$Y$59.5$KG$20221123$$CN$BR$BR
125867747$12586774$7$F$$20221118$20160725$20221122$EXP$$US-PFIZER INC-2016350543$PFIZER$$71$YR$$M$Y$$$20221122$$CN$US$US
1258700620$12587006$20$F$20160401$20220930$20160725$20221007$EXP$$CA-ROCHE-1799664$ROCHE$$60$YR$$F$Y$$$20221007$$CN$CA$CA
125908492$12590849$2$F$20140101$20221202$20160726$20221213$PER$$US-AMGEN-USASL2016094749$AMGEN$$55$YR$A$F$Y$$$20221212$$CN$US$US
1259605213$12596052$13$F$20200201$20221221$20160727$20221228$EXP$$CA-ROCHE-1801131$ROCHE$$46$YR$$F$Y$$$20221228$$CN$CA$CA
125964479$12596447$9$F$20010101$20221221$20160726$20221229$EXP$$US-PFIZER INC-2016320501$PFIZER$$55$YR$$M$Y$108.8$KG$20221229$$HP$US$US
1260155920$12601559$20$F$20141209$20221025$20160728$20221031$EXP$$PHHY2013CA096983$NOVARTIS$$64$YR$$F$Y$$$20221031$$MD$CA$CA
126026383$12602638$3$F$$20221114$20160728$20221117$EXP$$JP-GLAXOSMITHKLINE-JP2016JPN107167$GLAXOSMITHKLINE$$$$$$Y$$$20221117$$MD$JP$JP
1260344212$12603442$12$F$20160720$20221115$20160728$20221123$EXP$$ES-ROCHE-1799367$ROCHE$$75$YR$$F$Y$60$KG$20221123$$MD$ES$
1260584815$12605848$15$F$20140523$20221118$20160729$20221122$EXP$$PHHY2014CA065852$NOVARTIS$$32$YR$$F$Y$$$20221122$$HP$CA$CA
1260602521$12606025$21$F$20160101$20221115$20160729$20221118$EXP$$US-PFIZER INC-2016332106$PFIZER$$76$YR$$F$Y$63$KG$20221118$$CN$US$US
1261389712$12613897$12$F$20160718$20221013$20160802$20221018$PER$$US-PFIZER INC-2016354161$PFIZER$$72$YR$$F$Y$83$KG$20221018$$CN$US$US
126142597$12614259$7$F$20221226$20221227$20160802$20221229$EXP$$US-JAZZ-2016-US-002901$JAZZ$$64$YR$$M$Y$$$20221229$$MD$US$US
1261461516$12614615$16$F$20160101$20221103$20160802$20221111$EXP$$US-PFIZER INC-2016022099$PFIZER$$66$YR$$F$Y$86$KG$20221111$$CN$US$US
1261829811$12618298$11$F$20151016$20221207$20160803$20221213$EXP$$PHHY2015CO136842$NOVARTIS$$40$YR$$M$Y$75$KG$20221213$$CN$CO$CO
1262095310$12620953$10$F$20160322$20220912$20160804$20221006$EXP$$PHHY2016IT104278$NOVARTIS$$15$YR$$M$Y$64.5$KG$20221006$$MD$IT$IT
126218886$12621888$6$F$20160701$20221011$20160804$20221019$EXP$FR-PURDUE PHARMA-GBR-2016-0039405$FR-PURDUE PHARMA-GBR-2016-0039405$PURDUE$$76$YR$$F$Y$$$20221019$$MD$FR$FR
126287463$12628746$3$F$$20221101$20160808$20221114$EXP$CA-MLMSERVICE-20160721-0357315-1$CA-Accord-042925$ACCORD$$39$YR$A$M$Y$$$20221114$$HP$CA$CA
1263897021$12638970$21$F$20160711$20221212$20160809$20221221$EXP$$CL-BIOMARINAP-CL-2016-110693$BIOMARIN$$$$$$Y$$$20221221$$CN$US$CL
126396072$12639607$2$F$20120101$20221004$20160810$20221017$EXP$BE-MLMSERVICE-20160721-0358575-1$BE-Accord-042975$ACCORD$$55$YR$A$M$Y$$$20221017$$MD$BE$BE
126404793$12640479$3$F$20160601$20221121$20160810$20221124$EXP$$FR-PFIZER INC-2016371969$PFIZER$$36$YR$$F$Y$47$KG$20221124$$MD$FR$FR
126409323$12640932$3$F$20160524$20221206$20160810$20221213$EXP$FR-AFSSAPS-NT20161022$FR-GLAXOSMITHKLINE-FR2016GSK114734$GLAXOSMITHKLINE$$$$$$Y$$$20221213$$MD$FR$FR
126415634$12641563$4$F$20160701$20221220$20160810$20221228$PER$$US-PFIZER INC-2016366813$PFIZER$$37$YR$$M$Y$85$KG$20221228$$MD$US$US
126439252$12643925$2$F$20160708$20221108$20160811$20221123$EXP$$IT-AUROBINDO-AUR-APL-2016-09996$AUROBINDO$$33$YR$$F$Y$$$20221123$$MD$IT$IT
1264583516$12645835$16$F$20151218$20221017$20160811$20221024$EXP$$PHHY2016CA007779$NOVARTIS$$45$YR$$M$Y$$$20221024$$MD$CA$CA
126473764$12647376$4$F$20160307$20221107$20160812$20221111$EXP$$PHHY2016CA108699$NOVARTIS$$20$YR$$F$Y$$$20221111$$MD$CA$CA
1264903716$12649037$16$F$20160801$20221019$20160812$20221025$EXP$$PHHY2016IN109563$NOVARTIS$$42$YR$$M$Y$$$20221025$$MD$IN$IN
126518236$12651823$6$F$20150101$20221116$20160815$20221118$EXP$$PHHY2016CA111149$NOVARTIS$$$$$F$Y$$$20221118$$MD$CA$CA
1265259313$12652593$13$F$20160805$20221206$20160815$20221212$EXP$$US-PFIZER INC-2016387053$PFIZER$$72$YR$$M$Y$95.5$KG$20221212$$CN$US$US
126591833$12659183$3$F$$20221110$20160817$20221117$EXP$$PHHY2016CA111169$NOVARTIS$$$$$F$Y$$$20221117$$MD$CA$CA
1266158614$12661586$14$F$20160819$20221102$20160817$20221104$PER$$US-PFIZER INC-2016387665$PFIZER$$62$YR$$F$Y$70$KG$20221104$$MD$US$US
126675208$12667520$8$F$20100101$20221130$20160819$20221206$EXP$$US-PFIZER INC-2016392132$PFIZER$$58$YR$$F$Y$115$KG$20221206$$CN$US$US
126683269$12668326$9$F$20160801$20221207$20160819$20221213$EXP$$PHHY2016CA113655$NOVARTIS$$35$YR$$F$Y$$$20221213$$HP$CA$CA
126708007$12670800$7$F$$20221107$20160822$20221114$EXP$$US-JAZZ-2016-US-006149$JAZZ$$$$$M$Y$$$20221114$$MD$US$US
1267308828$12673088$28$F$20160301$20221128$20160822$20221201$EXP$$PHHY2016CA038348$NOVARTIS$$52$YR$$F$Y$$$20221201$$HP$CA$CA
1267361023$12673610$23$F$20160803$20221101$20160822$20221111$EXP$$GB-ELI_LILLY_AND_COMPANY-GB201608008113$ELI LILLY AND CO$$69$YR$$F$Y$101$KG$20221111$$CN$GB$GB
1267604332$12676043$32$F$$20220718$20160823$20221003$EXP$$CA-SA-2015SA146389$SANOFI AVENTIS$$43$YR$A$F$Y$$$20221003$$MD$CA$CA
1267742711$12677427$11$F$20160803$20221013$20160823$20221017$EXP$GB-MHRA-EYC 00143637$PHHY2016GB112616$NOVARTIS$$69$YR$$F$Y$101$KG$20221017$$PH$GB$GB
126774969$12677496$9$F$20210101$20221124$20160823$20221130$EXP$$CA-PFIZER INC-2016373806$PFIZER$$50$YR$$F$Y$$$20221130$$CN$CA$CA
126785298$12678529$8$F$20160802$20221116$20160823$20221121$EXP$$PHHY2016CA115075$NOVARTIS$$66$YR$$M$Y$$$20221121$$MD$CA$CA
1268190131$12681901$31$F$20160803$20221222$20160824$20221229$EXP$GB-MHRA-EYC 00143637$GB-MYLANLABS-2016M1034603$MYLAN$$69$YR$$F$Y$101$KG$20221229$$PH$GB$GB
1268278111$12682781$11$F$20160803$20221101$20160825$20221114$EXP$$GB-MACLEODS PHARMACEUTICALS US LTD-MAC2016003010$MACLEODS$$$$$$Y$$$20221114$$PH$GB$GB
126843893$12684389$3$F$20160101$20221223$20160825$20221229$EXP$FR-AFSSAPS-RE20160793$FR-VIIV HEALTHCARE LIMITED-FR2016GSK121710$VIIV$$$$$$Y$$$20221229$$MD$FR$FR
126848493$12684849$3$F$20160101$20221223$20160825$20221229$EXP$FR-AFSSAPS-RE20160793$FR-GLAXOSMITHKLINE-FR2016GSK121710$GLAXOSMITHKLINE$$$$$$Y$$$20221229$$MD$FR$FR
1268961213$12689612$13$F$20150401$20221107$20160826$20221109$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2016JPN121032$VIIV$$$$$$Y$$$20221109$$MD$JP$JP
1269022429$12690224$29$F$20160803$20221117$20160826$20221125$EXP$GB-MHRA-EYC 00143637$GB-drreddys-GER/UKI/16/0082539$DR REDDYS$$69$YR$E$F$Y$101$KG$20221125$$PH$GB$GB
126924094$12692409$4$F$20160126$20221221$20160828$20221223$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-006994$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20221223$$CN$CA$CA
1269299310$12692993$10$F$20160407$20221209$20160829$20221216$EXP$$CA-ROCHE-1821507$ROCHE$$70$YR$$M$Y$77$KG$20221216$$MD$CA$CA
126963186$12696318$6$F$$20221021$20160830$20221101$EXP$$NP-CIPLA LTD.-2016NP17824$CIPLA$Hirachan A., Baral S., Shareef M., Rijal R. and Tibrewala L.. Amlodipine overdose with hypotension and noncardiogenic pulmonary edema. Nepalese Heart Journal. 2016;13 (1):27 to 29$23$YR$$F$Y$$$20221101$$MD$NP$NP
1269705218$12697052$18$F$20160803$20221115$20160830$20221213$EXP$$GB-AUROBINDO-AUR-APL-2016-10627$AUROBINDO$$69$YR$$F$Y$101$KG$20221213$$PH$GB$GB
126984695$12698469$5$F$20080731$20221003$20160830$20221013$PER$$US-JNJFOC-20160709016$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221013$$HP$US$US
126995653$12699565$3$F$20221220$20221220$20160830$20221228$EXP$$US-KAMADA LIMITED-2016US001402$TAKEDA$$69$YR$$M$Y$$$20221228$$CN$US$US
127001772$12700177$2$F$20160811$20221116$20160830$20221122$EXP$$US-SHIRE-US201610863$TAKEDA$$41$YR$$F$Y$134.24$KG$20221122$$HP$US$US
1270337819$12703378$19$F$20140617$20221107$20160831$20221117$EXP$$JP-JNJFOC-20160824209$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20221117$$MD$JP$JP
127106412$12710641$2$F$20010101$20221208$20160902$20221215$EXP$$US-SHIRE-US201610636$TAKEDA$$$$$F$Y$91$KG$20221215$$MD$US$US
127116162$12711616$2$F$20160101$20221221$20160902$20221228$EXP$$CR-009507513-1609CRI000234$MERCK$$54$YR$$M$Y$$$20221228$$MD$CR$CR
127145078$12714507$8$F$20160101$20221118$20160905$20221125$EXP$$US-JAZZ-2016-US-008662$JAZZ$$$$$F$Y$$$20221125$$CN$US$US
1271532816$12715328$16$F$$20221005$20160906$20221008$EXP$$CA-ROCHE-1825208$ROCHE$$74$YR$$F$Y$$$20221008$$MD$CA$
1271619613$12716196$13$F$20140701$20221108$20160906$20221114$EXP$$PHHY2014CA097752$NOVARTIS$$$$E$F$Y$68$KG$20221114$$HP$CA$CA
127173267$12717326$7$F$20150807$20221129$20160906$20221212$EXP$$PH-BEH-2015053085$CSL BEHRING$$11$YR$C$M$Y$30$KG$20221212$$HP$US$PH
127208505$12720850$5$F$20140101$20221129$20160907$20221202$EXP$$US-JAZZ-2016-US-016598$JAZZ$$$$$F$Y$$$20221202$$CN$US$US
127219635$12721963$5$F$20160824$20221220$20160907$20221227$PER$$US-PFIZER INC-2016409271$PFIZER$$57$YR$$M$Y$92$KG$20221227$$MD$US$US
127247949$12724794$9$F$20160822$20221208$20160908$20221215$EXP$$AU-PFIZER INC-2016407637$PFIZER$$71$YR$$F$Y$101$KG$20221215$$MD$AU$AU
127255474$12725547$4$F$20160101$20221206$20160908$20221212$EXP$$US-JAZZ-2016-US-016834$JAZZ$$$$$F$Y$$$20221212$$MD$US$US
1272747531$12727475$31$F$20160609$20221125$20160909$20221202$EXP$$CA-ROCHE-1827432$ROCHE$$62$YR$$F$Y$74$KG$20221202$$CN$CA$CA
1272907414$12729074$14$F$20160705$20221202$20160909$20221207$EXP$$CA-TAKEDA-2016TUS012100$TAKEDA$$45$YR$$F$Y$$$20221207$$HP$CA$CA
127319598$12731959$8$F$20150101$20221028$20160912$20221102$EXP$$US-PFIZER INC-2016427778$PFIZER$$72$YR$$F$Y$68.027$KG$20221102$$CN$US$US
1273810627$12738106$27$F$20150414$20221116$20160913$20221123$EXP$$FI-SA-2015SA076433$SANOFI AVENTIS$$42$YR$A$M$Y$91.9$KG$20221123$$MD$FI$FI
127435816$12743581$6$F$20160822$20221215$20160914$20221222$EXP$$JP-INCYTE CORPORATION-2016IN005568$INCYTE$$$$$$Y$$$20221222$$MD$JP$JP
1275802011$12758020$11$F$20160101$20221107$20160919$20221111$EXP$$US-PFIZER INC-2016434097$PFIZER$$83$YR$$F$Y$$$20221111$$CN$US$US
127650047$12765004$7$F$20140801$20221130$20160921$20221208$EXP$$CA-ROCHE-1832465$ROCHE$$51$YR$$M$Y$$$20221208$$MD$CA$CA
127674619$12767461$9$F$$20221206$20160921$20221207$EXP$$US-PFIZER INC-2016422273$PFIZER$$74$YR$$F$Y$59.864$KG$20221207$$MD$US$US
127715263$12771526$3$F$20050424$20221201$20160922$20221209$EXP$$US-BIOGEN-2008BI026805$BIOGEN$$42$YR$$F$Y$$$20221209$$CN$US$US
127726833$12772683$3$F$$20221118$20160922$20221122$EXP$$PHHY2015CA105683$NOVARTIS$$$$$F$Y$$$20221122$$MD$CA$CA
1277328617$12773286$17$F$20160101$20221028$20160922$20221104$EXP$$CA-TAKEDA-2016TUS016639$TAKEDA$$52$YR$$F$Y$$$20221104$$MD$CA$CA
1277437223$12774372$23$F$$20220325$20160923$20221222$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076813$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20221223$$HP$CA$CA
1277463014$12774630$14$F$20160531$20180626$20160923$20221028$EXP$$PHHY2016US126962$NOVARTIS$$12$YR$$F$Y$53.3$KG$20221028$$MD$US$US
1277830949$12778309$49$F$$20221207$20160926$20221215$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-075856$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$97$KG$20221215$$HP$CA$CA
1278124222$12781242$22$F$20150101$20221128$20160926$20221205$EXP$$PHHY2015CA109453$NOVARTIS$$65$YR$$F$Y$$$20221205$$CN$CA$CA
127827902$12782790$2$F$20100101$20221205$20160927$20221223$PER$$US-BIOGEN-2016BI00294221$BIOGEN$$$$$F$Y$77.1$KG$20221223$$CN$US$US
1278807624$12788076$24$F$20150729$20221031$20160928$20221111$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-077476$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$90$KG$20221111$$HP$CA$CA
127891172$12789117$2$F$20160904$20221101$20160928$20221102$PER$$US-SHIRE-US201612229$TAKEDA$$48$YR$$F$Y$$$20221102$$MD$US$US
127900308$12790030$8$F$$20221115$20160928$20221121$EXP$$BR-PFIZER INC-2016448927$PFIZER$$41$YR$$M$Y$$$20221121$$CN$BR$BR
1279156719$12791567$19$F$20160916$20221122$20160929$20221129$EXP$$CA-ROCHE-1835532$ROCHE$$40$YR$$M$Y$$$20221129$$CN$CA$CA
127924905$12792490$5$F$20080201$20220929$20160929$20221012$PER$$US-JNJFOC-20160916929$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20221010$$LW$US$US
127966189$12796618$9$F$20160826$20221212$20160929$20221215$EXP$$US-PFIZER INC-2016407480$PFIZER$$42$YR$$F$Y$92$KG$20221215$$MD$US$US
127971963$12797196$3$F$20160801$20221118$20160930$20221123$PER$$US-PFIZER INC-2016456524$PFIZER$$64$YR$$F$Y$49.9$KG$20221123$$HP$US$US
1279748818$12797488$18$F$20140610$20221026$20160930$20221031$EXP$$PHHY2011CA40965$NOVARTIS$$79$YR$$F$Y$$$20221031$$HP$CA$CA
1279856612$12798566$12$F$20120625$20221109$20160930$20221124$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-124801$RANBAXY$Cuny P, Houot M, Ginisty S, Horowicz S, Plassart F, Mentec H et al. Quetiapine and anticholinergic drugs induced ischaemic colitis: A case study. Encephale. 2016;13 Sep:Epub ahead of print$34$YR$$M$Y$$$20221124$$MD$FR$FR
128004404$12800440$4$F$20140101$20221010$20160930$20221014$EXP$$US-JAZZ-2016-US-018638$JAZZ$$$$$F$Y$$$20221014$$CN$US$US
128044032$12804403$2$F$$20160923$20161003$20221003$EXP$$PHHY2016US132664$NOVARTIS$Williams JR, Tenforde MW, Chan JD, Ko A, Graham SM. Safety and clinical response of intraventricular caspofungin for Scedosporium apiospermum complex central nervous system infection. MEDICAL MYCOLOGY CASE REPORTS. 2016;13:1-4$71$YR$$F$Y$$$20221003$$HP$US$US
1280942514$12809425$14$F$20160903$20221004$20161005$20221007$EXP$$CA-TAKEDA-2016TUS017672$TAKEDA$$63$YR$$M$Y$$$20221007$$CN$CA$CA
1282551316$12825513$16$F$20221017$20221026$20161006$20221102$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK144027$GLAXOSMITHKLINE$$$$$$Y$$$20221102$$CN$BR$BR
128268562$12826856$2$F$$20220318$20161006$20221014$PER$$US-INDIVIOR LIMITED-INDV-088194-2016$RECKITT BENCKISER$$$$$M$Y$$$20221014$$CN$US$US
128413273$12841327$3$F$20161005$20221111$20161012$20221114$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2016-NB-000137$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$66.4$KG$20221114$$MD$JP$JP
128415612$12841561$2$F$20000711$20221213$20161012$20221219$EXP$$US-JNJFOC-20161006407$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20221219$$HP$US$US
1284257851$12842578$51$F$$20221222$20161013$20221227$EXP$$CA-Orion Corporation ORION PHARMA-TREX2016-1958$ORION$$63$YR$A$F$Y$$$20221228$$MD$CA$
128452457$12845245$7$F$20170101$20221019$20161013$20221021$EXP$$CA-TAKEDA-2016TUS013310$TAKEDA$$53$YR$$M$Y$$$20221021$$MD$CA$CA
1284910512$12849105$12$F$20160921$20221116$20161014$20221122$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-084065$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$78$KG$20221122$$CN$CA$CA
128540802$12854080$2$F$20080101$20220928$20161017$20221006$EXP$$US-JNJFOC-20161009352$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221006$$HP$US$US
1285693810$12856938$10$F$20160901$20221201$20161018$20221206$PER$$US-PFIZER INC-2016482587$PFIZER$$62$YR$$M$Y$74$KG$20221206$$CN$US$US
128592433$12859243$3$F$20161010$20221031$20161018$20221101$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-085274$BRISTOL MYERS SQUIBB$Jain N, Senapati J, Thakral B, Ferrajoli A, Thompson P, Burger J, et al. A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell richter transformation of CLL. Blood Advances. 2022; 1-24.doi:10.1182/bloodadvances.2022008790.$$$$M$Y$$$20221102$$MD$US$US
128598976$12859897$6$F$20160725$20221123$20161018$20221123$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2016-BI-066895$BOEHRINGER INGELHEIM$$90$YR$E$M$Y$70.8$KG$20221123$$MD$US$US
128620415$12862041$5$F$20160829$20170119$20161019$20221211$EXP$$FR-TEVA-704749ACC$TEVA$$71$YR$E$M$Y$$$20221212$$HP$FR$FR
128630377$12863037$7$F$20160901$20221215$20161019$20221221$PER$$US-PFIZER INC-2016487980$PFIZER$$64$YR$$M$Y$90.703$KG$20221221$$HP$US$US
128639229$12863922$9$F$20201231$20221228$20161019$20221230$EXP$$CA-TAKEDA-2016TUS018720$TAKEDA$$49$YR$$F$Y$$$20221230$$CN$CA$CA
128640405$12864040$5$F$20150601$20221024$20161019$20221029$EXP$$US-SHIRE-US201614677$TAKEDA$$44$YR$$F$Y$107.4$KG$20221029$$CN$US$US
128672216$12867221$6$F$20160101$20221212$20161020$20221220$EXP$$US-JAZZ-2016-US-014683$JAZZ$$$$$F$Y$$$20221220$$HP$US$US
128694655$12869465$5$F$20221030$20221215$20161021$20221222$EXP$$PHHY2016CA141723$NOVARTIS$$60$YR$$F$Y$$$20221222$$CN$CA$CA
128702817$12870281$7$F$20151105$20221221$20161021$20221226$EXP$$FR-GLAXOSMITHKLINE-FR2016GSK150405$GLAXOSMITHKLINE$$$$$$Y$$$20221226$$MD$FR$FR
128714059$12871405$9$F$20101124$20221222$20161021$20221223$EXP$$US-NAPPMUNDI-USA-2016-0131102$PURDUE$$70$YR$$M$Y$220$KG$20221223$$CN$US$US
128731326$12873132$6$F$20160531$20161219$20161021$20221031$EXP$$PHHO2016US013356$NOVARTIS$$12$YR$$F$Y$50.1$KG$20221031$$MD$US$US
128754122$12875412$2$F$20081209$20221206$20161024$20221213$EXP$$US-ROCHE-606607$ROCHE$$62$YR$$F$Y$$$20221213$$MD$US$US
1287853810$12878538$10$F$20151120$20221115$20161024$20221116$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-029278$BRISTOL MYERS SQUIBB$Ishii D, et al. A case of renal disorder during nivolumab therapy. The Japanese Journal of Nephrology 2017;59(6):914.$79$YR$E$M$Y$50$KG$20221116$$MD$JP$JP
1287997515$12879975$15$F$20161101$20221123$20161025$20221128$EXP$$US-PFIZER INC-2016495242$PFIZER$$83$YR$$F$Y$72$KG$20221128$$CN$US$US
128803473$12880347$3$F$20160901$20221216$20161025$20221222$EXP$$US-PFIZER INC-2016489834$PFIZER$$65$YR$$F$Y$99.34$KG$20221222$$CN$US$US
128813593$12881359$3$F$20070101$20220926$20161025$20221005$PER$$US-JNJFOC-20150713734$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221005$$HP$US$US
128814264$12881426$4$F$$20220922$20161025$20221002$PER$$US-JNJFOC-20161011983$JOHNSON AND JOHNSON$$$$$M$Y$$$20221002$$HP$US$US
128814453$12881445$3$F$20061001$20220922$20161025$20221003$EXP$$US-JNJFOC-20161011989$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20221003$$HP$US$US
128814466$12881446$6$F$20060901$20221020$20161025$20221027$EXP$$US-JNJFOC-20161011990$JOHNSON AND JOHNSON$$21$YR$A$M$Y$128.94$KG$20221027$$HP$US$US
128814504$12881450$4$F$20030301$20221020$20161025$20221028$PER$$US-JNJFOC-20161011992$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20221028$$HP$US$US
128815225$12881522$5$F$20061201$20221014$20161025$20221018$PER$$US-JNJFOC-20161012337$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20221018$$HP$US$US
128815334$12881533$4$F$20080401$20220922$20161025$20221001$PER$$US-JNJFOC-20161012352$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20221001$$HP$US$US
128826632$12882663$2$F$20161005$20221116$20161025$20221121$PER$$US-PFIZER INC-2016495644$PFIZER$$58$YR$$F$Y$$$20221121$$CN$US$US
128890973$12889097$3$F$20220701$20221025$20161027$20221031$EXP$$US-PFIZER INC-2016495265$PFIZER$$58$YR$$F$Y$$$20221031$$CN$US$US
1289195012$12891950$12$F$$20220921$20161028$20221003$EXP$$CA-APOPHARMA INC-2016AP013468$APOTEX$$58$YR$$M$Y$$$20221003$$HP$CA$CA
128946893$12894689$3$F$$20221006$20161028$20221011$EXP$$KR-SA-2016SA192117$SANOFI AVENTIS$Kim H, Bang ES, Lim S-K, Lee JM.. DRESS syndrome and acute generalized exanthematous pustulosis induced by antituberculosis medications and moxifloxacin: Case report.. Int J Clin Pharmacol Ther.. 2016;54(10):808-15.$25$YR$A$F$Y$40$KG$20221011$$PH$KR$KR
128981617$12898161$7$F$20161010$20221206$20161031$20221208$EXP$$CA-TAKEDA-2016TUS019342$TAKEDA$$51$YR$$M$Y$$$20221208$$CN$CA$CA
129015668$12901566$8$F$20161025$20221116$20161102$20221122$EXP$$DE-ROCHE-1848167$ROCHE$$67$YR$$M$Y$$$20221122$$MD$DE$
1290698912$12906989$12$F$20160725$20221223$20161103$20221229$EXP$$PHHY2016CA148830$NOVARTIS$$58$YR$$M$Y$$$20221229$$CN$CA$CA
129082513$12908251$3$F$$20220921$20161103$20221004$EXP$$JP-PFIZER INC-2016511210$PFIZER$Urae, S.. Tumor Lysis-like Syndrome in Eosinophilic Disease of the Lung: A Case Report and Review of the Literature. Internal Medicine. 2016;55 (20):3029-3034$77$YR$$M$Y$$$20221004$$MD$JP$JP
1291173227$12911732$27$F$20180614$20221214$20161104$20221220$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK144075$GLAXOSMITHKLINE$$$$$$Y$$$20221220$$CN$BR$BR
129132333$12913233$3$F$$20220921$20161104$20221004$EXP$$JP-PFIZER INC-2016511338$PFIZER$Yang, S.. Steroid-induced tumor lysis symdrome in a patient with preleukemia. Clinical Nephrology. 2003;59 (3):201-205$32$YR$$M$Y$$$20221004$$MD$TW$TW
129132746$12913274$6$F$20160425$20221129$20161104$20221206$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-035678$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20221206$$CN$CA$CA
1291330611$12913306$11$F$$20221201$20161104$20221206$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091788$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20221206$$MD$CA$CA
1291742713$12917427$13$F$20180101$20220928$20161107$20221012$EXP$$US-PFIZER INC-2016514720$MYLAN$$$$$F$Y$97$KG$20221012$$HP$US$US
129175146$12917514$6$F$20150701$20221206$20161107$20221213$EXP$$PHHY2015CA089817$NOVARTIS$$41$YR$$F$Y$$$20221213$$CN$CA$CA
1292320724$12923207$24$F$20201127$20221124$20161109$20221129$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK044940$GLAXOSMITHKLINE$$$$$$Y$$$20221129$$CN$BR$BR
129235696$12923569$6$F$20160821$20221004$20161108$20221012$EXP$$BR-BIOGEN-2016BI00315184$BIOGEN$$0$YR$$M$Y$2.85$KG$20221012$$CN$BR$BR
129272294$12927229$4$F$20161001$20221206$20161109$20221212$EXP$$US-JAZZ-2016-US-021819$JAZZ$$56$YR$$F$Y$$$20221213$$CN$US$US
1292783615$12927836$15$F$20130417$20221013$20161110$20221020$EXP$$CA-ROCHE-1851729$ROCHE$$49$YR$$F$Y$$$20221020$$CN$CA$CA
1292888834$12928888$34$F$$20220728$20161110$20221222$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091881$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20221222$$HP$CA$CA
1292888921$12928889$21$F$$20221020$20161110$20221026$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091709$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20221026$$MD$CA$CA
129293364$12929336$4$F$20160528$20221229$20161110$20221230$EXP$$FR-009507513-1611FRA003790$MERCK$$79$YR$$M$Y$103.5$KG$20221230$$HP$FR$FR
129301778$12930177$8$F$$20221020$20161110$20221025$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-093180$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20221025$$CN$CA$CA
129321032$12932103$2$F$20161104$20221006$20161111$20221013$EXP$$ES-ROCHE-1853276$ROCHE$$74$YR$$M$Y$66$KG$20221011$$MD$ES$ES
129402602$12940260$2$F$20160317$20221105$20161115$20221118$EXP$$IT-AUROBINDO-AUR-APL-2016-13847$AUROBINDO$$48$YR$$F$Y$$$20221118$$MD$IT$IT
129431622$12943162$2$F$$20151002$20161115$20221020$PER$$US-NOVOPROD-466507$NOVO NORDISK$$40$YR$$F$Y$$$20221020$$MD$US$US
129432722$12943272$2$F$$20160225$20161115$20221020$PER$$US-NOVOPROD-482415$NOVO NORDISK$$$$$F$Y$$$20221020$$CN$US$US
129432752$12943275$2$F$$20160121$20161115$20221020$PER$$US-NOVOPROD-482122$NOVO NORDISK$$60$YR$$F$Y$$$20221020$$CN$US$US
129433102$12943310$2$F$20160716$20160718$20161115$20221020$PER$$US-NOVOPROD-503338$NOVO NORDISK$$86$YR$$F$Y$$$20221020$$CN$US$US
129433212$12943321$2$F$20160701$20160727$20161115$20221020$PER$$US-NOVOPROD-504848$NOVO NORDISK$$58$YR$$F$Y$$$20221020$$CN$US$US
129433222$12943322$2$F$20150101$20160616$20161115$20221020$PER$$US-NOVOPROD-498599$NOVO NORDISK$$71$YR$$F$Y$$$20221020$$MD$US$US
1294337732$12943377$32$F$20220401$20221111$20161115$20221114$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK075816$GLAXOSMITHKLINE$$$$$$Y$$$20221114$$MD$BR$BR
129460879$12946087$9$F$$20221227$20161115$20221230$EXP$$US-JAZZ-2016-US-022236$JAZZ$$$$$M$Y$$$20221230$$MD$US$US
1294773419$12947734$19$F$20150101$20221026$20161117$20221102$EXP$$CA-ROCHE-1854413$ROCHE$$61$YR$$F$Y$141$KG$20221102$$MD$CA$CA
1294979814$12949798$14$F$20150901$20221221$20161117$20221228$EXP$$PHHY2016CA114428$NOVARTIS$$52$YR$$F$Y$$$20221228$$MD$CA$CA
1295427710$12954277$10$F$20160328$20221031$20161118$20221102$EXP$$JP-SHIRE-JP201616794AA$TAKEDA$$0$YR$$F$Y$5.4$KG$20221102$$MD$JP$JP
129565822$12956582$2$F$$20221128$20161118$20221202$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2016-BI-077034$BOEHRINGER INGELHEIM$$40$YR$A$F$Y$94$KG$20221202$$PH$CA$CA
1295753112$12957531$12$F$20111201$20221207$20161118$20221212$EXP$$US-SHIRE-US201617384$TAKEDA$$1$YR$$M$Y$29$KG$20221212$$HP$US$US
129575899$12957589$9$F$20130101$20221020$20161118$20221026$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-093145$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20221027$$MD$CA$CA
129582968$12958296$8$F$$20221124$20161121$20221227$EXP$$CA-ROCHE-1627311$ROCHE$$40$YR$$F$Y$$$20221227$$MD$CA$
1296415627$12964156$27$F$20160310$20221206$20161122$20221213$EXP$$PHHY2016CA034937$NOVARTIS$$71$YR$$F$Y$$$20221213$$CN$CA$CA
1296897411$12968974$11$F$$20221128$20161123$20221201$PER$$US-PFIZER INC-2016545465$PFIZER$$72$YR$$F$Y$56.689$KG$20221201$$CN$US$US
1296928613$12969286$13$F$20160101$20221221$20161123$20221222$EXP$$PHHY2016CA151435$NOVARTIS$$67$YR$$M$Y$$$20221222$$CN$CA$CA
1297160410$12971604$10$F$20160501$20221027$20161123$20221102$EXP$$US-JAZZ-2016-US-023004$JAZZ$$38$YR$$M$Y$$$20221102$$MD$US$US
129740596$12974059$6$F$20161117$20221012$20161124$20221013$EXP$$FR-ROCHE-1858054$ROCHE$$71$YR$$M$Y$80$KG$20221013$$MD$FR$FR
1297420329$12974203$29$F$20141127$20221222$20161125$20221227$EXP$$CA-ROCHE-1858307$ROCHE$$42$YR$$F$Y$$$20221227$$CN$CA$CA
1297591114$12975911$14$F$20110101$20220928$20161125$20221006$EXP$$GB-MYLANLABS-2016M1035518$MYLAN$$44$YR$$F$Y$114$KG$20221006$$MD$GB$GB
1297671514$12976715$14$F$20200109$20221015$20161128$20221021$EXP$$PHHY2016CA084468$NOVARTIS$$86$YR$$M$Y$$$20221021$$CN$CA$CA
129781427$12978142$7$F$$20221214$20161128$20221222$PER$$US-PFIZER INC-2016448534$PFIZER$$62$YR$$F$Y$$$20221222$$HP$US$US
1297914824$12979148$24$F$20221011$20221026$20161128$20221031$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK087434$GLAXOSMITHKLINE$$$$$$Y$$$20221031$$CN$BR$BR
129816348$12981634$8$F$20190719$20221212$20161129$20221219$EXP$$CA-ROCHE-1860859$ROCHE$$39$YR$$M$Y$$$20221219$$HP$CA$CA
1298165814$12981658$14$F$20160927$20221027$20161129$20221103$EXP$$CA-ROCHE-1860260$ROCHE$$52$YR$$F$Y$$$20221103$$CN$CA$CA
129849016$12984901$6$F$$20221104$20161129$20221108$EXP$$US-PURDUE-USA-2016-0134131$PURDUE$$$$$F$Y$67.59$KG$20221108$$MD$US$US
129879488$12987948$8$F$20160101$20221005$20161130$20221010$EXP$$US-BAXALTA-2016BLT008577$TAKEDA$$$$$F$Y$91$KG$20221010$$HP$US$US
129889867$12988986$7$F$$20221216$20161201$20221221$EXP$$CA-ROCHE-1860198$ROCHE$$$$$M$Y$$$20221221$$HP$CA$
129907712$12990771$2$F$$20221221$20161201$20221230$EXP$$CA-JNJFOC-20161128255$JOHNSON AND JOHNSON$$52$YR$A$F$Y$63.56$KG$20221230$$HP$CA$CA
1299241836$12992418$36$F$20161123$20220930$20161202$20221013$EXP$$CA-ROCHE-1862239$ROCHE$$53$YR$$F$Y$$$20221013$$CN$CA$CA
129925948$12992594$8$F$20161101$20221214$20161202$20221221$PER$$JP-AMGEN-JPNSP2016152588$AMGEN$$47$YR$A$M$Y$85$KG$20221221$$MD$JP$JP
1299455328$12994553$28$F$20160101$20221114$20161202$20221119$EXP$$PHHY2016CA074240$NOVARTIS$$$$$M$Y$$$20221119$$CN$CA$CA
129975195$12997519$5$F$20140212$20221212$20161205$20221215$EXP$$CA-ROCHE-1342887$ROCHE$$63$YR$$F$Y$82.8$KG$20221214$$HP$CA$
1299861416$12998614$16$F$20160614$20221221$20161205$20221227$EXP$$GB-TAKEDA-2016TUS021619$TAKEDA$$$$A$M$Y$$$20221227$$MD$GB$GB
129997106$12999710$6$F$20161116$20221117$20161205$20221121$EXP$$PHHY2016CA166327$NOVARTIS$$32$YR$$M$Y$$$20221121$$CN$CA$CA
130007592$13000759$2$F$20161003$20221105$20161206$20221119$EXP$$IT-AUROBINDO-AUR-APL-2016-14713$AUROBINDO$$51$YR$$F$Y$$$20221119$$MD$IT$IT
1300136918$13001369$18$F$20160101$20220929$20161206$20221001$EXP$$PHHY2016CA114488$NOVARTIS$$$$$F$Y$75$KG$20221001$$CN$CA$CA
130036203$13003620$3$F$20160528$20221221$20161206$20221228$EXP$$FR-ELI_LILLY_AND_COMPANY-FR201611009644$ELI LILLY AND CO$$79$YR$$M$Y$103.5$KG$20221228$$CN$FR$FR
130036768$13003676$8$F$$20221208$20161206$20221208$EXP$$US-PFIZER INC-2015308077$PFIZER$$63$YR$$F$Y$73.8$KG$20221208$$CN$US$US
130040622$13004062$2$F$$20161031$20161206$20221026$PER$$US-JAZZ-2016-US-021669$JAZZ$$$$$M$Y$$$20221026$$HP$US$US
130041264$13004126$4$F$$20221227$20161206$20221229$EXP$$US-JAZZ-2016-US-021749$JAZZ$$$$$F$Y$$$20221229$$HP$US$US
130049454$13004945$4$F$20120625$20221109$20161207$20221121$EXP$FR-MLMSERVICE-20161123-0509896-1$FR-LUPIN PHARMACEUTICALS INC.-2016-05377$LUPIN$Cuny P, Houot M, Ginisty S, Horowicz S, Plassart F, Mentec H et al. Quetiapine and anticholinergic drugs induced ischaemic colitis: A case study. Encephale. 2016$34$YR$$M$Y$$$20221121$$MD$FR$FR
130076682$13007668$2$F$20160818$20220927$20161207$20221003$PER$$US-AMGEN-USASL2016172854$AMGEN$$68$YR$E$F$Y$$$20221003$$CN$US$US
130099103$13009910$3$F$20140720$20221227$20161208$20221230$EXP$$PHHY2014IN084165$NOVARTIS$$34$YR$$F$Y$$$20221230$$CN$IN$IN
1301226122$13012261$22$F$20170823$20221227$20161209$20221230$EXP$$US-PFIZER INC-2016561839$PFIZER$$57$YR$$F$Y$114$KG$20221230$$CN$US$US
130177477$13017747$7$F$$20221107$20161212$20221111$EXP$$US-PFIZER INC-2016564692$PFIZER$$83$YR$$F$Y$$$20221111$$CN$US$US
1302193810$13021938$10$F$20120623$20221103$20161213$20221117$EXP$$FR-AUROBINDO-AUR-APL-2016-15207$AUROBINDO$Cuny P, Houot M, Ginisty S, Horowicz S, Plassart F, Mentec H, Eftekhari  P. et al. Quetiapine and anticholinergic drugs induced ischaemic colitis. A case study Encephale. 2016;43:81-84$34$YR$$M$Y$$$20221117$$MD$FR$FR
1302369512$13023695$12$F$20151222$20221007$20161213$20221013$EXP$$US-PFIZER INC-2016571070$PFIZER$$68$YR$$M$Y$84$KG$20221013$$CN$US$US
1302401114$13024011$14$F$20161101$20211116$20161213$20221212$EXP$$US-PFIZER INC-2016569208$PFIZER$$40$YR$$F$Y$$$20221212$$CN$US$US
130301234$13030123$4$F$$20221107$20161215$20221117$EXP$$PHJP2016JP036265$NOVARTIS$$$$A$M$Y$$$20221117$$MD$JP$JP
1303510110$13035101$10$F$20050201$20221012$20161216$20221018$EXP$$US-PFIZER INC-2016579864$PFIZER$$63$YR$$M$Y$95$KG$20221018$$CN$US$US
130358825$13035882$5$F$20130201$20221006$20161216$20221007$PER$$US-PFIZER INC-2016584425$PFIZER$$60$YR$$F$Y$112$KG$20221007$$CN$US$US
130369477$13036947$7$F$20160101$20221219$20161216$20221223$EXP$$CA-TAKEDA-2016TUS021434$TAKEDA$$48$YR$$F$Y$$$20221223$$CN$CA$CA
1303863515$13038635$15$F$20151228$20221011$20161219$20221019$EXP$$JP-AEGERION PHARMACEUTICAL INC.-AEGR002872$AEGERION$$$$$$Y$$$20221019$$MD$JP$JP
130420884$13042088$4$F$20120601$20221001$20161219$20221004$PER$$US-PFIZER INC-2016584349$PFIZER$$31$YR$$F$Y$111.1$KG$20221004$$LW$US$US
130469199$13046919$9$F$20220101$20221004$20161220$20221010$EXP$$PHHY2016CA172480$NOVARTIS$$60$YR$$M$Y$$$20221010$$CN$CA$CA
130476542$13047654$2$F$20161101$20221117$20161220$20221125$EXP$$US-JAZZ-2016-US-023967$JAZZ$$75$YR$$M$Y$$$20221125$$CN$US$US
130483473$13048347$3$F$20161129$20221129$20161221$20221208$EXP$$JP-TEVA-721834ISR$TEVA$$35$YR$A$F$Y$$$20221208$$MD$JP$JP
1305843511$13058435$11$F$$20221220$20161223$20221230$EXP$$CA-APOTEX-2016AP015741$APOTEX$$73$YR$$F$Y$$$20221230$$MD$CA$CA
130586493$13058649$3$F$20120301$20221005$20161223$20221006$PER$$US-PFIZER INC-2016596189$PFIZER$$42$YR$$F$Y$$$20221006$$LW$US$US
1305905611$13059056$11$F$$20221122$20161223$20221202$EXP$$CA-APOTEX-2016AP015753$APOTEX$$72$YR$$F$Y$$$20221202$$MD$CA$CA
130595802$13059580$2$F$$20221014$20161223$20221017$EXP$$ES-GLAXOSMITHKLINE-ES2016GSK189344$GLAXOSMITHKLINE$Ventura-Ribes O, Machancoses FH, Rosel Remirez JF. Vasculitis after blood pressure monitoring. Reumatol-Clin. 2016;12(4):216-218$80$YR$$M$Y$$$20221017$$HP$ES$ES
130598962$13059896$2$F$20101225$20221003$20161223$20221010$EXP$IT-MINISAL02-387319$IT-MYLANLABS-2016M1056156$MYLAN$Annaloro C, Costa A, Fracchiolla NS, Mometto G, Artuso S, Saporiti G, et al. Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: A case report.. Clinical Case Reports. 2015;3 (7):650-5$55$YR$$M$Y$$$20221010$$HP$IT$IT
130623974$13062397$4$F$20160101$20221214$20161226$20221222$EXP$$CA-TAKEDA-2016TUS022808$TAKEDA$$85$YR$$F$Y$$$20221222$$HP$CA$CA
1306563712$13065637$12$F$20090222$20221205$20161227$20221209$EXP$$US-PFIZER INC-2016595970$PFIZER$$59$YR$$F$Y$73$KG$20221209$$CN$US$US
1307079914$13070799$14$F$20090209$20221227$20161229$20221230$EXP$$CA-Orion Corporation ORION PHARMA-TREX2016-2790$ORION$$57$YR$A$M$Y$$$20221230$$MD$CA$
1307383416$13073834$16$F$20161128$20221213$20161229$20221217$EXP$$CA-TAKEDA-2016TUS023148$TAKEDA$$67$YR$$F$Y$$$20221217$$CN$CA$CA
130748976$13074897$6$F$20161214$20221220$20161230$20221227$PER$$US-PFIZER INC-2016596467$PFIZER$$35$YR$$M$Y$104$KG$20221227$$MD$US$US
130753587$13075358$7$F$20150603$20221006$20161230$20221011$EXP$$US-AstraZeneca-2016SF36386$ASTRAZENECA$$82$YR$$M$Y$83.5$KG$20221011$$LW$US$
1307700011$13077000$11$F$20161206$20221219$20161230$20221230$EXP$$CZ-BIOGEN-2016BI00328821$BIOGEN$$29$YR$$M$Y$$$20221230$$MD$CZ$CZ
130804845$13080484$5$F$$20220929$20170103$20221006$EXP$$CA-PFIZER INC-2016523517$PFIZER$$35$YR$$F$Y$$$20221006$$CN$CA$CA
130810228$13081022$8$F$$20221005$20170103$20221007$PER$$US-PFIZER INC-2016601370$PFIZER$$65$YR$$F$Y$$$20221007$$CN$US$US
1308165710$13081657$10$F$20080101$20221229$20170103$20221230$EXP$$US-PFIZER INC-2016598166$PFIZER$$38$YR$$F$Y$49.9$KG$20221230$$CN$US$US
130846534$13084653$4$F$20160912$20170118$20170104$20221212$EXP$IT-MINISAL02-389561$IT-TEVA-725686ACC$TEVA$$43$YR$A$F$Y$$$20221212$$MD$IT$IT
1308545212$13085452$12$F$$20221208$20170104$20221215$EXP$$US-PFIZER INC-2015269766$PFIZER$$83$YR$$F$Y$55$KG$20221215$$MD$US$US
130877668$13087766$8$F$20100329$20220930$20170105$20221008$EXP$$US-AstraZeneca-2017SE00122$ASTRAZENECA$$18575$DY$$F$Y$113.9$KG$20221008$$LW$US$
130895609$13089560$9$F$20201123$20221129$20170105$20221201$PER$$US-PFIZER INC-2017004247$PFIZER$$66$YR$$M$Y$71$KG$20221201$$CN$US$US
1309076910$13090769$10$F$$20221025$20170106$20221109$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-130668$RANBAXY$$30$YR$$M$Y$$$20221109$$PH$GB$GB
1309116614$13091166$14$F$$20221215$20170106$20221228$EXP$$GB-AUROBINDO-AUR-APL-2016-16077$AUROBINDO$$30$YR$$M$Y$$$20221228$$PH$GB$GB
130939163$13093916$3$F$20221101$20221215$20170106$20221221$EXP$$US-PFIZER INC-2016010159$PFIZER$$62$YR$$F$Y$$$20221221$$HP$US$US
1309437313$13094373$13$F$20181201$20221215$20170106$20221221$EXP$$US-PFIZER INC-2017005477$PFIZER$$63$YR$$F$Y$65.76$KG$20221221$$HP$US$US
130954754$13095475$4$F$$20221010$20170108$20221017$EXP$$GB-MYLANLABS-2017M1000526$MYLAN$$$$$M$Y$$$20221017$$MD$GB$GB
130955484$13095548$4$F$$20221222$20170108$20221227$EXP$$US-BIOGEN-2017BI00338624$BIOGEN$$$$$F$Y$$$20221227$$CN$US$US
1309595312$13095953$12$F$20160226$20221104$20170109$20221110$EXP$$CA-ROCHE-1782427$ROCHE$$$$A$F$Y$123.5$KG$20221110$$MD$CA$CA
130970466$13097046$6$F$20161208$20221212$20170109$20221219$PER$$US-PFIZER INC-2017007183$PFIZER$$65$YR$$F$Y$98$KG$20221219$$CN$US$US
131000368$13100036$8$F$$20221130$20170110$20221205$EXP$$CA-ROCHE-1877137$ROCHE$$69$YR$$F$Y$$$20221205$$MD$CA$
1310187616$13101876$16$F$20170101$20221031$20170110$20221102$EXP$$US-PFIZER INC-2017006260$PFIZER$$72$YR$$F$Y$73.3$KG$20221102$$CN$US$US
131044923$13104492$3$F$$20221212$20170111$20221216$PER$$US-BIOGEN-2017BI00340115$BIOGEN$$$$$F$Y$$$20221216$$CN$US$US
1310615211$13106152$11$F$20161209$20221207$20170111$20221213$PER$$US-PFIZER INC-2017007803$PFIZER$$61$YR$$M$Y$95.25$KG$20221213$$MD$US$US
131070847$13107084$7$F$$20221121$20170111$20221124$EXP$$CA-ROCHE-1789917$ROCHE$$$$$F$Y$$$20221124$$MD$CA$
1310779811$13107798$11$F$20150612$20221220$20170112$20221226$EXP$$CA-Orion Corporation ORION PHARMA-TREX2017-0119$ORION$$73$YR$E$F$Y$$$20221226$$MD$CA$
131095753$13109575$3$F$20070101$20221109$20170112$20221114$EXP$$US-TAKEDA-2017TUS000775$TAKEDA$$$$$$Y$$$20221114$$CN$US$US
131115623$13111562$3$F$$20221118$20170112$20221125$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-000750$BRISTOL MYERS SQUIBB$Reuss JE, Kunk PR, Stowman AM, Gru AA, Slingluff CL, Gaughan EM. Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report andamp; review of the literature. Journal for ImmunoTherapy of cancer. 2016; 4(94): 1-6.doi:10.1186/s40425-016-0199-9.$32$YR$A$F$Y$$$20221125$$CN$US$US
1311187019$13111870$19$F$$20221121$20170113$20221122$EXP$$CA-ROCHE-1717236$ROCHE$$$$$F$Y$$$20221122$$MD$CA$
1311312211$13113122$11$F$$20221212$20170113$20221218$PER$$CA-AMGEN-CANSP2017001862$AMGEN$$58$YR$A$F$Y$$$20221218$$MD$CA$CA
1311313323$13113133$23$F$20130101$20221222$20170113$20221228$EXP$$CA-Orion Corporation ORION PHARMA-TREX2016-0862$ORION$$65$YR$E$F$Y$$$20221228$$MD$CA$
131135934$13113593$4$F$$20221213$20170113$20221214$EXP$$US-BIOGEN-2017BI00342151$BIOGEN$$$$$F$Y$$$20221214$$CN$US$US
131155734$13115573$4$F$20160101$20220721$20170114$20221026$PER$$US-JAZZ-2016-US-022692$JAZZ$$$$$F$Y$$$20221026$$CN$US$US
131162183$13116218$3$F$20161214$20221125$20170116$20221206$PER$$GB-AMGEN-GBRSP2016180759$AMGEN$$54$YR$A$F$Y$$$20221205$$CN$GB$GB
1311644513$13116445$13$F$$20220921$20170116$20221006$EXP$$CA-BAUSCH-BL-2017-001069$BAUSCH AND LOMB$$74$YR$$F$Y$$$20221006$$CN$CA$CA
131167729$13116772$9$F$$20221201$20170116$20221202$EXP$$CA-ROCHE-1878330$ROCHE$$57$YR$$F$Y$$$20221202$$MD$CA$
1311681612$13116816$12$F$$20221031$20170116$20221102$PER$$US-PFIZER INC-2017015915$PFIZER$$69$YR$$F$Y$$$20221102$$CN$US$US
131178844$13117884$4$F$20040101$20221012$20170116$20221020$PER$$US-JNJFOC-20170104055$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221021$$LW$US$US
131178983$13117898$3$F$$20221213$20170116$20221215$EXP$$US-JNJFOC-20170106074$JOHNSON AND JOHNSON$$$$$M$Y$$$20221215$$HP$US$US
131200397$13120039$7$F$20100101$20221018$20170117$20221025$EXP$$US-AstraZeneca-2017SE02375$ASTRAZENECA$$57$YR$$F$Y$42.2$KG$20221025$$LW$US$
1312053711$13120537$11$F$20161201$20221208$20170117$20221213$PER$$US-PFIZER INC-2017013282$PFIZER$$75$YR$$F$Y$$$20221213$$CN$US$US
131205603$13120560$3$F$20140201$20221122$20170117$20221128$PER$$US-PFIZER INC-2017014247$PFIZER$$65$YR$$F$Y$64.853$KG$20221128$$CN$US$US
131215063$13121506$3$F$20161208$20221220$20170117$20221229$EXP$$CA-BIOGEN-2017BI00343393$BIOGEN$$49$YR$$F$Y$$$20221229$$MD$CA$CA
1312164812$13121648$12$F$$20221212$20170117$20221219$EXP$$CA-PFIZER INC-2017017327$PFIZER$$58$YR$$F$Y$$$20221219$$CN$CA$CA
131226566$13122656$6$F$20060101$20221128$20170117$20221206$EXP$$CA-SA-2016SA086812$SANOFI AVENTIS$$50$YR$A$M$Y$$$20221206$$MD$CA$CA
131237885$13123788$5$F$20070101$20221108$20170118$20221111$EXP$$US-AstraZeneca-2017SE03009$ASTRAZENECA$$444$MON$$M$Y$89.8$KG$20221111$$LW$US$
1312599736$13125997$36$F$20170110$20221206$20170118$20221213$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK017485$GLAXOSMITHKLINE$$$$$$Y$$$20221213$$CN$BR$BR
131299688$13129968$8$F$$20221028$20170119$20221101$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-002909$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20221101$$MD$GB$GB
131307153$13130715$3$F$20150101$20221024$20170119$20221027$PER$$US-JAZZ-2017-US-000387$JAZZ$$$$$F$Y$$$20221027$$CN$US$US
1313143216$13131432$16$F$20170110$20220928$20170119$20221004$EXP$$IE-MYLANLABS-2017M1002906$MYLAN$$44$YR$$M$Y$$$20221004$$MD$IE$IE
131317407$13131740$7$F$20160701$20221215$20170119$20221220$EXP$$US-PFIZER INC-2017024415$PFIZER$$69$YR$$M$Y$$$20221220$$CN$US$US
1313261510$13132615$10$F$$20221218$20170120$20221220$EXP$$CA-Orion Corporation ORION PHARMA-TREX2017-0240$ORION$$58$YR$A$F$Y$$$20221220$$MD$CA$
131352782$13135278$2$F$$20221220$20170120$20221222$EXP$$US-PFIZER INC-2016308561$PFIZER$$67$YR$$F$Y$$$20221222$$CN$US$US
131357277$13135727$7$F$20160101$20221101$20170120$20221108$PER$$US-PFIZER INC-2017020229$PFIZER$$20$YR$$M$Y$113.4$KG$20221108$$CN$US$US
131393333$13139333$3$F$20161201$20221222$20170123$20221230$EXP$$FR-PFIZER INC-2017020968$PFIZER$$72$YR$$F$Y$100$KG$20221230$$MD$FR$FR
131403488$13140348$8$F$20170101$20221219$20170123$20221227$EXP$$US-PFIZER INC-2017030225$PFIZER$$76$YR$$F$Y$$$20221227$$CN$US$US
131422307$13142230$7$F$20161201$20221123$20170124$20221125$EXP$$CA-TAKEDA-2017TUS001307$TAKEDA$$66$YR$$M$Y$122$KG$20221125$$CN$CA$CA
131427527$13142752$7$F$20150420$20221212$20170124$20221219$EXP$$JP-PFIZER INC-2017028174$PFIZER$$31$YR$$F$Y$50$KG$20221219$$MD$JP$JP
1314326411$13143264$11$F$20160101$20221123$20170124$20221130$EXP$$FR-GLAXOSMITHKLINE-FR2016GSK093577$GLAXOSMITHKLINE$$$$$$Y$$$20221130$$HP$FR$FR
1314540416$13145404$16$F$$20221024$20170124$20221027$PER$$US-PFIZER INC-2017029857$PFIZER$$64$YR$$F$Y$$$20221027$$CN$US$US
1314726614$13147266$14$F$$20221206$20170125$20221208$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005239$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$73$KG$20221209$$CN$CA$CA
131502044$13150204$4$F$20170119$20221014$20170125$20221020$EXP$$US-SHIRE-US201701265$TAKEDA$$16$YR$$M$Y$$$20221019$$MD$US$US
131531928$13153192$8$F$$20221223$20170126$20221227$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005886$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20221228$$CN$CA$CA
1315320010$13153200$10$F$$20221129$20170126$20221201$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005842$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20221201$$CN$CA$CA
131537144$13153714$4$F$$20221212$20170126$20221219$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2017-BI-003440$BOEHRINGER INGELHEIM$$85$YR$E$M$Y$$$20221219$$MD$CA$CA
1315500814$13155008$14$F$$20221011$20170126$20221014$EXP$$US-PFIZER INC-2017029933$PFIZER$$75$YR$$F$Y$90.72$KG$20221014$$CN$US$US
131584894$13158489$4$F$20161101$20221218$20170127$20221221$EXP$$CA-TAKEDA-2016TUS021205$TAKEDA$$30$YR$$M$Y$$$20221221$$MD$CA$CA
131588424$13158842$4$F$$20170130$20170127$20221212$EXP$$DE-TEVA-732118GER$TEVA$$79$YR$E$F$Y$50$KG$20221212$$HP$DE$DE
1315892219$13158922$19$F$20070101$20221020$20170127$20221025$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005391$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20221025$$HP$CA$CA
131656122$13165612$2$F$$20221129$20170131$20221205$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-004945$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20221205$$CN$CA$CA
131675254$13167525$4$F$$20221130$20170131$20221205$PER$$US-PFIZER INC-2017040672$PFIZER$$44$YR$$F$Y$$$20221205$$CN$US$US
1316786110$13167861$10$F$$20221207$20170131$20221208$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005498$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$58$KG$20221208$$CN$CA$CA
1317870811$13178708$11$F$$20221103$20170202$20221109$EXP$$CA-ROCHE-1886825$ROCHE$$51$YR$$F$Y$$$20221109$$HP$CA$
131790076$13179007$6$F$$20221220$20170202$20221227$PER$$US-PFIZER INC-2017045002$PFIZER$$58$YR$$M$Y$74.84$KG$20221227$$CN$US$US
131795173$13179517$3$F$20150915$20220929$20170202$20221006$EXP$$US-TAKEDA-2017TUS002251$TAKEDA$$24$YR$$F$Y$79.83$KG$20221006$$HP$US$US
131799375$13179937$5$F$20161130$20221222$20170202$20221228$EXP$$US-INCYTE CORPORATION-2017IN000613$INCYTE$$$$$$Y$$$20221228$$CN$US$US
131826877$13182687$7$F$20190801$20221109$20170203$20221111$EXP$$US-PFIZER INC-2017045478$PFIZER$$56$YR$$F$Y$$$20221111$$CN$US$US
131826984$13182698$4$F$20211001$20221208$20170203$20221215$PER$$US-PFIZER INC-2017045712$PFIZER$$64$YR$$F$Y$$$20221215$$CN$US$US
131830144$13183014$4$F$20130401$20221102$20170203$20221107$EXP$$US-009507513-1702USA001550$MERCK$$74$YR$$F$Y$68.027$KG$20221107$$CN$US$US
1318310313$13183103$13$F$20170101$20221020$20170203$20221028$EXP$$CA-TAKEDA-2017TUS002274$TAKEDA$$51$YR$$M$Y$$$20221028$$HP$CA$CA
1318771613$13187716$13$F$20160101$20221020$20170206$20221024$EXP$$US-PFIZER INC-2017047673$PFIZER$$85$YR$$F$Y$51.26$KG$20221024$$CN$US$US
1319115616$13191156$16$F$20161102$20220929$20170207$20221004$EXP$$CA-ROCHE-1889462$ROCHE$$60$YR$$M$Y$$$20221004$$MD$CA$CA
131914403$13191440$3$F$20150301$20221003$20170207$20221011$EXP$$FR-Accord-047915$ACCORD$Yapo Kouadio CG, Hasseine L, Goubaux B, Gari Toussaint M. (Disseminated fungal infection due to Magnusiomyces capitatus in a liver graft patient). J Mycol Med. 2016 Sep 26(3):261-4.$62$YR$A$M$Y$$$20221011$$HP$FR$FR
131932045$13193204$5$F$20170127$20221012$20170207$20221017$EXP$$JP-Eisai Medical Research-EC-2017-024575$EISAI$$73$YR$E$F$Y$59$KG$20221017$$MD$JP$
131943423$13194342$3$F$20161121$20220810$20170207$20221026$PER$$US-JAZZ-2016-US-023752$JAZZ$$31$YR$$M$Y$$$20221026$$HP$US$US
1319527628$13195276$28$F$20160606$20221109$20170208$20221118$EXP$$CA-ROCHE-1889780$ROCHE$$66$YR$$M$Y$85$KG$20221118$$MD$CA$CA
132005322$13200532$2$F$20160201$20221013$20170208$20221020$EXP$$PR-BIOGEN-2017BI00354587$BIOGEN$$55$YR$$F$Y$$$20221020$$CN$PR$PR
1320300811$13203008$11$F$$20220922$20170209$20221003$EXP$$US-PFIZER INC-2017054855$PFIZER$$69$YR$$F$Y$$$20221003$$HP$US$US
132079994$13207999$4$F$$20170220$20170209$20221212$EXP$$ES-TEVA-735074ISR$TEVA$$71$YR$E$F$Y$$$20221212$$HP$ES$ES
132134076$13213407$6$F$20150101$20221129$20170210$20221201$PER$$US-PFIZER INC-2017056695$PFIZER$$63$YR$$F$Y$75$KG$20221201$$HP$US$US
132135254$13213525$4$F$20170121$20221113$20170210$20221123$PER$$US-INCYTE CORPORATION-2017IN000639$INCYTE$$$$$$Y$$$20221123$$CN$US$US
1321461214$13214612$14$F$$20221025$20170210$20221101$EXP$$BE-PFIZER INC-2017059786$PFIZER$Heyrman, B.. A case report of immunosuppression-related Kaposi^s sarcoma after autologous stem cell transplantation. BMC Research Notes. 2016;9:188$61$YR$$M$Y$$$20221101$$HP$BE$BE
132246763$13224676$3$F$$20200520$20170213$20221219$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2017R1-132891$RANBAXY$Alghabra L, Iskandarani M. Spontaneous retroperitoneal haematoma resulting in bowel ischaemia. Br J Surg. 2019;106sup62$69$YR$$M$Y$$$20221219$$MD$GB$GB
1322689610$13226896$10$F$$20221018$20170213$20221020$EXP$$US-PFIZER INC-2017058171$PFIZER$$65$YR$$M$Y$$$20221020$$HP$US$US
132278815$13227881$5$F$20170206$20221222$20170213$20221229$EXP$$GB-MYLANLABS-2017M1007946$MYLAN$$38$YR$$M$Y$$$20221229$$MD$GB$GB
1322794413$13227944$13$F$20130919$20221018$20170213$20221025$EXP$$PHHY2017GB018424$NOVARTIS$$55$YR$$M$Y$$$20221025$$MD$GB$GB
1322882941$13228829$41$F$20130919$20221214$20170213$20221225$PER$US-ASTRAZENECA-2017SE07280$GB-AMGEN-GBRSP2017022053$AMGEN$$55$YR$A$M$Y$$$20221225$$MD$GB$GB
132300859$13230085$9$F$$20221221$20170214$20221227$EXP$$US-PFIZER INC-2017063888$PFIZER$$74$YR$$F$Y$87$KG$20221227$$CN$US$US
132345893$13234589$3$F$$20221027$20170215$20221031$PER$$US-PFIZER INC-2017062345$PFIZER$$62$YR$$F$Y$$$20221031$$MD$US$US
132382382$13238238$2$F$20161201$20221209$20170216$20221219$EXP$$US-SHIRE-US201702379$TAKEDA$$56$YR$$F$Y$48$KG$20221219$$CN$US$US
132387703$13238770$3$F$$20221206$20170216$20221210$EXP$$PHHY2017CA022870$NOVARTIS$$$$A$F$Y$$$20221210$$CN$CA$CA
132447002$13244700$2$F$$20220927$20170216$20221026$PER$$US-JAZZ-2017-US-000341$JAZZ$$$$$M$Y$$$20221026$$MD$US$US
132447379$13244737$9$F$20170101$20221013$20170216$20221026$PER$$US-JAZZ-2017-US-001025$JAZZ$$46$YR$$F$Y$$$20221026$$CN$US$US
132447445$13244744$5$F$20130101$20220809$20170216$20221026$PER$$US-JAZZ-2017-US-000946$JAZZ$$$$$F$Y$102.77$KG$20221026$$HP$US$US
1324667931$13246679$31$F$20130919$20221130$20170217$20221213$EXP$GB-MHRA-ADR 23836748$GB-Accord-048162$ACCORD$$55$YR$A$M$Y$$$20221213$$MD$GB$GB
132535656$13253565$6$F$20161201$20221121$20170220$20221130$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-001926$ACADIA PHARMACEUTICALS$$63$YR$$M$Y$108$KG$20221201$$CN$US$US
132535742$13253574$2$F$$20221205$20170220$20221214$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-001969$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20221215$$CN$US$US
1325627411$13256274$11$F$20161013$20221019$20170221$20221025$EXP$$CA-TAKEDA-2015TUS015633$TAKEDA$$25$YR$$F$Y$$$20221025$$HP$CA$CA
132596439$13259643$9$F$20161201$20221017$20170222$20221018$EXP$$US-PFIZER INC-2017077124$PFIZER$$67$YR$$M$Y$79.83$KG$20221018$$CN$US$US
132606723$13260672$3$F$20170208$20221213$20170222$20221221$PER$$JP-Eisai Medical Research-EC-2017-025034$EISAI$$72$YR$E$F$Y$$$20221221$$MD$JP$
132622114$13262211$4$F$$20221121$20170222$20221122$EXP$$CA-ROCHE-1662402$ROCHE$$41$YR$$F$Y$$$20221122$$MD$CA$
132635746$13263574$6$F$20040101$20220915$20170223$20221005$EXP$$FR-ABBVIE-16P-056-1791361-00$ABBVIE$$$$$F$Y$$$20221005$$HP$FR$FR
132642314$13264231$4$F$$20221109$20170223$20221111$PER$$US-PFIZER INC-2017079350$PFIZER$$66$YR$$M$Y$$$20221111$$CN$US$US
1326434415$13264344$15$F$20170101$20221111$20170223$20221117$EXP$$CA-PFIZER INC-2017076339$PFIZER$$63$YR$$F$Y$$$20221117$$CN$CA$CA
1326573912$13265739$12$F$20160707$20221116$20170223$20221120$EXP$$PHHY2016CA100024$NOVARTIS$$77$YR$$F$Y$$$20221121$$HP$CA$CA
1326710920$13267109$20$F$20170101$20221101$20170224$20221115$EXP$GB-MHRA-ADR 23845327$GB-Accord-048413$ACCORD$$82$YR$E$M$Y$50$KG$20221115$$PH$GB$GB
1327603117$13276031$17$F$$20221107$20170228$20221114$EXP$$CA-ROCHE-1898975$ROCHE$$42$YR$$F$Y$97$KG$20221114$$HP$CA$
1327610816$13276108$16$F$20120713$20221107$20170228$20221109$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2015JPN102192$VIIV$$$$$$Y$$$20221109$$MD$JP$JP
1328179114$13281791$14$F$20170101$20221227$20170301$20221229$PER$$US-PFIZER INC-2017086148$PFIZER$$69$YR$$F$Y$67.12$KG$20221229$$HP$US$US
132843414$13284341$4$F$$20221128$20170301$20221209$EXP$$CA-SA-2017SA029762$SANOFI AVENTIS$$40$YR$A$F$Y$$$20221209$$HP$CA$CA
1328785310$13287853$10$F$20170220$20221206$20170302$20221215$PER$$US-PFIZER INC-2016570442$PFIZER$$17$YR$$M$Y$59$KG$20221215$$CN$US$US
132888667$13288866$7$F$$20221021$20170302$20221108$30DAY$$US-PFIZER INC-2017091257$PFIZER$$31$YR$$F$Y$159.4$KG$20221108$$MD$US$US
132891263$13289126$3$F$20170120$20221114$20170302$20221124$PER$$TR-AMGEN-TURSP2017030474$AMGEN$Imre E.; Seker A.; Dilek G. Y.. Urticarial Vasculitis After First Denosumab Injection in an Osteoporotic Woman Diagnosed with Cushing^s Syndrome. Turkish Journal of Endocrinology and Metabolism. 2022;26 (3):181-183$45$YR$A$F$Y$71$KG$20221124$$HP$TR$TR
132984048$13298404$8$F$20140101$20221004$20170306$20221011$EXP$$US-BIOGEN-2017BI00365344$BIOGEN$$$$$F$Y$$$20221011$$CN$US$US
133026733$13302673$3$F$20170223$20221107$20170307$20221120$EXP$$PHHO2017US004465$NOVARTIS$$5$YR$$F$Y$24.2$KG$20221121$$MD$US$US
133036784$13303678$4$F$20170217$20221001$20170307$20221004$EXP$$CO-BAXALTA-2017BLT001601$TAKEDA$$18$YR$$F$Y$46$KG$20221004$$CN$CO$CO
133070782$13307078$2$F$20160301$20221013$20170308$20221021$EXP$$CA-AstraZeneca-2017SE22106$ASTRAZENECA$$24$YR$$M$Y$52.2$KG$20221021$$MD$CA$
133097835$13309783$5$F$$20220922$20170309$20221001$PER$$US-JNJFOC-20170216832$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221001$$HP$US$US
133098364$13309836$4$F$$20221020$20170309$20221103$PER$$US-JNJFOC-20170216980$JOHNSON AND JOHNSON$$$$$M$Y$$$20221103$$LW$US$US
133098524$13309852$4$F$20131114$20220929$20170309$20221013$PER$$US-JNJFOC-20170216800$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20221013$$HP$US$US
133098565$13309856$5$F$20070101$20221003$20170309$20221013$PER$$US-JNJFOC-20170216889$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221013$$LW$US$US
133098644$13309864$4$F$$20221006$20170309$20221018$PER$$US-JNJFOC-20170216990$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221018$$LW$US$US
133098874$13309887$4$F$20130701$20221020$20170309$20221028$EXP$$US-JNJFOC-20170216823$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20221028$$LW$US$US
133098884$13309888$4$F$19981001$20220922$20170309$20221002$EXP$$US-JNJFOC-20170216981$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221002$$HP$US$US
133099203$13309920$3$F$$20221014$20170309$20221026$PER$$US-JNJFOC-20170216781$JOHNSON AND JOHNSON$$$$$M$Y$$$20221026$$LW$US$US
133099303$13309930$3$F$20020901$20220929$20170309$20221012$PER$$US-JNJFOC-20170216985$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20221010$$LW$US$US
133100745$13310074$5$F$20061101$20221121$20170309$20221128$EXP$$US-JNJFOC-20170110056$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20221129$$HP$US$US
133101884$13310188$4$F$20160101$20221031$20170309$20221108$PER$$US-JNJFOC-20170201268$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20221108$$LW$US$US
133101954$13310195$4$F$$20221020$20170309$20221030$PER$$US-JNJFOC-20170201260$JOHNSON AND JOHNSON$$$$$M$Y$$$20221030$$LW$US$US
133101975$13310197$5$F$$20220922$20170309$20221003$EXP$$US-JNJFOC-20170201232$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
133102056$13310205$6$F$20170305$20221114$20170309$20221116$PER$$US-JNJFOC-20170201266$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20221116$$HP$US$US
133102115$13310211$5$F$20160506$20221031$20170309$20221104$PER$$US-JNJFOC-20170201274$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20221104$$HP$US$US
133102145$13310214$5$F$$20221031$20170309$20221102$PER$$US-JNJFOC-20170201276$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221102$$HP$US$US
133102153$13310215$3$F$$20221031$20170309$20221114$PER$$US-JNJFOC-20170201277$JOHNSON AND JOHNSON$$$$$M$Y$$$20221114$$LW$US$US
133102174$13310217$4$F$20120101$20221020$20170309$20221030$PER$$US-JNJFOC-20170201254$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20221030$$HP$US$US
133102244$13310224$4$F$20170305$20221031$20170309$20221103$PER$$US-JNJFOC-20170201270$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20221104$$HP$US$US
133102253$13310225$3$F$$20220929$20170309$20221012$PER$$US-JNJFOC-20170201271$JOHNSON AND JOHNSON$$$$$M$Y$$$20221010$$LW$US$US
133102424$13310242$4$F$$20221006$20170309$20221016$PER$$US-JNJFOC-20170201284$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221016$$HP$US$US
133102474$13310247$4$F$$20221006$20170309$20221014$PER$$US-JNJFOC-20170201287$JOHNSON AND JOHNSON$$$$$M$Y$$$20221014$$HP$US$US
133102515$13310251$5$F$$20221006$20170309$20221013$PER$$US-JNJFOC-20170201290$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$LW$US$US
133102525$13310252$5$F$$20221006$20170309$20221017$PER$$US-JNJFOC-20170201291$JOHNSON AND JOHNSON$$$$$M$Y$$$20221017$$HP$US$US
133102544$13310254$4$F$$20221006$20170309$20221014$PER$$US-JNJFOC-20170201292$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221014$$HP$US$US
133102576$13310257$6$F$20120401$20221020$20170309$20221028$PER$$US-JNJFOC-20170201406$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20221028$$HP$US$US
133102635$13310263$5$F$20010401$20221020$20170309$20221102$PER$$US-JNJFOC-20170201415$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20221102$$HP$US$US
133102665$13310266$5$F$$20221006$20170309$20221017$PER$$US-JNJFOC-20170201293$JOHNSON AND JOHNSON$$$$$M$Y$$$20221017$$HP$US$US
133102694$13310269$4$F$20081217$20221020$20170309$20221027$EXP$$US-JNJFOC-20170201297$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20221027$$LW$US$US
133103054$13310305$4$F$20080901$20221020$20170309$20221030$PER$$US-JNJFOC-20170201426$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20221030$$HP$US$US
133103165$13310316$5$F$20071121$20221020$20170309$20221102$PER$$US-JNJFOC-20170201422$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20221102$$HP$US$US
133103246$13310324$6$F$20090601$20220922$20170309$20221002$EXP$$US-JNJFOC-20170201413$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20221002$$HP$US$US
133103476$13310347$6$F$20110501$20221014$20170309$20221020$EXP$$US-JNJFOC-20170202573$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20221020$$HP$US$US
133103933$13310393$3$F$20110101$20221121$20170309$20221125$EXP$$US-JNJFOC-20170202972$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221125$$LW$US$US
133104224$13310422$4$F$20110601$20221014$20170309$20221020$PER$$US-JNJFOC-20170202640$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20221020$$HP$US$US
133106184$13310618$4$F$20090612$20221219$20170309$20221222$PER$$US-JNJFOC-20170118418$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221222$$LW$US$US
133106694$13310669$4$F$$20221205$20170309$20221208$EXP$$US-JNJFOC-20170124442$JOHNSON AND JOHNSON$$$$$M$Y$$$20221209$$LW$US$US
133106884$13310688$4$F$$20220929$20170309$20221012$PER$$US-JNJFOC-20170201256$JOHNSON AND JOHNSON$$$$$M$Y$$$20221009$$LW$US$US
133106915$13310691$5$F$20140101$20221020$20170309$20221030$PER$$US-JNJFOC-20170201264$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20221030$$HP$US$US
133107024$13310702$4$F$$20221006$20170309$20221014$PER$$US-JNJFOC-20170202591$JOHNSON AND JOHNSON$$$$$M$Y$$$20221014$$HP$US$US
133107095$13310709$5$F$20100401$20221014$20170309$20221019$EXP$$US-JNJFOC-20170202568$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20221019$$HP$US$US
133107225$13310722$5$F$$20221006$20170309$20221014$PER$$US-JNJFOC-20170202597$JOHNSON AND JOHNSON$$$$$M$Y$$$20221014$$HP$US$US
133107236$13310723$6$F$20030501$20221014$20170309$20221018$EXP$$US-JNJFOC-20170202577$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20221018$$HP$US$US
133107256$13310725$6$F$20130814$20221014$20170309$20221025$PER$$US-JNJFOC-20170202580$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20221025$$HP$US$US
133107395$13310739$5$F$$20221014$20170309$20221025$PER$$US-JNJFOC-20170202628$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221025$$HP$US$US
133107455$13310745$5$F$20170305$20220922$20170309$20221002$PER$$US-JNJFOC-20170202630$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20221002$$HP$US$US
133107566$13310756$6$F$20060201$20221014$20170309$20221021$EXP$$US-JNJFOC-20170202644$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20221021$$HP$US$US
133107576$13310757$6$F$20080101$20221014$20170309$20221027$PER$$US-JNJFOC-20170202645$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221027$$HP$US$US
133107824$13310782$4$F$$20221006$20170309$20221013$PER$$US-JNJFOC-20170202625$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$LW$US$US
133107834$13310783$4$F$$20221014$20170309$20221025$PER$$US-JNJFOC-20170202626$JOHNSON AND JOHNSON$$$$$M$Y$$$20221025$$HP$US$US
133107855$13310785$5$F$20080101$20221014$20170309$20221020$PER$$US-JNJFOC-20170202627$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20221020$$HP$US$US
133107886$13310788$6$F$20100101$20221020$20170309$20221025$PER$$US-JNJFOC-20170202657$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20221025$$HP$US$US
133107947$13310794$7$F$20170305$20221012$20170309$20221018$PER$$US-JNJFOC-20170202612$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20221018$$HP$US$US
133107965$13310796$5$F$20070815$20221006$20170309$20221013$PER$$US-JNJFOC-20170202615$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20221013$$HP$US$US
133108045$13310804$5$F$20080101$20221014$20170309$20221018$PER$$US-JNJFOC-20170202624$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20221018$$HP$US$US
133109024$13310902$4$F$20000101$20221020$20170309$20221026$PER$$US-JNJFOC-20150923148$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221026$$HP$US$US
133109595$13310959$5$F$$20220929$20170309$20221012$PER$$US-JNJFOC-20170213617$JOHNSON AND JOHNSON$$$$$M$Y$$$20221010$$HP$US$US
133109675$13310967$5$F$20140610$20221020$20170309$20221102$PER$$US-JNJFOC-20170213604$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20221102$$HP$US$US
133109804$13310980$4$F$$20220929$20170309$20221012$PER$$US-JNJFOC-20170213611$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221011$$LW$US$US
133109905$13310990$5$F$$20221006$20170309$20221013$EXP$$US-JNJFOC-20170213759$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$HP$US$US
133109915$13310991$5$F$$20221031$20170309$20221108$PER$$US-JNJFOC-20170213760$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221109$$HP$US$US
133110074$13311007$4$F$20130101$20221014$20170309$20221020$EXP$$US-JNJFOC-20170213645$JOHNSON AND JOHNSON$$2$DEC$A$M$Y$$$20221020$$HP$US$US
133110105$13311010$5$F$$20221014$20170309$20221025$PER$$US-JNJFOC-20170213647$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221025$$HP$US$US
133110205$13311020$5$F$$20221006$20170309$20221013$PER$$US-JNJFOC-20170213616$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$HP$US$US
133110235$13311023$5$F$19990507$20221020$20170309$20221027$PER$$US-JNJFOC-20170213648$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20221027$$HP$US$US
133110355$13311035$5$F$$20221006$20170309$20221016$PER$$US-JNJFOC-20170213653$JOHNSON AND JOHNSON$$$$$M$Y$$$20221017$$HP$US$US
133110404$13311040$4$F$20130101$20220929$20170309$20221012$PER$$US-JNJFOC-20170213711$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20221010$$LW$US$US
133110415$13311041$5$F$20170116$20220929$20170309$20221007$EXP$$US-JNJFOC-20170213734$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20221007$$HP$US$US
133110435$13311043$5$F$$20221031$20170309$20221109$PER$$US-JNJFOC-20170213631$JOHNSON AND JOHNSON$$$$$M$Y$$$20221109$$HP$US$US
133110665$13311066$5$F$$20221006$20170309$20221014$PER$$US-JNJFOC-20170213973$JOHNSON AND JOHNSON$$$$$M$Y$$$20221014$$HP$US$US
133110705$13311070$5$F$20170301$20220922$20170309$20221001$PER$$US-JNJFOC-20170213658$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221001$$HP$US$US
133110874$13311087$4$F$$20221020$20170309$20221026$PER$$US-JNJFOC-20170213716$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221026$$LW$US$US
133111144$13311114$4$F$20050101$20221031$20170309$20221110$PER$$US-JNJFOC-20170213633$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20221110$$HP$US$US
133111265$13311126$5$F$20170201$20221006$20170309$20221014$PER$$US-JNJFOC-20170213693$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20221014$$LW$US$US
133111334$13311133$4$F$20140204$20221014$20170309$20221026$PER$$US-JNJFOC-20170213884$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20221026$$LW$US$US
133111385$13311138$5$F$20120101$20220929$20170309$20221012$PER$$US-JNJFOC-20170213724$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20221010$$HP$US$US
133111495$13311149$5$F$$20221014$20170309$20221026$PER$$US-JNJFOC-20170213642$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221026$$HP$US$US
133112035$13311203$5$F$20170306$20220929$20170309$20221007$EXP$$US-JNJFOC-20170213636$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20221007$$HP$US$US
133112194$13311219$4$F$$20221006$20170309$20221013$PER$$US-JNJFOC-20170213852$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221014$$LW$US$US
133114242$13311424$2$F$$20220928$20170309$20221007$PER$$US-JNJFOC-20170300750$JOHNSON AND JOHNSON$$$$$M$Y$$$20221007$$LW$US$US
133114543$13311454$3$F$20110922$20221107$20170309$20221115$PER$$US-JNJFOC-20170300759$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20221115$$HP$US$US
133115155$13311515$5$F$$20221020$20170309$20221102$PER$$US-JNJFOC-20170216626$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221102$$HP$US$US
133116735$13311673$5$F$20170310$20221006$20170309$20221017$PER$$US-JNJFOC-20170216831$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20221017$$HP$US$US
133116785$13311678$5$F$$20221006$20170309$20221018$PER$$US-JNJFOC-20170216805$JOHNSON AND JOHNSON$$$$$M$Y$$$20221018$$HP$US$US
133116823$13311682$3$F$20170101$20221031$20170309$20221109$PER$$US-JNJFOC-20170216658$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20221109$$LW$US$US
133116855$13311685$5$F$20090205$20221006$20170309$20221015$PER$$US-JNJFOC-20170216816$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20221015$$HP$US$US
133116965$13311696$5$F$20130901$20221006$20170309$20221017$PER$$US-JNJFOC-20170216822$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20221017$$LW$US$US
133117324$13311732$4$F$20121109$20220922$20170309$20221001$PER$$US-JNJFOC-20170216815$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20221001$$HP$US$US
133117385$13311738$5$F$20170308$20221020$20170309$20221103$PER$$US-JNJFOC-20170216836$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20221103$$HP$US$US
133117394$13311739$4$F$$20221031$20170309$20221103$PER$$US-JNJFOC-20170216837$JOHNSON AND JOHNSON$$$$$M$Y$$$20221103$$HP$US$US
133117415$13311741$5$F$$20221006$20170309$20221018$PER$$US-JNJFOC-20170216818$JOHNSON AND JOHNSON$$$$$M$Y$$$20221018$$HP$US$US
133117495$13311749$5$F$20170305$20221014$20170309$20221021$PER$$US-JNJFOC-20170216879$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20221021$$HP$US$US
133117584$13311758$4$F$$20221014$20170309$20221026$PER$$US-JNJFOC-20170216780$JOHNSON AND JOHNSON$$$$$M$Y$$$20221026$$LW$US$US
133117604$13311760$4$F$20130201$20220929$20170309$20221012$EXP$$US-JNJFOC-20170216809$JOHNSON AND JOHNSON$$2$DEC$$M$Y$$$20221009$$HP$US$US
133117645$13311764$5$F$$20221014$20170309$20221026$PER$$US-JNJFOC-20170216783$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221026$$HP$US$US
133122166$13312216$6$F$$20221121$20170309$20221124$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-019157$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20221124$$HP$GB$GB
133148272$13314827$2$F$$20221025$20170309$20221101$EXP$$US-BAXALTA-2017BLT001752$TAKEDA$$$$$M$Y$93$KG$20221101$$HP$US$US
133154696$13315469$6$F$$20221121$20170310$20221123$EXP$$CA-ROCHE-1808080$ROCHE$$64$YR$$F$Y$$$20221123$$HP$CA$
133179788$13317978$8$F$20170303$20221205$20170310$20221208$PER$$US-PFIZER INC-2017104329$PFIZER$$70$YR$$F$Y$$$20221208$$CN$US$US
133197684$13319768$4$F$$20221121$20170310$20221123$PER$$US-BIOGEN-2017BI00369252$BIOGEN$$$$$F$Y$$$20221123$$CN$US$US
133216718$13321671$8$F$20170101$20221222$20170310$20221227$EXP$$US-PFIZER INC-2017095248$PFIZER$$61$YR$$F$Y$$$20221227$$CN$US$US
133217873$13321787$3$F$20170222$20221104$20170310$20221118$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2017CRT000159$CORCEPT$$61$YR$$F$Y$$$20221118$$CN$US$US
1332677614$13326776$14$F$20170224$20221130$20170312$20221206$EXP$$US-SHIRE-US201704221$TAKEDA$$43$YR$$F$Y$$$20221206$$PH$US$US
133341646$13334164$6$F$20081201$20221013$20170313$20221019$EXP$$US-BIOGEN-2008BI033337$BIOGEN$$46$YR$$M$Y$76.272$KG$20221019$$CN$US$US
133361274$13336127$4$F$20060911$20221109$20170315$20221117$EXP$$CA-ROCHE-1562582$ROCHE$$$$A$M$Y$67$KG$20221117$$CN$CA$CA
133404316$13340431$6$F$$20221207$20170316$20221209$PER$$US-PFIZER INC-2017106540$PFIZER$$65$YR$$F$Y$51.701$KG$20221209$$CN$US$US
133410403$13341040$3$F$20170130$20221020$20170316$20221109$EXP$$PL-TAKEDA-2017MPI000816$TAKEDA$$75$YR$$M$Y$90$KG$20221109$$MD$PL$PL
133420836$13342083$6$F$20150101$20221118$20170316$20221124$EXP$$US-ROCHE-1817225$ROCHE$$67$YR$$M$Y$$$20221124$$CN$US$
133427165$13342716$5$F$$20221219$20170316$20221222$EXP$$US-PFIZER INC-2017109378$PFIZER$$72$YR$$F$Y$$$20221222$$CN$US$US
133436492$13343649$2$F$20160101$20221207$20170316$20221213$EXP$$US-JAZZ-2017-US-003225$JAZZ$$$$$F$Y$$$20221213$$CN$US$US
1334444610$13344446$10$F$20170307$20221013$20170317$20221017$EXP$$CN-ROCHE-1903883$ROCHE$$64$YR$$F$Y$48$KG$20221017$$MD$CN$
1334561719$13345617$19$F$20150501$20221228$20170317$20221230$EXP$$GB-ROCHE-1614575$ROCHE$$79$YR$$F$Y$$$20221230$$MD$GB$GB
133464982$13346498$2$F$$20221024$20170317$20221027$EXP$$FR-TAKEDA-2017TUS003359$TAKEDA$$48$YR$$F$Y$$$20221027$$HP$FR$FR
133465025$13346502$5$F$20160130$20220929$20170317$20221004$EXP$$US-TAKEDA-2017TUS005104$TAKEDA$$36$YR$$F$Y$48.526$KG$20221004$$HP$US$US
1335105013$13351050$13$F$20150101$20221128$20170320$20221130$EXP$$US-PFIZER INC-2017107202$PFIZER$$78$YR$$F$Y$73$KG$20221130$$CN$US$US
1335383315$13353833$15$F$20150101$20221228$20170321$20221230$PER$$US-PFIZER INC-2017110744$PFIZER$$63$YR$$F$Y$$$20221230$$CN$US$US
133564493$13356449$3$F$20100101$20221019$20170321$20221021$EXP$$US-TAKEDA-2017TUS005943$TAKEDA$$$$$$Y$$$20221021$$CN$US$US
1335649119$13356491$19$F$20161121$20221012$20170321$20221019$EXP$$DK-SA-2016SA220324$SANOFI AVENTIS$$41$YR$A$F$Y$73$KG$20221019$$HP$DK$DK
1335763314$13357633$14$F$20170301$20220926$20170322$20221004$EXP$$CA-ROCHE-1909497$ROCHE$$44$YR$$F$Y$135$KG$20221004$$CN$CA$CA
133578236$13357823$6$F$$20221013$20170322$20221017$PER$$US-PFIZER INC-2016566868$PFIZER$$73$YR$$F$Y$74.84$KG$20221017$$CN$US$US
133578654$13357865$4$F$20170224$20221214$20170322$20221220$EXP$$US-PFIZER INC-2017077172$PFIZER$$70$YR$$F$Y$$$20221220$$CN$US$US
1335819714$13358197$14$F$$20221215$20170322$20221219$EXP$$AU-ROCHE-1908670$ROCHE$$74$YR$$M$Y$80$KG$20221219$$MD$AU$AU
133583394$13358339$4$F$20170301$20221109$20170322$20221114$EXP$$PHHY2017CA038044$NOVARTIS$$48$YR$$M$Y$$$20221114$$CN$CA$CA
133616822$13361682$2$F$$20221015$20170323$20221029$EXP$$IN-MACLEODS PHARMACEUTICALS US LTD-MAC2017004482$MACLEODS$Nag DS, Samaddar DP, Kant S, Mahanty PR.. Perianesthetic refractory anaphylactic shock with cefuroxime in a patient with history of penicillin allergy on multiple antihypertensive medications.. Revista Brasileira de Anestesiologia.. 2017;67(2):217-220$$$$$Y$$$20221029$$MD$IN$IN
1336401125$13364011$25$F$20170101$20220929$20170323$20221004$EXP$$US-INCYTE CORPORATION-2017IN001912$INCYTE$$$$$$Y$$$20221004$$HP$US$US
133662076$13366207$6$F$20161001$20221227$20170323$20221229$EXP$$US-INCYTE CORPORATION-2016IN006262$INCYTE$$$$$$Y$$$20221229$$HP$US$US
133665444$13366544$4$F$20160101$20221216$20170323$20221221$EXP$$CA-TAKEDA-2017TUS002403$TAKEDA$$26$YR$$F$Y$$$20221221$$CN$CA$CA
133737332$13373733$2$F$$20221004$20170327$20221006$PER$$US-PFIZER INC-2017127522$PFIZER$$58$YR$$M$Y$$$20221006$$HP$US$US
133778742$13377874$2$F$$20221003$20170328$20221012$EXP$$JP-JNJFOC-20170328860$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20221011$$MD$JP$JP
133811145$13381114$5$F$$20221025$20170329$20221031$EXP$$US-PFIZER INC-2017132859$PFIZER$$59$YR$$F$Y$52.16$KG$20221031$$MD$US$US
1338203312$13382033$12$F$20160708$20221020$20170329$20221026$EXP$$PHHY2016CA095571$NOVARTIS$$70$YR$$F$Y$$$20221026$$HP$CA$CA
133861053$13386105$3$F$20170317$20221019$20170330$20221028$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002727$ACADIA PHARMACEUTICALS$$64$YR$$M$Y$$$20221028$$CN$US$US
133868705$13386870$5$F$20130101$20220930$20170330$20221006$PER$$US-PFIZER INC-2017136159$PFIZER$$69$YR$$F$Y$57$KG$20221006$$CN$US$US
133904062$13390406$2$F$20170201$20221121$20170331$20221128$PER$$US-PFIZER INC-2017139331$PFIZER$$55$YR$$F$Y$$$20221128$$CN$US$US
1339079018$13390790$18$F$20160101$20221212$20170331$20221216$EXP$$PHHY2016CA039834$NOVARTIS$$50$YR$$F$Y$$$20221216$$CN$CA$CA
133952935$13395293$5$F$$20221103$20170403$20221108$PER$$US-PFIZER INC-2017141650$PFIZER$$70$YR$$F$Y$$$20221108$$CN$US$US
1339894425$13398944$25$F$20160101$20221102$20170404$20221104$EXP$$PHHY2016CA109964$NOVARTIS$$$$$M$Y$$$20221104$$CN$CA$CA
134033904$13403390$4$F$20080101$20221223$20170404$20221227$EXP$$US-JAZZ-2017-US-004064$JAZZ$$$$$M$Y$$$20221227$$CN$US$US
134058258$13405825$8$F$20170403$20221206$20170405$20221212$PER$$US-PFIZER INC-2017147520$PFIZER$$62$YR$$F$Y$$$20221212$$HP$US$US
134083663$13408366$3$F$20130101$20221116$20170406$20221119$PER$$US-JNJFOC-20170207233$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221119$$HP$US$US
134084083$13408408$3$F$$20221003$20170406$20221013$PER$$US-JNJFOC-20170208481$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$LW$US$US
134084824$13408482$4$F$20040101$20221213$20170406$20221214$PER$$US-JNJFOC-20170223643$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221214$$LW$US$US
134085414$13408541$4$F$19980205$20221114$20170406$20221122$PER$$US-JNJFOC-20170224183$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20221122$$LW$US$US
134085553$13408555$3$F$20030728$20220928$20170406$20221012$PER$$US-JNJFOC-20170223612$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221010$$LW$US$US
134085563$13408556$3$F$$20221121$20170406$20221130$PER$$US-JNJFOC-20170224754$JOHNSON AND JOHNSON$$$$$M$Y$$$20221130$$HP$US$US
134085935$13408593$5$F$$20221121$20170406$20221129$PER$$US-JNJFOC-20170225229$JOHNSON AND JOHNSON$$$$$M$Y$$$20221130$$LW$US$US
134086183$13408618$3$F$20010501$20221213$20170406$20221222$PER$$US-JNJFOC-20170224206$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20221222$$LW$US$US
134086274$13408627$4$F$$20221116$20170406$20221128$PER$$US-JNJFOC-20170225160$JOHNSON AND JOHNSON$$$$$M$Y$$$20221128$$LW$US$US
134088484$13408848$4$F$20020701$20221116$20170406$20221128$PER$$US-JNJFOC-20170224823$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221128$$LW$US$US
134088673$13408867$3$F$20010611$20221221$20170406$20221223$PER$$US-JNJFOC-20170225075$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20221223$$LW$US$US
134088853$13408885$3$F$$20220926$20170406$20221003$PER$$US-JNJFOC-20170225486$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
134089053$13408905$3$F$20040109$20221019$20170406$20221027$PER$$US-JNJFOC-20170109079$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20221027$$LW$US$US
134089073$13408907$3$F$20050101$20221121$20170406$20221129$PER$$US-JNJFOC-20170109216$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221129$$HP$US$US
134089295$13408929$5$F$20070823$20220926$20170406$20221006$PER$$US-JNJFOC-20170109470$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221006$$HP$US$US
134089463$13408946$3$F$20090101$20221121$20170406$20221201$PER$$US-JNJFOC-20170109743$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221202$$HP$US$US
134089784$13408978$4$F$20080422$20220926$20170406$20221004$PER$$US-JNJFOC-20170110307$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221004$$LW$US$US
134090063$13409006$3$F$20080101$20221107$20170406$20221110$PER$$US-JNJFOC-20170112677$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221110$$HP$US$US
134090495$13409049$5$F$20100413$20221207$20170406$20221215$EXP$$US-JNJFOC-20170112929$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221215$$HP$US$US
134090523$13409052$3$F$$20221213$20170406$20221215$PER$$US-JNJFOC-20170112930$JOHNSON AND JOHNSON$$$$$M$Y$$$20221215$$LW$US$US
134090603$13409060$3$F$$20220926$20170406$20221002$PER$$US-JNJFOC-20170113476$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
134090613$13409061$3$F$20060101$20220928$20170406$20221006$EXP$$US-JNJFOC-20170113485$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221007$$LW$US$US
134091823$13409182$3$F$20080320$20221213$20170406$20221215$PER$$US-JNJFOC-20170116633$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20221215$$LW$US$US
134091854$13409185$4$F$20070716$20221114$20170406$20221121$PER$$US-JNJFOC-20170116472$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20221121$$HP$US$US
134091974$13409197$4$F$$20221207$20170406$20221215$PER$$US-JNJFOC-20170116485$JOHNSON AND JOHNSON$$$$$M$Y$$$20221215$$LW$US$US
134092024$13409202$4$F$$20221121$20170406$20221130$PER$$US-JNJFOC-20170116727$JOHNSON AND JOHNSON$$$$$M$Y$$$20221130$$LW$US$US
134092384$13409238$4$F$20020207$20221207$20170406$20221212$EXP$$US-JNJFOC-20170116487$JOHNSON AND JOHNSON$$3$YR$C$M$Y$$$20221212$$LW$US$US
134092742$13409274$2$F$20020101$20221116$20170406$20221126$PER$$US-JNJFOC-20151100901$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221126$$LW$US$US
134093184$13409318$4$F$20091230$20221221$20170406$20221227$PER$$US-JNJFOC-20170124612$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221227$$LW$US$US
134094014$13409401$4$F$$20221107$20170406$20221110$PER$$US-JNJFOC-20170124619$JOHNSON AND JOHNSON$$$$$M$Y$$$20221110$$HP$US$US
134094114$13409411$4$F$20110519$20221031$20170406$20221108$PER$$US-JNJFOC-20170124622$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20221109$$LW$US$US
134094194$13409419$4$F$20070801$20221116$20170406$20221128$PER$$US-JNJFOC-20170124575$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20221128$$HP$US$US
134094304$13409430$4$F$20061205$20221213$20170406$20221220$PER$$US-JNJFOC-20170124641$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20221220$$HP$US$US
134094454$13409445$4$F$20030318$20221213$20170406$20221213$PER$$US-JNJFOC-20161005961$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221213$$HP$US$US
134094493$13409449$3$F$20090101$20221012$20170406$20221019$EXP$$US-JNJFOC-20170125907$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221020$$HP$US$US
134094544$13409454$4$F$20070101$20221031$20170406$20221104$PER$$US-JNJFOC-20170126463$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221104$$LW$US$US
134095104$13409510$4$F$20010710$20220928$20170406$20221012$PER$$US-JNJFOC-20170225622$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221009$$HP$US$US
134095154$13409515$4$F$20050506$20221221$20170406$20221227$PER$$US-JNJFOC-20170225851$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221227$$LW$US$US
134095414$13409541$4$F$20050729$20221107$20170406$20221109$PER$$US-JNJFOC-20170127186$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221109$$HP$US$US
134095534$13409553$4$F$20101116$20221228$20170406$20221230$PER$$US-JNJFOC-20170127439$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221230$$LW$US$US
134095874$13409587$4$F$20111101$20221213$20170406$20221214$PER$$US-JNJFOC-20170127374$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20221214$$HP$US$US
134097084$13409708$4$F$20001205$20221111$20170406$20221118$PER$$US-JNJFOC-20170224752$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221118$$LW$US$US
134098156$13409815$6$F$$20221122$20170406$20221124$EXP$$US-PFIZER INC-2017071242$PFIZER$$65$YR$$M$Y$$$20221124$$CN$US$US
134099455$13409945$5$F$20121012$20221031$20170406$20221102$EXP$$US-PFIZER INC-2017147004$PFIZER$$50$YR$$M$Y$95.7$KG$20221102$$CN$US$US
134103252$13410325$2$F$$20221213$20170406$20221220$PER$$US-JNJFOC-20170306485$JOHNSON AND JOHNSON$$$$$M$Y$$$20221220$$LW$US$US
134103294$13410329$4$F$20020114$20221129$20170406$20221205$PER$$US-JNJFOC-20170303091$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20221205$$LW$US$US
134103402$13410340$2$F$$20221228$20170406$20221230$PER$$US-JNJFOC-20170306467$JOHNSON AND JOHNSON$$$$$M$Y$$$20221230$$LW$US$US
134103632$13410363$2$F$20091001$20221121$20170406$20221130$PER$$US-JNJFOC-20170306612$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221130$$LW$US$US
134103692$13410369$2$F$$20220926$20170406$20221006$PER$$US-JNJFOC-20170306424$JOHNSON AND JOHNSON$$$$$M$Y$$$20221006$$LW$US$US
134103862$13410386$2$F$$20221116$20170406$20221128$PER$$US-JNJFOC-20170306488$JOHNSON AND JOHNSON$$$$$M$Y$$$20221128$$LW$US$US
134104142$13410414$2$F$$20220928$20170406$20221012$PER$$US-JNJFOC-20170306543$JOHNSON AND JOHNSON$$$$$M$Y$$$20221009$$LW$US$US
134104514$13410451$4$F$$20220922$20170406$20221001$PER$$US-JNJFOC-20170226376$JOHNSON AND JOHNSON$$$$$M$Y$$$20221001$$LW$US$US
134104923$13410492$3$F$19990715$20221221$20170406$20221229$PER$$US-JNJFOC-20170227583$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221230$$LW$US$US
134105054$13410505$4$F$$20220928$20170406$20221003$PER$$US-JNJFOC-20170227363$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
134105654$13410565$4$F$20050201$20221114$20170406$20221119$PER$$US-JNJFOC-20170300133$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20221119$$LW$US$US
134105664$13410566$4$F$19980520$20221121$20170406$20221130$PER$$US-JNJFOC-20170300134$JOHNSON AND JOHNSON$$4$YR$C$M$Y$$$20221130$$LW$US$US
134105784$13410578$4$F$20050604$20221107$20170406$20221109$PER$$US-JNJFOC-20170300143$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221109$$LW$US$US
134105873$13410587$3$F$20080322$20221219$20170406$20221227$PER$$US-JNJFOC-20170300315$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20221227$$LW$US$US
134105903$13410590$3$F$$20220926$20170406$20221003$PER$$US-JNJFOC-20170300463$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
134106494$13410649$4$F$20031106$20220926$20170406$20221004$PER$$US-JNJFOC-20170301290$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20221004$$LW$US$US
134106614$13410661$4$F$19990921$20220926$20170406$20221007$PER$$US-JNJFOC-20170300107$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20221007$$HP$US$US
134107324$13410732$4$F$20180829$20221219$20170406$20221222$PER$$US-JNJFOC-20170301398$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20221222$$LW$US$US
134107364$13410736$4$F$$20221012$20170406$20221020$PER$$US-JNJFOC-20170301417$JOHNSON AND JOHNSON$$$$$M$Y$$$20221021$$LW$US$US
134107733$13410773$3$F$20020205$20221031$20170406$20221109$PER$$US-JNJFOC-20170307893$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221109$$LW$US$US
134107754$13410775$4$F$20100902$20221019$20170406$20221027$PER$$US-JNJFOC-20170307957$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20221027$$LW$US$US
134107864$13410786$4$F$20111101$20221121$20170406$20221130$PER$$US-JNJFOC-20170307961$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20221130$$HP$US$US
134108364$13410836$4$F$20120224$20221221$20170406$20221228$PER$$US-JNJFOC-20170302025$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20221228$$LW$US$US
134108634$13410863$4$F$$20221116$20170406$20221126$PER$$US-JNJFOC-20170301473$JOHNSON AND JOHNSON$$$$$M$Y$$$20221126$$LW$US$US
134108654$13410865$4$F$20040623$20221219$20170406$20221222$PER$$US-JNJFOC-20170301591$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221222$$LW$US$US
134108713$13410871$3$F$$20221114$20170406$20221127$PER$$US-JNJFOC-20170300096$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20221128$$LW$US$US
134108794$13410879$4$F$$20221121$20170406$20221130$PER$$US-JNJFOC-20170300097$JOHNSON AND JOHNSON$$$$$M$Y$$$20221130$$LW$US$US
134109114$13410911$4$F$20050518$20220926$20170406$20221006$PER$$US-JNJFOC-20170302243$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20221006$$LW$US$US
134109563$13410956$3$F$20001201$20221012$20170406$20221019$PER$$US-JNJFOC-20170304598$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221019$$LW$US$US
134109793$13410979$3$F$20051228$20221219$20170406$20221221$PER$$US-JNJFOC-20170303447$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20221221$$LW$US$US
134109944$13410994$4$F$20150810$20221201$20170406$20221205$PER$$US-JNJFOC-20170304013$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20221205$$HP$US$US
134110073$13411007$3$F$20161001$20221003$20170406$20221014$PER$$US-JNJFOC-20170304028$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20221014$$LW$US$US
134110204$13411020$4$F$20070625$20220928$20170406$20221012$PER$$US-JNJFOC-20170304578$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221010$$LW$US$US
134110584$13411058$4$F$$20221107$20170406$20221109$PER$$US-JNJFOC-20170304459$JOHNSON AND JOHNSON$$$$$M$Y$$$20221109$$LW$US$US
134110714$13411071$4$F$$20221107$20170406$20221110$PER$$US-JNJFOC-20170304478$JOHNSON AND JOHNSON$$$$$M$Y$$$20221111$$LW$US$US
134110862$13411086$2$F$20050101$20221121$20170406$20221130$PER$$US-JNJFOC-20170306753$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221130$$LW$US$US
134111142$13411114$2$F$$20221228$20170406$20221230$PER$$US-JNJFOC-20170306729$JOHNSON AND JOHNSON$$$$$M$Y$$$20221230$$LW$US$US
134111382$13411138$2$F$20120330$20221121$20170406$20221129$PER$$US-JNJFOC-20170306735$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20221130$$LW$US$US
134111652$13411165$2$F$$20221114$20170406$20221123$PER$$US-JNJFOC-20170306740$JOHNSON AND JOHNSON$$$$$M$Y$$$20221123$$LW$US$US
134112463$13411246$3$F$20060201$20220928$20170406$20221006$PER$$US-JNJFOC-20170306659$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221006$$LW$US$US
134112603$13411260$3$F$20070101$20221207$20170406$20221213$PER$$US-JNJFOC-20170307189$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221213$$LW$US$US
134112634$13411263$4$F$20020411$20221107$20170406$20221114$EXP$$US-JNJFOC-20170306942$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221115$$LW$US$US
134112754$13411275$4$F$20070817$20221114$20170406$20221123$PER$$US-JNJFOC-20170307030$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221123$$LW$US$US
134112792$13411279$2$F$$20221213$20170406$20221219$PER$$US-JNJFOC-20170306432$JOHNSON AND JOHNSON$$$$$M$Y$$$20221219$$LW$US$US
134112974$13411297$4$F$20100812$20221205$20170406$20221212$PER$$US-JNJFOC-20170307184$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221212$$HP$US$US
134113022$13411302$2$F$$20221114$20170406$20221117$PER$$US-JNJFOC-20170306569$JOHNSON AND JOHNSON$$$$$$Y$$$20221117$$LW$US$US
134113152$13411315$2$F$19980101$20221121$20170406$20221128$PER$$US-JNJFOC-20170306586$JOHNSON AND JOHNSON$$$$$M$Y$$$20221128$$LW$US$US
134113622$13411362$2$F$20111021$20221116$20170406$20221124$PER$$US-JNJFOC-20170304905$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20221125$$LW$US$US
134113755$13411375$5$F$20120801$20221111$20170406$20221123$PER$$US-JNJFOC-20170304535$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20221123$$LW$US$US
134113794$13411379$4$F$20071010$20221114$20170406$20221123$PER$$US-JNJFOC-20170304310$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20221123$$LW$US$US
134113902$13411390$2$F$$20221213$20170406$20221215$PER$$US-JNJFOC-20170304919$JOHNSON AND JOHNSON$$$$$M$Y$$$20221215$$LW$US$US
134114142$13411414$2$F$$20221003$20170406$20221013$PER$$US-JNJFOC-20170304926$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$LW$US$US
134114152$13411415$2$F$20000101$20220926$20170406$20221004$PER$$US-JNJFOC-20170304927$JOHNSON AND JOHNSON$$$$$M$Y$$$20221004$$LW$US$US
134114252$13411425$2$F$20061001$20220928$20170406$20221012$PER$$US-JNJFOC-20170304859$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221010$$LW$US$US
134114312$13411431$2$F$$20221012$20170406$20221022$PER$$US-JNJFOC-20170304860$JOHNSON AND JOHNSON$$$$$M$Y$$$20221022$$LW$US$US
134114582$13411458$2$F$$20221205$20170406$20221212$EXP$$US-JNJFOC-20170304896$JOHNSON AND JOHNSON$$$$$M$Y$$$20221213$$LW$US$US
134115123$13411512$3$F$$20221114$20170406$20221119$PER$$US-JNJFOC-20170304979$JOHNSON AND JOHNSON$$$$$M$Y$$$20221119$$LW$US$US
134115232$13411523$2$F$$20221003$20170406$20221013$PER$$US-JNJFOC-20170304964$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$LW$US$US
134115242$13411524$2$F$$20221116$20170406$20221128$PER$$US-JNJFOC-20170304965$JOHNSON AND JOHNSON$$$$$M$Y$$$20221128$$LW$US$US
134115252$13411525$2$F$$20221219$20170406$20221223$PER$$US-JNJFOC-20170304982$JOHNSON AND JOHNSON$$$$$M$Y$$$20221223$$LW$US$US
134116263$13411626$3$F$20050131$20221129$20170406$20221206$PER$$US-JNJFOC-20170302957$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221206$$LW$US$US
134116644$13411664$4$F$$20221107$20170406$20221114$PER$$US-JNJFOC-20170303272$JOHNSON AND JOHNSON$$$$$M$Y$$$20221115$$HP$US$US
134116873$13411687$3$F$$20221228$20170406$20221230$PER$$US-JNJFOC-20170303435$JOHNSON AND JOHNSON$$$$$M$Y$$$20221230$$LW$US$US
134117394$13411739$4$F$$20221114$20170406$20221121$PER$$US-JNJFOC-20170304306$JOHNSON AND JOHNSON$$$$$M$Y$$$20221121$$LW$US$US
134117493$13411749$3$F$20040628$20221114$20170406$20221121$PER$$US-JNJFOC-20170303423$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221121$$LW$US$US
134117604$13411760$4$F$$20221114$20170406$20221119$PER$$US-JNJFOC-20170304307$JOHNSON AND JOHNSON$$$$$M$Y$$$20221119$$LW$US$US
134117783$13411778$3$F$20050303$20220926$20170406$20221006$PER$$US-JNJFOC-20170304278$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221006$$LW$US$US
134118172$13411817$2$F$20090501$20221207$20170406$20221216$PER$$US-JNJFOC-20170304872$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221216$$LW$US$US
134118313$13411831$3$F$$20221213$20170406$20221215$PER$$US-JNJFOC-20170304552$JOHNSON AND JOHNSON$$$$$M$Y$$$20221215$$LW$US$US
134118473$13411847$3$F$$20220928$20170406$20221003$PER$$US-JNJFOC-20170304283$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
134118763$13411876$3$F$20080312$20221019$20170406$20221031$PER$$US-JNJFOC-20170304210$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20221031$$LW$US$US
134118804$13411880$4$F$$20221121$20170406$20221128$PER$$US-JNJFOC-20170304323$JOHNSON AND JOHNSON$$$$$M$Y$$$20221128$$LW$US$US
134119874$13411987$4$F$20130101$20221228$20170406$20221230$PER$$US-JNJFOC-20170316148$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20221230$$LW$US$US
134119974$13411997$4$F$20070101$20221207$20170406$20221213$PER$$US-JNJFOC-20170316578$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221213$$LW$US$US
134120033$13412003$3$F$$20221114$20170406$20221123$PER$$US-JNJFOC-20170316657$JOHNSON AND JOHNSON$$$$$M$Y$$$20221123$$LW$US$US
134120994$13412099$4$F$$20221207$20170406$20221209$PER$$US-JNJFOC-20170316756$JOHNSON AND JOHNSON$$$$$M$Y$$$20221209$$LW$US$US
134121833$13412183$3$F$20080101$20220921$20170406$20221003$PER$$US-JNJFOC-20170314133$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20221003$$HP$US$US
134121943$13412194$3$F$$20221219$20170406$20221222$PER$$US-JNJFOC-20161009028$JOHNSON AND JOHNSON$$$$$M$Y$$$20221222$$LW$US$US
134123064$13412306$4$F$20110521$20221129$20170406$20221206$PER$$US-JNJFOC-20170307964$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20221206$$HP$US$US
134123242$13412324$2$F$$20221012$20170406$20221020$PER$$US-JNJFOC-20170308357$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221021$$LW$US$US
134123774$13412377$4$F$$20221012$20170406$20221021$PER$$US-JNJFOC-20170310348$JOHNSON AND JOHNSON$$$$$M$Y$$$20221021$$LW$US$US
134123874$13412387$4$F$$20220926$20170406$20221003$PER$$US-JNJFOC-20170309978$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
134123924$13412392$4$F$20160606$20221019$20170406$20221026$EXP$$US-JNJFOC-20170309959$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20221026$$HP$US$US
134124422$13412442$2$F$$20221213$20170406$20221215$PER$$US-JNJFOC-20170308324$JOHNSON AND JOHNSON$$$$$M$Y$$$20221215$$LW$US$US
134124524$13412452$4$F$$20221116$20170406$20221128$PER$$US-JNJFOC-20170308352$JOHNSON AND JOHNSON$$$$$M$Y$$$20221128$$LW$US$US
134124984$13412498$4$F$20020101$20221219$20170406$20221225$PER$$US-JNJFOC-20170309543$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221226$$LW$US$US
134125104$13412510$4$F$20090325$20221019$20170406$20221031$PER$$US-JNJFOC-20170309203$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20221031$$LW$US$US
134127504$13412750$4$F$20010510$20220922$20170406$20221001$PER$$US-JNJFOC-20170310766$JOHNSON AND JOHNSON$$4$YR$C$M$Y$$$20221001$$HP$US$US
134127835$13412783$5$F$$20221012$20170406$20221021$PER$$US-JNJFOC-20170312219$JOHNSON AND JOHNSON$$$$$M$Y$$$20221021$$LW$US$US
134128633$13412863$3$F$20070207$20220928$20170406$20221003$PER$$US-JNJFOC-20170312479$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20221003$$LW$US$US
134128874$13412887$4$F$$20221021$20170406$20221030$PER$$US-JNJFOC-20170312473$JOHNSON AND JOHNSON$$$$$M$Y$$$20221030$$LW$US$US
134129043$13412904$3$F$20071001$20221006$20170406$20221017$PER$$US-JNJFOC-20161012299$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20221017$$HP$US$US
134129764$13412976$4$F$20071119$20221207$20170406$20221213$EXP$$US-JNJFOC-20170312159$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20221213$$LW$US$US
134131085$13413108$5$F$20060613$20221111$20170406$20221114$PER$$US-JNJFOC-20170310810$JOHNSON AND JOHNSON$$3$YR$C$M$Y$$$20221114$$LW$US$US
134131233$13413123$3$F$20130401$20221003$20170406$20221014$PER$$US-JNJFOC-20170310918$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20221014$$LW$US$US
134131363$13413136$3$F$$20221114$20170406$20221117$PER$$US-JNJFOC-20170311511$JOHNSON AND JOHNSON$$$$$M$Y$$$20221117$$LW$US$US
134132044$13413204$4$F$20060710$20221207$20170406$20221209$PER$$US-JNJFOC-20161015927$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20221209$$LW$US$US
134132723$13413272$3$F$20090101$20221205$20170407$20221212$EXP$$US-JAZZ-2017-US-004232$JAZZ$$39$YR$$F$Y$$$20221212$$MD$US$US
134134764$13413476$4$F$20051116$20221012$20170406$20221020$PER$$US-JNJFOC-20170317340$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20221020$$HP$US$US
134135873$13413587$3$F$20060801$20221114$20170406$20221124$PER$$US-JNJFOC-20170317752$JOHNSON AND JOHNSON$$11$YR$$M$Y$$$20221124$$LW$US$US
134136574$13413657$4$F$$20221207$20170406$20221209$PER$$US-JNJFOC-20170317860$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221209$$LW$US$US
134137194$13413719$4$F$20090101$20221003$20170406$20221014$PER$$US-JNJFOC-20170313990$JOHNSON AND JOHNSON$$2$DEC$$M$Y$$$20221014$$LW$US$US
134139784$13413978$4$F$20081211$20221121$20170406$20221130$PER$$US-JNJFOC-20170315347$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20221130$$LW$US$US
134140074$13414007$4$F$20080101$20221219$20170406$20221227$PER$$US-JNJFOC-20170315349$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20221227$$LW$US$US
134140653$13414065$3$F$$20221207$20170406$20221215$PER$$US-JNJFOC-20170318536$JOHNSON AND JOHNSON$$$$$M$Y$$$20221215$$LW$US$US
134142134$13414213$4$F$20090701$20221114$20170406$20221123$PER$$US-JNJFOC-20170319707$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20221123$$LW$US$US
134148803$13414880$3$F$20041013$20221219$20170406$20221226$PER$$US-JNJFOC-20170319818$JOHNSON AND JOHNSON$$4$YR$C$M$Y$$$20221226$$LW$US$US
134148964$13414896$4$F$19980101$20221207$20170406$20221209$PER$$US-JNJFOC-20170319804$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221209$$LW$US$US
134155753$13415575$3$F$20170101$20221115$20170407$20221124$PER$$US-JAZZ-2017-US-004199$JAZZ$$$$$M$Y$$$20221124$$CN$US$US
134158524$13415852$4$F$20170101$20221128$20170406$20221203$EXP$$PHHY2017CA047941$NOVARTIS$$$$$M$Y$$$20221203$$CN$CA$CA
134159044$13415904$4$F$20170101$20221207$20170407$20221219$EXP$$US-PFIZER INC-2017149556$PFIZER$$82$YR$$F$Y$$$20221219$$HP$US$US
1341826926$13418269$26$F$20170330$20221118$20170407$20221123$EXP$$CA-TAKEDA-2017TUS007276$TAKEDA$$48$YR$$F$Y$$$20221123$$MD$CA$CA
134191303$13419130$3$F$20110101$20221111$20170407$20221121$EXP$$US-JNJFOC-20170320942$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221122$$LW$US$US
134193864$13419386$4$F$$20221020$20170407$20221102$PER$$US-JNJFOC-20170319591$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221102$$HP$US$US
134194964$13419496$4$F$20080501$20221213$20170407$20221221$PER$$US-JNJFOC-20170323475$JOHNSON AND JOHNSON$$23$YR$A$M$Y$$$20221221$$HP$US$US
134195113$13419511$3$F$20060612$20221221$20170407$20221226$PER$$US-JNJFOC-20170306427$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20221227$$LW$US$US
1341979412$13419794$12$F$20170201$20221223$20170407$20221229$EXP$$US-PFIZER INC-2017154081$PFIZER$$57$YR$$F$Y$47$KG$20221229$$CN$US$US
134236044$13423604$4$F$20020101$20221117$20170410$20221129$EXP$$US-ELI_LILLY_AND_COMPANY-US201704001084$ELI LILLY AND CO$$$$$M$Y$$$20221129$$CN$US$US
1342535213$13425352$13$F$20170322$20221114$20170411$20221123$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002878$ACADIA PHARMACEUTICALS$$63$YR$$F$Y$$$20221124$$CN$US$US
134313025$13431302$5$F$20170113$20221024$20170412$20221027$EXP$$FR-ASTELLAS-2017US013355$ASTELLAS$$76$YR$$M$Y$$$20221027$$MD$FR$FR
134338126$13433812$6$F$20170301$20221214$20170412$20221221$EXP$$FR-SHIRE-FR201706721$TAKEDA$$33$YR$$F$Y$44$KG$20221221$$HP$FR$FR
1344115040$13441150$40$F$20160101$20221024$20170413$20221026$EXP$$PHHY2016CA138250$NOVARTIS$$$$$F$Y$$$20221026$$CN$CA$CA
1344176218$13441762$18$F$20170331$20221004$20170414$20221006$EXP$$CA-TAKEDA-2016TUS022087$TAKEDA$$39$YR$$F$Y$$$20221006$$CN$CA$CA
1344302735$13443027$35$F$$20221108$20170414$20221111$EXP$$US-PFIZER INC-2016508384$MYLAN$$$$$F$Y$$$20221111$$CN$US$US
134479263$13447926$3$F$20110208$20221103$20170417$20221110$EXP$$US-JNJFOC-20170416037$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20221110$$LW$US$US
134492628$13449262$8$F$20180416$20221219$20170417$20221227$EXP$$US-PFIZER INC-2017102280$PFIZER$$78$YR$$M$Y$95.25$KG$20221227$$CN$US$US
134516319$13451631$9$F$20170101$20221202$20170418$20221205$EXP$$US-PFIZER INC-2017161562$PFIZER$$76$YR$$F$Y$$$20221205$$CN$US$US
134576587$13457658$7$F$$20221025$20170419$20221101$EXP$$CA-PFIZER INC-2017162130$PFIZER$Boileau, M.. Successful Treatment of Disseminated Anncaliia algerae Microsporidial Infection with Combination Fumagillin and Albendazole. Open Forum Infectious Diseases. 2016;3(3):10.1093/ofid/ofw158$49$YR$$M$Y$$$20221101$$MD$CA$CA
134609012$13460901$2$F$20130429$20221130$20170420$20221205$EXP$$BE-ROCHE-1220316$ROCHE$$42$YR$$F$Y$85.8$KG$20221205$$MD$BE$
1346209010$13462090$10$F$20170125$20221114$20170420$20221121$EXP$$JP-AEGERION PHARMACEUTICAL, INC-AEGR003026$AEGERION$$$$$$Y$$$20221121$$MD$JP$JP
1346262225$13462622$25$F$20170619$20221104$20170420$20221115$EXP$$CA-CELLTRION INC.-2017CA002002$CELLTRION$$$$$$Y$$$20221115$$CN$CA$CA
1346758110$13467581$10$F$20170101$20221219$20170421$20221222$EXP$$US-PFIZER INC-2017038221$PFIZER$$70$YR$$F$Y$54$KG$20221222$$CN$US$US
134809919$13480991$9$F$20170101$20221018$20170425$20221020$EXP$$CA-TAKEDA-2017TUS008390$TAKEDA$$47$YR$$F$Y$$$20221020$$CN$CA$CA
1348445811$13484458$11$F$20160927$20221102$20170426$20221108$EXP$$PHHY2016CA148710$NOVARTIS$$66$YR$$F$Y$$$20221108$$CN$CA$CA
134866394$13486639$4$F$20170401$20221026$20170426$20221028$PER$$US-PFIZER INC-2017180773$PFIZER$$47$YR$$F$Y$50$KG$20221028$$CN$US$US
1349693436$13496934$36$F$20170425$20221104$20170428$20221107$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2017-BI-023596$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$90$KG$20221107$$MD$DE$DE
1350002510$13500025$10$F$$20221109$20170501$20221116$EXP$$CA-PFIZER INC-2017188696$PFIZER$Thavendiranathan, P.. Left ventricular dysfunction with trastuzumab therapy: Is primary prevention the best option?. Journal of Clinical Oncology. 2017;35 (8):820-825$51$YR$$F$Y$$$20221116$$HP$CA$CA
1350521712$13505217$12$F$20170101$20221215$20170502$20221226$EXP$$CA-TAKEDA-2017TUS009171$TAKEDA$$51$YR$$F$Y$$$20221226$$CN$CA$CA
135167237$13516723$7$F$20141201$20221209$20170505$20221215$EXP$$US-BIOGEN-2015BI072120$BIOGEN$$62$YR$$F$Y$$$20221215$$CN$US$US
1351680010$13516800$10$F$20110101$20221110$20170505$20221117$EXP$$US-BIOGEN-2012BI010881$BIOGEN$$54$YR$$M$Y$$$20221116$$HP$US$US
135169383$13516938$3$F$$20221115$20170505$20221118$PER$$US-PFIZER INC-2017193055$PFIZER$$63$YR$$M$Y$$$20221118$$HP$US$US
135179163$13517916$3$F$20170425$20221207$20170505$20221209$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-037980$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20221209$$HP$US$US
1351935913$13519359$13$F$20000101$20221220$20170505$20221229$EXP$$CA-PFIZER INC-2017196797$PFIZER$$58$YR$$F$Y$52$KG$20221229$$CN$CA$CA
135212729$13521272$9$F$$20221020$20170508$20221025$PER$$US-PFIZER INC-2017192842$PFIZER$$69$YR$$F$Y$70$KG$20221025$$CN$US$US
1352437015$13524370$15$F$20170428$20221109$20170508$20221116$EXP$$PHHY2017CA061628$NOVARTIS$$46$YR$$F$Y$$$20221116$$MD$CA$CA
1352576223$13525762$23$F$20161012$20221212$20170509$20221219$EXP$$CA-ROCHE-1931235$ROCHE$$66$YR$$F$Y$$$20221219$$MD$CA$CA
135277513$13527751$3$F$$20221118$20170509$20221123$EXP$$CA-PFIZER INC-2017200671$PFIZER$$29$YR$$F$Y$$$20221123$$CN$CA$CA
135279808$13527980$8$F$20180701$20221108$20170509$20221111$EXP$$US-PFIZER INC-2017199271$PFIZER$$68$YR$$M$Y$91$KG$20221111$$CN$US$US
135316107$13531610$7$F$20170201$20221026$20170510$20221101$EXP$$PHHY2017CA025217$NOVARTIS$$48$YR$$F$Y$$$20221101$$MD$CA$CA
1353323018$13533230$18$F$$20221025$20170510$20221101$EXP$$CA-PFIZER INC-2017199190$PFIZER$Villeneuve, E.. Management of a mixed overdose in the prehospital setting: a case report. Clinical Toxicology. 2017;55 (5):511$71$YR$$F$Y$$$20221101$$HP$CA$CA
1353492724$13534927$24$F$20170101$20221020$20170511$20221031$EXP$$JP-ABBVIE-17K-087-1968634-00$ABBVIE$$$$$F$Y$44$KG$20221031$$MD$JP$JP
1353686735$13536867$35$F$20080101$20221115$20170511$20221122$EXP$$CA-Orion Corporation ORION PHARMA-TREX2017-1374$ORION$$44$YR$A$F$Y$63$KG$20221122$$MD$CA$
135370753$13537075$3$F$20160101$20221120$20170511$20221124$EXP$$CA-Orion Corporation ORION PHARMA-TREX2017-1373$ORION$$29$YR$A$F$Y$$$20221124$$CN$CA$
135389854$13538985$4$F$20040623$20221003$20170512$20221013$PER$$US-JNJFOC-20170416710$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221013$$LW$US$US
135421418$13542141$8$F$$20221025$20170512$20221031$EXP$$CA-BAUSCH-BL-2017-014965$BAUSCH AND LOMB$Villeneuve E, Delisle M, Wang J, Gosselin S. Management of a mixed overdose in the prehospital setting: A case report. Clinical Toxicology. 2017 JAN 01;55(5):511.$71$YR$$F$Y$$$20221031$$HP$CA$CA
135436358$13543635$8$F$20170501$20221031$20170515$20221102$EXP$$KR-ROCHE-1933494$ROCHE$$70$YR$$M$Y$60$KG$20221102$$MD$KR$
135450646$13545064$6$F$20170405$20221223$20170515$20221230$EXP$$JP-009507513-1705JPN000736J$MERCK$Matsumoto K, Wakatuki J, Sakuma D, Kin E, Kobayashi Y, Komata M. WS16-3 Immune-related side effects during the first 5 years of use of immune checkpoint inhibitors. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022$81$YR$$F$Y$41$KG$20221230$$MD$JP$JP
1354546512$13545465$12$F$20170101$20221209$20170515$20221216$EXP$$US-PFIZER INC-2016460842$PFIZER$$78$YR$$F$Y$59.87$KG$20221216$$CN$US$US
135461403$13546140$3$F$20151023$20170118$20170515$20221208$EXP$$IT-TEVA-2015-29152$TEVA$$49$YR$A$M$Y$$$20221208$$MD$IT$IT
135495299$13549529$9$F$20170430$20221004$20170516$20221014$EXP$$DE-ROCHE-1932235$ROCHE$$72$YR$$M$Y$87$KG$20221014$$MD$DE$
135517933$13551793$3$F$20161201$20221118$20170516$20221123$EXP$$US-BAXALTA-2017BLT004225$TAKEDA$$42$YR$$F$Y$$$20221123$$MD$US$US
135534048$13553404$8$F$20170831$20221115$20170517$20221122$EXP$$CA-ROCHE-1935668$ROCHE$$38$YR$$F$Y$$$20221122$$CN$CA$CA
1355584510$13555845$10$F$20160818$20221212$20170517$20221216$EXP$$CA-TAKEDA-2016TUS015919$TAKEDA$$24$YR$$M$Y$$$20221216$$MD$CA$CA
1355756022$13557560$22$F$20170101$20221114$20170517$20221123$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002993$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20221124$$CN$US$US
1355772815$13557728$15$F$$20221108$20170518$20221111$EXP$$US-PFIZER INC-2017212769$PFIZER$$71$YR$$F$Y$49$KG$20221111$$CN$US$US
135579073$13557907$3$F$20170401$20221014$20170517$20221107$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003177$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20221107$$CN$US$US
135580163$13558016$3$F$20170201$20221031$20170517$20221124$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003267$ACADIA PHARMACEUTICALS$$62$YR$$M$Y$$$20221125$$CN$US$US
1355807312$13558073$12$F$20140101$20221122$20170517$20221215$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002942$ACADIA PHARMACEUTICALS$$$$$F$Y$59$KG$20221216$$CN$US$US
135586332$13558633$2$F$$20221014$20170518$20221021$PER$$US-JAZZ-2017-US-006236$JAZZ$$$$$F$Y$$$20221021$$CN$US$US
135615405$13561540$5$F$$20221025$20170518$20221104$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2017-02331$LUPIN$Villeneuve E, Delisle M, Wang JJ, Gosselin S. Management of a mixed overdose in the prehospital setting: a case report. Clinical Toxicology. 2017;55(5):511$71$YR$$F$Y$$$20221104$$HP$CA$CA
1356231518$13562315$18$F$20150821$20221220$20170519$20221227$EXP$$CA-ROCHE-1936490$ROCHE$$55$YR$$F$Y$$$20221227$$CN$CA$CA
135625496$13562549$6$F$$20221215$20170519$20221226$EXP$$CA-APOTEX-2017AP011966$APOTEX$$64$YR$$M$Y$74$KG$20221226$$MD$CA$CA
135653773$13565377$3$F$20160501$20221024$20170519$20221031$EXP$$US-JAZZ-2017-US-005619$JAZZ$$54$YR$$F$Y$$$20221031$$CN$US$US
135675432$13567543$2$F$$20221207$20170522$20221213$PER$$US-PFIZER INC-2017219941$PFIZER$$64$YR$$F$Y$$$20221213$$CN$US$US
1356828519$13568285$19$F$20150803$20221215$20170522$20221220$EXP$$AU-SA-2015SA169162$SANOFI AVENTIS$$39$YR$A$F$Y$$$20221220$$HP$AU$AU
135708204$13570820$4$F$$20221003$20170523$20221005$EXP$$US-TAKEDA-2017TUS011346$TAKEDA$$$$$$Y$$$20221005$$CN$US$US
135738742$13573874$2$F$20170101$20221207$20170523$20221216$PER$$US-PFIZER INC-2017219840$PFIZER$$64$YR$$F$Y$$$20221216$$CN$US$US
135739157$13573915$7$F$20170106$20221213$20170523$20221220$EXP$$PHJP2017JP001384$NOVARTIS$$48$YR$$M$Y$$$20221220$$MD$JP$JP
135753943$13575394$3$F$$20221024$20170524$20221107$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2017US-141241$RANBAXY$$$$A$M$Y$$$20221107$$CN$US$US
135785608$13578560$8$F$20170501$20221220$20170524$20221223$EXP$$US-JAZZ-2017-US-006083$JAZZ$$71$YR$$M$Y$$$20221223$$CN$US$US
135787922$13578792$2$F$20160101$20220802$20170524$20221026$PER$$US-JAZZ-2017-US-004882$JAZZ$$$$$M$Y$$$20221026$$CN$US$US
135804002$13580400$2$F$20150529$20221117$20170525$20221123$EXP$$US-SHIRE-US201711036$TAKEDA$$46$YR$$F$Y$$$20221123$$HP$US$US
135829905$13582990$5$F$$20221219$20170525$20221222$EXP$$US-JAZZ-2017-US-006284$JAZZ$$$$$M$Y$$$20221222$$CN$US$US
1358505711$13585057$11$F$20150611$20221212$20170526$20221219$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN076917$VIIV$$$$$$Y$$$20221214$$MD$JP$JP
135876199$13587619$9$F$20170322$20221206$20170526$20221214$EXP$$CA-TAKEDA-2017TUS008487$TAKEDA$$42$YR$$M$Y$$$20221214$$CN$CA$CA
1359000038$13590000$38$F$20130919$20221220$20170529$20221228$EXP$$GB-drreddys-GER/UKI/17/0090884$DR REDDYS$$55$YR$A$M$Y$$$20221228$$MD$GB$GB
135912495$13591249$5$F$20170324$20221118$20170530$20221121$EXP$$US-PFIZER INC-2017127969$PFIZER$$68$YR$$F$Y$$$20221121$$CN$US$US
135923455$13592345$5$F$20111101$20221006$20170530$20221007$PER$$US-PFIZER INC-2017233572$PFIZER$$72$YR$$F$Y$75$KG$20221007$$LW$US$US
135923537$13592353$7$F$20111102$20221006$20170530$20221007$PER$$US-PFIZER INC-2016402029$PFIZER$$60$YR$$F$Y$$$20221007$$LW$US$US
135926288$13592628$8$F$20170501$20221004$20170530$20221007$EXP$$CA-TAKEDA-2017TUS011597$TAKEDA$$19$YR$$F$Y$$$20221007$$CN$CA$CA
1359283810$13592838$10$F$20130919$20221220$20170530$20221229$EXP$GB-MHRA-ADR 23836748$GB-TORRENT-00014939$TORRENT$$55$YR$A$M$Y$$$20221229$$MD$GB$GB
135991773$13599177$3$F$20170521$20221013$20170531$20221019$EXP$$US-ARIAD-2017US008265$TAKEDA$$59$YR$$F$Y$$$20221019$$CN$US$US
1360090413$13600904$13$F$20170521$20221116$20170601$20221118$EXP$$PL-ROCHE-1940860$ROCHE$$56$YR$$F$Y$63$KG$20221118$$MD$PL$
136021315$13602131$5$F$20170207$20221010$20170601$20221013$EXP$$IT-PFIZER INC-2017238938$PFIZER$$13$YR$$M$Y$$$20221013$$MD$IT$IT
1361086621$13610866$21$F$20160804$20221003$20170605$20221005$EXP$$PHHY2017IT021869$NOVARTIS$$13$YR$$M$Y$44$KG$20221005$$MD$IT$IT
136118675$13611867$5$F$$20170620$20170605$20221212$EXP$$ES-TEVA-774045ISR$TEVA$$67$YR$E$F$Y$$$20221212$$MD$ES$ES
136193443$13619344$3$F$20160101$20200627$20170606$20221008$PER$$US-PURDUE-USA-2016-0132275$PURDUE$$59$YR$$F$Y$$$20221008$$CN$US$US
136195624$13619562$4$F$20111101$20221123$20170606$20221130$EXP$$US-JAZZ-2017-US-006353$JAZZ$$27$YR$$M$Y$$$20221130$$MD$US$US
1362375226$13623752$26$F$20171103$20221121$20170608$20221128$EXP$$CA-ROCHE-1946081$ROCHE$$53$YR$$F$Y$90$KG$20221128$$CN$CA$CA
136251504$13625150$4$F$$20220928$20170607$20221012$PER$$US-JNJFOC-20170602495$JOHNSON AND JOHNSON$$$$$M$Y$$$20221010$$LW$US$US
136251904$13625190$4$F$20001109$20220928$20170607$20221007$PER$$US-JNJFOC-20170602379$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20221007$$HP$US$US
136270405$13627040$5$F$20151201$20221015$20170607$20221017$PER$$US-PFIZER INC-2017239506$PFIZER$$55$YR$$F$Y$$$20221017$$LW$US$US
136270596$13627059$6$F$20121001$20221001$20170607$20221004$PER$$US-PFIZER INC-2016584463$PFIZER$$58$YR$$F$Y$$$20221004$$LW$US$US
136270673$13627067$3$F$20130201$20221015$20170607$20221017$PER$$US-PFIZER INC-2017239452$PFIZER$$61$YR$$F$Y$$$20221017$$LW$US$US
136287903$13628790$3$F$20120101$20221005$20170607$20221006$PER$$US-PFIZER INC-2016584439$PFIZER$$46$YR$$F$Y$79$KG$20221006$$LW$US$US
136354294$13635429$4$F$$20221122$20170609$20221128$PER$$US-PFIZER INC-2017250307$PFIZER$$53$YR$$F$Y$$$20221128$$CN$US$US
1363703612$13637036$12$F$$20221214$20170609$20221220$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK085504$GLAXOSMITHKLINE$$$$$$Y$$$20221220$$MD$CA$CA
136401705$13640170$5$F$$20221213$20170609$20221219$EXP$$US-BAXALTA-2017BLT005408$TAKEDA$$$$$F$Y$134$KG$20221219$$CN$US$US
136432265$13643226$5$F$20170510$20221208$20170612$20221215$EXP$$CA-TAKEDA-2017TUS012584$TAKEDA$$33$YR$$F$Y$55.329$KG$20221215$$CN$CA$CA
136442425$13644242$5$F$$20221007$20170612$20221012$PER$$US-PFIZER INC-2017252015$PFIZER$$75$YR$$M$Y$113$KG$20221012$$CN$US$US
136461652$13646165$2$F$20170524$20221103$20170613$20221116$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-051724$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20221116$$CN$US$US
1364725214$13647252$14$F$20161216$20221110$20170613$20221114$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN088088$VIIV$$$$$$Y$$$20221114$$MD$JP$JP
1365101229$13651012$29$F$20170101$20221109$20170614$20221115$EXP$$US-INCYTE CORPORATION-2017IN004526$INCYTE$$$$$$Y$$$20221115$$CN$US$US
1365103610$13651036$10$F$$20221206$20170614$20221212$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK144065$GLAXOSMITHKLINE$$$$$$Y$$$20221212$$CN$BR$BR
136513203$13651320$3$F$$20221117$20170614$20221122$EXP$$AU-PFIZER INC-2017252504$PFIZER$$44$YR$$M$Y$$$20221122$$MD$AU$AU
136585424$13658542$4$F$20220101$20221207$20170616$20221212$EXP$$US-PFIZER INC-2017164379$PFIZER$$69$YR$$M$Y$$$20221212$$CN$US$US
1365857414$13658574$14$F$$20220927$20170616$20221010$EXP$$GB-GLENMARK PHARMACEUTICALS-2017GMK027851$GLENMARK$$$$$$Y$$$20221010$$PH$GB$GB
1365953730$13659537$30$F$20160101$20221019$20170616$20221026$EXP$$PHHY2014CA049928$NOVARTIS$$$$$F$Y$$$20221026$$HP$CA$CA
136612763$13661276$3$F$20131001$20221221$20170616$20221222$PER$$US-PFIZER INC-2017158441$PFIZER$$59$YR$$F$Y$$$20221222$$LW$US$US
136634412$13663441$2$F$$20221024$20170619$20221027$PER$$US-PFIZER INC-2017261500$PFIZER$$36$YR$$F$Y$$$20221027$$CN$US$US
136677834$13667783$4$F$20170516$20221125$20170620$20221129$EXP$$FR-SHIRE-FR201711214$TAKEDA$$51$YR$$M$Y$53$KG$20221129$$HP$FR$FR
136693863$13669386$3$F$20170401$20170608$20170620$20221209$EXP$$CA-TEVA-764373ACC$TEVA$$31$YR$A$M$Y$$$20221209$$CN$CA$CA
136732318$13673231$8$F$$20221215$20170621$20221221$EXP$$CA-ROCHE-1952034$ROCHE$$60$YR$$F$Y$64$KG$20221221$$HP$CA$
136743692$13674369$2$F$$20221026$20170621$20221102$PER$$US-AMGEN-USASP2017091074$AMGEN$$$$A$F$Y$$$20221102$$CN$US$US
136751873$13675187$3$F$20110104$20220926$20170621$20221004$EXP$$US-AstraZeneca-2017SE62631$ASTRAZENECA$$22692$DY$$F$Y$87.3$KG$20221004$$LW$US$
1367670212$13676702$12$F$20180404$20221003$20170622$20221014$EXP$$US-PFIZER INC-2017270929$MYLAN$$57$YR$$F$Y$100$KG$20221014$$CN$US$US
1368227512$13682275$12$F$$20221009$20170623$20221011$EXP$GB-MHRA-MIDB-CCF9279F-D2CB-42FC-ADF9-3A1581D4A5BD$PHFR2017GB004594$NOVARTIS$$47$YR$$F$Y$$$20221011$$PH$GB$GB
136824972$13682497$2$F$20170525$20221109$20170623$20221118$EXP$$CA-JNJFOC-20170617857$JOHNSON AND JOHNSON$$40$YR$A$M$Y$127.01$KG$20221118$$CN$CA$CA
1368793832$13687938$32$F$20121226$20221020$20170626$20221027$EXP$$CA-ROCHE-1196834$ROCHE$$45$YR$$F$Y$75$KG$20221027$$HP$CA$
1368847913$13688479$13$F$$20221122$20170626$20221205$EXP$$GB-AUROBINDO-AUR-APL-2017-35698$AUROBINDO$$47$YR$$F$Y$$$20221205$$PH$GB$GB
1369684235$13696842$35$F$20160914$20221122$20170628$20221201$EXP$$CO-INCYTE CORPORATION-2017IN005035$INCYTE$$$$$$Y$$$20221201$$CN$CO$CO
136979644$13697964$4$F$$20221219$20170628$20221231$EXP$$CA-APOTEX-2017AP013336$APOTEX$$60$YR$$F$Y$64$KG$20221231$$HP$CA$CA
136992574$13699257$4$F$$20221025$20170628$20221031$EXP$$BE-BAUSCH-BL-2017-019916$BAUSCH AND LOMB$Heyrman B, De Becker A, Schots R. A case report of immunosuppression-related Kaposi^s sarcoma after autologous stem cell transplantation. BMC research notes. 2016;9:1-5. doi:10.1186/s13104-016-1991-9$61$YR$$M$Y$$$20221031$$MD$BE$BE
1370316018$13703160$18$F$20170101$20221212$20170629$20221219$EXP$$US-PFIZER INC-2017142637$PFIZER$$78$YR$$F$Y$$$20221219$$CN$US$US
137043299$13704329$9$F$$20221121$20170630$20221210$EXP$$CA-ROCHE-1955170$ROCHE$$$$$F$Y$70$KG$20221210$$HP$CA$
137048737$13704873$7$F$$20221214$20170630$20221226$EXP$$CA-APOTEX-2017AP013514$APOTEX$$85$YR$$M$Y$$$20221226$$MD$CA$CA
137068084$13706808$4$F$20010501$20221116$20170630$20221128$PER$$US-JNJFOC-20170616667$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20221128$$LW$US$US
137076147$13707614$7$F$20150101$20221207$20170630$20221214$EXP$$US-JAZZ-2017-US-008350$JAZZ$$$$$F$Y$$$20221214$$MD$US$US
1370783912$13707839$12$F$$20221123$20170630$20221128$EXP$$US-PFIZER INC-2017284135$PFIZER$$71$YR$$F$Y$$$20221128$$CN$US$US
1371085214$13710852$14$F$20170507$20221115$20170703$20221118$EXP$$TR-ROCHE-1932955$ROCHE$$76$YR$$M$Y$78.3$KG$20221118$$MD$TR$
1371148735$13711487$35$F$20170101$20221214$20170703$20221222$EXP$$CA-CELLTRION INC.-2017CA008553$CELLTRION$$$$$$Y$$$20221222$$CN$CA$CA
137145129$13714512$9$F$20170601$20221116$20170704$20221119$EXP$$PHHY2017CA097764$NOVARTIS$$40$YR$$M$Y$$$20221119$$CN$CA$CA
1371571713$13715717$13$F$$20221013$20170705$20221021$EXP$$CA-JNJFOC-20170625604$JOHNSON AND JOHNSON$$50$YR$A$F$Y$110$KG$20221021$$HP$CA$CA
137168045$13716804$5$F$20220203$20221027$20170705$20221104$EXP$$CA-ROCHE-1959369$ROCHE$$75$YR$$F$Y$$$20221103$$MD$CA$CA
1371742525$13717425$25$F$20161114$20221103$20170705$20221108$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK176439$GLAXOSMITHKLINE$$$$$$Y$$$20221108$$CN$BR$BR
137174472$13717447$2$F$$20221212$20170705$20221219$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK101194$GLAXOSMITHKLINE$$$$$$Y$$$20221219$$MD$CA$CA
1371785211$13717852$11$F$$20221202$20170705$20221207$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK060417$GLAXOSMITHKLINE$$$$$$Y$$$20221207$$CN$BR$BR
137180054$13718005$4$F$20160127$20221220$20170705$20221227$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-083600$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$73$KG$20221227$$MD$JP$JP
137198107$13719810$7$F$20150501$20221220$20170705$20221228$EXP$$US-JAZZ-2017-US-008485$JAZZ$$49$YR$$F$Y$$$20221228$$HP$US$US
137212426$13721242$6$F$20160228$20221026$20170706$20221102$EXP$$CA-ROCHE-1958977$ROCHE$$65$YR$$F$Y$$$20221102$$MD$CA$CA
1372446910$13724469$10$F$20170501$20221114$20170706$20221117$EXP$$CA-PFIZER INC-2017285010$PFIZER$$61$YR$$F$Y$$$20221117$$CN$CA$CA
137245543$13724554$3$F$20160101$20221207$20170706$20221215$EXP$$US-PFIZER INC-2017288743$PFIZER$$69$YR$$F$Y$66.667$KG$20221215$$CN$US$US
137273677$13727367$7$F$20170113$20221206$20170707$20221214$EXP$$PHHY2016CA109137$NOVARTIS$$78$YR$$F$Y$$$20221214$$CN$CA$CA
1373534710$13735347$10$F$20170101$20221109$20170710$20221115$EXP$$PHHY2017CA100155$NOVARTIS$$$$$M$Y$120$KG$20221115$$CN$CA$CA
1373879924$13738799$24$F$20170601$20221205$20170710$20221213$EXP$$CA-CELLTRION INC.-2017CA008652$CELLTRION$$$$$$Y$$$20221213$$CN$CA$CA
137419374$13741937$4$F$20170622$20221007$20170711$20221011$PER$$US-PFIZER INC-2017298881$PFIZER$$64$YR$$M$Y$$$20221011$$CN$US$US
137457707$13745770$7$F$$20221017$20170712$20221025$EXP$$US-PFIZER INC-2017268709$PFIZER$$9$YR$$M$Y$30$KG$20221025$$HP$US$US
137554058$13755405$8$F$20140424$20221012$20170714$20221014$PER$$US-PFIZER INC-2017305436$PFIZER$$70$YR$$F$Y$$$20221014$$MD$US$US
1375543414$13755434$14$F$20170301$20221209$20170714$20221216$EXP$$US-PFIZER INC-2017306034$PFIZER$$57$YR$$F$Y$$$20221216$$CN$US$US
137554607$13755460$7$F$$20221006$20170714$20221007$PER$$US-PFIZER INC-2017303511$PFIZER$$69$YR$$F$Y$$$20221007$$MD$US$US
137555542$13755554$2$F$20150101$20221122$20170714$20221129$PER$$US-AMGEN-USASL2017104973$AMGEN$$74$YR$E$M$Y$$$20221128$$CN$US$US
137578103$13757810$3$F$$20221017$20170717$20221027$EXP$$CA-ROCHE-1962285$ROCHE$$40$YR$$F$Y$$$20221027$$CN$CA$CA
137578184$13757818$4$F$20140801$20221119$20170717$20221201$EXP$$FR-Accord-053593$ACCORD$Bodard Q, Litrowski N, Carre D, Midhat M, Chenal P, Bravard P.. Mycosis fungoides in a heart transplant recipient.. Ann Dermatol Venereol..2017;144(10):624-8.$68$YR$E$M$Y$$$20221201$$HP$FR$FR
1375930214$13759302$14$F$20151110$20180822$20170717$20221003$EXP$$PHHY2016DE115328$NOVARTIS$$2$YR$$M$Y$12.2$KG$20221003$$MD$DE$DE
137612837$13761283$7$F$20140101$20221012$20170717$20221017$EXP$$PHHY2015CR008160$NOVARTIS$$$$$F$Y$56.7$KG$20221017$$CN$CR$CR
137618042$13761804$2$F$20170201$20221010$20170718$20221013$EXP$FR-AFSSAPS-AM20170810$FR-TAKEDA-2017TUS015034$TAKEDA$$55$YR$$M$Y$72$KG$20221013$$HP$FR$FR
1376235313$13762353$13$F$20170703$20221214$20170718$20221220$EXP$$US-PFIZER INC-2017301253$PFIZER$$59$YR$$M$Y$61$KG$20221220$$CN$US$US
137660856$13766085$6$F$20170630$20221114$20170719$20221124$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004619$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20221124$$CN$US$US
137679273$13767927$3$F$$20221212$20170719$20221215$PER$$US-PFIZER INC-2017307830$PFIZER$$72$YR$$M$Y$$$20221215$$HP$US$US
137679849$13767984$9$F$20160201$20221214$20170719$20221227$EXP$$IN-INCYTE CORPORATION-2016IN000807$INCYTE$$$$$$Y$$$20221227$$CN$IN$IN
137700023$13770002$3$F$20160917$20220929$20170719$20221003$EXP$$US-TAKEDA-2017TUS015029$TAKEDA$$30$YR$$F$Y$66.667$KG$20221003$$HP$US$US
137728373$13772837$3$F$20170619$20221208$20170720$20221216$EXP$$JP-SHIRE-JP201716085$TAKEDA$$9$YR$$F$Y$$$20221216$$MD$JP$JP
1377312214$13773122$14$F$20170706$20221012$20170720$20221021$PER$$US-INCYTE CORPORATION-2017IN005517$INCYTE$$$$$$Y$$$20221021$$CN$US$US
1377331615$13773316$15$F$20170101$20220930$20170720$20221004$EXP$$CA-PFIZER INC-2017165290$PFIZER$$62$YR$$F$Y$$$20221004$$CN$CA$CA
137754354$13775435$4$F$20170601$20221207$20170720$20221209$EXP$$CA-TAKEDA-2017TUS015054$TAKEDA$$65$YR$$F$Y$$$20221209$$CN$CA$CA
1377743412$13777434$12$F$20160715$20221209$20170721$20221220$EXP$$CA-ROCHE-1964975$ROCHE$$17$YR$$M$Y$$$20221220$$CN$CA$CA
137788618$13778861$8$F$20170929$20221101$20170721$20221103$PER$$US-PFIZER INC-2017316465$PFIZER$$70$YR$$F$Y$66.22$KG$20221103$$HP$US$US
137790453$13779045$3$F$20130101$20220927$20170721$20221010$EXP$$FR-AUROBINDO-AUR-APL-2015-01074$AUROBINDO$Barbara Doudier, Hugues Vencatassin, Sarah Aherfi, Philippe Colsonb. Fatal fulminant hepatitis E associated with autoimmune hepatitis and excessive paracetamol intake in Southeastern France. Journal of Clinical Microbiology. 2014;52(4):1294-1297$77$YR$$F$Y$$$20221010$$HP$FR$FR
137837237$13783723$7$F$$20221121$20170724$20221122$PER$$US-PFIZER INC-2017320556$PFIZER$$69$YR$$F$Y$$$20221122$$HP$US$US
137851605$13785160$5$F$$20221129$20170725$20221202$EXP$$US-ROCHE-1966350$ROCHE$$30$YR$$M$Y$80.812$KG$20221202$$HP$US$
137902963$13790296$3$F$20170101$20170818$20170725$20221027$EXP$$US-VIIV HEALTHCARE LIMITED-US2017113730$VIIV$$$$$F$Y$$$20221027$$PH$US$US
137911163$13791116$3$F$20160527$20221206$20170725$20221215$PER$$US-INCYTE CORPORATION-2017IN003389$INCYTE$$$$$$Y$$$20221215$$CN$US$US
137925767$13792576$7$F$20161129$20221130$20170726$20221204$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2017-BI-041483$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$75$KG$20221204$$HP$ES$ES
1379432715$13794327$15$F$$20221020$20170726$20221024$PER$$US-PFIZER INC-2017241581$PFIZER$$25$YR$$M$Y$$$20221024$$CN$US$US
137953567$13795356$7$F$20190320$20221018$20170726$20221020$EXP$$US-PFIZER INC-2017324138$PFIZER$$65$YR$$F$Y$84$KG$20221020$$HP$US$US
137981064$13798106$4$F$$20221117$20170727$20221118$PER$$US-PFIZER INC-2017324389$PFIZER$$46$YR$$F$Y$$$20221118$$CN$US$US
138024487$13802448$7$F$20170424$20221201$20170728$20221208$EXP$$CA-ROCHE-1967729$ROCHE$$31$YR$$F$Y$$$20221208$$MD$CA$CA
138056073$13805607$3$F$20150511$20221005$20170728$20221007$PER$$US-PFIZER INC-2016584416$PFIZER$$47$YR$$F$Y$84.8$KG$20221007$$LW$US$US
138056185$13805618$5$F$20131101$20221005$20170728$20221006$PER$$US-PFIZER INC-2017053691$PFIZER$$56$YR$$F$Y$104$KG$20221006$$LW$US$US
138060924$13806092$4$F$20160315$20221007$20170728$20221014$EXP$$PHHY2016CA036453$NOVARTIS$$43$YR$$M$Y$$$20221014$$MD$CA$CA
138066333$13806633$3$F$$20221019$20170728$20221019$EXP$$CA-PFIZER INC-2017325722$PFIZER$$49$YR$$F$Y$$$20221019$$CN$CA$CA
138126095$13812609$5$F$20170724$20221114$20170728$20221117$EXP$$PHHY2017CA111503$NOVARTIS$$46$YR$$F$Y$$$20221117$$CN$CA$CA
1381361619$13813616$19$F$20170716$20221102$20170731$20221108$EXP$$CA-ROCHE-1971321$ROCHE$$22$YR$$F$Y$$$20221108$$MD$CA$CA
138154434$13815443$4$F$$20170801$20170731$20221212$EXP$$GB-TEVA-793081ISR$TEVA$$48$YR$A$F$Y$$$20221212$$MD$GB$GB
138159066$13815906$6$F$20141022$20220912$20170731$20221005$EXP$$PHHY2017IT104422$NOVARTIS$$$$$F$Y$10.7$KG$20221005$$MD$IT$IT
138211993$13821199$3$F$20120501$20221005$20170801$20221006$PER$$US-PFIZER INC-2016584472$PFIZER$$48$YR$$F$Y$68$KG$20221006$$LW$US$US
138227253$13822725$3$F$$20221125$20170801$20221130$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-067963$BRISTOL MYERS SQUIBB$Vivar KL, Deschaine M, Messina J, Divine JM, Rabionet A, Patel N, et al. Epidermal programmed cell death-ligand 1 expression in TEN associated with Nivolumab therapy. Journal of Cutaneous Pathology. 2017; 44: 381-4.doi:10.1111/cup.12876.$50$YR$A$F$Y$$$20221201$$HP$US$US
1382387614$13823876$14$F$20170717$20221117$20170802$20221121$EXP$$US-PFIZER INC-2017331290$PFIZER$$78$YR$$F$Y$82$KG$20221121$$CN$US$US
1382411511$13824115$11$F$20170601$20221124$20170802$20221202$EXP$$AU-BIOGEN-2017BI00437644$BIOGEN$$30$YR$$F$Y$$$20221202$$CN$AU$AU
138241803$13824180$3$F$20120101$20221004$20170802$20221007$EXP$$US-AstraZeneca-2017SE78104$ASTRAZENECA$$61$YR$$F$Y$78.5$KG$20221007$$LW$US$
138257976$13825797$6$F$20170522$20221021$20170802$20221024$EXP$$PHJP2017JP021551$NOVARTIS$$70$YR$$M$Y$92.7$KG$20221024$$MD$JP$JP
138262686$13826268$6$F$20100101$20221109$20170802$20221117$EXP$$US-EMD Serono-7056049$EMD SERONO INC$$45$YR$A$F$Y$88$KG$20221117$$CN$US$
1382796012$13827960$12$F$$20221220$20170803$20221226$EXP$$CA-Orion Corporation ORION PHARMA-TREX2017-2277$ORION$$56$YR$A$F$Y$$$20221227$$MD$CA$
1383632415$13836324$15$F$20160101$20221109$20170804$20221116$EXP$$PHHY2017BR113598$NOVARTIS$$$$$M$Y$100$KG$20221116$$CN$BR$BR
138415763$13841576$3$F$20170726$20221102$20170807$20221108$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-067594$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$99$KG$20221109$$HP$US$US
138441075$13844107$5$F$$20221013$20170808$20221106$PER$$US-AMGEN-USASP2017117244$AMGEN$$$$$F$Y$$$20221106$$MD$US$US
138460474$13846047$4$F$$20221003$20170808$20221108$EXP$$US-ROCHE-737962$ROCHE$$$$$F$Y$$$20221108$$MD$US$
1384660216$13846602$16$F$20170529$20221007$20170808$20221008$EXP$$PHHY2017GR116283$NOVARTIS$$13$YR$$M$Y$60$KG$20221008$$MD$GR$GR
138478844$13847884$4$F$20170707$20200407$20170809$20221008$PER$$US-PURDUE-USA-2017-0139866$PURDUE$$$$$F$Y$$$20221008$$CN$US$US
1384976424$13849764$24$F$20170101$20221212$20170809$20221219$EXP$$CA-ROCHE-1976139$ROCHE$$45$YR$$F$Y$85$KG$20221219$$CN$CA$CA
138499738$13849973$8$F$20170701$20221028$20170809$20221104$EXP$$US-ROCHE-1973193$ROCHE$$54$YR$$M$Y$94.432$KG$20221103$$HP$US$
1385082222$13850822$22$F$$20221017$20170809$20221019$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK044952$GLAXOSMITHKLINE$$$$$$Y$$$20221019$$MD$BR$BR
1385138926$13851389$26$F$$20221201$20170809$20221207$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-069714$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20221207$$CN$CA$CA
138553479$13855347$9$F$20160611$20221128$20170810$20221206$PER$$US-Vifor (International) Inc.-VIT-2017-05244$VIFOR$$86$YR$$F$Y$73.548$KG$20221206$$CN$US$US
138559915$13855991$5$F$20170701$20221031$20170810$20221108$EXP$$US-EMD Serono-8174566$EMD SERONO INC$$76$YR$E$F$Y$$$20221108$$PH$US$
138564634$13856463$4$F$$20221228$20170810$20221230$EXP$$US-JAZZ-2017-US-010131$JAZZ$$$$$F$Y$$$20221230$$CN$US$US
1385764316$13857643$16$F$$20221221$20170811$20221227$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-052306$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20221227$$MD$CA$CA
138610353$13861035$3$F$$20221031$20170811$20221104$PER$$US-PFIZER INC-2017346776$PFIZER$$64$YR$$F$Y$$$20221104$$CN$US$US
138668264$13866826$4$F$20170601$20221222$20170814$20221229$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003979$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20221230$$CN$US$US
138670185$13867018$5$F$20180430$20220908$20170814$20221003$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003808$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20221003$$CN$US$US
138677886$13867788$6$F$20180513$20221004$20170814$20221013$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003633$ACADIA PHARMACEUTICALS$$42$YR$$F$Y$$$20221014$$CN$US$US
138678762$13867876$2$F$20170401$20220914$20170814$20221006$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003500$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20221007$$CN$US$US
138679235$13867923$5$F$20170601$20221103$20170814$20221111$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004312$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20221111$$CN$US$US
138679723$13867972$3$F$$20221216$20170814$20221226$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004456$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20221226$$CN$US$US
138679883$13867988$3$F$$20221215$20170814$20221223$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004485$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20221223$$CN$US$US
138680936$13868093$6$F$20170724$20221007$20170814$20221101$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004919$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20221101$$CN$US$US
138690014$13869001$4$F$20170510$20220927$20170815$20221004$EXP$$US-TAKEDA-2017TUS016678$TAKEDA$$30$YR$$F$Y$63.5$KG$20221004$$HP$US$US
1386944517$13869445$17$F$20161001$20221102$20170815$20221104$EXP$$GB-PFIZER INC-2017352058$MYLAN$$44$YR$$F$Y$$$20221104$$CN$GB$GB
138701086$13870108$6$F$20170614$20221007$20170815$20221010$EXP$GB-MHRA-EYC 00162837$GB-MYLANLABS-2017M1048814$MYLAN$$39$YR$$F$Y$56$KG$20221010$$CN$GB$GB
138730725$13873072$5$F$20170101$20221002$20170816$20221017$EXP$$GB-AUROBINDO-AUR-APL-2017-38614$AUROBINDO$$39$YR$$F$Y$51$KG$20221017$$CN$GB$GB
1387394518$13873945$18$F$20170612$20221118$20170816$20221124$EXP$$PHHY2017CO102043$NOVARTIS$$57$YR$$M$Y$97$KG$20221124$$CN$CO$CO
138758513$13875851$3$F$$20221222$20170817$20221229$PER$$US-AMGEN-USASP2017122132$AMGEN$$59$YR$A$F$Y$$$20221229$$MD$US$US
1387637910$13876379$10$F$$20221026$20170817$20221031$PER$$US-AMGEN-USASP2017122188$AMGEN$$68$YR$E$F$Y$99.79$KG$20221031$$MD$US$US
138777208$13877720$8$F$20170805$20221129$20170817$20221205$EXP$$PHHY2017MT118533$NOVARTIS$$72$YR$$F$Y$$$20221205$$MD$MT$MT
138805647$13880564$7$F$20160316$20221128$20170818$20221205$EXP$$CA-ROCHE-1743894$ROCHE$$52$YR$$F$Y$$$20221205$$CN$CA$CA
138816473$13881647$3$F$20111201$20221005$20170818$20221006$PER$$US-PFIZER INC-2016584465$PFIZER$$52$YR$$F$Y$98$KG$20221006$$LW$US$US
1388192213$13881922$13$F$20170814$20221023$20170818$20221027$EXP$$VN-ASTELLAS-2017US032784$ASTELLAS$$35$YR$$F$Y$44$KG$20221027$$MD$VN$VN
138824007$13882400$7$F$20170220$20220912$20170818$20221008$EXP$$PHHY2017IT081024$NOVARTIS$$$$$M$Y$50$KG$20221008$$MD$IT$IT
138908193$13890819$3$F$20130101$20221014$20170822$20221019$PER$$US-AMGEN-USASP2017123660$AMGEN$$38$YR$A$F$Y$$$20221019$$HP$US$US
138921482$13892148$2$F$$20221011$20170822$20221026$EXP$$JP-PFIZER INC-2017354669$PFIZER$Naruse, K.. A patent with SGA short stature post Fontan procedure who experienced Protein-losing gastroenteropathy during growth hormone (GH) therapy. The 53rd Chubu Regional Meeting of Japan Pediatric Society. 2017;53rd:53$13$YR$$F$Y$$$20221026$$MD$JP$JP
138927632$13892763$2$F$$20221208$20170822$20221215$EXP$$US-ROCHE-1348333$ROCHE$$72$YR$$M$Y$59.02$KG$20221215$$MD$US$
138956283$13895628$3$F$$20221116$20170823$20221118$PER$$US-PFIZER INC-2017358935$PFIZER$$59$YR$$M$Y$$$20221118$$CN$US$US
1389564415$13895644$15$F$$20221013$20170823$20221017$EXP$$US-PFIZER INC-2016603073$PFIZER$$70$YR$$F$Y$57$KG$20221017$$MD$US$US
138977085$13897708$5$F$20140305$20221003$20170823$20221004$PER$$US-PFIZER INC-2017360446$PFIZER$$66$YR$$F$Y$107$KG$20221004$$LW$US$US
139063625$13906362$5$F$20170710$20191024$20170825$20221101$EXP$$PHHY2017CO108158$NOVARTIS$$75$YR$$M$Y$68$KG$20221101$$CN$CO$CO
139112748$13911274$8$F$$20221212$20170828$20221219$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK130321$GLAXOSMITHKLINE$$$$$$Y$$$20221219$$MD$CA$CA
139124942$13912494$2$F$$20221102$20170828$20221109$PER$$US-INCYTE CORPORATION-2017IN007041$INCYTE$$$$$$Y$$$20221109$$CN$US$US
139125918$13912591$8$F$20160501$20221114$20170828$20221119$EXP$$PHHY2016CA077562$NOVARTIS$$47$YR$$M$Y$$$20221119$$CN$CA$CA
1391742124$13917421$24$F$20161001$20221129$20170829$20221202$EXP$$GB-PURDUE PHARMA-GBR-2017-0048229$PURDUE$$44$YR$$F$Y$$$20221202$$HP$GB$GB
139182179$13918217$9$F$20210510$20220929$20170829$20221007$PER$$US-SA-2017SA040537$SANOFI AVENTIS$$48$YR$A$F$Y$$$20221007$$MD$US$US
139221953$13922195$3$F$$20221109$20170830$20221117$EXP$$IN-SA-2017SA157868$SANOFI AVENTIS$$15$YR$T$M$Y$$$20221117$$MD$IN$IN
139268785$13926878$5$F$20170818$20221021$20170831$20221024$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076454$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$108.4$KG$20221024$$MD$GB$GB
139301108$13930110$8$F$20150101$20221108$20170901$20221114$EXP$$US-PFIZER INC-2017379523$MYLAN$$$$$M$Y$$$20221114$$CN$US$US
1393032821$13930328$21$F$20161031$20221020$20170901$20221102$EXP$$PHHY2016CA151784$NOVARTIS$$65$YR$$M$Y$$$20221102$$CN$CA$CA
1393048511$13930485$11$F$20170707$20221018$20170901$20221028$EXP$$IN-INCYTE CORPORATION-2017IN007203$INCYTE$$$$$$Y$$$20221028$$CN$IN$IN
1393173211$13931732$11$F$20170602$20221205$20170904$20221213$EXP$$CA-ROCHE-1986006$ROCHE$$50$YR$$F$Y$90$KG$20221213$$CN$CA$CA
139322145$13932214$5$F$$20221228$20170904$20221229$PER$$US-PFIZER INC-2017379021$PFIZER$$62$YR$$F$Y$$$20221229$$MD$US$US
139347373$13934737$3$F$$20221010$20170905$20221021$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2017US-148873$RANBAXY$$$$$M$Y$$$20221021$$MD$US$US
1393654218$13936542$18$F$20170801$20221013$20170905$20221019$EXP$$US-INCYTE CORPORATION-2017IN007200$INCYTE$$$$$$Y$$$20221019$$CN$US$US
139370253$13937025$3$F$20121001$20221005$20170905$20221006$PER$$US-PFIZER INC-2017379826$PFIZER$$38$YR$$F$Y$$$20221006$$LW$US$US
1393769011$13937690$11$F$20170706$20221202$20170905$20221206$EXP$$US-INCYTE CORPORATION-2017IN006594$INCYTE$$$$$$Y$$$20221206$$CN$US$US
139382473$13938247$3$F$20160101$20221201$20170905$20221209$EXP$$US-JAZZ-2017-US-011327$JAZZ$$50$YR$$F$Y$$$20221209$$MD$US$US
1394052634$13940526$34$F$20150301$20221024$20170906$20221028$EXP$$PHHY2015CA034068$NOVARTIS$$39$YR$$F$Y$$$20221028$$MD$CA$CA
139413876$13941387$6$F$20170101$20221122$20170906$20221125$EXP$$PHHY2017CA019786$NOVARTIS$$50$YR$$M$Y$$$20221125$$CN$CA$CA
139421762$13942176$2$F$20120101$20221122$20170906$20221129$EXP$$US-JAZZ-2017-US-011393$JAZZ$$$$$M$Y$$$20221129$$MD$US$US
139426403$13942640$3$F$20170831$20221221$20170906$20221226$EXP$$US-JAZZ-2017-US-011475$JAZZ$$32$YR$$F$Y$$$20221226$$CN$US$US
139430986$13943098$6$F$20170801$20221122$20170907$20221207$EXP$$CA-UCBSA-2017033656$UCB$$40$YR$$F$Y$$$20221207$$MD$CA$CA
1394656310$13946563$10$F$20170601$20221019$20170907$20221026$EXP$$PHHY2017CA131866$NOVARTIS$$26$YR$$F$Y$$$20221026$$MD$CA$CA
1394916131$13949161$31$F$20170607$20221212$20170908$20221219$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK177634$GLAXOSMITHKLINE$$$$$$Y$$$20221219$$MD$BR$BR
139505022$13950502$2$F$$20221115$20170908$20221121$EXP$$PT-MYLANLABS-2017M1055566$MYLAN$Pereira M, Guerra I.. Clinical case: Acute pancreatitis and lipemia. Clin-Chem-Lab-Med. 2016;54 (10):eA321$41$YR$$F$Y$$$20221121$$HP$PT$PT
139515283$13951528$3$F$20130101$20221122$20170908$20221202$EXP$$US-JAZZ-JPI-P-030318$JAZZ$$$$$F$Y$$$20221202$$MD$US$US
139519135$13951913$5$F$20160525$20221013$20170910$20221017$EXP$$PHHY2016CO080191$NOVARTIS$$61$YR$$F$Y$76$KG$20221017$$CN$CO$CO
139530633$13953063$3$F$$20170828$20170911$20221212$PER$$US-TEVA-796677ACC$TEVA$Latif S, Ohri P, Taxel P. Kyphoplasty complicated by short interval and adjacent multiple vertebral compression fractures: Eight is enough. Endocrine Reviews. 2017;38:.$63$YR$A$F$Y$$$20221212$$MD$US$US
139565924$13956592$4$F$20170817$20221109$20170911$20221109$EXP$$JP-BAYER-2017-169779$BAYER$$69$YR$E$M$Y$55.3$KG$20221109$$MD$JP$JP
1395736413$13957364$13$F$20180329$20221110$20170911$20221116$EXP$$PHHY2017CA132557$NOVARTIS$$57$YR$$F$Y$$$20221117$$CN$CA$CA
139619554$13961955$4$F$$20221129$20170912$20221203$EXP$$PHHY2017CO126665$NOVARTIS$$$$$F$Y$58$KG$20221203$$CN$CO$CO
139630684$13963068$4$F$20170101$20221007$20170913$20221012$PER$$US-PFIZER INC-2017393844$PFIZER$$53$YR$$F$Y$$$20221012$$MD$US$US
1396312812$13963128$12$F$20170801$20221103$20170913$20221111$EXP$$US-PFIZER INC-2017231807$PFIZER$$70$YR$$F$Y$95$KG$20221111$$MD$US$US
1396317813$13963178$13$F$20161201$20221209$20170913$20221213$EXP$$CA-TAKEDA-2017TUS001449$TAKEDA$$53$YR$$M$Y$$$20221213$$CN$CA$CA
139639809$13963980$9$F$20170516$20221005$20170913$20221007$EXP$$JP-ABBVIE-17K-087-1995756-00$ABBVIE$$75$YR$$F$Y$46$KG$20221007$$CN$JP$JP
139669767$13966976$7$F$$20221121$20170914$20221122$EXP$$CA-ROCHE-1992036$ROCHE$$$$$F$Y$$$20221123$$MD$CA$
1396707532$13967075$32$F$20161001$20221220$20170914$20221222$EXP$GB-TEVA-801034ACC$GB-JNJFOC-20170905683$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20221222$$HP$GB$GB
139684475$13968447$5$F$20170301$20221018$20170914$20221020$PER$$US-PFIZER INC-2017396906$PFIZER$$66$YR$$F$Y$131.5$KG$20221020$$CN$US$US
1397123126$13971231$26$F$20150101$20221123$20170914$20221129$EXP$$US-ASTELLAS-2017US014871$ASTELLAS$$$$$M$Y$$$20221129$$CN$US$US
139723852$13972385$2$F$20210101$20221108$20170914$20221115$PER$$US-AMGEN-USASL2017137811$AMGEN$$$$A$F$Y$$$20221115$$CN$US$US
139742916$13974291$6$F$$20221107$20170915$20221114$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-082672$BRISTOL MYERS SQUIBB$Pf?hler C. Autoimmune thrombopenia or aggravation of a previously unknown werlhof disease?.$73$YR$E$M$Y$$$20221114$$MD$DE$DE
139751876$13975187$6$F$20170516$20221110$20170915$20221118$EXP$$US-SHIRE-US201720939$TAKEDA$$60$YR$$F$Y$78.912$KG$20221118$$MD$US$US
1397559410$13975594$10$F$20170101$20221006$20170915$20221010$PER$$US-PFIZER INC-2017395067$PFIZER$$86$YR$$F$Y$$$20221010$$HP$US$US
139768756$13976875$6$F$20170805$20221128$20170915$20221203$EXP$$PHHY2017IT133922$NOVARTIS$$51$YR$$F$Y$$$20221203$$MD$IT$IT
139806808$13980680$8$F$$20221130$20170918$20221204$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2017-BI-050658$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20221204$$MD$ES$ES
139813049$13981304$9$F$20180301$20221020$20170918$20221024$PER$$US-PFIZER INC-2017397283$PFIZER$$67$YR$$F$Y$90$KG$20221024$$CN$US$US
139858876$13985887$6$F$$20221221$20170919$20221227$PER$$US-PFIZER INC-2017401395$PFIZER$$72$YR$$F$Y$$$20221227$$MD$US$US
1398623519$13986235$19$F$20161001$20221019$20170919$20221031$EXP$$GB-AUROBINDO-AUR-APL-2017-40140$AUROBINDO$$44$YR$$F$Y$$$20221031$$HP$GB$GB
139866345$13986634$5$F$$20221007$20170919$20221014$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK144375$GLAXOSMITHKLINE$$$$$$Y$$$20221014$$MD$CA$CA
1398766111$13987661$11$F$20180601$20221209$20170919$20221215$EXP$$US-ASTELLAS-2017US036923$ASTELLAS$$79$YR$$M$Y$$$20221215$$CN$US$US
139879677$13987967$7$F$$20221031$20170919$20221104$EXP$$US-PFIZER INC-2017404513$PFIZER$$48$YR$$F$Y$77.11$KG$20221104$$CN$US$US
139900919$13990091$9$F$20170808$20221128$20170920$20221201$EXP$$US-BIOGEN-2017BI00459495$BIOGEN$$47$YR$$F$Y$$$20221201$$CN$US$US
139915524$13991552$4$F$20100601$20221123$20170920$20221129$PER$$US-JNJFOC-20170802244$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20221129$$HP$US$US
139915926$13991592$6$F$$20221003$20170920$20221013$PER$$US-JNJFOC-20170802625$JOHNSON AND JOHNSON$$$$$M$Y$$$20221014$$LW$US$US
139915953$13991595$3$F$20060502$20221228$20170920$20221229$PER$$US-JNJFOC-20170803003$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20221229$$LW$US$US
139922834$13992283$4$F$20140517$20221107$20170920$20221110$PER$$US-JNJFOC-20170906272$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20221110$$LW$US$US
140029609$14002960$9$F$20171212$20221020$20170922$20221025$EXP$$CA-TAKEDA-2017TUS019399$TAKEDA$$51$YR$$M$Y$$$20221025$$CN$CA$CA
140034722$14003472$2$F$$20220922$20170922$20221004$EXP$$PT-AUROBINDO-AUR-APL-2017-40672$AUROBINDO$Pereira M, Guerra I.. Acute pancreatitis and lipemia.. Clinical Chemistry and Laboratory Medicine. 2016;51(10):eA321$41$YR$$F$Y$$$20221004$$HP$PT$PT
140068515$14006851$5$F$$20221123$20170925$20221128$PER$$US-PFIZER INC-2017409298$PFIZER$$60$YR$$F$Y$$$20221128$$MD$US$US
140070265$14007026$5$F$20170701$20221115$20170925$20221125$PER$$US-LUPIN PHARMACEUTICALS INC.-2017-04741$LUPIN$$62$YR$$M$Y$65.76$KG$20221125$$CN$US$US
1400711314$14007113$14$F$$20221205$20170925$20221208$PER$$US-PFIZER INC-2017407271$PFIZER$$50$YR$$M$Y$81.65$KG$20221208$$CN$US$US
140074969$14007496$9$F$20000101$20221215$20170925$20221220$EXP$$US-PFIZER INC-2017409778$PFIZER$$44$YR$$M$Y$88.5$KG$20221220$$CN$US$US
140080678$14008067$8$F$20170801$20221018$20170925$20221021$PER$$US-PFIZER INC-2017411278$PFIZER$$77$YR$$F$Y$73$KG$20221021$$CN$US$US
1400847539$14008475$39$F$$20221118$20170925$20221212$EXP$$PT-PFIZER INC-2017405189$GLAXOSMITHKLINE$$$$$$Y$$$20221212$$HP$PT$PT
140090955$14009095$5$F$20120501$20221005$20170925$20221006$PER$$US-PFIZER INC-2016584504$PFIZER$$40$YR$$F$Y$68.027$KG$20221006$$LW$US$US
140090984$14009098$4$F$20160211$20221001$20170925$20221004$PER$$US-PFIZER INC-2016586541$PFIZER$$47$YR$$F$Y$105$KG$20221004$$LW$US$US
140106347$14010634$7$F$20170831$20221129$20170926$20221202$EXP$$GB-SHIRE-GB201723650$TAKEDA$$61$YR$$F$Y$$$20221202$$MD$GB$GB
140125315$14012531$5$F$20170911$20180118$20170926$20221211$EXP$$DE-TEVA-808038GER$TEVA$$55$YR$A$M$Y$$$20221211$$CN$DE$DE
140128642$14012864$2$F$20170805$20221011$20170926$20221013$EXP$$CA-TAKEDA-2017TUS019690$TAKEDA$$39$YR$$F$Y$$$20221013$$MD$CA$CA
1401401511$14014015$11$F$$20221013$20170926$20221020$PER$$US-AMGEN-USASP2017143522$AMGEN$$66$YR$E$F$Y$66$KG$20221020$$MD$US$US
140141128$14014112$8$F$$20221202$20170927$20221208$EXP$$CA-JNJFOC-20170923187$JOHNSON AND JOHNSON$$38$YR$A$F$Y$66$KG$20221208$$CN$CA$CA
1401530534$14015305$34$F$$20221118$20170927$20221121$EXP$$PT-JNJFOC-20170921376$JOHNSON AND JOHNSON$$23$YR$A$F$Y$102$KG$20221121$$HP$PT$PT
140166943$14016694$3$F$$20221222$20170927$20221227$PER$$US-PFIZER INC-2017416226$PFIZER$$51$YR$$F$Y$$$20221227$$MD$US$US
140182996$14018299$6$F$20150422$20221206$20170928$20221216$PER$$JP-AMGEN-JPNSP2017144345$AMGEN$Yamada R, Murakami A, Kusakabe E, Yamazawa H, Taguchi K, Nishiyama K, et al.. A case of anti-resorptive agents-related osteonecrosis of jaw in a patient with denosumab for multiple metastases to bone from breast cancer and healing after interruption of denosumab. The 14th Ann Met of The Japanese Breast Cancer Society, Chugoku-Shikoku Branch. 2017;83$$$$F$Y$$$20221216$$MD$JP$JP
1402081129$14020811$29$F$$20221118$20170928$20221121$EXP$$PHHY2017PT139841$NOVARTIS$Lopes JB, Cadinha S, Malheiro D, Brosseron L, Moreira D, Silva J. Multiple drug hypersensitivity syndrome to antihistamines, corticosteroids and nonsteroidal anti-inflammatories in a patient with asthma and urticaria. ALLERGY: EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2017;72 (103):219$23$YR$$F$Y$102$KG$20221121$$HP$PT$PT
1402407334$14024073$34$F$20171101$20221214$20170929$20221223$EXP$$CA-CELLTRION INC.-2017CA012918$CELLTRION$$$$$$Y$$$20221223$$CN$CA$CA
140257665$14025766$5$F$20140701$20221001$20170929$20221004$PER$$US-PFIZER INC-2016584462$PFIZER$$67$YR$$F$Y$$$20221004$$LW$US$US
140258075$14025807$5$F$20141001$20221006$20170929$20221007$PER$$US-PFIZER INC-2016584500$PFIZER$$56$YR$$F$Y$93$KG$20221007$$LW$US$US
140263874$14026387$4$F$20170921$20221129$20170929$20221202$EXP$$CA-TAKEDA-2017TUS019872$TAKEDA$$51$YR$$F$Y$$$20221202$$MD$CA$CA
140266275$14026627$5$F$20160101$20221126$20170929$20221206$EXP$$US-ACORDA-ACO_142380_2017$ACORDA$$$$$F$Y$63.5$KG$20221206$$MD$US$US
140274402$14027440$2$F$20220101$20221205$20170929$20221209$EXP$$US-ASTELLAS-2017US038598$ASTELLAS$$$$$M$Y$$$20221209$$CN$US$US
140276768$14027676$8$F$20170401$20221017$20170929$20221019$PER$$US-PFIZER INC-2017419527$PFIZER$$51$YR$$F$Y$55$KG$20221019$$CN$US$US
1403160813$14031608$13$F$20130419$20221214$20171003$20221222$EXP$$CA-ROCHE-2000971$ROCHE$$38$YR$$M$Y$$$20221222$$MD$CA$CA
140324918$14032491$8$F$20170101$20221024$20171003$20221103$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005614$ACADIA PHARMACEUTICALS$$$$$M$Y$59$KG$20221103$$CN$US$US
140326375$14032637$5$F$$20221010$20171002$20221014$PER$$US-PFIZER INC-2017421865$PFIZER$$68$YR$$F$Y$$$20221014$$MD$US$US
140331062$14033106$2$F$20170901$20221026$20171003$20221031$PER$$US-PFIZER INC-2017424362$PFIZER$$37$YR$$F$Y$83$KG$20221031$$HP$US$US
140331384$14033138$4$F$20110301$20221006$20171003$20221007$PER$$US-PFIZER INC-2016586384$PFIZER$$57$YR$$F$Y$$$20221007$$LW$US$US
1403366322$14033663$22$F$$20221116$20171003$20221130$EXP$$PT-AUROBINDO-AUR-APL-2017-41180$AUROBINDO$Lopes JB, Cadinha S, Malheiro D, Brosseron L, Moreira Da Silva JP.. Multiple drug hypersensitivity syndrome to antihistamines, corticosteroids and nonsteroidal anti-inflammatories in a patient with asthma and urticaria. Allergy:. European Journal of Allergy and Clinical Immunology.. 2017;72(103):219$23$YR$$F$Y$102$KG$20221130$$MD$PT$PT
140341782$14034178$2$F$20161221$20170215$20171003$20221212$PER$$US-TEVA-724836USA$TEVA$$40$YR$A$M$Y$93$KG$20221212$$CN$US$US
140345534$14034553$4$F$20130409$20221005$20171003$20221006$PER$$US-PFIZER INC-2016596185$PFIZER$$65$YR$$F$Y$61$KG$20221006$$LW$US$US
140352984$14035298$4$F$20051010$20220928$20171003$20221004$EXP$$US-PFIZER INC-2017425983$PFIZER$$46$YR$$M$Y$115.67$KG$20221004$$CN$US$US
140368748$14036874$8$F$$20221010$20171004$20221014$PER$$US-AMGEN-USASP2017148397$AMGEN$$72$YR$E$F$Y$74.84$KG$20221014$$MD$US$US
140430193$14043019$3$F$20131201$20221005$20171004$20221006$PER$$US-PFIZER INC-2016596182$PFIZER$$45$YR$$F$Y$54$KG$20221006$$LW$US$US
140456102$14045610$2$F$$20220307$20171005$20221013$PER$$US-INDIVIOR LIMITED-INDV-103505-2017$RECKITT BENCKISER$$$$$F$Y$$$20221013$$CN$US$US
1404664912$14046649$12$F$20170901$20221207$20171005$20221214$EXP$$PHHY2017CA144588$NOVARTIS$$49$YR$$F$Y$$$20221214$$CN$CA$CA
140477603$14047760$3$F$$20221111$20171005$20221114$EXP$$PHHY2017AU144587$NOVARTIS$$$$$F$Y$$$20221114$$MD$AU$AU
140581313$14058131$3$F$$20221213$20171006$20221215$EXP$$US-PFIZER INC-2017428648$PFIZER$Dunkel, I.. Intensive multi-modality therapy for extra-ocular retinoblastoma (RB): A Children^s Oncology Group (COG) trial (ARET0321). Journal of Clinical Oncology. 2017;35 (15 Suppl 1):10506-10506$$$C$$Y$$$20221215$$HP$US$US
140581323$14058132$3$F$$20221213$20171006$20221215$EXP$$US-PFIZER INC-2017428901$PFIZER$Dunkel, I.. Intensive multi-modality therapy for extra-ocular retinoblastoma (RB): A Children^s Oncology Group (COG) trial (ARET0321). Journal of Clinical Oncology. 2017;35 (15 Suppl 1):10506-10506$$$I$$Y$$$20221215$$HP$US$US
140619585$14061958$5$F$20120101$20221006$20171009$20221007$PER$$US-PFIZER INC-2016586545$PFIZER$$55$YR$$F$Y$$$20221007$$LW$US$US
140619996$14061999$6$F$20130101$20221011$20171009$20221012$PER$$US-PFIZER INC-2017419128$PFIZER$$44$YR$$F$Y$$$20221012$$LW$US$US
140620534$14062053$4$F$20150327$20221005$20171009$20221006$PER$$US-PFIZER INC-2016584481$PFIZER$$78$YR$$F$Y$113$KG$20221006$$LW$US$US
140650884$14065088$4$F$20131008$20221118$20171009$20221121$PER$$US-PFIZER INC-2017427387$PFIZER$$48$YR$$F$Y$78$KG$20221121$$LW$US$US
140652023$14065202$3$F$20110801$20221013$20171009$20221014$PER$$US-PFIZER INC-2017427385$PFIZER$$52$YR$$F$Y$$$20221014$$LW$US$US
140675125$14067512$5$F$$20221117$20171010$20221118$EXP$$CA-ROCHE-2004147$ROCHE$$59$YR$$F$Y$$$20221118$$HP$CA$
140680927$14068092$7$F$$20221212$20171010$20221220$PER$$CA-AMGEN-CANSP2017151688$AMGEN$$70$YR$E$M$Y$$$20221220$$HP$CA$CA
1406848613$14068486$13$F$$20221201$20171010$20221205$PER$$US-PFIZER INC-2017430392$PFIZER$$62$YR$$F$Y$$$20221205$$MD$US$US
140688604$14068860$4$F$20140101$20221206$20171010$20221212$PER$$US-PFIZER INC-2017434539$PFIZER$$68$YR$$M$Y$$$20221212$$HP$US$US
1406897031$14068970$31$F$20180326$20221104$20171010$20221115$EXP$$CA-CELLTRION INC.-2017CA013585$CELLTRION$$$$$$Y$$$20221115$$CN$CA$CA
140721067$14072106$7$F$20180312$20221026$20171010$20221103$PER$$US-SA-2017SA160185$SANOFI AVENTIS$$28$YR$A$F$Y$53.5$KG$20221103$$MD$US$US
140725638$14072563$8$F$20220318$20221221$20171011$20221227$EXP$$PHHY2017CA147131$NOVARTIS$$55$YR$$F$Y$$$20221227$$CN$CA$CA
1407420322$14074203$22$F$20170510$20221115$20171011$20221118$EXP$$TR-ROCHE-1938068$ROCHE$$59$YR$$M$Y$58$KG$20221118$$MD$TR$
140752883$14075288$3$F$20160301$20221104$20171011$20221108$PER$$US-PFIZER INC-2017438070$PFIZER$$59$YR$$F$Y$100$KG$20221108$$CN$US$US
140758364$14075836$4$F$20120101$20171011$20171011$20221212$EXP$$GB-TEVA-812988ACC$TEVA$$$$$F$Y$$$20221212$$CN$GB$GB
140758734$14075873$4$F$20151027$20221005$20171011$20221007$PER$$US-PFIZER INC-2016584466$PFIZER$$46$YR$$F$Y$63$KG$20221007$$LW$US$US
140784482$14078448$2$F$$20221019$20171012$20221021$PER$$US-PFIZER INC-2017439244$PFIZER$$60$YR$$F$Y$$$20221021$$HP$US$US
140793434$14079343$4$F$20161124$20220912$20171012$20221006$EXP$$PHHY2017IT148353$NOVARTIS$$12$YR$$F$Y$34.5$KG$20221006$$MD$IT$IT
140797325$14079732$5$F$20120301$20221001$20171012$20221004$PER$$US-PFIZER INC-2016584469$PFIZER$$62$YR$$F$Y$59$KG$20221004$$LW$US$US
140797462$14079746$2$F$20141001$20221003$20171012$20221005$PER$$US-PFIZER INC-2016586544$PFIZER$$69$YR$$F$Y$97$KG$20221005$$LW$US$US
140876295$14087629$5$F$20170601$20221215$20171013$20221221$EXP$$US-JAZZ-2017-US-013346$JAZZ$$10$YR$$F$Y$$$20221221$$HP$US$US
140891056$14089105$6$F$20160901$20221116$20171013$20221119$EXP$$PHHY2016CA150097$NOVARTIS$$44$YR$$F$Y$$$20221119$$CN$CA$CA
1409055611$14090556$11$F$$20191121$20171015$20221109$EXP$$PHEH2017US032775$NOVARTIS$$$$$F$Y$$$20221109$$CN$US$US
1409190337$14091903$37$F$20170731$20221004$20171016$20221011$EXP$$PHHY2017AR151832$NOVARTIS$$44$YR$$M$Y$$$20221011$$CN$AR$AR
140987219$14098721$9$F$20160916$20221208$20171017$20221212$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN156841$VIIV$$$$$$Y$$$20221212$$MD$JP$JP
140990616$14099061$6$F$20170101$20221217$20171017$20221227$EXP$$CA-PFIZER INC-2017205225$PFIZER$$65$YR$$M$Y$$$20221227$$CN$CA$CA
140996047$14099604$7$F$20170501$20221031$20171017$20221104$EXP$$PHHY2016CA127662$NOVARTIS$$22$YR$$F$Y$$$20221104$$HP$CA$CA
141014174$14101417$4$F$20160101$20221202$20171018$20221209$EXP$$US-PFIZER INC-2017447581$MYLAN$$$$$F$Y$89$KG$20221209$$HP$US$US
1410143518$14101435$18$F$20160101$20220929$20171018$20221003$EXP$$US-PFIZER INC-2017448357$PFIZER$$85$YR$$F$Y$79$KG$20221003$$CN$US$US
1410198213$14101982$13$F$20170101$20221202$20171018$20221207$EXP$$US-PFIZER INC-2017446613$PFIZER$$60$YR$$F$Y$$$20221207$$HP$US$US
141040447$14104044$7$F$$20221013$20171018$20221018$EXP$$PHHY2016CA158111$NOVARTIS$$$$$M$Y$$$20221018$$MD$CA$CA
141065769$14106576$9$F$$20221123$20171019$20221128$PER$$US-PFIZER INC-2017447585$PFIZER$$73$YR$$F$Y$63.5$KG$20221128$$CN$US$US
141088986$14108898$6$F$20120822$20220929$20171019$20221008$EXP$$PL-ABBVIE-17P-129-2134389-00$ABBVIE$Jablonowska E. Progression of coronary artery disease in a HIV-infected patient previously treated for ascending aorta aneurysm.. Kardiochirurgia i Torakochirurgia Polska.. 2017;14 (3):211-213; Marcinkiewicz A. Progression of coronary artery disease in a HIV-infected patient previously treated for ascending aorta aneurysm.. Kardiochirurgia i Torakochirurgia Polska.. 2017;14 (3):211-213; Zwoliski R. Progression of coronary artery disease in a HIV-infected patient previously treated for ascendi...$35$YR$$M$Y$$$20221008$$MD$PL$PL
1411149610$14111496$10$F$20170727$20221202$20171020$20221207$EXP$$CA-TAKEDA-2017TUS021444$TAKEDA$$52$YR$$F$Y$$$20221207$$MD$CA$CA
1411302422$14113024$22$F$20160505$20221027$20171022$20221108$EXP$$PHHY2017CA152629$NOVARTIS$$27$YR$$F$Y$$$20221108$$CN$CA$CA
1411446714$14114467$14$F$20160101$20221113$20171023$20221115$PER$$US-PFIZER INC-2017453141$PFIZER$$72$YR$$F$Y$53$KG$20221115$$CN$US$US
141145609$14114560$9$F$20180101$20221208$20171023$20221213$PER$$US-PFIZER INC-2017118785$PFIZER$$70$YR$$F$Y$82$KG$20221213$$HP$US$US
141151275$14115127$5$F$$20221027$20171023$20221102$EXP$$US-PFIZER INC-2017455015$PFIZER$$83$YR$$F$Y$67.13$KG$20221102$$CN$US$US
141189155$14118915$5$F$$20221021$20171024$20221025$PER$$US-AMGEN-USASP2017158583$AMGEN$$74$YR$E$F$Y$$$20221025$$MD$US$US
141189833$14118983$3$F$20170922$20221129$20171024$20221202$EXP$$US-SHIRE-US201724065$TAKEDA$$60$YR$$M$Y$$$20221202$$MD$US$US
141190905$14119090$5$F$20170501$20221031$20171024$20221108$EXP$$CA-ROCHE-2010731$ROCHE$$22$YR$$F$Y$$$20221107$$HP$CA$CA
141194454$14119445$4$F$$20221104$20171024$20221108$PER$$US-PFIZER INC-2017455586$PFIZER$$66$YR$$F$Y$$$20221108$$MD$US$US
141195794$14119579$4$F$$20221206$20171024$20221209$PER$$US-PFIZER INC-2017455204$PFIZER$$71$YR$$F$Y$$$20221209$$MD$US$US
141217587$14121758$7$F$20120822$20221114$20171024$20221121$EXP$$PL-MYLANLABS-2017M1065817$MYLAN$Zwolinski R, Kamerys J, Jablonowska E, Marcinkiewicz A, Jaszewski R, Krecki R, et al.. Progression of coronary artery disease in a HIV-infected patient previously treated for ascending aorta aneurysm. Kardiochirurgia i Torakochirurgia Polska. 2017;14 (3):211-13$35$YR$$M$Y$$$20221121$$HP$PL$PL
141231576$14123157$6$F$20170725$20221123$20171025$20221129$EXP$$US-ROCHE-1958822$ROCHE$$$$A$F$Y$83.99$KG$20221129$$HP$US$
141243284$14124328$4$F$$20221021$20171025$20221025$PER$$US-PFIZER INC-2017452708$PFIZER$$76$YR$$F$Y$$$20221025$$MD$US$US
141249839$14124983$9$F$20170101$20221007$20171025$20221014$EXP$$CA-TAKEDA-2017TUS012787$TAKEDA$$26$YR$$F$Y$$$20221014$$CN$CA$CA
141259743$14125974$3$F$$20221122$20171025$20221129$EXP$$US-JAZZ-2017-US-013759$JAZZ$$$$$F$Y$$$20221129$$CN$US$US
141268668$14126866$8$F$$20221202$20171025$20221208$PER$$US-AMGEN-USASP2017158588$AMGEN$$68$YR$E$F$Y$$$20221208$$MD$US$US
141274112$14127411$2$F$$20170515$20171026$20221212$PER$$US-TEVA-765967ACC$TEVA$$$$$M$Y$$$20221212$$CN$US$US
141334162$14133416$2$F$20131225$20221013$20171026$20221014$PER$$US-PFIZER INC-2017460494$PFIZER$$58$YR$$F$Y$$$20221014$$LW$US$US
141405059$14140505$9$F$$20221214$20171030$20221219$EXP$$US-PFIZER INC-2017461544$PFIZER$$71$YR$$F$Y$$$20221219$$CN$US$US
141407467$14140746$7$F$$20221107$20171030$20221109$PER$$US-PFIZER INC-2017465703$PFIZER$$66$YR$$F$Y$$$20221109$$MD$US$US
1414134610$14141346$10$F$20170811$20221125$20171030$20221205$EXP$$GB-TEVA-818638ACC$TEVA$$29$YR$A$M$Y$$$20221205$$HP$GB$GB
141420935$14142093$5$F$$20221222$20171030$20221229$PER$$US-AMGEN-USASP2017163353$AMGEN$$70$YR$E$F$Y$$$20221229$$MD$US$US
141448448$14144844$8$F$20140514$20221101$20171031$20221104$EXP$$US-SHIRE-US201726642$TAKEDA$$61$YR$$F$Y$$$20221104$$CN$US$US
141455669$14145566$9$F$20040314$20211231$20171031$20221005$EXP$$GB-BAUSCH-BL-2017-030139$BAUSCH AND LOMB$$66$YR$$M$Y$77.4$KG$20221005$$MD$GB$GB
141461874$14146187$4$F$20171001$20221019$20171031$20221028$EXP$$IT-JNJFOC-20171031905$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20221028$$MD$IT$IT
141468655$14146865$5$F$$20220930$20171031$20221005$EXP$$CA-PFIZER INC-2017460118$PFIZER$$59$YR$$F$Y$$$20221005$$CN$CA$CA
141473857$14147385$7$F$20120718$20221117$20171101$20221125$EXP$$US-AstraZeneca-2017SF10090$ASTRAZENECA$$24630$DY$$F$Y$68$KG$20221125$$LW$US$
141481088$14148108$8$F$20170101$20221128$20171101$20221130$EXP$$US-PFIZER INC-2017467374$PFIZER$$94$YR$$F$Y$58$KG$20221130$$CN$US$US
141488275$14148827$5$F$20221004$20221104$20171101$20221111$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK076533$GLAXOSMITHKLINE$$$$$$Y$$$20221111$$CN$BR$BR
141492546$14149254$6$F$20171016$20180208$20171101$20221010$PER$$GB-AMGEN-GBRCT2017160102$AMGEN$$52$YR$A$M$Y$84.5$KG$20221010$$MD$GB$GB
141498325$14149832$5$F$$20221117$20171101$20221121$EXP$$PHHY2017CA158824$NOVARTIS$$$$$F$Y$$$20221121$$MD$CA$CA
141502032$14150203$2$F$$20161222$20171101$20221020$PER$$US-NOVOPROD-524861$NOVO NORDISK$$70$YR$$F$Y$$$20221020$$CN$US$US
141502202$14150220$2$F$$20160908$20171101$20221020$PER$$US-NOVOPROD-510902$NOVO NORDISK$$$$$F$Y$$$20221020$$CN$US$US
141502252$14150225$2$F$20160907$20160912$20171101$20221020$PER$$US-NOVOPROD-511668$NOVO NORDISK$$69$YR$$F$Y$$$20221020$$CN$US$US
141502272$14150227$2$F$20150101$20161102$20171101$20221020$PER$$US-NOVOPROD-518555$NOVO NORDISK$$60$YR$$F$Y$$$20221020$$CN$US$US
141502722$14150272$2$F$$20170104$20171101$20221020$PER$$US-NOVOPROD-522980$NOVO NORDISK$$66$YR$$F$Y$$$20221020$$MD$US$US
141502732$14150273$2$F$20160101$20170410$20171101$20221020$PER$$US-NOVOPROD-541174$NOVO NORDISK$$65$YR$$F$Y$$$20221020$$CN$US$US
141502742$14150274$2$F$$20170215$20171101$20221020$PER$$US-NOVOPROD-533141$NOVO NORDISK$$$$$F$Y$$$20221020$$CN$US$US
141502752$14150275$2$F$$20170630$20171101$20221020$PER$$US-NOVOPROD-553323$NOVO NORDISK$$$$$F$Y$$$20221020$$CN$US$US
141502762$14150276$2$F$$20170801$20171101$20221020$PER$$US-NOVOPROD-557888$NOVO NORDISK$$$$$F$Y$$$20221020$$PH$US$US
141502842$14150284$2$F$20170607$20170609$20171101$20221020$PER$$US-NOVOPROD-550367$NOVO NORDISK$$67$YR$$F$Y$$$20221020$$HP$US$US
141502862$14150286$2$F$$20161217$20171101$20221020$PER$$US-NOVOPROD-524010$NOVO NORDISK$$56$YR$$F$Y$$$20221020$$PH$US$US
141502882$14150288$2$F$$20161206$20171101$20221020$PER$$US-NOVOPROD-522615$NOVO NORDISK$$$$$F$Y$$$20221020$$CN$US$US
141502892$14150289$2$F$20170201$20170216$20171101$20221020$PER$$US-NOVOPROD-533317$NOVO NORDISK$$66$YR$$F$Y$$$20221020$$CN$US$US
141502912$14150291$2$F$$20170605$20171101$20221020$PER$$US-NOVOPROD-549595$NOVO NORDISK$$$$E$F$Y$$$20221020$$CN$US$US
141503844$14150384$4$F$$20221117$20171101$20221128$EXP$$US-JAZZ-2017-US-014147$JAZZ$$$$$F$Y$$$20221128$$CN$US$US
141507586$14150758$6$F$$20221123$20171102$20221125$EXP$$CA-ABBVIE-17K-028-2145793-00$ABBVIE$$$$$M$Y$$$20221125$$MD$CA$CA
141575454$14157545$4$F$20171009$20221021$20171103$20221028$EXP$$BR-TAKEDA-2017TUS022779$TAKEDA$$29$YR$$F$Y$75$KG$20221028$$CN$BR$BR
141615294$14161529$4$F$20170915$20221223$20171106$20221230$EXP$$JP-009507513-1710JPN003595J$MERCK$Matsumoto K, Wakatuki J, Sakuma D, Kin E, Kobayashi Y, Komata M. WS16-3 Immune-related side effects during the first 5 years of use of immune checkpoint inhibitors. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022$58$YR$$M$Y$57$KG$20221230$$MD$JP$JP
1416298558$14162985$58$F$20160929$20221228$20171107$20221230$EXP$$CA-ROCHE-1837378$ROCHE$$58$YR$$F$Y$140$KG$20221230$$CN$CA$
1416514010$14165140$10$F$20190101$20221201$20171107$20221206$EXP$$US-PFIZER INC-2017474236$PFIZER$$58$YR$$M$Y$92.971$KG$20221206$$CN$US$US
141660256$14166025$6$F$20140106$20221208$20171107$20221216$EXP$$JP-MYLANLABS-2013S1024256$MYLAN$$17$YR$$M$Y$39.3$KG$20221216$$MD$JP$JP
141676254$14167625$4$F$20220401$20221004$20171107$20221010$EXP$$US-JAZZ-2017-US-014566$JAZZ$$34$YR$$F$Y$$$20221010$$MD$US$US
1416890311$14168903$11$F$20171101$20221107$20171108$20221109$PER$$US-PFIZER INC-2017474746$PFIZER$$60$YR$$F$Y$$$20221109$$PH$US$US
1416928110$14169281$10$F$20150119$20221221$20171108$20221228$EXP$$PHHY2011CA34112$NOVARTIS$$52$YR$$M$Y$$$20221228$$HP$CA$CA
1416957317$14169573$17$F$20170715$20221223$20171108$20221230$EXP$$PHHY2017CA107620$NOVARTIS$$55$YR$$F$Y$$$20221230$$CN$CA$CA
141715565$14171556$5$F$$20221122$20171108$20221125$PER$$US-BIOGEN-2017BI00478416$BIOGEN$$$$$F$Y$$$20221125$$CN$US$US
1417204311$14172043$11$F$20170116$20221213$20171108$20221220$EXP$$PHHY2017CA009421$NOVARTIS$$56$YR$$F$Y$$$20221220$$CN$CA$CA
141721956$14172195$6$F$20170101$20221020$20171109$20221028$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005979$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20221028$$CN$US$US
141726957$14172695$7$F$20160601$20221207$20171109$20221215$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005197$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$64$KG$20221216$$CN$US$US
141728412$14172841$2$F$20170701$20220930$20171109$20221024$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005288$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20221025$$CN$US$US
141730263$14173026$3$F$$20221005$20171109$20221011$PER$$US-AMGEN-USASL2017167815$AMGEN$$68$YR$E$M$Y$$$20221011$$CN$US$US
141730938$14173093$8$F$$20221220$20171109$20221222$EXP$$CA-Orion Corporation ORION PHARMA-TREX2017-3466$ORION$$58$YR$A$F$Y$$$20221222$$MD$CA$
141731986$14173198$6$F$20210101$20221208$20171109$20221216$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005673$ACADIA PHARMACEUTICALS$$$$$M$Y$123$KG$20221216$$CN$US$US
141742448$14174244$8$F$20161116$20221222$20171109$20221229$EXP$$JP-MYLANLABS-2017M1068472$MYLAN$$18$YR$$F$Y$30.4$KG$20221229$$MD$JP$JP
141747713$14174771$3$F$20111001$20211210$20171109$20221019$PER$$US-ALLERGAN-1716615US$ALLERGAN$$68$YR$$F$Y$$$20221019$$MD$US$US
141759932$14175993$2$F$20170722$20221118$20171109$20221121$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-071340$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20221121$$HP$US$US
141771233$14177123$3$F$$20221117$20171110$20221121$PER$$US-PFIZER INC-2017481323$PFIZER$$58$YR$$F$Y$$$20221121$$CN$US$US
1417714814$14177148$14$F$20170101$20220930$20171110$20221006$EXP$$US-PFIZER INC-2017484503$PFIZER$$80$YR$$F$Y$64$KG$20221006$$CN$US$US
141778675$14177867$5$F$20200901$20221114$20171110$20221208$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005203$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20221209$$CN$US$US
141782092$14178209$2$F$20170907$20221010$20171110$20221020$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005758$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$83$KG$20221020$$CN$US$US
141793463$14179346$3$F$20180401$20221101$20171110$20221110$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-006014$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20221111$$CN$US$US
1418295313$14182953$13$F$20211001$20221004$20171113$20221007$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK111501$GLAXOSMITHKLINE$$$$$$Y$$$20221007$$CN$BR$BR
141831116$14183111$6$F$20170101$20221117$20171113$20221122$PER$$US-BIOGEN-2017BI00478420$BIOGEN$$$$$F$Y$$$20221122$$CN$US$US
141865887$14186588$7$F$20171023$20221209$20171114$20221216$EXP$$JP-ABBVIE-17P-087-2162696-00$ABBVIE$$48$YR$$M$Y$$$20221214$$MD$JP$JP
1418942914$14189429$14$F$20171017$20221101$20171115$20221104$EXP$$US-ROCHE-2019577$ROCHE$$58$YR$$F$Y$54.934$KG$20221103$$CN$US$
141911337$14191133$7$F$$20221003$20171115$20221006$EXP$$CA-TAKEDA-2017TUS023263$TAKEDA$$46$YR$$F$Y$$$20221006$$CN$CA$CA
141920425$14192042$5$F$20180101$20220301$20171115$20221012$PER$$US-CELLTRION INC.-2017US014375$CELLTRION$$$$$$Y$$$20221012$$MD$US$US
142055784$14205578$4$F$$20221114$20171120$20221118$EXP$$TR-ALEXION-A201712866$ALEXION$Oruc A, Ayar Y, Aktas N, Yildiz A, Yavuz M, Ersoy A, et al.. Hepatoxicity associated with eculizumab treatment. Nephrology Dialysis Transplantation. 2017;32(Suppl 3):iii137$39$YR$$M$Y$$$20221118$$HP$TR$TR
142063095$14206309$5$F$20171115$20220929$20171120$20221006$PER$$US-JAZZ-2017-US-015228$JAZZ$$64$YR$$F$Y$$$20221006$$CN$US$US
142092174$14209217$4$F$$20221220$20171121$20221229$EXP$$JP-ASTELLAS-2017US047784$ASTELLAS$$35$YR$$M$Y$$$20221229$$MD$JP$JP
142152857$14215285$7$F$20220101$20221005$20171122$20221012$EXP$$PHHY2017CA137159$NOVARTIS$$$$$F$Y$$$20221012$$MD$CA$CA
1421591612$14215916$12$F$20161001$20221013$20171122$20221018$EXP$$PHHY2016CA151751$NOVARTIS$$24$YR$$F$Y$$$20221018$$MD$CA$CA
142189532$14218953$2$F$20080101$20221012$20171123$20221025$PER$$US-JNJFOC-20171012099$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20221025$$LW$US$US
142192744$14219274$4$F$20070101$20221031$20171123$20221108$PER$$US-JNJFOC-20171031358$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20221108$$LW$US$US
142192802$14219280$2$F$20010201$20220926$20171123$20221006$PER$$US-JNJFOC-20171031521$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221006$$LW$US$US
142192833$14219283$3$F$$20221219$20171123$20221226$PER$$US-JNJFOC-20171031532$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221226$$LW$US$US
1421982416$14219824$16$F$20171201$20221012$20171123$20221017$EXP$$CA-TAKEDA-2017TUS024098$TAKEDA$$57$YR$$F$Y$$$20221017$$CN$CA$CA
142200043$14220004$3$F$19980211$20221107$20171123$20221110$PER$$US-JNJFOC-20171116664$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20221110$$LW$US$US
142200903$14220090$3$F$20030430$20221207$20171123$20221214$PER$$US-JNJFOC-20170923847$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20221214$$LW$US$US
142201014$14220101$4$F$$20221207$20171123$20221213$PER$$US-JNJFOC-20170923700$JOHNSON AND JOHNSON$$$$$M$Y$$$20221213$$LW$US$US
142201723$14220172$3$F$20030101$20221213$20171123$20221217$PER$$US-JNJFOC-20171011077$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20221217$$LW$US$US
142201814$14220181$4$F$$20220922$20171123$20221004$PER$$US-JNJFOC-20171011309$JOHNSON AND JOHNSON$$$$$M$Y$$$20221004$$LW$US$US
142209283$14220928$3$F$$20221130$20171123$20221206$PER$$US-JNJFOC-20171033455$JOHNSON AND JOHNSON$$$$$M$Y$$$20221206$$LW$US$US
142210782$14221078$2$F$$20221221$20171123$20221226$PER$$US-JNJFOC-20171106330$JOHNSON AND JOHNSON$$$$$M$Y$$$20221226$$LW$US$US
142246522$14224652$2$F$20171102$20221202$20171127$20221206$PER$$US-SHIRE-US201730249$TAKEDA$$10$YR$$M$Y$$$20221206$$HP$US$US
142249133$14224913$3$F$$20221215$20171127$20221219$EXP$$JP-BEH-2017085417$CSL BEHRING$$$$$M$Y$5.5$KG$20221219$$MD$JP$JP
142250215$14225021$5$F$$20221121$20171127$20221124$EXP$$GB-ROCHE-1711532$ROCHE$$$$A$F$Y$$$20221124$$CN$GB$
142271383$14227138$3$F$20171101$20221214$20171127$20221223$EXP$$AU-JNJFOC-20171130563$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20221223$$CN$AU$AU
142271614$14227161$4$F$$20171205$20171127$20221209$EXP$$PT-TEVA-2017-PT-826524$TEVA$Duarte A. Rhabdomyolysis as a Rare Clinical Manifestation of Hypothyroidism:About Two Clinical Cases. Review Port Endocrial Diabetes Metab. 2017;12(1):50-59.$49$YR$A$M$Y$$$20221209$$MD$PT$PT
142302723$14230272$3$F$$20220922$20171128$20221007$EXP$$DE-MYLANLABS-2017M1074109$MYLAN$Hoppe J, Holderied A, Schafer H, Schonermarck U, Anders HJ, Fischereder M. Drug-induced cytochrome-P450 induction as therapy for calcineurin inhibitor intoxication. Transpl-Int 2017;30 (Suppl. 4):33 abstr. P30.$54$YR$$M$Y$$$20221007$$HP$DE$DE
142302813$14230281$3$F$$20220922$20171128$20221007$EXP$$DE-MYLANLABS-2017M1074094$MYLAN$Hoppe J, Holderied A, Schafer H, Schonermarck U, Anders HJ, Fischereder M. Drug-induced cytochrome-P450 induction as therapy for calcineurin inhibitor intoxication. Transpl-Int 2017;30 (Suppl. 4):33 abstr. P30.$56$YR$$M$Y$$$20221007$$HP$DE$DE
1423528612$14235286$12$F$20170704$20221206$20171129$20221214$EXP$$GB-ASPEN-GLO2017GB007654$ASPEN$$$$$$Y$$$20221214$$MD$GB$GB
142360524$14236052$4$F$20170101$20221020$20171129$20221025$EXP$$CA-TAKEDA-2017TUS018228$TAKEDA$$35$YR$$F$Y$$$20221025$$CN$CA$CA
142364778$14236477$8$F$$20221104$20171129$20221108$PER$$US-PFIZER INC-2017510314$PFIZER$$72$YR$$F$Y$100$KG$20221108$$HP$US$US
142374203$14237420$3$F$$20221221$20171129$20221230$EXP$$GB-PFIZER INC-2017511602$PFIZER$$53$YR$$F$Y$$$20221230$$MD$GB$GB
1424521513$14245215$13$F$20171128$20221130$20171202$20221204$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2017-BI-064210$BOEHRINGER INGELHEIM$$82$YR$E$F$Y$60$KG$20221204$$MD$ES$ES
142462408$14246240$8$F$20171115$20221022$20171204$20221026$EXP$$TW-ROCHE-2026355$ROCHE$$60$YR$$F$Y$42.6$KG$20221026$$MD$TW$
1424660919$14246609$19$F$$20221212$20171204$20221224$EXP$$GB-AUROBINDO-AUR-APL-2017-43959$AUROBINDO$$85$YR$$M$Y$$$20221224$$MD$GB$GB
142467266$14246726$6$F$$20221128$20171204$20221130$EXP$$US-PFIZER INC-2017514361$PFIZER$$59$YR$$M$Y$$$20221130$$CN$US$US
1424675014$14246750$14$F$20171127$20221025$20171204$20221026$EXP$$US-PFIZER INC-2017514798$PFIZER$$82$YR$$F$Y$73$KG$20221026$$CN$US$US
1424879736$14248797$36$F$20170710$20220912$20171204$20221006$EXP$$PHHY2017FR121490$NOVARTIS$$8$YR$$M$Y$25$KG$20221006$$MD$FR$FR
142493453$14249345$3$F$20170929$20221121$20171204$20221123$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-087839$BRISTOL MYERS SQUIBB$$72$YR$E$M$Y$$$20221123$$HP$US$US
142497429$14249742$9$F$20171024$20221205$20171205$20221208$EXP$$CY-ROCHE-2031101$ROCHE$$66$YR$$F$Y$84$KG$20221208$$MD$CY$CY
142500619$14250061$9$F$20171101$20221130$20171205$20221206$EXP$$CA-TAKEDA-2017TUS023618$TAKEDA$$48$YR$$M$Y$$$20221206$$HP$CA$CA
142515045$14251504$5$F$20171127$20221219$20171205$20221224$EXP$$PHHY2017CA178808$NOVARTIS$$44$YR$$F$Y$$$20221224$$MD$CA$CA
1425234030$14252340$30$F$20170925$20221112$20171205$20221118$EXP$$US-SA-2017SA207805$SANOFI AVENTIS$$62$YR$A$F$Y$59.4$KG$20221118$$MD$US$US
1425529618$14255296$18$F$20170913$20221208$20171206$20221215$EXP$$CA-TAKEDA-2017TUS024863$TAKEDA$$18$YR$$F$Y$$$20221215$$MD$CA$CA
142576832$14257683$2$F$$20221130$20171207$20221208$EXP$$CA-ROCHE-2033051$ROCHE$$62$YR$$M$Y$$$20221208$$CN$CA$CA
142578718$14257871$8$F$$20221109$20171207$20221114$PER$$US-AMGEN-USASP2017180861$AMGEN$$63$YR$A$M$Y$$$20221114$$MD$US$US
142582958$14258295$8$F$$20221109$20171207$20221115$PER$$US-AMGEN-USASP2017180854$AMGEN$$58$YR$A$F$Y$$$20221115$$MD$US$US
142583924$14258392$4$F$$20221111$20171207$20221115$PER$$US-PFIZER INC-2017517099$PFIZER$$38$YR$$F$Y$$$20221115$$MD$US$US
142605762$14260576$2$F$$20221214$20171207$20221220$PER$$US-PFIZER INC-2017521003$PFIZER$$68$YR$$F$Y$$$20221220$$MD$US$US
142632082$14263208$2$F$20170924$20221114$20171208$20221129$EXP$$IT-AUROBINDO-AUR-APL-2017-44070$AUROBINDO$$22$YR$$F$Y$$$20221129$$PH$IT$IT
1426336319$14263363$19$F$20171120$20221124$20171208$20221205$EXP$$CA-PFIZER INC-2017524170$PFIZER$$48$YR$$F$Y$$$20221205$$CN$CA$CA
1426418413$14264184$13$F$20170403$20221223$20171208$20221230$EXP$$PHHY2017GB180222$NOVARTIS$$76$YR$$F$Y$69.9$KG$20221230$$HP$GB$GB
142647992$14264799$2$F$$20221003$20171208$20221013$EXP$$DE-TEVA-2017-DE-830763$TEVA$$54$YR$A$M$Y$$$20221013$$HP$DE$DE
142656688$14265668$8$F$20170403$20221110$20171208$20221117$EXP$$GB-BAUSCH-BL-2017-032426$BAUSCH AND LOMB$$76$YR$$F$Y$69.9$KG$20221117$$HP$GB$GB
142665055$14266505$5$F$20160101$20221013$20171210$20221019$PER$$BR-AMGEN-BRASP2016023746$AMGEN$$44$YR$A$F$Y$60$KG$20221019$$CN$BR$BR
1426665820$14266658$20$F$20170907$20221128$20171211$20221201$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-112180$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$71$KG$20221201$$MD$NL$NL
142673184$14267318$4$F$$20221207$20171211$20221213$PER$$US-PFIZER INC-2017526732$PFIZER$$70$YR$$F$Y$$$20221213$$MD$US$US
1426832110$14268321$10$F$20170511$20221021$20171211$20221028$EXP$$PHHY2017CA071454$NOVARTIS$$76$YR$$F$Y$$$20221028$$CN$CA$CA
142688572$14268857$2$F$$20221011$20171211$20221012$PER$$US-PFIZER INC-2017524277$PFIZER$$$$$F$Y$$$20221012$$LW$US$US
1426901210$14269012$10$F$$20221125$20171211$20221202$EXP$$GB-Otsuka-DJ20126363$OTSUKA$$15$YR$$F$Y$$$20221202$$MD$GB$GB
142691846$14269184$6$F$20140101$20221111$20171211$20221114$EXP$$IT-MYLANLABS-2017M1077268$MYLAN$Grosso F, Roveta A, Gallizzi G, Belletti M.. Management of Recurrent Pleura Mesothelioma:Successful Rechallenge with Nintedanib in Combination with Chemotherapy.. Clin. Case Rep.. 2018;6(10):2000-4$53$YR$$M$Y$100$KG$20221114$$MD$IT$IT
1427186711$14271867$11$F$20171101$20221219$20171212$20221228$PER$$US-PFIZER INC-2016155881$PFIZER$$73$YR$$F$Y$91$KG$20221228$$CN$US$US
1427202313$14272023$13$F$$20221007$20171211$20221014$EXP$$CA-OTSUKA-2017_012834$OTSUKA$$22$YR$$F$Y$$$20221014$$HP$CA$CA
142722512$14272251$2$F$$20221003$20171211$20221013$EXP$$DE-TEVA-2017-DE-830764$TEVA$$56$YR$A$M$Y$$$20221013$$HP$DE$DE
142735863$14273586$3$F$$20221030$20171211$20221104$EXP$$FR-OTSUKA-2017_003321$OTSUKA$$48$YR$$F$Y$$$20221104$$MD$FR$FR
1427400921$14274009$21$F$20160614$20221216$20171212$20221230$EXP$$GB-AUROBINDO-AUR-APL-2017-44584$AUROBINDO$$$$A$M$Y$$$20221230$$MD$GB$GB
1427503912$14275039$12$F$$20221030$20171211$20221108$EXP$$GB-OTSUKA-2016_030143$OTSUKA$$30$YR$$M$Y$$$20221108$$PH$GB$GB
142762074$14276207$4$F$$20220925$20171211$20221003$EXP$$GB-Otsuka-DJ20094243$OTSUKA$$$$$F$Y$1.81$KG$20221003$$HP$GB$GB
1427643329$14276433$29$F$20171013$20221027$20171212$20221105$EXP$$CA-CELLTRION INC.-2017CA014614$CELLTRION$$$$$$Y$$$20221106$$CN$CA$CA
142774957$14277495$7$F$$20221006$20171212$20221013$EXP$$GB-SHIRE-GB201732945$TAKEDA$$85$YR$$M$Y$$$20221013$$CN$GB$GB
142777175$14277717$5$F$20160826$20221216$20171212$20221220$EXP$$GB-GALDERMA-GB17012480$GALDERMA$$$$$$Y$$$20221220$$HP$GB$GB
1427871914$14278719$14$F$20171101$20221123$20171212$20221130$EXP$$CA-TAKEDA-2017TUS025270$TAKEDA$$26$YR$$M$Y$$$20221130$$MD$CA$CA
142816912$14281691$2$F$20150709$20221219$20171213$20221227$EXP$$FR-MYLANLABS-2017M1076761$MYLAN$$45$YR$$F$Y$54$KG$20221227$$MD$FR$FR
142825658$14282565$8$F$$20221007$20171213$20221010$EXP$$US-PFIZER INC-2017393431$PFIZER$$69$YR$$F$Y$$$20221010$$HP$US$US
142840805$14284080$5$F$$20221205$20171214$20221209$PER$$US-AMGEN-USASP2017183983$AMGEN$$78$YR$E$F$Y$$$20221208$$MD$US$US
142844039$14284403$9$F$$20221115$20171214$20221117$PER$$US-PFIZER INC-2017534678$PFIZER$$63$YR$$F$Y$$$20221117$$MD$US$US
1428496427$14284964$27$F$20171127$20221116$20171214$20221123$EXP$$PHHY2017DE182835$NOVARTIS$$11$YR$$M$Y$60$KG$20221123$$MD$DE$DE
142859759$14285975$9$F$$20221117$20171214$20221119$EXP$$PHHY2017CA170489$NOVARTIS$$$$$F$Y$$$20221119$$MD$CA$CA
142863712$14286371$2$F$20110801$20221102$20171214$20221110$EXP$$PHHY2017NO180055$NOVARTIS$$$$A$M$Y$$$20221110$$CN$NO$NO
142896024$14289602$4$F$20140101$20221129$20171215$20221202$EXP$$US-AstraZeneca-2017SF27494$ASTRAZENECA$$57$YR$$F$Y$81.6$KG$20221202$$LW$US$
142911234$14291123$4$F$20170101$20221013$20171215$20221017$EXP$$US-PFIZER INC-2017534643$PFIZER$$57$YR$$F$Y$74.512$KG$20221017$$HP$US$US
1429500910$14295009$10$F$$20221207$20171218$20221208$PER$$US-AMGEN-USASP2017183978$AMGEN$$70$YR$E$F$Y$$$20221208$$HP$US$US
142966916$14296691$6$F$20110101$20220930$20171218$20221003$EXP$$US-PFIZER INC-2017536261$PFIZER$$75$YR$$F$Y$$$20221003$$LW$US$US
142973108$14297310$8$F$20170101$20221227$20171218$20221229$EXP$$US-PFIZER INC-2017536717$PFIZER$$66$YR$$F$Y$85.73$KG$20221229$$HP$US$US
142983665$14298366$5$F$20170101$20221212$20171218$20221213$EXP$$PHHY2016CA182630$NOVARTIS$$70$YR$$M$Y$$$20221213$$CN$CA$CA
1430029611$14300296$11$F$$20221214$20171219$20221220$PER$$US-PFIZER INC-2017534888$PFIZER$$64$YR$$F$Y$$$20221220$$MD$US$US
143018454$14301845$4$F$20160419$20221101$20171219$20221104$EXP$$US-PFIZER INC-2017536310$PFIZER$$67$YR$$F$Y$$$20221104$$LW$US$US
143043784$14304378$4$F$$20221205$20171219$20221207$PER$$US-BIOGEN-2017BI00496082$BIOGEN$$$$$F$Y$$$20221207$$CN$US$US
1430640520$14306405$20$F$20171101$20221101$20171220$20221104$EXP$$PHHY2017CO185553$NOVARTIS$$70$YR$$F$Y$58$KG$20221104$$CN$CO$CO
1430727512$14307275$12$F$20161101$20221012$20171220$20221014$EXP$$PHHY2016CA145319$NOVARTIS$$64$YR$$M$Y$$$20221014$$CN$CA$CA
143085666$14308566$6$F$20080301$20221011$20171220$20221024$EXP$$SK-PFIZER INC-2017523755$MYLAN$$$$$F$Y$53$KG$20221024$$MD$SK$SK
143086605$14308660$5$F$20150101$20221010$20171220$20221012$PER$$US-PFIZER INC-2017538048$PFIZER$$52$YR$$F$Y$104$KG$20221012$$LW$US$US
143096543$14309654$3$F$$20221109$20171220$20221114$EXP$$US-PFIZER INC-2017536628$PFIZER$$70$YR$$F$Y$$$20221114$$CN$US$US
143106094$14310609$4$F$$20221031$20171220$20221104$EXP$$SE-MYLANLABS-2017M1079697$MYLAN$Eriksson E, Thorsoon M, Grass J. Hogdos insulin, High dose insulin euglycemia therapy - an important addition to the treatment arsenal in severe toxic myocardial depression. Lakartidningen$51$YR$$F$Y$$$20221104$$HP$SE$SE
143111008$14311100$8$F$20171204$20221006$20171221$20221010$EXP$$JP-ROCHE-2039469$ROCHE$$69$YR$$M$Y$61.2$KG$20221010$$MD$JP$
143125972$14312597$2$F$$20221130$20171221$20221205$PER$$US-PFIZER INC-2017078881$PFIZER$$51$YR$$F$Y$$$20221205$$CN$US$US
143130293$14313029$3$F$20130301$20221013$20171221$20221014$PER$$US-PFIZER INC-2017541307$PFIZER$$76$YR$$F$Y$58.957$KG$20221014$$LW$US$US
143144375$14314437$5$F$20140625$20220926$20171221$20221004$EXP$$US-AstraZeneca-2017SF28535$ASTRAZENECA$$17896$DY$$F$Y$66.2$KG$20221004$$LW$US$
143153027$14315302$7$F$20170101$20221221$20171221$20221223$EXP$$CA-TAKEDA-2017TUS004747$TAKEDA$$59$YR$$M$Y$$$20221223$$HP$CA$CA
143166086$14316608$6$F$$20221110$20171222$20221125$EXP$GB-MHRA-EYC 00150638$GB-MACLEODS PHARMACEUTICALS US LTD-MAC2016004106$MACLEODS$$$$$$Y$$$20221125$$PH$GB$GB
143168007$14316800$7$F$$20221209$20171222$20221214$PER$$US-PFIZER INC-2017542735$PFIZER$$62$YR$$F$Y$$$20221214$$MD$US$US
143173102$14317310$2$F$$20221010$20171222$20221021$EXP$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2017-01227$NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2017-01227$ALKEM$Kampenhout EV, Bolhuis MS, Alffenaar JC, Oswald LM, et al.. Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis. Eur Respir J.. 2017;49(3):1-3$25$YR$$F$Y$$$20221021$$MD$NL$NL
1431832718$14318327$18$F$20170712$20220923$20171222$20221005$EXP$$CA-CELLTRION INC.-2017CA017054$CELLTRION$$$$$$Y$$$20221006$$CN$CA$CA
1431951811$14319518$11$F$20170713$20221124$20171222$20221201$EXP$$ES-SA-2017SA150386$SANOFI AVENTIS$$36$YR$A$F$Y$$$20221201$$HP$ES$ES
1432006823$14320068$23$F$20170901$20221108$20171222$20221111$EXP$$US-PFIZER INC-2017541886$PFIZER$$68$YR$$F$Y$75$KG$20221111$$HP$US$US
143212883$14321288$3$F$20150709$20180326$20171223$20221028$EXP$PHHY2017FR193176$PHHY2017FR193176$NOVARTIS$$45$YR$$F$Y$54$KG$20221028$$MD$FR$FR
143212907$14321290$7$F$20170425$20221111$20171223$20221114$EXP$$PHHY2017DE187788$NOVARTIS$$65$YR$$M$Y$90$KG$20221114$$MD$DE$DE
143222949$14322294$9$F$$20221011$20171225$20221026$EXP$$NL-AUROBINDO-AUR-APL-2017-47132$AUROBINDO$Van Kampenhout E, Bolhuis MS, Alffenaar JWC, Oswald LMA, Kerstjens HAM, De Lange WCM et al.. Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis.. European Respiratory Journal. 2017;49(3)$25$YR$$F$Y$$$20221026$$MD$NL$NL
143233002$14323300$2$F$$20211118$20171226$20221111$PER$$US-CIPLA LTD.-2017US12215$CIPLA$$41$YR$$F$Y$$$20221111$$PH$US$US
143233164$14323316$4$F$$20180221$20171226$20221209$PER$$US-TEVA-2017-US-836421$TEVA$$$$$$Y$$$20221209$$CN$US$US
1432365622$14323656$22$F$20171001$20221103$20171226$20221108$EXP$$CA-ROCHE-2044455$ROCHE$$28$YR$$F$Y$$$20221107$$MD$CA$CA
143239464$14323946$4$F$20171118$20221115$20171226$20221118$EXP$$TR-ROCHE-2028912$ROCHE$$69$YR$$M$Y$62.5$KG$20221118$$MD$TR$
143254665$14325466$5$F$20170101$20221227$20171226$20221229$EXP$$US-JAZZ-2017-US-017146$JAZZ$$$$$M$Y$$$20221229$$HP$US$US
143259293$14325929$3$F$$20221114$20171226$20221124$EXP$$US-BAUSCH-BL-2017-034806$BAUSCH AND LOMB$Acharya G, Cruz C, Rice T. 5-FU-induced leukoencephalopathy with reversible lesion of splenium of corpus callosum in a patient with colorectal cancer. BMJ Case Reports. 2017;.$67$YR$$M$Y$$$20221124$$HP$US$US
143259308$14325930$8$F$$20221021$20171226$20221027$EXP$$GB-BAUSCH-BL-2017-035229$BAUSCH AND LOMB$$30$YR$$M$Y$$$20221027$$PH$GB$GB
1432667513$14326675$13$F$20171204$20220928$20171227$20221004$EXP$$JP-ABBVIE-17K-087-2198372-00$ABBVIE$$74$YR$$M$Y$59$KG$20221004$$MD$JP$JP
1432719212$14327192$12$F$20170301$20221110$20171227$20221117$EXP$$PHHY2017CA040994$NOVARTIS$$52$YR$$M$Y$$$20221117$$MD$CA$CA
143273015$14327301$5$F$$20221219$20171227$20221222$PER$$US-PFIZER INC-2017544657$PFIZER$$66$YR$$F$Y$$$20221222$$HP$US$US
143273435$14327343$5$F$20171201$20221123$20171227$20221129$PER$$US-PFIZER INC-2017544156$PFIZER$$48$YR$$F$Y$$$20221129$$CN$US$US
143276227$14327622$7$F$$20221102$20171227$20221105$EXP$$PHHY2017GB194317$NOVARTIS$$53$YR$$F$Y$$$20221105$$HP$GB$GB
143283563$14328356$3$F$$20221130$20171227$20221202$PER$$US-PFIZER INC-2017547874$PFIZER$$66$YR$$F$Y$$$20221202$$MD$US$US
143283767$14328376$7$F$$20221212$20171227$20221215$PER$$US-PFIZER INC-2017548649$PFIZER$$62$YR$$F$Y$$$20221215$$MD$US$US
1432848031$14328480$31$F$20210301$20221206$20171227$20221213$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK162592$GLAXOSMITHKLINE$$$$$$Y$$$20221213$$CN$BR$BR
1432858015$14328580$15$F$20151110$20221012$20171227$20221024$EXP$DE-EMA-DD-20171213-KUMARNVEVHP-172943$DE-PFIZER INC-2017546144$PFIZER$$34$MON$$M$Y$12.2$KG$20221024$$MD$DE$DE
143295807$14329580$7$F$$20221208$20171227$20221213$EXP$$US-PFIZER INC-2015388221$PFIZER$$64$YR$$F$Y$$$20221213$$MD$US$US
143298493$14329849$3$F$$20221109$20171227$20221114$EXP$$US-SA-2017SA257819$SANOFI AVENTIS$$67$YR$E$M$Y$$$20221114$$HP$US$US
1433140038$14331400$38$F$20170101$20220929$20171228$20221011$EXP$$CA-CELLTRION INC.-2017CA012620$CELLTRION$$$$$$Y$$$20221011$$CN$CA$CA
143318743$14331874$3$F$20170101$20221005$20171228$20221019$PER$$PL-PFM-2017-12696$PIERRE FABRE MEDICAMENT$Bembenek J, Piechal A, Rakowicz M. Zespol Guillain-Barre u chorego z nawrotowym chloniakiem hodgkina. Polski Przeglad Neurologiczny. 2017;13:A130-A131$$$$$Y$$$20221020$$MD$PL$PL
143321348$14332134$8$F$20160316$20221128$20171228$20221201$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN198663$VIIV$$$$$$Y$$$20221201$$MD$JP$JP
1433213512$14332135$12$F$20161101$20221026$20171228$20221101$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN198665$VIIV$$$$$$Y$$$20221101$$MD$JP$JP
1433265514$14332655$14$F$20160614$20221219$20171228$20221226$EXP$$BE-SA-2016SA123993$SANOFI AVENTIS$$38$YR$A$M$Y$$$20221226$$MD$BE$BE
1433306212$14333062$12$F$20170203$20221117$20171228$20221121$EXP$$ES-SA-2017SA155725$SANOFI AVENTIS$$54$YR$A$F$Y$90$KG$20221121$$HP$ES$ES
1433331838$14333318$38$F$20171201$20221129$20171228$20221208$EXP$$CA-CELLTRION INC.-2017CA017356$CELLTRION$$$$$$Y$$$20221208$$CN$CA$CA
143335879$14333587$9$F$20170101$20221130$20171228$20221202$EXP$$JP-ABBVIE-17K-087-2186265-00$ABBVIE$$71$YR$$F$Y$$$20221202$$MD$JP$JP
143339688$14333968$8$F$20150706$20221116$20171228$20221124$EXP$$GB-BAUSCH-BL-2017-035501$BAUSCH AND LOMB$$75$YR$$F$Y$81.5$KG$20221124$$HP$GB$GB
143346377$14334637$7$F$20150101$20221003$20171228$20221013$EXP$$PL-ELI_LILLY_AND_COMPANY-PL201712008326$ELI LILLY AND CO$$32$YR$$M$Y$$$20221013$$CN$PL$PL
143363582$14336358$2$F$$20171215$20171229$20221118$EXP$$US-APOTEX-2017AP023880$APOTEX$Toprak M, Katz RB, Ostroff R. Safe Treatment of a Patient With an Ommaya Reservoir With Electroconvulsive Therapy. DOI: 10.1097/YCT.0000000000000427. The Journal of ECT.. 2017;33(4):1-2$58$YR$$F$Y$$$20221118$$HP$US$US
1433650912$14336509$12$F$20120524$20220929$20171229$20221019$EXP$$DE-ABBVIE-17S-062-2201777-00$ABBVIE$$30$YR$$M$Y$$$20221019$$MD$DE$DE
143368592$14336859$2$F$$20221114$20171229$20221120$PER$$PT-AMGEN-PRTSP2017191003$AMGEN$Gravito-soares E.. Fatal colitis associated with active systemic lupus erythematosus complicated by cytomegalovirus superinfection. BMJ. 2017;1-2$47$YR$A$F$Y$$$20221120$$MD$PT$PT
1433806210$14338062$10$F$20171106$20221107$20171229$20221111$EXP$$FR-MYLANLABS-2017M1082885$MYLAN$$50$YR$$M$Y$52$KG$20221111$$MD$FR$FR
1433934518$14339345$18$F$20180118$20221215$20171230$20221228$EXP$$GB-AUROBINDO-AUR-APL-2017-47963$AUROBINDO$$76$YR$$M$Y$69$KG$20221228$$MD$GB$GB
143394286$14339428$6$F$20171129$20221125$20171230$20221209$EXP$$GB-AUROBINDO-AUR-APL-2017-47978$AUROBINDO$$30$YR$$M$Y$81$KG$20221209$$MD$GB$GB
143399922$14339992$2$F$20170403$20220928$20171231$20221008$EXP$$GB-TEVA-2017-GB-836691$TEVA$$76$YR$E$F$Y$$$20221008$$MD$GB$GB
1434359322$14343593$22$F$20171214$20221227$20180102$20221230$EXP$$US-PFIZER INC-2017555069$PFIZER$$77$YR$$F$Y$88$KG$20221230$$HP$US$US
1434557613$14345576$13$F$20170507$20221215$20180103$20221222$EXP$$PHHY2017IN085195$NOVARTIS$$60$YR$$M$Y$$$20221222$$CN$IN$IN
1434765915$14347659$15$F$20170101$20221025$20180103$20221028$PER$$US-PFIZER INC-2017555032$PFIZER$$50$YR$$F$Y$77$KG$20221028$$CN$US$US
143477005$14347700$5$F$$20221028$20180103$20221102$PER$$US-PFIZER INC-2017555194$PFIZER$$70$YR$$M$Y$$$20221102$$CN$US$US
143482897$14348289$7$F$$20221129$20180103$20221202$PER$$US-PFIZER INC-2017553822$PFIZER$$73$YR$$F$Y$73.48$KG$20221202$$CN$US$US
1434974914$14349749$14$F$20171201$20221216$20180104$20221223$EXP$$PHHY2017CA196773$NOVARTIS$$69$YR$$M$Y$$$20221223$$CN$CA$CA
143497619$14349761$9$F$20170101$20221021$20180104$20221028$EXP$$PHHY2017CA101908$NOVARTIS$$$$$M$Y$$$20221028$$CN$CA$CA
1434978416$14349784$16$F$20150101$20221129$20180104$20221205$EXP$$PL-MYLANLABS-2017M1083625$MYLAN$Bembenek J, Piechal A, Rakowicz M.. A patient with guillainbarre syndrome with recurrent hodgkin^s lymphoma.. Polish Neurological Review. 2017;13 (Suppl A):A130-31$32$YR$$M$Y$$$20221205$$HP$PL$PL
143513944$14351394$4$F$$20221130$20180104$20221202$PER$$US-PFIZER INC-2017552948$PFIZER$$65$YR$$M$Y$$$20221202$$CN$US$US
143518824$14351882$4$F$20160118$20221123$20180104$20221129$EXP$$AR-SHIRE-AR201735681$TAKEDA$$$$A$M$Y$$$20221129$$MD$AR$AR
1435237039$14352370$39$F$20171103$20221216$20180104$20221221$EXP$$GB-MYLANLABS-2018M1000507$MYLAN$$73$YR$$F$Y$50$KG$20221221$$PH$GB$GB
1435269911$14352699$11$F$20170101$20221118$20180104$20221121$EXP$$US-PFIZER INC-2017549728$PFIZER$$78$YR$$F$Y$50$KG$20221121$$CN$US$US
143527829$14352782$9$F$20210630$20221118$20180104$20221122$EXP$$US-PFIZER INC-2017551393$PFIZER$$74$YR$$F$Y$61.288$KG$20221122$$CN$US$US
1435354011$14353540$11$F$20160401$20221108$20180105$20221111$EXP$$CA-TAKEDA-2016TUS006034$TAKEDA$$38$YR$$F$Y$$$20221111$$HP$CA$CA
143553422$14355342$2$F$20170101$20221114$20180105$20221129$EXP$$IE-AUROBINDO-AUR-APL-2018-000393$AUROBINDO$$67$YR$$M$Y$$$20221129$$MD$IE$IE
143558992$14355899$2$F$$20221109$20180105$20221111$PER$$US-PFIZER INC-2018005020$PFIZER$$57$YR$$F$Y$86.18$KG$20221111$$CN$US$US
143571082$14357108$2$F$20221006$20221102$20180105$20221104$EXP$$US-SHIRE-US201735284$TAKEDA$$43$YR$$F$Y$$$20221104$$HP$US$US
143607318$14360731$8$F$20171213$20221223$20180106$20221230$EXP$$PHHY2017DE196716$NOVARTIS$$$$E$F$Y$94$KG$20221230$$CN$DE$DE
143609654$14360965$4$F$20170927$20221212$20180107$20221219$EXP$$US-SHIRE-US201732076$TAKEDA$$37$YR$$F$Y$135$KG$20221219$$HP$US$US
143618046$14361804$6$F$20221031$20221107$20180108$20221115$EXP$$US-AstraZeneca-2018SE01490$ASTRAZENECA$$24494$DY$$F$Y$78.9$KG$20221115$$LW$US$
143636052$14363605$2$F$$20221213$20180108$20221219$PER$$US-BIOGEN-2018BI00505518$BIOGEN$$$$$F$Y$$$20221219$$CN$US$US
1436395630$14363956$30$F$20180222$20221214$20180108$20221223$EXP$$CA-CELLTRION INC.-2017CA016524$CELLTRION$$$$$$Y$$$20221223$$MD$CA$CA
1436445111$14364451$11$F$$20221031$20180108$20221107$EXP$$DK-MYLANLABS-2018M1001800$MYLAN$Faaborg L, Niemann I, Ostenfeld E, Hanseen E, Sunde L, Lindegaard J et al.. A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group.. Acta Oncologica. 2016;55(2):234-239$30$YR$$F$Y$$$20221107$$HP$DK$DK
1436614113$14366141$13$F$20150811$20221111$20180109$20221117$PER$$US-AMGEN-USASP2018001653$AMGEN$$69$YR$E$F$Y$70$KG$20221116$$MD$US$US
1436788037$14367880$37$F$20151225$20221011$20180109$20221017$EXP$$PHHY2015CA111727$NOVARTIS$$27$YR$$F$Y$$$20221017$$CN$CA$CA
143687147$14368714$7$F$20171201$20221102$20180109$20221104$PER$$US-PFIZER INC-2016476864$PFIZER$$76$YR$$F$Y$64$KG$20221104$$CN$US$US
143687613$14368761$3$F$20170208$20221114$20180109$20221117$PER$$US-PFIZER INC-2018003870$PFIZER$$38$YR$$F$Y$$$20221117$$PH$US$US
143694149$14369414$9$F$$20221128$20180109$20221202$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-120164$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$72$KG$20221202$$MD$CA$CA
143705894$14370589$4$F$$20221214$20180110$20221221$PER$$US-PFIZER INC-2018005170$PFIZER$$43$YR$$F$Y$$$20221221$$CN$US$US
1437062817$14370628$17$F$20150811$20221111$20180110$20221115$EXP$$US-PFIZER INC-2018005394$PFIZER$$69$YR$$F$Y$70$KG$20221115$$MD$US$US
1437455128$14374551$28$F$20171003$20221003$20180111$20221013$EXP$$CA-ROCHE-2053198$ROCHE$$10$YR$$F$Y$$$20221011$$HP$CA$CA
143780624$14378062$4$F$$20221004$20180111$20221007$EXP$$US-TAKEDA-2018TUS000486$TAKEDA$$$$$$Y$$$20221007$$CN$US$US
143799295$14379929$5$F$20220101$20221213$20180112$20221222$EXP$$US-PFIZER INC-2018014288$PFIZER$$78$YR$$F$Y$$$20221222$$CN$US$US
143805123$14380512$3$F$20171015$20220929$20180112$20221003$EXP$$US-PFIZER INC-2018013982$PFIZER$$73$YR$$F$Y$$$20221003$$CN$US$US
1438241913$14382419$13$F$$20221006$20180112$20221013$EXP$$PL-MYLANLABS-2018M1003406$MYLAN$Wojcik-Pedziwiatr M, Michalski M.. A 70-year-old woman with pneumonia, hallucinations and diagnosis of Parkinson?s disease.. LEKARZ RODZINNY.. 2017;5:82-88$70$YR$$F$Y$$$20221013$$HP$PL$PL
143826945$14382694$5$F$20130204$20221024$20180112$20221102$EXP$$US-AstraZeneca-2018SE03261$ASTRAZENECA$$21436$DY$$F$Y$109.8$KG$20221102$$LW$US$
143829684$14382968$4$F$20170501$20180529$20180114$20221220$EXP$$FR-TEVA-2018-FR-846287$TEVA$$75$YR$E$M$Y$$$20221220$$CN$FR$FR
143837594$14383759$4$F$20111109$20221102$20180115$20221110$EXP$$US-AstraZeneca-2018SE03434$ASTRAZENECA$$23842$DY$$F$Y$91.2$KG$20221110$$LW$US$
143839835$14383983$5$F$20120624$20221006$20180115$20221010$EXP$$US-AstraZeneca-2018SE03276$ASTRAZENECA$$11037$DY$$F$Y$149.2$KG$20221010$$LW$US$
143842837$14384283$7$F$20130301$20221202$20180115$20221205$PER$$US-PFIZER INC-2018013284$PFIZER$$69$YR$$F$Y$$$20221205$$LW$US$US
143872566$14387256$6$F$20160914$20221011$20180115$20221018$EXP$$US-Vifor (International) Inc.-VIT-2018-00322$VIFOR$$66$YR$$M$Y$$$20221018$$CN$US$US
143901028$14390102$8$F$$20221104$20180115$20221110$PER$$US-AMGEN-USASP2018005587$AMGEN$$37$YR$A$F$Y$$$20221110$$MD$US$US
143908047$14390804$7$F$20180105$20221014$20180116$20221018$EXP$$JP-ROCHE-2051436$ROCHE$$48$YR$$M$Y$71.4$KG$20221018$$MD$JP$
143910044$14391004$4$F$$20221005$20180116$20221006$PER$$US-PFIZER INC-2018009125$PFIZER$$73$YR$$F$Y$$$20221006$$LW$US$US
143910473$14391047$3$F$20180109$20221219$20180116$20221227$EXP$$US-PFIZER INC-2018015963$PFIZER$$77$YR$$F$Y$$$20221227$$CN$US$US
143916525$14391652$5$F$20151110$20221010$20180116$20221020$EXP$$DE-Rare Disease Therapeutics, Inc.-2040093$NOVA LABORATORIES$$34$MON$$M$Y$12.2$KG$20221020$$MD$DE$DE
1439181116$14391811$16$F$20160301$20221103$20180116$20221110$EXP$$GB-ASPEN-GLO2016GB005993$ASPEN$$$$$$Y$$$20221110$$HP$GB$GB
1439241215$14392412$15$F$$20221006$20180116$20221013$EXP$$PHHY2018PL005683$NOVARTIS$Wojcik-Pedziwiatr M, Michalski M. A 70-year-old woman with pneumonia, hallucinations and diagnosis of Parkinson?s disease. LEKARZ RODZINNY. 2017;5:82-8$70$YR$$F$Y$$$20221013$$HP$PL$PL
143947889$14394788$9$F$$20221118$20180116$20221123$EXP$$BE-PFIZER INC-2017526791$PFIZER$Smets, G.. Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review. Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine. 2017;1-7$59$YR$$F$Y$$$20221123$$HP$BE$BE
144005198$14400519$8$F$20170413$20221215$20180117$20221223$EXP$$GB-BAUSCH-BL-2017-035964$BAUSCH AND LOMB$$67$YR$$M$Y$69.4$KG$20221223$$MD$GB$GB
1440061352$14400613$52$F$$20221212$20180117$20221222$PER$$CA-AMGEN-CANSP2017193304$AMGEN$$63$YR$A$F$Y$$$20221222$$HP$CA$CA
144010107$14401010$7$F$20171209$20221220$20180117$20221222$EXP$$CA-TAKEDA-2018TUS001007$TAKEDA$$81$YR$$F$Y$$$20221222$$MD$CA$CA
144020885$14402088$5$F$$20210325$20180117$20221128$EXP$$IN-ROCHE-2053650$ROCHE$Beri S, Shandil A and Garg R Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis. The Indian Journal of Ophthalmology 2021;65 (11):1166-71.$57$YR$$F$Y$$$20221128$$HP$IN$
144020955$14402095$5$F$$20210325$20180117$20221129$EXP$$IN-ROCHE-2053653$ROCHE$Beri S, Shandil A, and Garg R Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis.. Indian-J-Ophthalmol 2017;65(11):1166-1171.$72$YR$$M$Y$$$20221129$$MD$IN$
144030056$14403005$6$F$20171201$20221121$20180117$20221123$EXP$$US-PFIZER INC-2018020050$PFIZER$$65$YR$$F$Y$104$KG$20221123$$CN$US$US
144033973$14403397$3$F$20130204$20221025$20180117$20221026$EXP$$US-TAKEDA-2018TUS000861$TAKEDA$$$$$$Y$$$20221026$$CN$US$US
144038472$14403847$2$F$20200801$20220926$20180117$20221006$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2018-007066$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20221006$$CN$US$US
144041349$14404134$9$F$20180101$20221020$20180117$20221024$PER$$US-PFIZER INC-2018020013$PFIZER$$67$YR$$F$Y$46$KG$20221024$$CN$US$US
144042923$14404292$3$F$20150101$20221013$20180117$20221017$EXP$$US-TAKEDA-2018TUS000898$TAKEDA$$$$$$Y$$$20221017$$CN$US$US
144077157$14407715$7$F$20171231$20221008$20180118$20221013$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-000658$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$66.9$KG$20221014$$HP$US$US
144105658$14410565$8$F$20170801$20220926$20180119$20221002$EXP$$PHHY2018SE004029$NOVARTIS$$$$N$$Y$$$20221002$$MD$SE$SE
144116644$14411664$4$F$20150101$20221013$20180119$20221019$EXP$$US-PFIZER INC-2018024229$PFIZER$$$$$M$Y$$$20221019$$CN$US$US
144125592$14412559$2$F$20170101$20221213$20180119$20221220$PER$$CA-AMGEN-CANSL2015050257$AMGEN$$59$YR$A$F$Y$$$20221220$$CN$CA$CA
1441268446$14412684$46$F$20180101$20221117$20180119$20221125$EXP$$CA-CELLTRION INC.-2018CA017333$CELLTRION$$$$$$Y$$$20221125$$CN$CA$CA
144128614$14412861$4$F$$20221223$20180119$20221227$EXP$$US-JAZZ-2018-US-001273$JAZZ$$$$$F$Y$$$20221227$$CN$US$US
144129312$14412931$2$F$20170501$20221006$20180119$20221018$EXP$DK-DKMA-WBS-0008432$DK-SA-2018SA009733$SANOFI AVENTIS$$27$YR$A$F$Y$42$KG$20221018$$MD$DK$DK
144137404$14413740$4$F$$20180209$20180119$20221208$EXP$$FR-TEVA-2018-FR-846502$TEVA$Heitzmann E, Muller C, Tebacher M, Michel B, Javelot H. Increased QT interval due to antiandrogenic therapy, majorated by psychotropic drugs: About one case. Therapie 2017;72(6):701-703.$78$YR$E$M$Y$$$20221208$$HP$FR$FR
144161317$14416131$7$F$20170801$20220928$20180122$20221003$EXP$SE-UCBSA-2018002372$SE-UCBSA-2018002372$UCB$$$$$$Y$$$20221003$$MD$SE$SE
144165046$14416504$6$F$$20221213$20180122$20221225$EXP$$FR-AUROBINDO-AUR-APL-2018-002434$AUROBINDO$Heitzmann E, Muller C, Tebacher M, Michel B, Javelot H.. Increased QT interval due to antiandrogenic therapy, majorated by psychotropic drugs: About one case. Therapie. 2017;72 (6):701-703$78$YR$$M$Y$$$20221225$$HP$FR$FR
1441680712$14416807$12$F$20171229$20221012$20180122$20221020$EXP$$CA-ROCHE-2049492$ROCHE$$43$YR$$F$Y$$$20221020$$HP$CA$
144169249$14416924$9$F$20170101$20221017$20180122$20221020$EXP$$US-PFIZER INC-2018025001$PFIZER$$57$YR$$F$Y$46.712$KG$20221020$$CN$US$US
144170349$14417034$9$F$$20221103$20180122$20221107$PER$$US-PFIZER INC-2018024662$PFIZER$$67$YR$$F$Y$$$20221107$$MD$US$US
144186822$14418682$2$F$$20170527$20180122$20221209$PER$$US-TEVA-2016-14830$TEVA$$86$YR$E$F$Y$$$20221209$$PH$US$US
1441938832$14419388$32$F$20170901$20221115$20180122$20221121$EXP$$GB-MYLANLABS-2017M1077447$MYLAN$$32$YR$$F$Y$$$20221121$$MD$GB$GB
144209002$14420900$2$F$20150101$20221012$20180122$20221014$EXP$$US-ROCHE-1885432$ROCHE$$80$YR$$F$Y$43.13$KG$20221014$$CN$US$
144217816$14421781$6$F$$20221220$20180122$20221227$PER$$CA-AMGEN-CANSP2018005831$AMGEN$$48$YR$A$F$Y$106$KG$20221227$$PH$CA$CA
144218975$14421897$5$F$$20221103$20180122$20221110$PER$$US-AMGEN-USASP2018006841$AMGEN$$67$YR$E$F$Y$$$20221110$$MD$US$US
1442354112$14423541$12$F$20170101$20221222$20180123$20221228$PER$$US-PFIZER INC-2018027236$PFIZER$$81$YR$$F$Y$52$KG$20221228$$CN$US$US
1442356740$14423567$40$F$$20221027$20180123$20221103$EXP$$US-PFIZER INC-2018026203$PFIZER$$68$YR$$M$Y$86.18$KG$20221103$$MD$US$US
144244787$14424478$7$F$$20221202$20180123$20221207$EXP$$FR-MYLANLABS-2018M1004016$MYLAN$Quaesaet L, Stindel E, Lanternier F, Williams T, Jaffuel S, Moalic E et al. Miltefosine-based regimen as salvage therapy in Lomentospora prolificans bone and joint infection. Medecine et Maladies Infectieuses. 2018;48:63-65$70$YR$$M$Y$$$20221207$$MD$FR$FR
1442690115$14426901$15$F$20170701$20221003$20180123$20221013$EXP$NL-LRB-00254512$NL-TEVA-2018-NL-848285$TEVA$$79$YR$E$M$Y$73$KG$20221013$$CN$NL$NL
144305597$14430559$7$F$20120416$20221004$20180124$20221012$EXP$$US-AstraZeneca-2018SE08506$ASTRAZENECA$$27313$DY$$M$Y$$$20221012$$LW$US$
1443395011$14433950$11$F$$20221003$20180124$20221007$EXP$$PHHY2017NL199683$NOVARTIS$Van Kampenhout E, Bolhuis MS, Alffenaar J-WC, Oswald LMA, Kerstjens HAM, De Lange WCM et al.. Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis. EUROPEAN RESPIRATORY JOURNAL. 2017;49(3):1-3$25$YR$$F$Y$$$20221007$$HP$NL$NL
1443858732$14438587$32$F$20170803$20221114$20180125$20221118$EXP$$PHHY2017CA116099$NOVARTIS$$85$YR$$F$Y$$$20221118$$HP$CA$CA
144478567$14447856$7$F$$20221128$20180126$20221202$EXP$$FR-SA-2018SA014262$SANOFI AVENTIS$$62$YR$A$M$Y$$$20221202$$MD$FR$FR
1444863411$14448634$11$F$20170101$20221006$20180126$20221013$EXP$$CA-PFIZER INC-2017317447$PFIZER$$73$YR$$M$Y$$$20221013$$CN$CA$CA
144488598$14448859$8$F$20170413$20221220$20180126$20221230$EXP$$GB-TEVA-2018-GB-850413$TEVA$$67$YR$E$M$Y$69.4$KG$20221230$$MD$GB$GB
144489524$14448952$4$F$$20220927$20180126$20221007$EXP$$FR-MYLANLABS-2018M1004979$MYLAN$Risse J, Vieira M, Beuret F, Petitpain N, Zuily S, Wahl D.. Reversible drug-induced antiphospholipid syndrome.. Lupus.. 2018;27(2):333-335$18$YR$$M$Y$$$20221007$$HP$FR$FR
144490516$14449051$6$F$20170101$20221128$20180126$20221129$EXP$$CA-TAKEDA-2017TUS024839$TAKEDA$$67$YR$$F$Y$$$20221129$$MD$CA$CA
144491883$14449188$3$F$$20221027$20180126$20221102$EXP$$IT-ROCHE-2060825$ROCHE$Ghione P, Cavallo F, Visco C, Chen Z, Castellino A, Tisi MC, Dogliotti I, Nicolosi, M, Boccadoro M, Leonard JP, Vitolo U and Martin P. A retrospective study of RDHAP/ Ox for early progressing follicular lymphoma. Doi; 10.1111/BJH.15057. British Journal of Haematology 2018 Dec;183 (5):828-31.$$$$$Y$$$20221101$$HP$IT$IT
1445052445$14450524$45$F$20170406$20221009$20180129$20221013$EXP$$CA-ROCHE-2061880$ROCHE$$19$YR$$M$Y$$$20221013$$MD$CA$CA
1445361121$14453611$21$F$20200101$20221021$20180129$20221026$EXP$$PHHY2017BR169385$NOVARTIS$$$$$M$Y$67$KG$20221026$$MD$BR$BR
144540165$14454016$5$F$$20221010$20180129$20221021$EXP$$GB-MYLANLABS-2018M1002396$MYLAN$Gonzaga-Lopez A, Munoz-Rodriguez J, Ruiz-Casado A.. Necrotising fasciitis in a patient treated with FOLFIRI-aflibercept for colorectal cancer.. Ann R Coll Surg Engl.. 2017;99(8):225-6$64$YR$$M$Y$$$20221021$$HP$GB$ES
144541364$14454136$4$F$$20221014$20180129$20221018$EXP$$US-PFIZER INC-2017555973$PFIZER$$70$YR$$F$Y$$$20221018$$CN$US$US
144541932$14454193$2$F$$20210624$20180129$20221219$EXP$$US-GLAXOSMITHKLINE-US2018GSK012354$GLAXOSMITHKLINE$Gleghorn K, Kelly B. Severe cutaneous drug reactions, such as Steven-Johnson syndrome and toxic epidermal necrolysis, in pediatric patients with an emphasis on recently approved medications. 76th Annual Meeting of the American Academy of Dermatology (AAD). 2018$$$$$Y$$$20221219$$MD$US$US
1445587715$14455877$15$F$$20221118$20180130$20221129$EXP$$PT-ROCHE-2058319$ROCHE$PRIVACY P, Cadinha S, Malheiro D, Brosseron L, Moreira Da Silva JP. Multiple drug hypersensitivity syndrome, including antihistamines and corticosteroids, in a patient diagnosed with asthma and chronic urticaria. REVISTA PORTUGUESA DE IMUNOALERGOLOGIA 2017;25 (3):216-217.$23$YR$$F$Y$102$KG$20221129$$HP$COUNTRY NOT SPECIFIED$PT
144568212$14456821$2$F$$20221102$20180130$20221117$EXP$$US-West-Ward Pharmaceuticals Corp.-US-H14001-18-00542$HIKMA$$67$YR$$F$Y$$$20221117$$MD$US$
144575053$14457505$3$F$$20221214$20180130$20221227$PER$$US-PFIZER INC-2018037093$PFIZER$$78$YR$$F$Y$$$20221227$$CN$US$US
144575186$14457518$6$F$$20221130$20180130$20221205$PER$$US-PFIZER INC-2018036988$PFIZER$$68$YR$$F$Y$$$20221205$$MD$US$US
1445770220$14457702$20$F$20171107$20221212$20180130$20221219$EXP$$PHHY2017GB199493$NOVARTIS$$73$YR$$F$Y$50$KG$20221219$$PH$GB$GB
1445851814$14458518$14$F$$20221014$20180130$20221021$EXP$$CA-APOTEX-2018AP005828$APOTEX$$76$YR$$F$Y$$$20221021$$MD$CA$CA
1445886619$14458866$19$F$20120524$20221202$20180130$20221206$EXP$$DE-MYLANLABS-2018M1005245$MYLAN$$30$YR$$M$Y$76$KG$20221206$$MD$DE$DE
144637395$14463739$5$F$20180124$20221216$20180130$20221221$PER$$US-BIOGEN-2018BI00512716$BIOGEN$$68$YR$$F$Y$$$20221221$$CN$US$US
144659274$14465927$4$F$$20221216$20180131$20221230$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2018US-161534$RANBAXY$Defayette A, Perrello A, Brewer T, Picano J, Ahmed S. Enteral baclofen withdrawal managed with intravenous dexmedetomidine: A case report. Am J health Syst Pharm. 2020;Mar 01; 77:352-355$61$YR$$M$Y$$$20221230$$HP$US$US
144663619$14466361$9$F$$20221004$20180131$20221015$EXP$$PL-AUROBINDO-AUR-APL-2018-003673$AUROBINDO$Wojcik-Pedziwiatr M, Michalski M.. A 70-year-old woman with pneumonia, hallucinations and diagnosis of Parkinson?s disease. Lekarz Rodzinny. 2017;82:84-8$70$YR$$F$Y$$$20221015$$MD$PL$PL
144666087$14466608$7$F$20140401$20221123$20180131$20221206$EXP$$US-ACORDA-ACO_137979_2017$ACORDA$$49$YR$$F$Y$55.34$KG$20221206$$MD$US$US
1446725341$14467253$41$F$20140101$20221018$20180131$20221024$EXP$$PHHY2014CA056516$NOVARTIS$$$$$F$Y$$$20221024$$PH$CA$CA
144675923$14467592$3$F$$20221128$20180131$20221205$EXP$$US-ADIENNEP-2018AD000038$ADIENNE PHARMA + BIOTECH$Hashem H, Kumar AR, Mueller I, Babor F, Bredius R, Dalal J, et al. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2. Blood 2017 130:24 (2682-2688). Doi:  10.1182/blood-2017-07-798660.$11$YR$$F$Y$$$20221130$$MD$US$
1446968528$14469685$28$F$$20221206$20180131$20221212$EXP$$GB-MYLANLABS-2018M1005349$MYLAN$$44$YR$$M$Y$$$20221212$$HP$GB$GB
144738083$14473808$3$F$$20221012$20180201$20221013$PER$$US-PFIZER INC-2018041827$PFIZER$$62$YR$$F$Y$$$20221013$$HP$US$US
1447381725$14473817$25$F$20170101$20221222$20180201$20221230$EXP$$US-PFIZER INC-2018041621$PFIZER$$68$YR$$F$Y$49$KG$20221230$$CN$US$US
1447501740$14475017$40$F$20170826$20221215$20180201$20221224$EXP$$CA-CELLTRION INC.-2017CA011633$CELLTRION$$$$$$Y$$$20221224$$CN$CA$CA
144754514$14475451$4$F$20180101$20221028$20180201$20221101$PER$$US-PFIZER INC-2018045680$PFIZER$$80$YR$$M$Y$$$20221101$$CN$US$US
144768166$14476816$6$F$$20221024$20180201$20221028$PER$$US-AMGEN-USASP2018013922$AMGEN$$68$YR$E$F$Y$$$20221027$$HP$US$US
144780747$14478074$7$F$20100407$20221117$20180202$20221125$EXP$$US-AstraZeneca-2018SE11774$ASTRAZENECA$$19768$DY$$F$Y$59.4$KG$20221125$$LW$US$
144782794$14478279$4$F$$20180726$20180202$20221220$EXP$$SE-TEVA-2018-SE-850316$TEVA$$30$YR$A$M$Y$$$20221220$$MD$SE$SE
144801012$14480101$2$F$$20221012$20180202$20221015$PER$$US-AMGEN-USASP2018013293$AMGEN$$62$YR$A$F$Y$$$20221015$$HP$US$US
144807565$14480756$5$F$20180101$20221104$20180202$20221109$EXP$$PHHY2018CA014001$NOVARTIS$$53$YR$$M$Y$$$20221109$$HP$CA$CA
1448295038$14482950$38$F$20171222$20221020$20180203$20221020$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-008328$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$75.74$KG$20221021$$HP$US$US
144843516$14484351$6$F$20100722$20221017$20180205$20221020$EXP$$US-AstraZeneca-2018SE12552$ASTRAZENECA$$23698$DY$$M$Y$104.3$KG$20221020$$LW$US$
1448708629$14487086$29$F$20170731$20221018$20180205$20221026$EXP$$CA-CELLTRION INC.-2017CA010299$CELLTRION$$$$$$Y$$$20221026$$CN$CA$CA
1448755229$14487552$29$F$20180716$20221121$20180205$20221129$EXP$$CA-CELLTRION INC.-2017CA004112$CELLTRION$$$$$$Y$$$20221129$$MD$CA$CA
144881207$14488120$7$F$20171001$20221121$20180205$20221124$EXP$$US-PFIZER INC-2017273721$PFIZER$$57$YR$$F$Y$59$KG$20221124$$CN$US$US
144882112$14488211$2$F$$20220927$20180205$20221007$EXP$$FR-MYLANLABS-2018M1006915$MYLAN$Risse J, Vieira M,  Beuret F, Petitpain N, Zuily S, Wahl D.. Reversible drug-induced antiphospholipid syndrome.. Lupus. 2018;27(2):333-5$$$A$M$Y$$$20221007$$HP$FR$FR
144909348$14490934$8$F$20180126$20221024$20180206$20221026$PER$$US-PFIZER INC-2017229694$PFIZER$$78$YR$$F$Y$72$KG$20221026$$CN$US$US
1449325130$14493251$30$F$20170616$20221219$20180206$20221229$EXP$$CA-CELLTRION INC.-2017CA008080$CELLTRION$$$$$$Y$$$20221229$$CN$CA$CA
1449601314$14496013$14$F$$20221129$20180207$20221208$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-007268$BRISTOL MYERS SQUIBB$$68$YR$E$F$Y$$$20221208$$MD$CA$CA
1449652214$14496522$14$F$20160803$20221122$20180207$20221130$EXP$GB-MHRA-ADR 23595830$GB-TORRENT-00007686$TORRENT$$69$YR$E$F$Y$101$KG$20221130$$MD$GB$GB
144968225$14496822$5$F$20180129$20221205$20180207$20221208$PER$$US-PFIZER INC-2018053031$PFIZER$$76$YR$$F$Y$90.72$KG$20221208$$CN$US$US
1449736919$14497369$19$F$20211201$20221129$20180207$20221205$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK066828$GLAXOSMITHKLINE$$$$$$Y$$$20221205$$MD$BR$BR
145002403$14500240$3$F$20180101$20221213$20180207$20221219$EXP$$US-JAZZ-2018-US-002426$JAZZ$$36$YR$$F$Y$$$20221219$$HP$US$US
1450166939$14501669$39$F$$20221213$20180207$20221216$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-007157$BRISTOL MYERS SQUIBB$$63$YR$A$F$Y$$$20221216$$HP$CA$CA
145021727$14502172$7$F$20121115$20221010$20180208$20221014$EXP$$US-AstraZeneca-2018SE15637$ASTRAZENECA$$22804$DY$$F$Y$108.9$KG$20221014$$LW$US$
145024325$14502432$5$F$20161223$20221117$20180208$20221123$EXP$$CA-TAKEDA-2017TUS000654$TAKEDA$$55$YR$$F$Y$$$20221123$$CN$CA$CA
145027029$14502702$9$F$$20221221$20180208$20221228$EXP$$US-ARIAD PHARMACEUTICALS, INC-2017US008872$TAKEDA$$$$$F$Y$59$KG$20221228$$CN$US$US
145028484$14502848$4$F$$20221116$20180208$20221118$PER$$US-BIOGEN-2018BI00518225$BIOGEN$$$$$F$Y$58.9$KG$20221118$$CN$US$US
145031546$14503154$6$F$20171226$20221116$20180208$20221118$EXP$$US-PFIZER INC-2018054905$PFIZER$$66$YR$$F$Y$83.01$KG$20221118$$CN$US$US
1450608630$14506086$30$F$20171208$20221213$20180208$20221226$EXP$$CA-CELLTRION INC.-2017CA011940$CELLTRION$$$$$$Y$$$20221226$$CN$CA$CA
1450676033$14506760$33$F$20170913$20221124$20180208$20221202$EXP$$PHHY2016CA077754$NOVARTIS$$50$YR$$F$Y$$$20221202$$CN$CA$CA
145073822$14507382$2$F$$20211202$20180208$20221008$PER$$US-PURDUE-USA-2017-0140907$PURDUE$$$$$F$Y$$$20221008$$CN$US$US
145098625$14509862$5$F$$20221021$20180209$20221025$PER$$US-PFIZER INC-2018056457$PFIZER$$77$YR$$F$Y$$$20221025$$MD$US$US
145098745$14509874$5$F$$20221027$20180209$20221031$PER$$US-PFIZER INC-2018057651$PFIZER$$70$YR$$F$Y$$$20221031$$MD$US$US
145102703$14510270$3$F$$20180309$20180209$20221019$EXP$$IE-JNJFOC-20180203321$JOHNSON AND JOHNSON$$73$YR$E$F$Y$44.4$KG$20221019$$MD$IE$IE
1451089110$14510891$10$F$20161201$20221117$20180209$20221122$EXP$$CA-TAKEDA-2016TUS023123$TAKEDA$$44$YR$$M$Y$$$20221122$$HP$CA$CA
1451182314$14511823$14$F$$20221115$20180209$20221117$PER$$US-PFIZER INC-2018056942$PFIZER$$68$YR$$F$Y$$$20221117$$MD$US$US
145119542$14511954$2$F$20170101$20221130$20180209$20221212$EXP$$US-TAKEDA-2018MPI001261$TAKEDA$$58$YR$$M$Y$83$KG$20221212$$MD$US$US
145120034$14512003$4$F$$20180305$20180209$20221209$EXP$$US-TEVA-2018-US-856263$TEVA$$$$$F$Y$$$20221209$$HP$US$US
145142534$14514253$4$F$20180101$20221222$20180209$20221223$EXP$$CA-SHIRE-CA201803915$SERVIER$$$$$$Y$$$20221223$$HP$CA$CA
1451633724$14516337$24$F$$20221124$20180211$20221201$EXP$$CA-ABBVIE-18K-028-2248990-00$ABBVIE$$63$YR$$F$Y$$$20221201$$MD$CA$CA
1451639810$14516398$10$F$$20221115$20180212$20221121$PER$$US-AMGEN-USASP2018018118$AMGEN$$68$YR$E$F$Y$$$20221121$$MD$US$US
145166893$14516689$3$F$$20221121$20180212$20221129$PER$$US-JNJFOC-20180201823$JOHNSON AND JOHNSON$$$$$M$Y$$$20221130$$LW$US$US
145172074$14517207$4$F$20150607$20221021$20180212$20221028$EXP$$US-SHIRE-US201804265$TAKEDA$$39$YR$$F$Y$66.168$KG$20221028$$CN$US$US
145191153$14519115$3$F$$20221019$20180212$20221031$PER$$US-JNJFOC-20180202186$JOHNSON AND JOHNSON$$$$$M$Y$$$20221031$$LW$US$US
145193732$14519373$2$F$20100301$20220928$20180212$20221007$PER$$US-JNJFOC-20180202108$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221007$$LW$US$US
145225068$14522506$8$F$$20221124$20180212$20221129$EXP$$PHHY2017PT200721$NOVARTIS$Gravito-soares E, Gravito-Soares M, Cipriano MA, Amaro P. Fatal colitis associated with active systemic lupus erythematosus complicated by cytomegalovirus superinfection. BRITISH MEDICAL JOURNAL. 2017;1-2$47$YR$$F$Y$$$20221129$$HP$PT$PT
145226804$14522680$4$F$20110117$20221116$20180212$20221119$EXP$$PHHY2018CO020193$NOVARTIS$$53$YR$$F$Y$58$KG$20221119$$CN$CO$CO
145236893$14523689$3$F$$20221202$20180213$20221210$PER$$US-AMGEN-USASP2018018972$AMGEN$$69$YR$E$M$Y$$$20221210$$MD$US$US
145242604$14524260$4$F$$20220926$20180213$20221004$EXP$$US-AstraZeneca-2018SE17018$ASTRAZENECA$$$$$F$Y$140.6$KG$20221004$$LW$US$
145244039$14524403$9$F$$20221214$20180213$20221219$PER$$US-PFIZER INC-2018062204$PFIZER$$52$YR$$M$Y$$$20221219$$MD$US$US
1452600919$14526009$19$F$20180130$20221007$20180213$20221010$EXP$$JP-ROCHE-2070125$ROCHE$$69$YR$$M$Y$65.9$KG$20221010$$MD$JP$
1452632821$14526328$21$F$20180426$20221024$20180213$20221101$EXP$$CA-CELLTRION INC.-2017CA002020$CELLTRION$$$$$$Y$$$20221101$$CN$CA$CA
145271894$14527189$4$F$20060101$20221017$20180213$20221020$EXP$$US-PFIZER INC-2018061139$PFIZER$$59$YR$$F$Y$$$20221020$$LW$US$US
145281596$14528159$6$F$19970101$20221123$20180214$20221124$PER$$US-BIOGEN-2013BI114629$BIOGEN$$$$$F$Y$$$20221124$$CN$US$US
145292932$14529293$2$F$20220929$20221004$20180214$20221006$PER$$US-SHIRE-US201805035$TAKEDA$$69$YR$$F$Y$91.156$KG$20221006$$CN$US$US
145294114$14529411$4$F$$20180209$20180214$20221209$EXP$$US-TEVA-2018-US-859279$TEVA$$$$$M$Y$$$20221209$$MD$US$US
145308238$14530823$8$F$20180101$20221019$20180214$20221024$EXP$$US-PFIZER INC-2018061673$PFIZER$$27$YR$$M$Y$90.72$KG$20221024$$HP$US$US
1453299720$14532997$20$F$20171125$20221021$20180215$20221031$EXP$$CA-ROCHE-2037517$ROCHE$$7$YR$$M$Y$35.5$KG$20221031$$HP$CA$
1453398911$14533989$11$F$20180201$20221227$20180215$20221229$PER$$US-PFIZER INC-2018062283$PFIZER$$75$YR$$F$Y$118$KG$20221229$$CN$US$US
145340465$14534046$5$F$20171001$20221206$20180215$20221212$EXP$$US-PFIZER INC-2018063220$PFIZER$$65$YR$$F$Y$45.36$KG$20221212$$CN$US$US
145349707$14534970$7$F$20150717$20221116$20180215$20221128$EXP$$GB-ASPEN-GLO2015GB010141$ASPEN$$$$$$Y$$$20221128$$HP$GB$GB
145350318$14535031$8$F$20191002$20220930$20180215$20221002$EXP$$PHJP2018JP003345$NOVARTIS$$50$YR$$F$Y$$$20221003$$MD$JP$JP
1453521549$14535215$49$F$20171227$20221011$20180215$20221020$EXP$$CA-CELLTRION INC.-2018CA017660$CELLTRION$$$$$$Y$$$20221020$$CN$CA$CA
1453794813$14537948$13$F$$20221007$20180216$20221013$PER$$US-AMGEN-USASP2018021138$AMGEN$$88$YR$E$F$Y$$$20221013$$MD$US$US
145418982$14541898$2$F$$20221003$20180216$20221013$PER$$US-JNJFOC-20180206421$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$LW$US$US
145430023$14543002$3$F$20120101$20221005$20180216$20221007$EXP$$US-TAKEDA-2018TUS004146$TAKEDA$$$$$$Y$$$20221007$$CN$US$US
145430054$14543005$4$F$20130201$20220923$20180216$20221004$EXP$$US-TAKEDA-2018TUS004273$TAKEDA$$$$$$Y$$$20221004$$CN$US$US
145433605$14543360$5$F$20060101$20221017$20180216$20221024$EXP$$US-TAKEDA-2018TUS004230$TAKEDA$$$$$$Y$$$20221024$$CN$US$US
1454426112$14544261$12$F$20170916$20221019$20180216$20221019$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-121037$BRISTOL MYERS SQUIBB$$68$YR$E$M$Y$71$KG$20221019$$HP$DE$DE
145454855$14545485$5$F$$20221212$20180219$20221216$PER$$CA-AMGEN-CANSP2018022155$AMGEN$$67$YR$E$M$Y$$$20221216$$HP$CA$CA
145455057$14545505$7$F$$20221209$20180219$20221221$PER$$US-AMGEN-USASP2018020913$AMGEN$$67$YR$E$M$Y$67$KG$20221220$$CN$US$US
145468344$14546834$4$F$$20221108$20180219$20221110$PER$$US-PFIZER INC-2018065357$PFIZER$$72$YR$$F$Y$$$20221110$$CN$US$US
1454684410$14546844$10$F$20180206$20221216$20180219$20221223$EXP$$US-PFIZER INC-2018065235$PFIZER$$73$YR$$F$Y$77$KG$20221223$$CN$US$US
145469773$14546977$3$F$$20221102$20180219$20221107$EXP$$CA-009507513-1802CAN009207$MERCK$Yu R, Dale S, Yamamura D, Stankus V, Lee C. Daptomycin-nonsusceptible, vancomycin-intermediate, methicillin-resistant Staphylococcus aureus endocarditis. Can J Infect Dis Med Microbiol. 2012;23(2):e48-e50$75$YR$$F$Y$$$20221107$$HP$CA$CA
145469818$14546981$8$F$$20221219$20180219$20221227$EXP$$US-PFIZER INC-2018068998$PFIZER$$66$YR$$F$Y$$$20221227$$CN$US$US
145477992$14547799$2$F$$20180213$20180219$20221208$EXP$$CA-TEVA-2017-CA-836651$TEVA$$$$$$Y$$$20221208$$PH$CA$CA
145490707$14549070$7$F$20171201$20221108$20180219$20221111$PER$$US-PFIZER INC-2018068964$PFIZER$$55$YR$$F$Y$73.03$KG$20221111$$CN$US$US
145498003$14549800$3$F$$20220913$20180219$20221007$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-006156$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20221007$$CN$US$US
145498072$14549807$2$F$20171001$20221105$20180219$20221130$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-006142$ACADIA PHARMACEUTICALS$$65$YR$$M$Y$$$20221130$$CN$US$US
145498722$14549872$2$F$20171113$20221031$20180219$20221109$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-006264$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20221110$$CN$US$US
145499402$14549940$2$F$$20221104$20180219$20221114$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-006335$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20221114$$CN$US$US
145499968$14549996$8$F$20170101$20220923$20180219$20221003$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-006458$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20221003$$CN$US$US
145500434$14550043$4$F$20200201$20221114$20180219$20221123$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-006342$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20221123$$CN$US$US
145502683$14550268$3$F$20220829$20220926$20180219$20221021$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-006829$ACADIA PHARMACEUTICALS$$87$YR$$F$Y$$$20221021$$CN$US$US
145505468$14550546$8$F$20210101$20221107$20180219$20221117$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2018-007192$ACADIA PHARMACEUTICALS$$$$$M$Y$79$KG$20221117$$CN$US$US
145520486$14552048$6$F$20160307$20221021$20180220$20221025$PER$$US-PFIZER INC-2018049626$PFIZER$$55$YR$$F$Y$$$20221025$$LW$US$US
145531419$14553141$9$F$$20221128$20180220$20221208$EXP$$CA-APOTEX-2018AP006524$APOTEX$$61$YR$$F$Y$67$KG$20221208$$HP$CA$CA
145538822$14553882$2$F$20170731$20180205$20180220$20221220$EXP$FR-AFSSAPS-BX20174081$FR-TEVA-2018-FR-856970$TEVA$$73$YR$E$F$Y$68$KG$20221220$$PH$FR$FR
145567032$14556703$2$F$$20221214$20180221$20221219$PER$$US-PFIZER INC-2018073186$PFIZER$$66$YR$$M$Y$90.703$KG$20221219$$CN$US$US
1455747410$14557474$10$F$20210101$20221108$20180221$20221114$EXP$$CA-PFIZER INC-2018058533$PFIZER$$55$YR$$F$Y$$$20221114$$CN$CA$CA
145578515$14557851$5$F$20160501$20221130$20180221$20221202$EXP$$US-PFIZER INC-2017262528$PFIZER$$65$YR$$M$Y$71$KG$20221202$$CN$US$US
1455912610$14559126$10$F$20180208$20221026$20180221$20221102$EXP$$US-PFIZER INC-2018070862$PFIZER$$86$YR$$F$Y$58.97$KG$20221102$$CN$US$US
145595895$14559589$5$F$20180215$20221027$20180221$20221031$EXP$$US-SHIRE-US201806683$TAKEDA$$57$YR$$F$Y$$$20221031$$HP$US$US
1456000916$14560009$16$F$20170202$20221213$20180221$20221217$EXP$$PHHY2017CA018665$NOVARTIS$$47$YR$$F$Y$$$20221217$$CN$CA$CA
145613735$14561373$5$F$20221106$20221117$20180222$20221122$EXP$$US-PFIZER INC-2018074735$PFIZER$$72$YR$$F$Y$81.65$KG$20221122$$HP$US$US
145617986$14561798$6$F$20200114$20221116$20180222$20221123$EXP$$CA-ROCHE-2077557$ROCHE$$70$YR$$F$Y$$$20221123$$CN$CA$CA
1456330815$14563308$15$F$20170728$20221205$20180222$20221210$EXP$$PHHY2017CA113510$NOVARTIS$$61$YR$$M$Y$76$KG$20221210$$CN$CA$CA
145652582$14565258$2$F$$20221207$20180223$20221209$PER$$US-JNJFOC-20180216613$JOHNSON AND JOHNSON$$$$$M$Y$$$20221209$$LW$US$US
145673103$14567310$3$F$$20221003$20180223$20221012$PER$$US-JNJFOC-20180216736$JOHNSON AND JOHNSON$$$$$M$Y$$$20221009$$LW$US$US
145673434$14567343$4$F$20080221$20221116$20180223$20221128$PER$$US-JNJFOC-20180216753$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20221128$$LW$US$US
145684063$14568406$3$F$20090417$20221207$20180223$20221212$PER$$US-JNJFOC-20180217396$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20221212$$LW$US$US
145695312$14569531$2$F$20130101$20221213$20180224$20221220$PER$$US-JNJFOC-20180216754$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20221220$$LW$US$US
1457172012$14571720$12$F$20180220$20221221$20180226$20221228$EXP$$US-PFIZER INC-2018076610$PFIZER$$70$YR$$F$Y$94$KG$20221228$$CN$US$US
145718043$14571804$3$F$$20221011$20180226$20221013$PER$$US-PFIZER INC-2018079147$PFIZER$$57$YR$$F$Y$$$20221013$$MD$US$US
145725993$14572599$3$F$20180101$20221109$20180226$20221111$PER$$US-PFIZER INC-2018078834$PFIZER$$66$YR$$M$Y$123$KG$20221111$$CN$US$US
145764193$14576419$3$F$$20221006$20180227$20221102$PER$$US-TEVA-2018-US-863141$TEVA$$$$$F$Y$$$20221102$$CN$US$US
145780692$14578069$2$F$20171119$20221125$20180227$20221201$EXP$FI-FIMEA-20180202$FI-009507513-1802FIN011193$MERCK$$71$YR$$M$Y$$$20221201$$MD$FI$FI
1457847944$14578479$44$F$20180101$20221101$20180227$20221123$EXP$$CA-CELLTRION INC.-2017CA014453$CELLTRION$$$$$$Y$$$20221123$$CN$CA$CA
1457848037$14578480$37$F$20180101$20221216$20180227$20221226$EXP$$CA-CELLTRION INC.-2018CA018149$CELLTRION$$$$$$Y$$$20221226$$CN$CA$CA
145788396$14578839$6$F$20180120$20221223$20180227$20221229$EXP$$US-PFIZER INC-2018083145$PFIZER$$78$YR$$F$Y$72.57$KG$20221229$$CN$US$US
145791044$14579104$4$F$20171120$20221005$20180227$20221013$EXP$$US-BIOGEN-2018BI00528986$BIOGEN$$42$YR$$M$Y$$$20221013$$HP$US$US
145798632$14579863$2$F$20180210$20221011$20180228$20221013$PER$$US-BIOGEN-2018BI00527308$BIOGEN$$36$YR$$F$Y$$$20221013$$CN$US$US
145810268$14581026$8$F$$20221125$20180228$20221129$PER$$US-PFIZER INC-2018080969$PFIZER$$69$YR$$F$Y$54$KG$20221129$$CN$US$US
145812394$14581239$4$F$20140101$20220927$20180228$20221005$EXP$$US-AstraZeneca-2018SE24251$ASTRAZENECA$$71$YR$$F$Y$81.2$KG$20221005$$LW$US$
145821149$14582114$9$F$$20221122$20180228$20221128$PER$$US-PFIZER INC-2018081329$PFIZER$$66$YR$$F$Y$$$20221128$$HP$US$US
145838399$14583839$9$F$20140101$20221130$20180228$20221207$EXP$$PHHY2014CA022004$NOVARTIS$$54$YR$$M$Y$170$KG$20221207$$CN$CA$CA
1458495132$14584951$32$F$20171101$20221207$20180301$20221216$EXP$GB-MYLANLABS-2018M1008353$GB-TORRENT-00016177$TORRENT$$32$YR$A$F$Y$$$20221216$$MD$GB$GB
1458531252$14585312$52$F$$20221014$20180301$20221019$EXP$$GB-JNJFOC-20180234113$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20221019$$HP$GB$GB
145854645$14585464$5$F$$20221025$20180301$20221031$EXP$$US-PFIZER INC-2018081267$PFIZER$$80$YR$$F$Y$$$20221031$$CN$US$US
1458681914$14586819$14$F$20140101$20221214$20180301$20221216$EXP$$US-PFIZER INC-2018085158$PFIZER$$58$YR$$F$Y$86$KG$20221216$$CN$US$US
1458842816$14588428$16$F$20171026$20221102$20180301$20221104$EXP$$PHHY2017CA159357$NOVARTIS$$54$YR$$F$Y$86$KG$20221104$$CN$CA$CA
145896004$14589600$4$F$20170216$20221125$20180302$20221201$EXP$$US-BIOGEN-2018BI00530898$BIOGEN$$27$YR$$F$Y$$$20221201$$CN$US$US
145902399$14590239$9$F$20170123$20221102$20180302$20221110$EXP$$US-PFIZER INC-2018083088$PFIZER$$67$YR$$F$Y$$$20221110$$CN$US$US
1459102113$14591021$13$F$20160101$20221017$20180302$20221020$EXP$$CA-PFIZER INC-2016532697$PFIZER$$57$YR$$F$Y$$$20221020$$CN$CA$CA
1459287532$14592875$32$F$20180103$20221117$20180302$20221124$EXP$$CA-CELLTRION INC.-2018CA017304$CELLTRION$$$$$$Y$$$20221125$$CN$CA$CA
145962562$14596256$2$F$$20221018$20180303$20221027$PER$$US-AMGEN-USASP2018027086$AMGEN$$65$YR$E$F$Y$$$20221026$$CN$US$US
145979306$14597930$6$F$$20221201$20180305$20221206$PER$$US-PFIZER INC-2018085458$PFIZER$$69$YR$$M$Y$$$20221206$$MD$US$US
1459910019$14599100$19$F$20160823$20221110$20180305$20221115$EXP$$CA-TAKEDA-2018TUS004977$TAKEDA$$52$YR$$M$Y$$$20221115$$HP$CA$CA
145994704$14599470$4$F$20220118$20221013$20180305$20221018$EXP$$BR-PFIZER INC-2018087022$PFIZER$$69$YR$$F$Y$$$20221018$$HP$BR$BR
1460003530$14600035$30$F$20180501$20221117$20180305$20221125$EXP$$CA-CELLTRION INC.-2018CA018287$CELLTRION$$$$$$Y$$$20221125$$CN$CA$CA
146024872$14602487$2$F$$20221114$20180306$20221116$PER$$US-PFIZER INC-2018089699$PFIZER$$68$YR$$M$Y$$$20221116$$CN$US$US
146025538$14602553$8$F$20180101$20221124$20180306$20221128$EXP$$US-PFIZER INC-2018092582$PFIZER$$71$YR$$F$Y$64.853$KG$20221128$$CN$US$US
1460423541$14604235$41$F$20170101$20221220$20180306$20221229$EXP$$CA-CELLTRION INC.-2017CA014066$CELLTRION$$$$$$Y$$$20221229$$CN$CA$CA
146043364$14604336$4$F$20180101$20220712$20180306$20221213$PER$$US-AMGEN-USASL2018028889$AMGEN$$$$$F$Y$$$20221213$$CN$US$US
146043624$14604362$4$F$20160407$20221010$20180306$20221018$EXP$$CN-AstraZeneca-2018SE27702$ASTRAZENECA$Liu X, Zhai A, Zhang B. A case report of severe adverse reaction of exenatide: Anaphylactic shock. Medicine 2022;101(39):e30805-.$47$YR$$M$Y$124$KG$20221018$$HP$CN$
1460442831$14604428$31$F$20180222$20221216$20180306$20221226$EXP$$CA-CELLTRION INC.-2018CA018314$CELLTRION$$$$$$Y$$$20221226$$CN$CA$CA
146047156$14604715$6$F$20171118$20221115$20180306$20221118$EXP$$CA-009507513-1803CAN001544$MERCK$$71$YR$$F$Y$57$KG$20221118$$PH$CA$CA
1460493741$14604937$41$F$20170919$20221209$20180306$20221216$EXP$$PHHY2018CA031979$NOVARTIS$$66$YR$$F$Y$$$20221216$$CN$CA$CA
146059233$14605923$3$F$$20221007$20180307$20221014$PER$$US-AMGEN-USASL2018030105$AMGEN$$$$$M$Y$$$20221013$$CN$US$US
146060185$14606018$5$F$20170525$20221130$20180307$20221206$EXP$$CA-ROCHE-2084690$ROCHE$$65$YR$$F$Y$$$20221206$$CN$COUNTRY NOT SPECIFIED$CA
1460652426$14606524$26$F$20180207$20221110$20180307$20221125$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-165261$RANBAXY$$86$YR$$F$Y$$$20221125$$HP$GB$GB
1460670246$14606702$46$F$20180213$20221219$20180307$20221226$EXP$$CA-ROCHE-2075035$ROCHE$$37$YR$$F$Y$$$20221226$$CN$CA$
146069164$14606916$4$F$20120611$20221115$20180307$20221122$EXP$$US-AstraZeneca-2018SE27918$ASTRAZENECA$$22095$DY$$F$Y$78$KG$20221122$$LW$US$
1460707012$14607070$12$F$20160801$20221025$20180307$20221028$EXP$$US-ROCHE-2081802$ROCHE$$33$YR$$F$Y$$$20221028$$CN$US$
1460756433$14607564$33$F$20190717$20221028$20180307$20221102$EXP$$PHHY2018CA036209$NOVARTIS$$43$YR$$F$Y$$$20221102$$CN$CA$CA
1460974941$14609749$41$F$$20221012$20180307$20221021$EXP$$GB-TAKEDA-2018TUS005225$TAKEDA$$53$YR$$M$Y$$$20221021$$HP$CA$CA
146101199$14610119$9$F$20180226$20221202$20180307$20221207$PER$$US-PFIZER INC-2018092189$PFIZER$$78$YR$$F$Y$59$KG$20221207$$CN$US$US
146115083$14611508$3$F$20171102$20220930$20180308$20221014$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-165466$RANBAXY$$$$$F$Y$$$20221014$$MD$SE$SE
146116924$14611692$4$F$$20221121$20180308$20221124$EXP$$US-PFIZER INC-2018091693$PFIZER$$63$YR$$F$Y$$$20221124$$CN$US$US
146121765$14612176$5$F$$20221104$20180308$20221111$EXP$$PHHY2018SE035062$NOVARTIS$Chandler RE. Serious neurological adverse events after Ivermectin-do they occur beyond the Indication of onchocerciasis?. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. 2018;98(2):328-82$56$YR$$F$Y$55$KG$20221111$$HP$SE$SE
146122996$14612299$6$F$20171129$20221215$20180308$20221227$EXP$GB-MHRA-INP12070F88-28C6-46F5-BD7B-FB62F61761C4$GB-drreddys-GER/UKI/18/0096623$DR REDDYS$$30$YR$A$M$Y$81$KG$20221227$$MD$GB$GB
1461288818$14612888$18$F$$20220324$20180308$20221128$EXP$$GB-JNJFOC-20180116422$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20221128$$CN$GB$GB
1461359641$14613596$41$F$20180101$20221214$20180308$20221222$EXP$$CA-CELLTRION INC.-2018CA018359$CELLTRION$$$$$$Y$$$20221222$$MD$CA$CA
146144674$14614467$4$F$$20210406$20180308$20221012$PER$$US-CELLTRION INC.-2017US010070$CELLTRION$$$$$$Y$$$20221012$$MD$US$US
146148373$14614837$3$F$20141008$20221021$20180308$20221026$EXP$IT-MINISAL02-422135$IT-PFIZER INC-2018093976$PFIZER$$15$YR$$M$Y$78$KG$20221026$$HP$IT$IT
146148627$14614862$7$F$$20220930$20180308$20221003$EXP$$US-PFIZER INC-2018094940$PFIZER$$65$YR$$F$Y$$$20221003$$LW$US$US
146163365$14616336$5$F$$20221208$20180309$20221212$PER$$US-PFIZER INC-2018095559$PFIZER$$69$YR$$M$Y$$$20221212$$CN$US$US
146163429$14616342$9$F$$20221109$20180309$20221111$PER$$US-PFIZER INC-2018096140$PFIZER$$82$YR$$F$Y$$$20221111$$MD$US$US
1461698013$14616980$13$F$$20221118$20180309$20221202$EXP$$GB-AUROBINDO-AUR-APL-2017-48251$AUROBINDO$$22$YR$$F$Y$56$KG$20221202$$MD$GB$GB
1461764426$14617644$26$F$20171215$20220926$20180309$20221003$EXP$$CA-ROCHE-2086120$ROCHE$$44$YR$$F$Y$$$20221003$$CN$CA$
146189996$14618999$6$F$20170929$20221213$20180309$20221221$EXP$$PHJP2018JP005168$NOVARTIS$$70$YR$$M$Y$60$KG$20221221$$MD$JP$JP
146215563$14621556$3$F$20161222$20221111$20180310$20221122$EXP$$IT-AUROBINDO-AUR-APL-2018-012747$AUROBINDO$$46$YR$$F$Y$$$20221122$$MD$IT$IT
146277585$14627758$5$F$20180201$20221103$20180312$20221111$EXP$$CA-PFIZER INC-2018099712$PFIZER$$73$YR$$F$Y$$$20221111$$CN$CA$CA
146296766$14629676$6$F$$20221207$20180313$20221213$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038174$BRISTOL MYERS SQUIBB$$47$YR$A$F$Y$73$KG$20221213$$HP$CA$CA
1462981013$14629810$13$F$20180228$20221024$20180313$20221026$EXP$$DE-ROCHE-2087412$ROCHE$$43$YR$$F$Y$$$20221026$$CN$DE$
1463001910$14630019$10$F$20221001$20221209$20180313$20221216$EXP$$US-PFIZER INC-2018098171$PFIZER$$61$YR$$M$Y$$$20221216$$MD$US$US
146311404$14631140$4$F$20170914$20221121$20180313$20221128$EXP$$JP-SA-2017SA206584$SANOFI AVENTIS$$60$YR$A$M$Y$64$KG$20221129$$MD$JP$JP
1463138124$14631381$24$F$20180109$20221026$20180313$20221102$EXP$$PHHY2017CA195903$NOVARTIS$$56$YR$$M$Y$$$20221102$$CN$CA$CA
146325786$14632578$6$F$20171101$20221020$20180313$20221021$EXP$$US-ROCHE-2043645$ROCHE$$65$YR$$F$Y$72.64$KG$20221022$$CN$US$
146335769$14633576$9$F$20171001$20221025$20180314$20221027$EXP$$CA-ROCHE-2023946$ROCHE$$34$YR$$M$Y$$$20221027$$MD$CA$
1463360122$14633601$22$F$20080101$20221129$20180314$20221205$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-038682$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20221205$$MD$CA$CA
146356073$14635607$3$F$20180120$20180403$20180314$20221220$EXP$DE-CADRBFARM-2018021367$DE-TEVA-2018-DE-870594$TEVA$$26$YR$A$F$Y$53$KG$20221220$$CN$DE$DE
146359335$14635933$5$F$19990101$20221227$20180314$20221230$PER$$US-PFIZER INC-2018102759$PFIZER$$46$YR$$F$Y$76.66$KG$20221230$$CN$US$US
146359845$14635984$5$F$20160614$20221221$20180314$20221228$EXP$$PHHY2016GB186243$NOVARTIS$$$$A$M$Y$$$20221228$$MD$GB$GB
146380578$14638057$8$F$$20221208$20180314$20221213$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-058741$BRISTOL MYERS SQUIBB$$40$YR$A$F$Y$$$20221213$$MD$CA$CA
1463807621$14638076$21$F$20170101$20221019$20180314$20221020$EXP$$PHHY2017CA080143$NOVARTIS$$$$$F$Y$$$20221020$$CN$CA$CA
146394054$14639405$4$F$20170124$20221018$20180315$20221021$PER$$US-AMGEN-USASP2018033839$AMGEN$$64$YR$A$F$Y$$$20221021$$HP$US$US
146409862$14640986$2$F$20210101$20221206$20180315$20221212$EXP$$US-PFIZER INC-2018103544$PFIZER$$67$YR$$F$Y$$$20221212$$CN$US$US
146413226$14641322$6$F$20190101$20221202$20180315$20221207$PER$$US-PFIZER INC-2018103114$PFIZER$$57$YR$$F$Y$73.197$KG$20221207$$CN$US$US
1464672938$14646729$38$F$20140216$20221213$20180316$20221216$EXP$$PHHY2014CA045336$NOVARTIS$$65$YR$$F$Y$$$20221216$$HP$CA$CA
1464825330$14648253$30$F$20171215$20221209$20180316$20221219$EXP$$CA-CELLTRION INC.-2018CA017412$CELLTRION$$$$$$Y$$$20221219$$MD$CA$CA
146483053$14648305$3$F$$20221130$20180316$20221202$EXP$$US-PFIZER INC-2018106683$PFIZER$$55$YR$$F$Y$74.83$KG$20221202$$CN$US$US
146484054$14648405$4$F$$20221026$20180316$20221027$EXP$$US-GILEAD-2018-0314410$GILEAD$$63$YR$A$M$Y$$$20221027$$CN$US$US
146487192$14648719$2$F$20170123$20221111$20180316$20221123$EXP$$IT-AUROBINDO-AUR-APL-2018-014649$AUROBINDO$$85$YR$$F$Y$$$20221123$$MD$IT$IT
146496757$14649675$7$F$20160804$20221012$20180316$20221026$EXP$$IT-PFIZER INC-2018103724$PFIZER$$13$YR$$M$Y$44$KG$20221026$$MD$IT$IT
146496867$14649686$7$F$20180214$20221128$20180316$20221201$EXP$$NZ-ROCHE-2083327$ROCHE$$73$YR$$M$Y$82$KG$20221201$$MD$NZ$
146505385$14650538$5$F$20170819$20210122$20180316$20221012$PER$$US-CELLTRION INC.-2017US010782$CELLTRION$$$$$$Y$$$20221012$$MD$US$US
146514844$14651484$4$F$20170124$20221125$20180317$20221201$EXP$$CA-ROCHE-2089314$ROCHE$$64$YR$$F$Y$$$20221201$$CN$CA$CA
146517812$14651781$2$F$20170620$20221114$20180317$20221128$EXP$$IT-AUROBINDO-AUR-APL-2018-014656$AUROBINDO$$76$YR$$F$Y$$$20221128$$MD$IT$IT
1465261410$14652614$10$F$$20220922$20180319$20221003$EXP$$CA-APOTEX-2018AP007741$APOTEX$$44$YR$$M$Y$$$20221003$$HP$CA$CA
146537362$14653736$2$F$20180313$20221114$20180319$20221116$PER$$US-PFIZER INC-2018108329$PFIZER$$61$YR$$F$Y$$$20221116$$HP$US$US
146545333$14654533$3$F$$20201230$20180319$20221012$PER$$US-CELLTRION INC.-2017US012219$CELLTRION$$$$$$Y$$$20221012$$MD$US$US
146545375$14654537$5$F$$20220525$20180319$20221012$PER$$US-CELLTRION INC.-2017US010793$CELLTRION$$$$$$Y$$$20221012$$MD$US$US
146546195$14654619$5$F$$20220218$20180319$20221012$PER$$US-CELLTRION INC.-2017US012468$CELLTRION$$$$$$Y$$$20221012$$MD$US$US
146547044$14654704$4$F$20220128$20220926$20180319$20221012$PER$$US-CELLTRION INC.-2017US014638$CELLTRION$$$$$$Y$$$20221012$$MD$US$US
146547175$14654717$5$F$$20210713$20180319$20221012$PER$$US-CELLTRION INC.-2017US015495$CELLTRION$$$$$$Y$$$20221012$$MD$US$US
146551584$14655158$4$F$$20221020$20180319$20221027$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2018-BI-014441$BOEHRINGER INGELHEIM$$52$YR$A$F$Y$$$20221027$$HP$CA$CA
1465553624$14655536$24$F$20180214$20221124$20180319$20221129$EXP$$ES-SA-2018SA074269$SANOFI AVENTIS$$55$YR$A$F$Y$90$KG$20221129$$MD$ES$ES
1465589911$14655899$11$F$20180309$20221019$20180319$20221021$EXP$$CA-TAKEDA-2018TUS006269$TAKEDA$$58$YR$$F$Y$$$20221021$$CN$CA$CA
146559149$14655914$9$F$$20220927$20180319$20221007$EXP$$CA-GLENMARK PHARMACEUTICALS-2018GMK033302$GLENMARK$$$$$$Y$$$20221007$$MD$CA$CA
146564446$14656444$6$F$$20221116$20180319$20221118$PER$$US-PFIZER INC-2018110171$PFIZER$$60$YR$$F$Y$$$20221118$$MD$US$US
1465657118$14656571$18$F$20171101$20221026$20180319$20221102$EXP$$CA-PFIZER INC-2017485911$PFIZER$$40$YR$$F$Y$$$20221102$$CN$CA$CA
146577282$14657728$2$F$20171005$20180312$20180320$20221012$EXP$$IE-UCBSA-2018002057$UCB$$18$YR$$M$Y$82$KG$20221012$$CN$IE$IE
1465787612$14657876$12$F$$20221103$20180320$20221110$PER$$US-BIOGEN-2017BI00450377$BIOGEN$$$$$M$Y$$$20221110$$CN$US$US
146583623$14658362$3$F$20110707$20220926$20180320$20221004$EXP$$US-AstraZeneca-2018SE33170$ASTRAZENECA$$20924$DY$$F$Y$101.6$KG$20221004$$LW$US$
146584445$14658444$5$F$20170101$20221026$20180320$20221101$EXP$$US-PFIZER INC-2017417872$PFIZER$$59$YR$$F$Y$$$20221101$$HP$US$US
1465877230$14658772$30$F$20180206$20221115$20180320$20221122$EXP$$DE-ROCHE-2071555$ROCHE$$48$YR$$F$Y$$$20221122$$CN$DE$DE
146595773$14659577$3$F$$20220117$20180320$20221012$PER$$US-CELLTRION INC.-2017US017303$CELLTRION$$$$$$Y$$$20221012$$MD$US$US
146595896$14659589$6$F$20170101$20220527$20180320$20221012$PER$$US-CELLTRION INC.-2017US015903$CELLTRION$$$$$$Y$$$20221012$$MD$US$US
146595955$14659595$5$F$$20221031$20180320$20221102$PER$$US-PFIZER INC-2018110140$PFIZER$$61$YR$$F$Y$$$20221102$$HP$US$US
1465980053$14659800$53$F$20180213$20221108$20180320$20221110$EXP$$US-SA-2018SA074660$SANOFI AVENTIS$$34$YR$A$F$Y$77.1$KG$20221110$$HP$US$US
146598098$14659809$8$F$20170805$20221130$20180320$20221208$EXP$$IT-AstraZeneca-2018SE31874$ASTRAZENECA$$51$YR$$F$Y$$$20221208$$MD$IT$
146603096$14660309$6$F$20100101$20221101$20180320$20221104$EXP$$US-PFIZER INC-2018115504$PFIZER$$62$YR$$F$Y$$$20221104$$LW$US$US
146617433$14661743$3$F$$20221027$20180320$20221104$EXP$$CA-ALLERGAN-1814960US$ALLERGAN$Dong V, Dieleman LA. Medication Induced Interstitial Lung Disease In A Patient With Ulcerative Colitis. Journal of the Canadian Association of Gastroenterology. 2018;1(Supplement 1):260-1$$$$M$Y$$$20221104$$MD$CA$CA
146638993$14663899$3$F$$20201207$20180321$20221012$PER$$US-CELLTRION INC.-2018US017294$CELLTRION$$$$$$Y$$$20221012$$MD$US$US
1466414729$14664147$29$F$20160826$20221117$20180321$20221124$EXP$$PHHY2014CA043342$NOVARTIS$$81$YR$$M$Y$$$20221124$$HP$CA$CA
1466415317$14664153$17$F$20170118$20221205$20180321$20221213$EXP$$GB-ALLERGAN-1814947US$ALLERGAN$$$$$F$Y$60.1$KG$20221213$$MD$GB$GB
146646512$14664651$2$F$20180311$20221115$20180321$20221122$PER$$US-TAKEDA-2018TUS006371$TAKEDA$$51$YR$$F$Y$57.596$KG$20221122$$MD$US$US
146654735$14665473$5$F$20110101$20221017$20180321$20221025$EXP$$US-AstraZeneca-2018SE33806$ASTRAZENECA$$44$YR$$M$Y$95.3$KG$20221025$$LW$US$
146654763$14665476$3$F$20080609$20221212$20180321$20221214$EXP$$US-AstraZeneca-2018SE33057$ASTRAZENECA$$19154$DY$$F$Y$$$20221214$$LW$US$
146658302$14665830$2$F$20171110$20221202$20180321$20221215$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-107439$BRISTOL MYERS SQUIBB$$75$YR$E$M$Y$56.599$KG$20221215$$HP$JP$JP
1466702544$14667025$44$F$20180207$20221221$20180322$20221228$EXP$GB-MHRA-EYC 00174086$GB-CIPLA LTD.-2018GB11986$CIPLA$$86$YR$$F$Y$$$20221228$$MD$GB$GB
1466743018$14667430$18$F$20180215$20221206$20180322$20221212$EXP$$DE-ROCHE-2079206$ROCHE$$44$YR$$F$Y$60$KG$20221212$$CN$DE$
146677683$14667768$3$F$20180320$20221109$20180322$20221111$PER$$US-PFIZER INC-2018118570$PFIZER$$65$YR$$F$Y$$$20221111$$HP$US$US
146692157$14669215$7$F$20180101$20221212$20180322$20221218$EXP$$BR-JNJFOC-20180322106$JOHNSON AND JOHNSON$$7$DEC$E$F$Y$62$KG$20221218$$CN$BR$BR
146693054$14669305$4$F$20160111$20220930$20180322$20221003$EXP$$US-PFIZER INC-2018119380$PFIZER$$65$YR$$F$Y$57$KG$20221003$$CN$US$US
146700207$14670020$7$F$20180313$20221209$20180322$20221214$EXP$$US-PFIZER INC-2018118195$PFIZER$$66$YR$$F$Y$69$KG$20221214$$CN$US$US
146708268$14670826$8$F$$20221129$20180322$20221202$PER$$US-PFIZER INC-2018000286$PFIZER$$73$YR$$F$Y$61$KG$20221202$$CN$US$US
146714733$14671473$3$F$20100101$20221020$20180323$20221021$EXP$$US-TAKEDA-2018TUS007090$TAKEDA$$$$$$Y$$$20221021$$CN$US$US
146718593$14671859$3$F$$20221111$20180323$20221114$PER$$US-BIOGEN-2015BI007341$BIOGEN$$$$$F$Y$$$20221114$$CN$US$US
146720594$14672059$4$F$20151201$20220928$20180323$20221001$EXP$$US-TAKEDA-2018TUS007221$TAKEDA$$$$$$Y$$$20221001$$CN$US$US
146721233$14672123$3$F$20140101$20221017$20180323$20221026$EXP$$US-AstraZeneca-2018SE34926$ASTRAZENECA$$58$YR$$F$Y$97.5$KG$20221026$$LW$US$
146721534$14672153$4$F$20121220$20220926$20180323$20221004$EXP$$US-AstraZeneca-2018SE34851$ASTRAZENECA$$21090$DY$$M$Y$72.6$KG$20221004$$LW$US$
146724927$14672492$7$F$$20221117$20180323$20221122$EXP$$US-PFIZER INC-2017469736$PFIZER$$72$YR$$M$Y$$$20221122$$CN$US$US
146726184$14672618$4$F$$20221004$20180323$20221006$PER$$US-PFIZER INC-2018120075$PFIZER$$93$YR$$F$Y$$$20221006$$MD$US$US
1467338534$14673385$34$F$20180207$20221208$20180323$20221222$EXP$$GB-AUROBINDO-AUR-APL-2018-015492$AUROBINDO$$86$YR$$F$Y$$$20221222$$MD$GB$GB
1467551846$14675518$46$F$20180101$20221103$20180323$20221110$EXP$$CA-CELLTRION INC.-2018CA018113$CELLTRION$$$$$$Y$$$20221111$$CN$CA$CA
146769662$14676966$2$F$$20221003$20180324$20221013$PER$$US-JNJFOC-20180316125$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$LW$US$US
1467877011$14678770$11$F$$20221221$20180326$20221231$EXP$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-002909$GB-Accord-064906$ACCORD$$53$YR$A$F$Y$$$20221231$$CN$GB$GB
146788193$14678819$3$F$20140101$20221018$20180326$20221020$EXP$$US-TAKEDA-2018TUS007420$TAKEDA$$$$$$Y$$$20221020$$CN$US$US
146790255$14679025$5$F$20180213$20221220$20180326$20221227$EXP$$PHHY2018IN047426$NOVARTIS$$44$YR$$M$Y$$$20221227$$CN$IN$IN
146792662$14679266$2$F$$20221207$20180326$20221209$PER$$US-PFIZER INC-2018122075$PFIZER$$48$YR$$M$Y$149$KG$20221209$$CN$US$US
146799433$14679943$3$F$20150401$20221010$20180326$20221012$EXP$$US-TAKEDA-2018TUS007394$TAKEDA$$$$$$Y$$$20221012$$CN$US$US
1468024220$14680242$20$F$20171019$20221202$20180326$20221212$EXP$$CA-CELLTRION INC.-2017CA014822$CELLTRION$$$$$$Y$$$20221212$$CN$CA$CA
146808194$14680819$4$F$20090101$20221014$20180326$20221020$EXP$$US-TAKEDA-2018TUS007510$TAKEDA$$$$$$Y$$$20221020$$LW$US$US
1468085339$14680853$39$F$20170801$20221017$20180326$20221025$EXP$$CA-CELLTRION INC.-2017CA011649$CELLTRION$$$$$$Y$$$20221025$$CN$CA$CA
146817186$14681718$6$F$20150401$20221017$20180326$20221020$EXP$$US-PFIZER INC-2018119488$PFIZER$$58$YR$$F$Y$$$20221020$$LW$US$US
1468211619$14682116$19$F$20180311$20221008$20180326$20221014$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-026633$BRISTOL MYERS SQUIBB$$48$YR$A$F$Y$61.4$KG$20221014$$MD$US$US
1468348311$14683483$11$F$20190201$20221110$20180327$20221114$EXP$$US-PFIZER INC-2018125954$PFIZER$$79$YR$$F$Y$79$KG$20221114$$HP$US$US
146834849$14683484$9$F$20171001$20221202$20180327$20221207$PER$$US-PFIZER INC-2018126678$PFIZER$$74$YR$$F$Y$52$KG$20221207$$CN$US$US
146837388$14683738$8$F$20171220$20221129$20180327$20221206$EXP$$PHHY2017CA194354$NOVARTIS$$80$YR$$M$Y$80.9$KG$20221206$$MD$CA$CA
146837567$14683756$7$F$20180514$20221201$20180327$20221208$EXP$$US-AstraZeneca-2018SE34908$ASTRAZENECA$$21622$DY$$M$Y$70.3$KG$20221208$$LW$US$
146844382$14684438$2$F$20171201$20221129$20180327$20221201$EXP$$TW-ROCHE-2096205$ROCHE$$71$YR$$F$Y$$$20221201$$HP$TW$
146851023$14685102$3$F$20140101$20221024$20180327$20221026$EXP$$US-PFIZER INC-2018125360$PFIZER$$58$YR$$F$Y$$$20221026$$CN$US$US
1468565517$14685655$17$F$20180201$20221226$20180327$20221227$EXP$$CA-PFIZER INC-2018115963$PFIZER$$63$YR$$F$Y$$$20221227$$HP$CA$CA
146860959$14686095$9$F$20180201$20221121$20180327$20221122$EXP$$US-PFIZER INC-2018122149$PFIZER$$73$YR$$M$Y$68$KG$20221122$$CN$US$US
146863606$14686360$6$F$20180323$20221110$20180327$20221116$EXP$$US-SHIRE-US201811764$TAKEDA$$58$YR$$F$Y$$$20221116$$MD$US$US
146887584$14688758$4$F$20120501$20221005$20180328$20221006$PER$$US-PFIZER INC-2016584473$PFIZER$$66$YR$$F$Y$$$20221006$$LW$US$US
146888024$14688802$4$F$20160101$20221121$20180328$20221128$EXP$$PHHY2017MX130132$NOVARTIS$$$$$F$Y$57$KG$20221128$$CN$MX$MX
146890348$14689034$8$F$20120524$20221021$20180328$20221102$EXP$$DE-AUROBINDO-AUR-APL-2018-016889$AUROBINDO$$31$YR$$M$Y$76$KG$20221102$$MD$DE$DE
146903616$14690361$6$F$$20221212$20180328$20221214$EXP$$PHHY2018NL045905$NOVARTIS$Witjes B, Zandvliet, Dijkstra, Kors A, Abbink F, Smetsers S et al.. Voriconazole dosing strategies in young children: Challenges and recommendations. ARCHIVES OF DISEASE IN CHILDHOOD. 2017;102 (10)$13$MON$$M$Y$$$20221214$$HP$NL$NL
146904222$14690422$2$F$20170519$20221108$20180328$20221116$EXP$SE-MPA-2017-004231$SE-MYLANLABS-2018M1018160$MYLAN$$70$YR$$F$Y$$$20221116$$MD$SE$SE
146914435$14691443$5$F$20120901$20221110$20180328$20221116$EXP$$US-AstraZeneca-2018SE36309$ASTRAZENECA$$803$MON$$F$Y$123.8$KG$20221116$$LW$US$
146938756$14693875$6$F$20120824$20221004$20180329$20221010$EXP$$US-GLAXOSMITHKLINE-US2018GSK053222$PERRIGO$$60$YR$$M$Y$126.5$KG$20221010$$LW$US$US
146940007$14694000$7$F$$20221206$20180329$20221212$EXP$$US-PFIZER INC-2017467525$PFIZER$$56$YR$$F$Y$$$20221212$$CN$US$US
1469461332$14694613$32$F$20180502$20221031$20180329$20221108$EXP$$CA-CELLTRION INC.-2018CA018914$CELLTRION$$$$$$Y$$$20221108$$CN$CA$CA
146958313$14695831$3$F$$20221219$20180329$20221222$EXP$$US-JAZZ-2018-US-004885$JAZZ$$$$$M$Y$$$20221222$$CN$US$US
146959128$14695912$8$F$20160101$20221026$20180329$20221101$EXP$$CA-TAKEDA-2016TUS018823$TAKEDA$$41$YR$$M$Y$$$20221101$$CN$CA$CA
1469894933$14698949$33$F$20180226$20221228$20180330$20221230$EXP$$DE-ROCHE-2096691$ROCHE$$50$YR$$M$Y$70.9$KG$20221230$$CN$DE$
146993985$14699398$5$F$20160119$20180727$20180330$20221026$EXP$$JP-TEVA-698911ISR$TEVA$$36$YR$A$F$Y$72$KG$20221026$$HP$JP$JP
147002354$14700235$4$F$$20180405$20180330$20221208$EXP$$NL-TEVA-2018-NL-874522$TEVA$$13$MON$I$M$Y$$$20221208$$HP$NL$NL
147039046$14703904$6$F$20170801$20221011$20180402$20221027$PER$$US-PFIZER INC-2018132425$MYLAN$$43$YR$$F$Y$91$KG$20221027$$CN$US$US
147045617$14704561$7$F$$20221031$20180402$20221103$PER$$US-PFIZER INC-2018130721$PFIZER$$74$YR$$F$Y$$$20221103$$CN$US$US
147046203$14704620$3$F$20170706$20180405$20180402$20221020$PER$$NZ-AMGEN-NZLCT2018041493$AMGEN$$24$YR$A$F$Y$$$20221020$$MD$NZ$NZ
147056505$14705650$5$F$20100101$20221006$20180402$20221011$EXP$$US-AstraZeneca-2018SE39740$ASTRAZENECA$$54$YR$$M$Y$117.9$KG$20221011$$LW$US$
147063373$14706337$3$F$20171010$20221214$20180402$20221219$EXP$FR-AFSSAPS-NY20172034$FR-MYLANLABS-2018M1019287$MYLAN$$87$YR$$M$Y$86.3$KG$20221219$$MD$FR$FR
147070552$14707055$2$F$20180101$20221226$20180403$20221228$EXP$FR-AFSSAPS-AN20180318$FR-ABBVIE-18K-056-2306416-00$ABBVIE$$47$YR$$F$Y$57$KG$20221228$$MD$FR$FR
1470742620$14707426$20$F$20180315$20221207$20180403$20221215$EXP$$DE-ROCHE-2098104$ROCHE$$36$YR$$F$Y$$$20221214$$CN$DE$DE
1470787236$14707872$36$F$20190507$20221219$20180403$20221228$EXP$$US-PFIZER INC-2017231089$PFIZER$$63$YR$$F$Y$$$20221228$$CN$US$US
147080046$14708004$6$F$$20221118$20180403$20221123$PER$$US-PFIZER INC-2018132354$PFIZER$$72$YR$$F$Y$$$20221123$$MD$US$US
1470818614$14708186$14$F$20150101$20221031$20180403$20221109$EXP$$PHHY2010CA31063$NOVARTIS$$$$$M$Y$$$20221109$$HP$CA$CA
147084896$14708489$6$F$$20221003$20180403$20221101$EXP$$US-AstraZeneca-2018SE38937$ASTRAZENECA$$$$$M$Y$126.6$KG$20221101$$LW$US$
147089115$14708911$5$F$20171101$20221114$20180403$20221121$EXP$$CA-PFIZER INC-2017524306$PFIZER$$69$YR$$M$Y$76$KG$20221121$$CN$CA$CA
147093236$14709323$6$F$20161130$20221102$20180403$20221110$EXP$$US-AstraZeneca-2018SE39001$ASTRAZENECA$$69$YR$$F$Y$88.9$KG$20221110$$LW$US$
147112587$14711258$7$F$20160101$20221212$20180403$20221219$EXP$$US-PFIZER INC-2018133558$PFIZER$$67$YR$$F$Y$$$20221219$$LW$US$US
147113659$14711365$9$F$20120824$20221011$20180403$20221014$EXP$$US-PFIZER INC-2018133339$PFIZER$$60$YR$$M$Y$$$20221014$$LW$US$US
147130267$14713026$7$F$20161001$20221213$20180404$20221219$EXP$$US-PFIZER INC-2016472583$PFIZER$$79$YR$$M$Y$102$KG$20221219$$CN$US$US
147146003$14714600$3$F$$20221219$20180404$20221229$PER$$US-PFIZER INC-2018135475$PFIZER$$71$YR$$F$Y$65.32$KG$20221229$$CN$US$US
147153172$14715317$2$F$20171119$20221128$20180404$20221208$EXP$FI-FIMEA-20180202$FI-TEVA-2018-FI-876080$TEVA$$71$YR$E$M$Y$$$20221208$$MD$FI$FI
147168512$14716851$2$F$20171001$20221020$20180404$20221022$EXP$$US-SHIRE-US201812210$TAKEDA$$68$YR$$M$Y$$$20221022$$CN$US$US
1471939927$14719399$27$F$20180310$20221123$20180405$20221201$EXP$$DE-ROCHE-2090784$ROCHE$$31$YR$$F$Y$$$20221201$$CN$DE$DE
1471942226$14719422$26$F$20180315$20221223$20180405$20221228$EXP$$DE-ROCHE-2102569$ROCHE$$43$YR$$F$Y$$$20221228$$CN$DE$
147195674$14719567$4$F$$20221110$20180405$20221114$PER$$US-PFIZER INC-2018137781$PFIZER$$75$YR$$F$Y$$$20221114$$HP$US$US
147206243$14720624$3$F$20100101$20221007$20180405$20221011$EXP$$US-TAKEDA-2018TUS008481$TAKEDA$$$$$$Y$$$20221011$$CN$US$US
147236092$14723609$2$F$20151110$20221129$20180405$20221206$EXP$DE-002147023-PHHY2016DE115328$DE-MYLANLABS-2018M1020362$MYLAN$$34$MON$$M$Y$12.2$KG$20221206$$MD$DE$DE
147258334$14725833$4$F$20150701$20221121$20180406$20221125$EXP$$US-TAKEDA-2018TUS008474$TAKEDA$$$$$$Y$$$20221125$$CN$US$US
147258584$14725858$4$F$20150101$20221031$20180406$20221103$EXP$$US-TAKEDA-2018TUS008701$TAKEDA$$$$$$Y$$$20221103$$LW$US$US
147267578$14726757$8$F$20180224$20221010$20180406$20221013$EXP$$PHHY2018DE058976$NOVARTIS$$51$YR$$F$Y$99$KG$20221013$$MD$DE$DE
147301539$14730153$9$F$20100302$20221212$20180406$20221219$EXP$$US-PFIZER INC-2018141165$PFIZER$$47$YR$$M$Y$120$KG$20221219$$LW$US$US
147327977$14732797$7$F$$20221219$20180409$20221227$PER$$US-PFIZER INC-2018140873$PFIZER$$47$YR$$F$Y$$$20221227$$CN$US$US
1473499943$14734999$43$F$20170101$20221206$20180409$20221215$EXP$$CA-CELLTRION INC.-2017CA015610$CELLTRION$$$$$$Y$$$20221215$$MD$CA$CA
147353285$14735328$5$F$20170927$20221107$20180409$20221114$EXP$$JP-BIOGEN-2018BI00551915$BIOGEN$$41$YR$$M$Y$66.3$KG$20221114$$MD$JP$JP
147356519$14735651$9$F$20100101$20221024$20180409$20221026$EXP$$US-PFIZER INC-2018143264$PFIZER$$63$YR$$F$Y$$$20221026$$LW$US$US
147382312$14738231$2$F$20171201$20221006$20180409$20221014$EXP$$US-VERTEX PHARMACEUTICALS-2018-001400$VERTEX$$6$YR$$F$Y$20$KG$20221014$$MD$US$US
147386595$14738659$5$F$20100302$20221208$20180409$20221214$EXP$$US-TAKEDA-2018TUS008946$TAKEDA$$$$$$Y$$$20221214$$CN$US$US
147398037$14739803$7$F$20180227$20221011$20180410$20221014$EXP$$US-PFIZER INC-2018141014$PFIZER$$76$YR$$M$Y$79$KG$20221014$$CN$US$US
147399226$14739922$6$F$$20221213$20180410$20221215$PER$$US-PFIZER INC-2018145712$PFIZER$$72$YR$$F$Y$$$20221215$$CN$US$US
147403192$14740319$2$F$20180328$20221116$20180410$20221117$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-029927$BRISTOL MYERS SQUIBB$$46$YR$A$F$Y$44.9$KG$20221117$$HP$US$US
147403799$14740379$9$F$20180101$20221213$20180410$20221220$EXP$$US-JAZZ-2018-US-004137$JAZZ$$$$$F$Y$67$KG$20221220$$MD$US$US
147404217$14740421$7$F$20180207$20220923$20180410$20221003$EXP$GB-EMA-DD-20180307-PAGRAHARIP-153318$GB-MICRO LABS LIMITED-BB2018-00489$MICRO LABS$$86$YR$E$F$Y$$$20221003$$HP$GB$GB
147416013$14741601$3$F$20180101$20221025$20180410$20221031$EXP$$US-PFIZER INC-2018142318$PFIZER$$63$YR$$F$Y$65.77$KG$20221031$$HP$US$US
147422425$14742242$5$F$20180328$20221018$20180410$20221025$EXP$$PHHY2018CA057860$NOVARTIS$$61$YR$$F$Y$$$20221025$$CN$CA$CA
147426399$14742639$9$F$$20221128$20180410$20221201$PER$$US-BIOGEN-2017BI00486736$BIOGEN$$$$$M$Y$$$20221201$$CN$US$US
147449343$14744934$3$F$$20221222$20180411$20221227$PER$$US-PFIZER INC-2018144085$PFIZER$$64$YR$$F$Y$$$20221227$$MD$US$US
147451385$14745138$5$F$20170705$20221006$20180411$20221014$EXP$$US-ROCHE-1985433$ROCHE$$72$YR$$F$Y$53.6$KG$20221014$$MD$US$
147460163$14746016$3$F$20180101$20221013$20180411$20221019$EXP$$US-ROCHE-2102985$ROCHE$$$$$F$Y$81.72$KG$20221019$$MD$US$
1474607210$14746072$10$F$$20221025$20180411$20221102$EXP$$CA-APOTEX-2018AP009435$APOTEX$$67$YR$$F$Y$$$20221102$$MD$CA$CA
147461889$14746188$9$F$20170923$20221012$20180411$20221014$EXP$$CA-PFIZER INC-2017214689$PFIZER$$67$YR$$M$Y$51$KG$20221014$$CN$CA$CA
147468314$14746831$4$F$$20221125$20180411$20221128$EXP$$CA-ROCHE-2104630$ROCHE$$60$YR$$F$Y$$$20221128$$CN$CA$
147478293$14747829$3$F$20180402$20221114$20180411$20221116$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031242$BRISTOL MYERS SQUIBB$$52$YR$A$F$Y$$$20221116$$HP$US$US
1475032111$14750321$11$F$20171011$20221125$20180412$20221202$EXP$$CA-ROCHE-2105460$ROCHE$$36$YR$$F$Y$$$20221202$$CN$CA$
147504985$14750498$5$F$20030101$20220927$20180412$20221003$EXP$$BR-BIOGEN-2018BI00553837$BIOGEN$$$$$F$Y$52$KG$20221003$$CN$BR$BR
147510469$14751046$9$F$20170814$20190913$20180412$20221026$EXP$$JP-TEVA-808807ROM$TEVA$$49$YR$A$F$Y$56$KG$20221026$$HP$JP$JP
147515017$14751501$7$F$20170301$20221212$20180412$20221216$EXP$$US-PFIZER INC-2018147654$PFIZER$$67$YR$$F$Y$$$20221216$$LW$US$US
147515806$14751580$6$F$20170101$20221207$20180412$20221220$EXP$$US-GLAXOSMITHKLINE-US2018GSK061921$PERRIGO$$$$$$Y$$$20221220$$CN$US$US
147517775$14751777$5$F$20180115$20221209$20180412$20221215$EXP$$US-JAZZ-2018-US-005826$JAZZ$$50$YR$$F$Y$$$20221215$$MD$US$US
147520544$14752054$4$F$$20221115$20180412$20221116$EXP$$US-PFIZER INC-2018148411$PFIZER$$75$YR$$F$Y$60$KG$20221116$$CN$US$US
1475224219$14752242$19$F$20171220$20220923$20180412$20221006$EXP$$CA-CELLTRION INC.-2017CA017658$CELLTRION$$$$$$Y$$$20221007$$CN$CA$CA
1475229533$14752295$33$F$20170801$20221024$20180412$20221102$EXP$$CA-CELLTRION INC.-2017CA011395$CELLTRION$$$$$$Y$$$20221102$$HP$CA$CA
1475330719$14753307$19$F$20180301$20221121$20180412$20221125$EXP$$PHHY2018CA051472$NOVARTIS$$40$YR$$M$Y$$$20221125$$MD$CA$CA
147539476$14753947$6$F$20170301$20221207$20180412$20221212$EXP$$US-TAKEDA-2018TUS009521$TAKEDA$$$$$$Y$$$20221212$$CN$US$US
147549552$14754955$2$F$20160101$20221028$20180413$20221101$PER$$US-BIOGEN-2018BI00553540$BIOGEN$$$$$F$Y$$$20221101$$CN$US$US
147558407$14755840$7$F$20200201$20221115$20180413$20221116$PER$$US-PFIZER INC-2018150352$PFIZER$$64$YR$$F$Y$48$KG$20221116$$CN$US$US
1475829428$14758294$28$F$20180403$20221216$20180413$20221226$EXP$$CA-CELLTRION INC.-2018CA018698$CELLTRION$$$$$$Y$$$20221226$$CN$CA$CA
1475829631$14758296$31$F$20180101$20221028$20180413$20221108$EXP$$CA-CELLTRION INC.-2018CA019155$CELLTRION$$$$$$Y$$$20221108$$MD$CA$CA
147590154$14759015$4$F$$20221228$20180413$20221230$EXP$$US-JAZZ-2018-US-005943$JAZZ$$$$$M$Y$$$20221230$$CN$US$US
1475947412$14759474$12$F$20180601$20221121$20180413$20221125$EXP$$PHHY2018CA062608$NOVARTIS$$51$YR$$M$Y$$$20221125$$CN$CA$CA
1475956825$14759568$25$F$20181001$20221125$20180413$20221202$EXP$$PHHY2018CA061569$NOVARTIS$$59$YR$$F$Y$$$20221202$$CN$CA$CA
147606027$14760602$7$F$20080101$20220926$20180414$20221004$EXP$$US-AstraZeneca-2018SE44497$ASTRAZENECA$$61$YR$$F$Y$65.8$KG$20221004$$LW$US$
147607443$14760744$3$F$20110101$20221205$20180414$20221210$EXP$$US-TAKEDA-2018TUS009924$TAKEDA$$$$$$Y$$$20221210$$CN$US$US
147627226$14762722$6$F$$20221029$20180416$20221102$EXP$$US-PFIZER INC-2018151193$PFIZER$$74$YR$$F$Y$54$KG$20221102$$CN$US$US
147627484$14762748$4$F$$20221116$20180416$20221121$PER$$US-PFIZER INC-2018153177$PFIZER$$67$YR$$F$Y$$$20221121$$CN$US$US
147634692$14763469$2$F$$20221003$20180416$20221005$PER$$US-PFIZER INC-2018153268$PFIZER$$62$YR$$F$Y$$$20221005$$MD$US$US
147638494$14763849$4$F$$20180604$20180416$20221128$EXP$$CH-ROCHE-2105374$ROCHE$$$$$M$Y$106$KG$20221128$$HP$CH$
1476556335$14765563$35$F$20180207$20221006$20180416$20221011$EXP$GB-MHRA-EYC 00174086$GB-MYLANLABS-2018M1023120$MYLAN$$86$YR$$F$Y$$$20221011$$HP$GB$GB
147656923$14765692$3$F$20161201$20221115$20180416$20221121$EXP$$PL-MYLANLABS-2018M1023163$MYLAN$Magdalena Blonska, Katarzyna Josko, Krystyna Koczynska-Nowacka.. Hypersensitivity to non-steroidal anti-inflammatory drugs in children.. Klinika Pediatryczna.. 25 (4):452-6$4$YR$$M$Y$$$20221121$$HP$PL$PL
147661554$14766155$4$F$20180410$20221202$20180416$20221212$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034514$BRISTOL MYERS SQUIBB$$78$YR$E$M$Y$41$KG$20221212$$HP$JP$JP
147663819$14766381$9$F$20150215$20221214$20180416$20221221$EXP$$US-INCYTE CORPORATION-2018IN003333$INCYTE$$$$$$Y$$$20221221$$CN$US$US
147668965$14766896$5$F$20180404$20221202$20180417$20221212$EXP$$CO-ROCHE-2107157$ROCHE$$43$YR$$F$Y$69$KG$20221212$$CN$CO$CO
147671418$14767141$8$F$20130101$20221025$20180417$20221027$EXP$BE-EMA-20170220-ISHAEVHP-102440898$BE-ROCHE-2108277$ROCHE$Heyrman B, De Becker A, Schots R. A case report of immunosuppressiohn-related Kaposi^s sarcoma after autologous stem cell transplantation. BMC Research Notes 2016;9:188:1-5.$61$YR$$M$Y$$$20221027$$MD$BE$BE
147679254$14767925$4$F$20110101$20221122$20180417$20221128$EXP$$US-AstraZeneca-2018SE45642$ASTRAZENECA$$81$YR$$M$Y$98.9$KG$20221128$$LW$US$
147687325$14768732$5$F$$20221031$20180417$20221114$EXP$$FR-Ascend Therapeutics-2045859$ASCEND$EMA Ref: 04P-056-0765047-00$29$YR$$F$Y$55$KG$20221114$$HP$FR$FR
1476874782$14768747$82$F$20120101$20221215$20180417$20221220$EXP$$CA-ROCHE-1173899$ROCHE$$$$$F$Y$96$KG$20221220$$CN$CA$
1476955526$14769555$26$F$20171103$20221215$20180417$20221223$EXP$$CA-CELLTRION INC.-2017CA016332$CELLTRION$$$$$$Y$$$20221223$$CN$CA$CA
147697632$14769763$2$F$$20221020$20180417$20221107$EXP$$US-GLAXOSMITHKLINE-US2018GSK065932$GLAXOSMITHKLINE$$$$$$Y$$$20221107$$LW$US$US
147698463$14769846$3$F$$20221012$20180417$20221014$PER$$US-PFIZER INC-2018156925$PFIZER$$67$YR$$F$Y$$$20221014$$CN$US$US
147755165$14775516$5$F$20090604$20221003$20180418$20221007$EXP$$US-AstraZeneca-2018SE46622$ASTRAZENECA$$22511$DY$$M$Y$115.7$KG$20221007$$LW$US$
147755814$14775581$4$F$$20221202$20180418$20221207$EXP$$GR-ROCHE-2106711$ROCHE$Kiapidou S, Sinakos E. Xytiroglou P, Koustiani G, Kaprinis A, Akriviadis E. Exposure to chemotherapeutic agents: an emerging cause of non-cirrhotic portal hypertension.. Annals of Gastroenterology 2017;30:28:-.$49$YR$$M$Y$$$20221207$$MD$GR$GR
147756865$14775686$5$F$20220708$20221012$20180418$20221017$EXP$$US-AstraZeneca-2018SE46465$ASTRAZENECA$$30456$DY$$M$Y$72.6$KG$20221017$$LW$US$
1477692027$14776920$27$F$20140101$20221212$20180419$20221214$EXP$$CA-ROCHE-1412884$ROCHE$$$$$F$Y$$$20221214$$HP$CA$
147788633$14778863$3$F$20150701$20221013$20180419$20221017$EXP$$US-TAKEDA-2018TUS010079$TAKEDA$$$$$$Y$$$20221017$$CN$US$US
147792493$14779249$3$F$$20221013$20180419$20221025$30DAY$$US-APOTEX-2018AP010877$APOTEX$Kaplan FS, Andolina JR, Adamson PC, Teachey DT, Finklestein JZ, Ebb DH, Whitehead B, Jacobs B, Siegel DM, Keen R, Hsiao E, Pignolo RJ. Early clinical observations on the use of imatinib mesylate in FOP: A report of seven cases.. Bone. 2018;109:276-280$2$YR$$F$Y$$$20221025$$HP$US$US
1477976725$14779767$25$F$20180701$20221228$20180419$20221229$EXP$$US-PFIZER INC-2018159616$PFIZER$$60$YR$$M$Y$76.19$KG$20221229$$HP$US$US
147815129$14781512$9$F$20170126$20221118$20180419$20221125$EXP$$CA-ROCHE-2107638$ROCHE$$34$YR$$F$Y$105$KG$20221125$$MD$CA$CA
147821649$14782164$9$F$20180405$20221209$20180420$20221216$EXP$$JP-ABBVIE-18P-087-2329407-00$ABBVIE$$57$YR$$M$Y$$$20221214$$MD$JP$JP
1478259315$14782593$15$F$20180401$20221110$20180420$20221117$EXP$$CA-ROCHE-2105464$ROCHE$$37$YR$$F$Y$$$20221117$$MD$CA$
147832673$14783267$3$F$20180326$20221115$20180420$20221129$EXP$$IT-AUROBINDO-AUR-APL-2018-020496$AUROBINDO$$37$YR$$F$Y$$$20221129$$MD$IT$IT
1478395117$14783951$17$F$20180101$20221027$20180420$20221031$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK146398$GLAXOSMITHKLINE$$$$$$Y$$$20221031$$MD$BR$BR
147845448$14784544$8$F$20160101$20220930$20180420$20221004$EXP$$US-PFIZER INC-2018163175$PFIZER$$70$YR$$F$Y$64$KG$20221004$$LW$US$US
147852625$14785262$5$F$20100202$20221205$20180421$20221213$EXP$$US-AstraZeneca-2018SE48196$ASTRAZENECA$$24781$DY$$M$Y$91.2$KG$20221213$$LW$US$
147857694$14785769$4$F$20140101$20220930$20180420$20221004$PER$$US-PFIZER INC-2016584490$PFIZER$$58$YR$$F$Y$$$20221004$$LW$US$US
1478676715$14786767$15$F$20180101$20221024$20180420$20221028$EXP$$US-Vifor (International) Inc.-VIT-2018-03607$VIFOR$$71$YR$$M$Y$$$20221028$$HP$US$US
1478740313$14787403$13$F$20180222$20221121$20180421$20221124$EXP$$CA-TAKEDA-2018TUS010395$TAKEDA$$64$YR$$F$Y$$$20221124$$MD$CA$CA
147874974$14787497$4$F$20150501$20221123$20180421$20221208$EXP$$PL-AUROBINDO-AUR-APL-2018-020879$AUROBINDO$Krzysztofiak T, Majewski W.. The influence of hyperbaric pressure on the recurring pain from trigeminal nuralgia after stereotactic radiotherapy.. Pain. 2017;18(2):41-43$39$YR$$$Y$$$20221208$$HP$PL$PL
1478915814$14789158$14$F$20140101$20221215$20180423$20221221$EXP$$PHHY2014CA158244$NOVARTIS$$$$$M$Y$$$20221221$$HP$CA$CA
147892233$14789223$3$F$$20221014$20180423$20221017$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034911$BRISTOL MYERS SQUIBB$$71$YR$E$M$Y$90$KG$20221017$$MD$DE$DE
147898695$14789869$5$F$$20221216$20180423$20221221$PER$$US-PFIZER INC-2018164942$PFIZER$$86$YR$$F$Y$$$20221221$$MD$US$US
1479403623$14794036$23$F$20180104$20221215$20180423$20221224$EXP$$CA-CELLTRION INC.-2018CA017365$CELLTRION$$$$$$Y$$$20221224$$CN$CA$CA
1479406819$14794068$19$F$20170201$20221212$20180423$20221220$EXP$$CA-CELLTRION INC.-2017CA001878$CELLTRION$$$$$$Y$$$20221220$$MD$CA$CA
147949128$14794912$8$F$20180109$20221115$20180423$20221121$EXP$$DE-SHIRE-DE201801410$TAKEDA$$67$YR$$F$Y$87$KG$20221121$$CN$DE$DE
147950716$14795071$6$F$20060101$20221221$20180423$20221229$EXP$$US-AstraZeneca-2018SE47825$ASTRAZENECA$$52$YR$$M$Y$138.1$KG$20221229$$LW$US$
147980414$14798041$4$F$20130213$20221102$20180424$20221104$EXP$$DE-ROCHE-2112597$ROCHE$$65$YR$$F$Y$80$KG$20221104$$MD$DE$DE
147984066$14798406$6$F$20180101$20221219$20180424$20221227$PER$$US-PFIZER INC-2018165959$PFIZER$$57$YR$$F$Y$68$KG$20221227$$CN$US$US
1480116318$14801163$18$F$20180118$20221202$20180424$20221212$EXP$$CA-CELLTRION INC.-2018CA017682$CELLTRION$$$$$$Y$$$20221212$$CN$CA$CA
148022372$14802237$2$F$$20220516$20180424$20221026$PER$$US-PURDUE-USA-2018-0142636$PURDUE$$$$$F$Y$$$20221027$$CN$US$US
148023193$14802319$3$F$20160611$20221010$20180424$20221011$EXP$$US-NAPPMUNDI-USA-2018-0142890$PURDUE$$24$YR$$M$Y$67.347$KG$20221011$$MD$US$US
148023758$14802375$8$F$20140101$20220915$20180424$20221026$PER$$US-PURDUE PHARMA-USA-2018-0142318$PURDUE$$$$$F$Y$$$20221027$$CN$US$US
148033604$14803360$4$F$$20221019$20180425$20221028$EXP$$PL-JNJFOC-20180414534$JOHNSON AND JOHNSON$Majewski  W, Krzysztofiak T. The influence of hyperbaric pressure on the recurring pain from trigeminal nuralgia after stereotactic radiotherapy. 2017;18 (2):41-43.$39$YR$A$$Y$$$20221028$$HP$PL$PL
148040083$14804008$3$F$20220401$20221013$20180425$20221014$EXP$$US-PFIZER INC-2018167507$PFIZER$$73$YR$$F$Y$41$KG$20221014$$CN$US$US
148041965$14804196$5$F$20180302$20220615$20180425$20221017$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-022003$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$46$KG$20221017$$MD$JP$JP
1480560925$14805609$25$F$20180101$20221003$20180425$20221005$PER$$US-PFIZER INC-2018168305$PFIZER$$70$YR$$M$Y$91$KG$20221005$$CN$US$US
1480897629$14808976$29$F$20180207$20221024$20180425$20221029$EXP$PHHY2018GB072295$PHHY2018GB072295$NOVARTIS$$86$YR$$F$Y$$$20221029$$HP$GB$GB
148090446$14809044$6$F$$20221202$20180425$20221206$PER$$US-BIOGEN-2018BI00559213$BIOGEN$$$$$F$Y$$$20221206$$CN$US$US
1481568817$14815688$17$F$$20221130$20180426$20221208$PER$$US-PFIZER INC-2016305051$PFIZER$$51$YR$$F$Y$78$KG$20221208$$CN$US$US
148186983$14818698$3$F$20180101$20221101$20180427$20221103$PER$$US-PFIZER INC-2018170159$PFIZER$$66$YR$$F$Y$$$20221103$$MD$US$US
1481955911$14819559$11$F$20180411$20221129$20180427$20221207$EXP$$JP-ABBVIE-18P-087-2337762-00$ABBVIE$$64$YR$$M$Y$$$20221207$$MD$JP$JP
1482068723$14820687$23$F$20161215$20221212$20180427$20221221$EXP$$CA-CELLTRION INC.-2017CA002961$CELLTRION$$$$$$Y$$$20221221$$MD$CA$CA
1482077038$14820770$38$F$20180101$20221128$20180427$20221206$EXP$$CA-CELLTRION INC.-2018CA019461$CELLTRION$$$$$$Y$$$20221207$$MD$CA$CA
148220379$14822037$9$F$20180201$20220930$20180427$20221012$EXP$$GB-AUROBINDO-AUR-APL-2018-017843$AUROBINDO$$72$YR$$M$Y$93.2$KG$20221012$$MD$GB$GB
148243663$14824366$3$F$20040304$20221012$20180429$20221021$PER$$US-JNJFOC-20180424137$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20221021$$LW$US$US
148245712$14824571$2$F$$20221107$20180429$20221110$PER$$US-JNJFOC-20170417235$JOHNSON AND JOHNSON$$$$$M$Y$$$20221110$$LW$US$US
148258612$14825861$2$F$$20221108$20180430$20221110$PER$$US-PFIZER INC-2017478113$PFIZER$$62$YR$$M$Y$$$20221110$$CN$US$US
148264124$14826412$4$F$$20221212$20180430$20221215$EXP$$PHHY2018SE068670$NOVARTIS$Lindeman E, Erikson LB, Thorsson M, Nordmark J. High-dose insulin euglycemia therapy in severe toxic myocardial depression- An important addition to the treatment arsenal. LAKARTIDNINGEN (SWEDISH JOURNAL OF MEDICINE). 2018;114:1-5$55$YR$$F$Y$$$20221215$$HP$SE$SE
148265472$14826547$2$F$20171226$20180426$20180430$20221107$EXP$$PHHY2018RO074896$NOVARTIS$$75$YR$$M$Y$$$20221107$$CN$RO$RO
1482824819$14828248$19$F$20200914$20221122$20180430$20221201$EXP$$CA-CELLTRION INC.-2018CA017679$CELLTRION$$$$$$Y$$$20221201$$CN$CA$CA
148289102$14828910$2$F$20180206$20221205$20180430$20221206$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-011948$BRISTOL MYERS SQUIBB$$$$E$M$Y$$$20221206$$HP$US$US
148326076$14832607$6$F$$20221205$20180501$20221213$EXP$$US-GLAXOSMITHKLINE-US2018GSK068188$PERRIGO$$$$$$Y$$$20221213$$MD$US$US
148327083$14832708$3$F$20151001$20221017$20180501$20221018$PER$$US-BIOGEN-2015BI147861$BIOGEN$$52$YR$$F$Y$$$20221018$$CN$US$US
1483342316$14833423$16$F$$20221011$20180501$20221012$EXP$$PHHY2018PL068707$NOVARTIS$Wikiera-Magott I, Fornaiczyk K, Zwolinska D. From body piercing to acute kidney injury - A case report. PEDIATRIA I MEDYCYNA RODZINNA. 2017;13(4):561-6$17$YR$$F$Y$$$20221012$$HP$PL$PL
